Public Contract

Annex 2 Conditions for Packaging and Delivering Spare Parts 1. Labelling Spare Parts (hereinafter „Goods“) The label attached to the original packaging of the Goods must contain the following details at a minimum: • name of the Goods; • vehicle make; • NSN-code (if applicable); • product code; • the Seller’s warehouse code. 2. Packaging When transporting Goods on pallets, the products are packaged into grouped packaging (packing crates). The Seller agrees to provide packaging that ensures the Goods’ conservation during its transportation to the destination and its long-term storage in unchanged form. Labels for grouped packaging are at least an A4-size in capital letters and in bold. The minimum letter height is 8 mm. There is a label on at least two sides of the packing box. The labelling details on the label are in the following order: • name of the Goods; • product and/or NSN-code (if applicable); • quantity and unit (pieces/EA); • delivery time (month and year); • contract number and batch number (if the Goods are delivered in several parts); • the Seller’s name; • the Seller’s address; • delivery address. Packing crates are placed on pallets. The pallet dimensions are 800x1200 mm. Pallets must be intact (not decayed, mouldy and with no broken boards), clean and there cannot be any protruding nails. Pallets must endure the long-term storage of the Goods. The maximum height of packing crates placed on pallets is 1200 mm (pallets are not returnable). Plastic film is used for transport, which covers the packing crates on the pallets. Plastic film keeps the product crates firmly on pallets and protects them from the elements. Labels for transporting packaging are at least an A4-size in capital letters and in bold. The minimum letter height is 8 mm. There is a label attached on all sides (four labels on one package). The conservation conditions are up to five years in ventilated permanent structures. Transport is in confined form and on land, air and sea. The package must endure handling with mechanical tools. The labelling details on the label are in the following order: • NSN-code (if applicable); • product name; • quantity and unit (pieces/EA); • delivery time (month and year); • contract number and batch number; 1/2 • the Seller’s name; • the Seller’s address; • delivery address. If the order is for a single product or a small quantity of Goods, then the Goods must be packaged in other appropriate and suitable packaging. The cost of the Goods’s packaging is covered within the cost of the sold Goods. 3. Delivery Conditions The Goods must be delivered unbroken and unspoiled and in suitable packaging for transport. Delivery addresses in Moldova: - Headquarters Regiment ”General de brigadă Nicolae Petrica”, 3 Petrarilor Street, Chisinau, Republic of Moldova. The Buyer shall specify delivery locations during the performance of the Contract. Transport of the Goods to the destination set by the Buyer takes place with the Seller’s own mode of transportation. 2/2 PAKKUMUS HINDAMISKRITEERIUMID JA HINNATAVAD NÄITAJAD Viitenumber: 279740 Hankija: Riigi Kaitseinvesteeringute Keskus (70009764) Hange: Mobiilne röntgenseade Pakkumus: 530334 Ettevõtja: Neotec SRL (1002600048135), roll: peapakkuja Pakkumuse maksumust hinnatakse - Ilma maksudeta 1. Maksumus Röntgenseadme maksumus koos kaasnevate teenustega (tarne ja paigaldus Moldova Vabariigis, esmane kasutajakoolitus) Tüüp ja hindamismeetod: Maksumus, vähim on parim Osakaal: 70% Hindamismetoodika kirjeldus: Madalaima väärtusega pakkumus saab maksimaalse arvu punkte. Teised pakkumused saavad punkte arvutades valemiga: "osakaal" - ("pakkumuse väärtus" - madalaim väärtus") / "suurim väärtus" * "osakaal". Kogus Ühik Ühiku hind Maksumus KM% Maksumus KM-ga Märkused EUR 88000,000 88000,000 0 88000,000 2. Tarneaeg Tüüp ja hindamismeetod: Kvaliteet, vähim on parim Osakaal: 15% Hindamismetoodika kirjeldus: Madalaima väärtusega pakkumus saab maksimaalse arvu punkte. Teised pakkumused saavad punkte arvutades valemiga: "osakaal" - ("pakkumuse väärtus" - madalaim väärtus") / "suurim väärtus" * "osakaal". Väärtus Ühik Märkused 1,000 kuud 3. Garantiiaeg Tüüp ja hindamismeetod: Kvaliteet, suurim on parim Osakaal: 15% Koostatud 14.01.2025 10:37:59 1/2 https://riigihanked.riik.ee/rhr-web/#/procurement/ 7352184/general-info  Hindamismetoodika kirjeldus: Suurima väärtusega pakkumus saab maksimaalse arvu punkte. Teised pakkumused saavad punkte proportsionaalselt vähem ja arvutatakse valemiga: "pakkumuse väärtus" / "suurim väärtus" * "osakaal". Väärtus Ühik Märkused 1,000 aastat Pakkumuse maksumus kokku Maksumus kokku KM-ta: 88000,000 Maksumus kokku KM-ga: 88000,000 Koostatud 14.01.2025 10:37:59 2/2 https://riigihanked.riik.ee/rhr-web/#/procurement/ 7352184/general-info  1/3 PAKKUMUS VASTAVUSTINGIMUSED Viitenumber: 279740 Hankija: Riigi Kaitseinvesteeringute Keskus (70009764) Hange: Mobiilne röntgenseade Pakkumus: 530334 Ettevõtja: Neotec SRL (1002600048135), roll: peapakkuja ÜHISPAKKUJATE VOLIKIRI Ühispakkujad nimetavad riigihankega ning hankelepingu sõlmimise ja täitmisega seotud toimingute tegemiseks endi seast volitatud esindaja. Ettevõtjalt oodatavad vastused: 1. Kas tegemist on ühispakkumusega? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 2. Kui tegemist on ühispakkumusega, kas olete lisanud pakkumuse "Lisadokumentide" lehele ühispakkujate volikirja? Kui tegemist ei ole ühispakkumusega, vastake "Ei"". (Raadionupp valikutega "Jah/Ei") Vastus: Ei PAKKUMUSE ESITAMINE Pakkumuse esitamisega kinnitab pakkuja kõigi riigihanke alusdokumentides esitatud tingimuste ülevõtmist. Tingimusliku pakkumuse esitamine ei ole lubatud. Ettevõtjalt oodatavad vastused: 1. Kas ettevõtja saab kinnitada, et pakkumus vastab hanke alusdokumentides sätestatud tingimustele? (Raadionupp valikutega "Jah/Ei") Vastus: Jah PAKKUMUSE MAKSUMUS Pakkumuse maksumus tuleb esitada töölehel "Hindamiskriteeriumid ja hinnatavad näitajad" toodud struktuuri kohaselt. Ettevõtjalt oodatavad vastused: 1. Kas ettevõtja kinnitab, et täidab pakkumuse lehe "Hindamiskriteeriumid ja hinnatavad näitajad" lehel ette antud struktuuri kohaselt? (Raadionupp valikutega "Jah/Ei") Vastus: Jah ÄRISALADUS Pakkuja märgib pakkumuses, milline teave on pakkuja ärisaladus ning põhjendab teabe määramist ärisaladuseks. Teabe ärisaladuseks määramisel lähtutakse ebaausa konkurentsi takistamise ja ärisaladuse kaitse seaduse § 5 lõikes 2 sätestatust. Pakkuja ei või ärisaladusena märkida: 1) pakkumuse maksumust ega osamaksumusi; 2) teenuste hankelepingute puhul lisaks punktis 1 nimetatule muid pakkumuste hindamise kriteeriumidele vastavaid pakkumust iseloomustavaid numbrilisi näitajaid; 3) asjade ja ehitustööde hankelepingute puhul lisaks punktis 1 nimetatule muid pakkumuste hindamise kriteeriumidele vastavaid pakkumust iseloomustavaid näitajaid (RHS § 46 (1)). Koostatud 14.01.2025 10:37:59 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  2/3 Ettevõtjalt oodatavad vastused: 1. Kirjeldage lühidalt pakkumuses sisalduvat ärisaladust ja lisage selle määramise põhjendus või märkige, et pakkumus ei sisalda ärisaladust. (Suur sisestusala (max pikkus 4000 tähemärki)) Vastus: N/A SAMAVÄÄRSUS Pakkuja kinnitab, et pakkumus vastab hanke alusdokumentides nõutule ja vajadusel on samaväärsus selgitatud ja tõendid samaväärsuse kohta lisatud. Iga viidet, mille hankija teeb riigihanke alusdokumentides mõnele RHS-i § 88 lõikes 2 nimetatud alusele (standardile, tehnilisele tunnustusele, tehnilisele kontrollisüsteemile vms), tuleb lugeda selliselt, et see on täiendatud märkega „või sellega samaväärne“. Iga viidet, mille hankija teeb riigihanke alusdokumentides ostuallikale, protsessile, kaubamärgile, patendile, tüübile, päritolule, tootmisviisile, märgisele või vastavushindamisasutuse väljastatud katsearuandele või tõendile, tuleb lugeda selliselt, et see on täiendatud märkega „või sellega samaväärne“ (RHS § 88 lg-d 5-6, § 89 lg 2, 114 lg-d 5-7). Hankija aktsepteerib objektiivsetel põhjustel muid asjakohaseid tõendeid, kui pakkuja tõendab hankijale vastuvõetaval viisil, et pakutav asi, teenus või ehitustöö vastab konkreetse märgise või hankija esitatud nõuetele, välja arvatud juhul, kui hankija nõutud märgis, samaväärne märgis või konkreetse või samaväärse vastavushindamisasutuse väljastatud katsearuanne või muu tõend on seaduse alusel eelduseks asja, teenuse või ehitustöö pakkumiseks turul (RHS § 114 lg 7). Ettevõtjalt oodatavad vastused: 1. Pakkuja kinnitab, et pakkumus vastab hanke alusdokumentides nõutule ja vajadusel on samaväärsus selgitatud ja tõendid samaväärsuse kohta lisatud. (Raadionupp valikutega "Jah/Ei") Vastus: Jah EL NÕUKOGU SANKTSIOON. ALLTÖÖVÕTJAD JA TARNIJAD. Pakkuja kinnitab, et ta ei kaasa üle 10% hankelepingu maksumusest hankelepingu täitmisele alltöövõtjaid ega tarnijaid, kes on: 1. Vene Föderatsiooni kodanik, resident või Vene Föderatsioonis asutatud ettevõtja, sh füüsilisest isikust ettevõtja, juriidiline isik, asutus või muu üksus; 2. rohkem kui 50% ulatuses otseselt või kaudselt punktis 1 nimetatud isiku, asutuse või muu üksuse omandis; 3. punktis 1 või 2 nimetatud isiku, asutuse või muu üksuse esindaja või tegutseb sellise isiku juhiste alusel. Hankija lükkab tagasi pakkumuse, mille alusel sõlmitav hankeleping oleks RSanS § 7 lg 1 alusel tühine. Määrust kohaldatakse riigihangetele alates rahvusvahelisest piirmäärast. NÕUKOGU MÄÄRUS (EL) 2022/576, 8. aprill 2022, millega muudetakse määrust (EL) nr 833/2014, mis käsitleb piiravaid meetmeid seoses Venemaa tegevusega, mis destabiliseerib olukorda Ukrainas. Ettevõtjalt oodatavad vastused: 1. Pakkuja kinnitab, et ta ei kaasa üle 10% hankelepingu maksumusest hankelepingu täitmisele alltöövõtjaid ega tarnijaid, kes on: 1. Vene Föderatsiooni kodanik, resident või Vene Föderatsioonis asutatud ettevõtja, sh füüsilisest isikust ettevõtja, juriidiline isik, asutus või muu üksus; 2. rohkem kui 50% ulatuses otseselt või kaudselt punktis 1 nimetatud isiku, asutuse või muu üksuse omandis; 3. punktis 1 või 2 nimetatud isiku, asutuse või muu üksuse esindaja või tegutseb sellise isiku juhiste alusel. (Raadionupp valikutega "Jah/Ei") Vastus: Jah RAHVUSVAHELISE SANKTSIOONI OBJEKT Pakkuja kinnitab, et pakutav kaup ei ole rahvusvahelise sanktsiooni objektiks või pärit sanktsiooni all olevatest piirkondadest. Hankija lükkab tagasi pakkumuse, mille alusel sõlmitav hankeleping oleks RSanS § 7 lg 1 alusel tühine. Koostatud 14.01.2025 10:37:59 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  3/3 Ettevõtjalt oodatavad vastused: 1. Pakkuja kinnitab, et pakutav kaup ei ole rahvusvahelise sanktsiooni objektiks ega pärit sanktsiooni all olevatest piirkondadest. (Raadionupp valikutega "Jah/Ei") Vastus: Jah VASTAVUSMAATRIKSI TÄITMINE (TEHNILISED TINGIMUSED) Pakkuja peab esitama nõuetele vastavalt täidetud vastavusmaatriksi faili. Ettevõtjalt oodatavad vastused: 1. Pakkuja täidab ja esitab täidetud vastavusmaatriksi faili (Dokumendi vorm / Lisa (annex) __ Technical compliance (technical specifications)_Mobile x-ray_v2.xlsx) Vastus: 8_1_Copy of Lisa (annex) __ Technical compliance (technical specifications)_Mobile x-ray (version 1).xlsx MÜÜGIESINDUSE OLEMASOLU MOLDOVA VABARIIGIS Pakkuja peab omama pakutava seadme tootja poolt heaks kiidetud müügiesindust Moldova Vabariigis, tagamaks seadme kasutajakoolitused ning hooldus- ja remont Ettevõtjalt oodatavad vastused: 1. Pakkuja lisab tootjapoolse kinnituse müügiesinduse olemasolu kohta (Vabas vormis dokument) Vastus: 9_1_Shimadzu lettersigned.pdf 2. Pakkuja sisestab müügiesinduse kontaktandmed (Sisestusväli (max pikkus 250 tähemärki)) Vastus: Official distribuitor Neotec SRL . Tel. +373 69111661 Manufacturer Shimadzu. Prentki Peter [email protected] Koostatud 14.01.2025 10:37:59 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:25:49 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ  C) otpbonk Digitally signed by Botnaru Andrei Date: 2023.04.20 14:42:01 EEST Reason: MoldSign Signature Location: Moldova FtcoM/cct23t02 Nr. CtF36-9945.2022 Dala: O1 .O4 .2022 CERTIFICAT PRIVIND EXISTENTA CONTURILOR CURENTE Prin prezentul' oiP Bank s A ' codul biincii (Brc): MoBBMD22, confirmd ce compania NEorEc 1002600048'135' detine urmatoarere s.R.L. cod fiscar (lDNo) conturi curente ra orp Bank s.A., sucursara. 36 petru Movira : 1. MDL " MD6oMo2224Asv234o8ss71oo 2 Beneficiary's bank / Banca lNanrr4rJurnc,orpgu_ beneficiarului I Address/Adresa: Moldo!a. Chisincu. Bri. Srefan cel Mare si Sfinr, g lA t))a I r^'] ,''",'o b , ^^^.,,, ^v|j,zl^ -. ',.t \x Lorrespondent ban k of fhe beneficiary's banll / Banca Namc.4\ume; Ihe Bank 0fNc$ york corespondenti a bincii I\,leJton. Ncrv York. USA benelicia rului BICi IIiV.t US3NXXX 3. Beneficiarr's banh / Banca lalrc/N!rmc : O Il, llankS.A benelicia rujui drcsar Moldor a. C.hisinau_ lld. ^ddrcss,/n sreJan cel Marc si Sfint. g lA BIC: MOIIBMD22XXX Name/Nufie: Sociele Gcncrale, paris l.rance blC: SOCEFRppXXt( OrlSau Corrcspondent ba nk of the Natnr. NLtnL.: Cotnrncf/bbrk. frt,tLtufl JDr \4din. Licrmin) beneficiary's banh / Banca 8lL: COBADL.t:f.XXX corcspondenfd a bincii bcneficiarului OrlSau Rajfrejsen trank JIr(rnirio at n )1"::)y:.: rlr(:l(,/_ti^Aluwxxx U. Vienna. n usrria Or'Sau Nantc/NLlmc Ol p Ilank I]l(:oII)VHlillBXXX Certificatul este emis in baza 1 din 01.04.2022 pin e-mait nun1,6,O-J.ZZ@SA"a!l.cAn Numele, Prenumele {:".:#"*' Director sucursalei ."Por"." Jo - .i, Executor:Gusan Tel: 022-81-26-69 u"i^::$ OTP Bank S.A. 'Capital Social: 1OO 000 OO-O [/DL . Numar de inregistrare de stat _ 1002600006089 bd. Stefan cel l\.4a.e si Sfinr 81A. MD_2012 chiginau, Motdo;. t;;;o;-*iii iizsl qsa . ._majt: [email protected] . www.orpbank.md  Digitally signed by Botnaru Andrei Date: 2023.10.11 14:02:17 EEST Reason: MoldSign Signature Location: Moldova  Digitally signed by Botnaru Andrei Date: 2025.01.09 11:20:06 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ CERTIFICAT privind lipsa sau existența restanțelor față de bugetul public național Nr. Din 1119135 09.01.2025 11:19 № От DATE DESPRE CONTRIBUABIL / ИНФОРМАЦИЯ О НАЛОГОПЛАТЕЛЬЩИКЕ Codul fiscal / Numărul de identificare Фискальный код / Идентификационный номер 1002600048135 Denumirea Наименование Societatea cu Răspundere Limitată NEOTEC ATESTAREA LIPSEI SAU EXISTENȚEI RESTANȚELOR CONFORM DATELOR SISTEMULUI INFORMAȚIONAL AUTOMATIZAT / ПОДТВЕРЖДЕНИЕ ОТСУТСВИЯ ИЛИ НАЛИЧИЯ ЗАДОЛЖНОСТЕЙ СОГЛАСНО ДАННЫМ ИНФОРМАЦИОННОЙ АВТОМАТИЗИРОВАННОЙ СИСТЕМЫ La data emiterii prezentului certificat restanța față de bugetul public național constituie На дату выдачи данной справки задолжность перед национальном публичным бюджетом составляет 0 MDL VALABIL PÂNĂ LA / ДЕЙСТВИТЕЛЕН ДО 24.01.2025 11:19 Prezentul document este eliberat în temeiul Art. 29, alin. (3) din Legea cu privire la registre nr. 71/2007 și în baza datelor furnizate de Serviciul Fiscal de Stat în Portalul Guvernamental al Cetățeanului și al Unităților de Drept / Справка выдана в соответсвие со ст. 29 п. (3) Закона о реестрах № 71/2007 на основании данных, предостоставленных Государственной налоговой службой на Портале Правительства Гражданина и Юридических Лиц. Generat și semnat de Portalul Guvernamental al Cetățeanului și al Unităților de Drept la 09.01.2025 11:19 Prezentul certificat este semnat electronic în conformitate cu Legea nr.124 din 19.05.2022 Сертификат подписан электронной попдписью в соответсвие с Законом № 124 от 19.05.2022 Certificatul este descărcat din Portalul Guvernamental al Сертификат скачен с Правительственного Портала Cetățeanului și al Unităților de Drept (mcabinet.gov.md) și Гражданина и Юридических Лиц (mcabinet.gov.md) и este semnat electronic de către posesorul acestui portal și подписан электронной подписью владельца портала и are aceiași valoare juridică ca și documentele eliberate pe имеет такаю же юридическую силу, как и документы suport de hârtie de către organele cu atribuții de выдаваемые на бумаге органами налоговой administrare fiscală. Verificarea autenticității semnăturii администрации. Проверку подлиности электронной electronice poate fi realizată cu ajutorul Serviciului подписи можно осуществить c помощью Государсвенной Guvernamental de Semnătură Electronică (msign.gov.md) Cлужбой Электронной Подписью (msign.gov.md)  -f, 08"rw;rg Anexe la SNC t "Prezentarea situatiilor financiare" Aprobat de Ministerul Finantelor al Republicii Moldova I SITUATIILE FINANCIARE I I i pentru perioada 0J..0J..2023' 3L-L2.?OZ3 I Entitatea: \ NEOT,q.C S.R.L. Cod CUITO: 2743946 Cod IDNO: 1002600048135 Digitally signed by Botnaru Andrei Date: 2024.06.10 15:47:48 EEST Sediul: Reason: MoldSign Signature MD: Location: Moldova Raionul(municipiul) : 1-g!, JIEE$ANICA Cod CUATM: 0I1O,SEE@IANICA Strada: IndepSOdC$9!-O-f.-L9-9f,$ Activitatea principali: c4774. Comert cu amanuntul al articolelor medicale si ortopSdie,@SazinCsEiglizglg Forma de proprietate: 15., PropllglelgE-pllvaH Forma organizatorico-juridicil 530"-SocieEA$lu r5spunAere ti m ita$ Date de contact: Telefon: +37322852250 WEBr E-maih mvm160177@omail,com Numele li coordonatele al contabilului-gef: Dl (dna) Mucerschi Maria Tel. *IZ359LM@ Numiirul mediu al salariafilor in perioada de gestiune: 1Q persoane' Persoanele responsabile de semnarea situafiilor financiarex Botnaru Andrei isur6: leu BILANTUL Anexa 1 la 3L.72.2A23 !: il f Solt la Nr, cpt. i Indicatori Cod rd. inceputul perioadei Sfirgitul perioadei de de gestiune gestiune 1 2 3 4 5 ACTIV A. ACTIVE IMOBILIZATE I. Imobiliziri necorporale 1. Imobilizdri necorporale in curs de execufie 010 2. Imobilizdri necorporale in exploatare, total 020 207L2 L2046 din care: o2L 2.L. concesiuni, licenle ;i mErci 2.2. drepturi de autor $i titluri de proteclie 022 2.3. programe i nformatice 023 2.4. alte imobilizdri necorporale 024 20712 L2046  i 3. Fond comercial 030 :| 4. Avansuri acordate pentru imobiliziri necorporale 040 Total imobilizdri necorporale (rd.010 + rd.020 + rd.030 + rd.040) 050 207 L2 12046 fI. fmobiliziri corporale 1. ImobilizSri corporale in curs de executie 060 499548 499548 2. Terenuri 070 7370L 0 3. Mijloace fixe, total 080 1305106 845111 din care: 081 3.1. clSdiri 3.2. construcfii speciale 082 I 3.3, magini, utilaje gi instalalii tehnice I i 083 L44BOB 728807 i., 3.4. m ijloace de tra nsport 084 1065556 659338 3.5. inventar ;i mobilier 085 94742 56966 3.6. alte mijloace fixe 086 4. Resurse minerale 090 5. Active biologice imobilizate 100 6. Investifii imobiliare 110 7. Avansuri acordate pentru imobilizdri corporale L20 Total imobiliziri corporale (rd.060 + rd.o7o + rd.080 + rd.0go + rd.100 + 130 1 878355 L344659 rd. 1 10 + rd. 120) IfL lnvestilii financiare pe termen Iung 1. Investi!ii financiare pe termen lung in p5r!i ,,,:_?fil:u:e r40 2. Investifii financiare pe termen lung in p54i 150 afiliate, total din care: 2.L. acfiuni ;i cote de participalie delinute in p5rlile 151 afiliate 2.2 imprumuturi acordate pErlilor afiliate L52 2.3 imprumuturi acordate aferente intereselor de pa rticipa re 153 2.4 alte investitii financiare 154 Total investifii financiare pe termen lung (rd. L4O + rd.150) 160 IV. Creante pe termen lung ti alte active imobilizate 1. Creanle comerciale pe termen lung 170 2. Creanfe ale p5rlilor afiliate pe termen lung 180 inclusiv: creanle aferente intereselor de participare 181 3. Alte creanfe pe termen lung 190 4. Cheltuieli anticipate pe termen lung 200  5. Alte active imobilizate 2L0 Total creante pe termen lung Si alte active imobilizate 220 (rd.170 + rd.1B0 + rd.190 + rd.200 * rd.210) TOTAL ACTIVE IMOBILIZATE 230 1 899067 1356705 (rd.050 + rd.130 + rd.160 + rd.220) B. ACTIVE CIRCULANTE I. Stocuri 1. Materiale ;i obiecte de mic5 valoare ;i scurt5 240 7 t2L3 77900 d u rat6 2. Active biologice circulante 250 3. Producfia in curs de executie 260 L239032 0 4. Produse;i mSrfuri 270 9068989 6573840 5. Avansuri acordate pentru stocuri 280 282180 3621850 Total stocuri 290 1066 t4t4 L0273590 (rd.240 + rd.250 + rd.260 + rd.270 + rd.2B0) II. Crean[e curente ;i alte active circulante 1. Creanle comerciale curente 300 L720827 7925765 2. Creanle ale p5fiilor afiliate curente 310 inclusiv: creanle aferente intereselor de participare 311 3. Creanle ale bugetului 320 t749t79 B 1 5866 4. Creantele ale personalului 330 t4t34 5544 5. Alte creante curente 340 830967 L522777 6. Cheltuieli anticipate curente 350 44304 233266 7. Alte active circulante 360 34920 258 10 Total creanle curente ;i alte active circulante (rd.300 + rd.310 + rd,320 + rd.330 + rd.340 + 370 439433L 10529028 rd.350 + rd,360) III. Investilii financiare curente 1. Investilii financiare curente in pirli neafiliate 380 36000 66000 2. Investitii financiare curente ?n pErli afiliate, total 390 d in ca re; 391 2.L. actiuni gi cote de participalie delinute in p5rlile afiliate 2.2. imprumuturi acordate p5rlilor afiliate 392 2,3. imprumuturi acordate aferente intereselor de 393 pa rticipa re 2.4. alte investitii financiare in pHrli afiliate 394 Total investifii financiare curente 400 36000 66000 (rd.3B0 + rd.390) IV. Numerar gi documente binegti 4t0 21862L9 28L3759 TOTAL ACTIVE CIRCULANTE 420 L7277964 23682377 (rd.29O + rd.370 + rd.400 * rd.410) TOTAL ACTIVE 430 19 17703L 25039082  (rd.230 + rd .420) PASIV CAPITAL PROPRIU I. Capital social gi neinregistrat 1 . Ca pita I socia I 440 5400 5400 ( ( 2. Capital nev5rsat 450 ) ) 3. Capital neinregistrat 460 ( ( 4 . Cap ita I retra s 470 ) ) 5, Patrimoniul primit de la stat cu drept de proprietate 480 Total capital social gi neinregistrat (rd.44O + rd.450 + rd.460 * rd.470 * rd.4B0) 490 5400 5400 II. Prime de capital 500 fII. Rezerve 1. Capital de rezerv5 510 14586 14586 2. Rezerve statutare 520 810 810 c. 3. Alte rezerve 530 Total rezerve (rd.510 + rd.520 + rd.530) 540 1 5396 1 5396 IV. Profit (pierdere) 1. Coreclii ale rezultatelor anilor precedenf i 550 X 2. Profit nerepartizat (pierdere neacoperit6) al a nilor precedenti 560 L2309992 8503748 3. Profit net (pierdere net5) al perioadei de gestiu ne 570 X 3427297 ( 4, Profit utilizat al perioadei de gestiune 580 X ) Total profit (pierdere) (rd.550 + rd.560 + rd.570 + rd.5B0) 590 12309992 1 193 1045 V. Rezerve din reevaluare 600 VI. Alte elemente de capital propriu 610 TOTAL CAPITAL PROPRIU (rd.490 + rd.50O + rd.540 + rd.590 + rd.600 + 620 12330788 11951841 rd .6 10) D. DATORII PE TERMEN LUNG 1. Credite bancare pe termen lung 630 2. lmprumuturi pe termen lung 640 din care: 64t 2.L. imprumuturi din emisiunea de obligaliuni inclusiv: imprumuturi din emisiunea de obligafiuni convertibile 642 2.2. alte imprumuturi pe termen lung 643 3. Datorii comerciale pe termen lung 650 227692 L35799  4. Datorii fa!5 de p5(ile afiliate pe termen lung 660 inclusiv: datorii aferente intereselor de participare 661 5. Avansuri primite pe termen lung 670 6. Venituri anticipate pe termen lung 680 7. Alte datorii pe termen lung 690 TOTAL DATORII PE TERMEN LUNG (rd.630 + rd,640 + rd.650 + rd,660 + rd.67O + 700 227692 135799 rd.580 + rd.690) DATORII CURENTE 1. Credite bancare pe termen scurt 7r0 L822797 2. tmprumuturi pe termen scurt, total 724 500000 340439r din care: 72L 2.L. imprumuturi din emisiunea de obligaliuni inclusiv: imprumuturi din emisiunea de obligaliuni 722 convertibile 2.2. alte imprumuturi pe termen scurt 723 500000 340439L 3. Datorii comerciale curente 730 4852567 6059686 4, Datorii fa!5 de p5rlile afiliate curente 740 E. inclusiv: datorii aferente intereselor de participare 74L 5. Ava nsu ri prim ite cu rente 750 1117081 1 560402 6. Datorii fal6 de personal 760 23094 24443 7. Datorii privind asigur5rile sociale;i medicale 770 32L28 T22L7 B. Datorii fa!5 de buget 780 34836 L2656 9. Datorii fa15 de proprietari 790 5B 145 58150 10, Venituri anticipate curente 800 1 1. Alte datorii curente 810 TOTAL DATORII CURENTE (rd.7L0 + rd.72O + rd.73O + rd.740 * rd.750 * 820 6617851 L2950742 rd.760 + rd.770 + rd.7B0 + rd.790 + rd.B00 + rd. B 10) PROVIZIOANE 1. Provizioane pentru beneficiile angajalilor 830 2. Provizioane pentru garanlii acordate 840 cu m pE r5torilor/clienlilor F, 3 . Provizioa ne pentru im pozite 850 4. Alte provizioane 860 700 700 TOTAL PROVIZIOANE 870 700 700 (rd.B30 + rd.B40 + rd.B50 + rd.860) TOTAL PASIVE BBO 19177031 25039082 (rd.620 + rd,700 + rd.B20 + rd.B70) SITUATIA DE PROFIT SI PIERDERE de la 01,01.2023 pind la 3L.L2.2023 Anexa 2 Indicatori  precedenta curenta 1 2 3 4 Venituri din vinzdri, total 010 L7324087 32585387 din care: 011 L0964047 25290998 venituri din vinzarea produselor ti m5rfurilor venituri din prestarea serviciilor gi executarea 072 543 2316 596 5107 lucr5rilor venituri din contracte de constructie 013 927724 1329282 ven itu ri d in contracte de leasing 0L4 venituri din contracte de microfinantare 015 a lte ven itu ri d in vin zdri 016 Costul vinz5rilor, total 020 L073t42L 23813037 din care: 02L 835894 1 2090080 1 valoarea contabilS a produselor;i m5rfurilor vind ute costul serviciilor prestate ;i lucr5rilor executate 022 L445023 L6232r3 terlilor costu ri aferente contractelor de constructie 023 927457 1289023 costuri aferente contractelor de leasing 024 costuri aferente contractelor de microfinantare 025 alte costuri aferente vinz6rilor 026 Profit brut (pierdere brutS) (rd.010 - rd.020) 030 6592666 8772350 Alte venituri din activitatea operalionalS 040 28773 1 8307 Cheltuieli de distribuire 050 2200L25 2L29L92 Cheltuieli administrative 060 1682557 185 1039 Alte cheltuieli din activitatea operationalS 070 37 L266 76L299 Rezultatul din activitatea operafionalS: profit (pierdere) (rd.030 + rd.040 - rd.050 - rd.060 - 080 236749L 4049t27 rd .070) Venituri financiare, total 090 62933 186708 din care: 091 venituri din interese de participare inclusiv: veniturile oblinute de la pArlile afiliate 092 ven itu ri d in dobinzi 093 inclusiv: veniturile oblinute de la p;rtile afiliate 094 venituri din alte investitii financiare pe termen lung 095 inclusiv: veniturile obtinute de la pe4ile afiliate 096 venituri aferente ajustErilor de valoare privind 097 investifiile financiare pe termen lung gi curente venituri din iesirea investitiilor financiare 098 venituri aferente diferentelor de curs valutar si de 099 62933 186708 sumE Cheltuieli financiare, total 100 48544 306326 din care: 101 cheltuieli privind doblnzile ;;i;,;, il;.'ffi ;;;;;;#;;;;;; ;il;;" LO2 cheltuieli aferente ajustbrilor de valoare privind 103 investiliile financiare pe termen lung;i curente cheltuieli aferente ie;irii investiliilor financiare 704 cheltuieli aferente diferenlelor de curs valutar gi de 105 48544 3063 26 sumE Rezultatul: profit (pierdere) financiar(n) 110 14389 -11961B (rd.090 - rd.100) Venituri cu active imobilizate gi exceplionale L20 75000 79903 Cheltuieli cu active imobilizate ;i excepfionale 130 7370L 7370L Rezultatul din operafiuni cu active imobilizate gi excepfionale: profit (pierdere) (rd,120 - L40 L299 6202 rd . 130) Rezultatul din alte activitili: profit (pierdere) 150 1 568B -113416 (rd.110 + rd.140) Profit (pierdere) pini la impozitare (rd,080 + 160 2383L79 393 57 LL rd . 150) Cheltuieli privind impozitul pe venit t70 328494 5084 14 Profit net (pierdere neti) al perioadei de 180 2054685 3427297 gestiune (rd,160 - rd.170) srruATrA MoDrrrcAnrloR cAprrALULUr pRopRru de la 01.01.2023 pind la 31.12.2023 Anexa 3 Sold la Sold la sfirgitul Nr. Indicatori Cod rd inceputu! Majoriri Diminuiri perioadei de dlo perioadei de gestiune gestiune 1 2 3 4 5 6 7 Capital social gi neinregistrat 1. Capital social 010 5400 5400 ( ( ( ( 2. Capital nev5rsat 020 ) ) ) ) 3. Capital neinregistrat 030 I ( ( ( ( 4. Capital retras 040 ) ) ) ) 5. Patrimoniul primit de la stat cu 050 drept de proprietate Total capital social gi neinregistrat 060 5400 5400 (rd.010 + rd,020 + rd,030 + rd.040 + rd.050) II Prime de capital 070 III. Rezerve 1. Capital de rezervi 080 14586 14586 2. Rezerve statutare 090 810 810  3, Alte rezerve 100 Total rezerve 110 1 5396 1 5396 (rd.0B0 + rd.090 + rd.100) Profit (pierdere) 1. Coreclii ale rezultatelor anilor L20 X precedenti 2. Profit nerepartizat (pierdere 130 12349992 -490 3805754 8503748 neacoperit5) al anilor precedenfi IV. 3. Profit net (pierdere net5) al t40 3427297 perioadei de gestiune X 3427297 4. Profit utilizat al perioadei de 150 X ( ( ( g estiu ne ) ) ) Total profit (pierdere) 160 L2309992 3426807 3805754 11931045 (rd.LzO + rd.130 + rd.L4O + rd.150) V. Rezerve din reevaluare L70 VI. Alte elemente de capital propriu 180 Total capital propriu (rd.060 + rd.070 + rd.110 + rd.160 190 12330788 3426807 3805754 11951841 + rd.L7O + rd.1B0) SITUATIA FLUXURILOR DE NUMERAR de la 01.01.2023 pind la 3L.L2.2023 Anexa 4 Perioada de gestiune Indicatori Cod rd precedenti curentd 1 2 3 4 Fluxuri de numerar din activitatea operafionali tncasi ri d in vinz5 ri 010 24162302 289683 1 5 PlSIi pentru stocuri gi servicii procurate 020 11380100 22269382 Pleli cdtre angajali gi organe de asigurare socialE ;i 030 2949231 3058 L76 medicalS Dobinzi pl5tite 040 87974 L6L472 Plata impozitului pe venit 050 540968 Alte incasE ri 060 L376695 L994502 Alte pl5!i 070 5957 07 L 8660047 Fluxul net de numerar din activitatea operationali 080 4623657 -3186260 (rd.010 - rd.020 - rd.030 - rd.040 - rd.050 + rd.060 - rd.070) Fluxuri de numerar din activitatea de investifii tncasdri din vinzarea activelor imobilizate 090 Pl5!i aferente intr5rilor de active imobilizate 100 3 198 19 1 03 275 Dobinzi incasate 110 Dividende incasate L20 inclusiv: dividende tncasate din str5in5tate L2L  Alte incasHri (pl5!i) 130 Fluxul net de numerar din activitatea de investifii L40 -3 198 19 - 1032L5 (rd.090 - rd.100 + rd,110 + rd,120 + rd,130) Fluxuri de numerar din activitatea financiari incas5 ri su b form5 de cred ite ;i im pru m utu ri 150 1 ss6250 8t34266 PlSIi aferente rambursdrii creditelor Si 160 2000000 3457203 im pru m utu rilor Dividende pl5tite L70 L894269 832504 inclusiv: dividende pl5tite nerezidenlilor L7t incasiri din operaliuni de capital 180 Alte incasSri (pl5!i) 190 Fluxul net de numerar din activitatea financiari 200 -2358019 3844559 (rd.150 - rd,160 - rd.L7O + rd.1B0 * rd.190) Fluxul net de numerar total 2LO 1945819 5 5 5084 ( * rd.0B0 * rd. 140 t rd.200) Diferente de curs valutar favorabile (nefavorabile) 224 4903 1 72456 Sold de numerar la inceputul perioadei de 230 19 1 369 2LB62L9 gestiune Sold de numerar la sfirgitul perioadei de gestiune 240 2tB62L9 28L3759 (* rd.2L0 * rd.22O + rd,230) Documente atagate - Noti explicativi (figierul pdf) ry# IS*tm *xpfii**tivm Ia sitr-r*tiitre firlfiftermre $ter:tmfi 3fi?3"s*rrlnffit"pdf i;.YS#i  Nota explicativa la situatiile financiare la o'Neotec" SRL pentru anul 2023 Entitatea este inregistrata cu numarul 1002600048135 la data de 07.11.2000. Activitatea de baza este: 1) C ome rc ializar ea ma rfurilo r (teh nica medicala, artico le medicale). 2) Servicii de impachetare 3) Servicii de instalare si intretinere a tehnicii medicale. Capitalul social constituie 5400 lei. Componenta veniturilor si cheltuielilor sunt reflectate in rapoartele financiare inbaza metodei de angajamente si acumulari. *Neotec"SRI, a inregistrat in anul2023 venituri din vinzari in marime de 32 585 387lei. Costul vinzarilor a constituit 23 813 037 lei. Cheltuieli administrative generale a constituit -1 851 039 lei, de distribuire-z129 192lei, alte cheltuieli din activitatea operationala-761 299 lei. In anul 2023r "Neotec"SRL a obtinut profit pina la impozitare in marime de 3 935 711 lei. Impozitul pe venit din activitatea de intreprinzator in marime de l2o/o a constituit -508 414lei. Profitul net in anal2023 a constituit 3 427 297lei. Contabil sef Mucerschi Maria Digitally signed by Mucerschi Maria Date: 2024.06.02 19'22:59 EEST Reason: MoldSign Signature Location: Moldova  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:11:58 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ  Business Stream Products Certification Department TÜV Rheinland LGA Products GmbH  51105 Köln Contact Tel. +49 911 655-5225 Shimadzu Corporation, Medical Systems Division Mail: medical- 1, Nishinokyo-Kuwabara-cho [email protected] Nakagyo-ku, Kyoto Date April 11, 2024 604-8511 Japan Notified Body Confirmation Letter Reference. : SHIMA_CL607_2024-04-11 To whom it may concern, Confirmation of the status of a formal application, written agreement, and appropriate surveillance in the framework of Regulation EU 2023/607 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices. This letter confirms that TÜV Rheinland LGA Products GmbH, a Notified Body (NB) designated against Regulation (EU) 2017/745 (MDR) and identified by the number 0197 on NANDO, has received a formal application in accordance with Section 4.3, first subparagraph of Annex VII of MDR and has signed a written agreement in accordance with Section 4.3, second subparagraph of Annex VII of MDR with the following manufacturer: Shimadzu Corporation, Medical Systems Division 1, Nishinokyo-Kuwabara-cho Nakagyo-ku, Kyoto 604-8511 Japan SRN Number: JP-MF-000025145 TÜV, TUEV, TUV are registered trademarks. Utilisation and application requires prior approval. The devices covered by the formal application and the written agreement mentioned above are identified in the tables below. Table 1 identifies the devices for which TÜV Rheinland an MDR application has been received, written agreement concluded and for which the LGA Products GmbH NB is also responsible for appropriate surveillance under the applicable Directive. Am Grauen Stein 51105 Köln The transition timelines that apply to the devices covered by this letter, subject to the Germany manufacturer’s continued compliance to the other conditions specified in Article 120.3c Headquarter of MDR (as amended by (EU) 2023/607), are shown below: Tillystraße 2 90431 Nuremberg  December 31, 2028 for other Class IIb devices, Class IIa, Class I devices Phone. +49 911 655 5225 placed on the market in sterile condition or have a measuring function Fax +49 911 655 5226 [email protected] www.tuv.com/safety Board of Management On behalf of the Notified Body Dipl.-Ing. Thomas Weigand, Spokesman Dipl.-Kfm. Dr. Jörg Schlösser Michiaki Aihara Certification body Nuremberg HRB 26013 ® VAT No.: DE 811835490 9/610 E 10.10 Chairman of the Supervisory Board Dr.-Ing. Michael Fübi MS-0048822, rev.1  -2- Table 1: Devices covered by this letter and for which the NB is also responsible for appropriate surveillance of the corresponding devices under the applicable Directive: Device name or Basic UDI-DI MDR Device If the MDR device MDD Certificate (under MDR application) classification (as is a substitute Reference(s) of the proposed by the device, devices under MDR manufacturer and identification of application, and the verified at the pre- the corresponding NB Identification application stage) MDD device X-RAY TV SYSTEM Class IIb N/A HD 60147504 0001 SONIALVISION G4 NB# 0197 Digital Angiography System Class IIb N/A HD 60147504 0001 Trinias NB# 0197 RADspeed Pro Class IIb N/A HD 60147504 0001 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.2/0.8P38C-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.3/0.8P18DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P13DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P33DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P18DE-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P38DE-85 NB# 0197 X-ray tube assembly 1/2P13DK- Class IIb N/A HD 60147504 0001 85 NB# 0197 X-ray tube assembly 1/2P33D-85 Class IIb N/A HD 60147504 0001 NB# 0197 X-ray tube assembly 1/2P18DK- Class IIb N/A HD 60147504 0001 85 NB# 0197 X-ray tube assembly 1/2P38D-85 Class IIb N/A HD 60147504 0001 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.3/0.8P323DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P123DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P323DK-85 NB# 0197 X-ray tube assembly 0.8P323DK- Class IIb N/A HD 60147504 0001 85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.2/0.8P39CK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.3/0.8P324DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P324DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P164DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P364DK-85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P324DK-125 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P364DK-125 NB# 0197 X-ray tube assembly 0.8P324DK- Class IIb N/A HD 60147504 0001 85 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.4/0.7JG326D-265 NB# 0197 MS-0048822, rev.1  -3- Device name or Basic UDI-DI MDR Device If the MDR device MDD Certificate (under MDR application) classification (as is a substitute Reference(s) of the proposed by the device, devices under MDR manufacturer and identification of application, and the verified at the pre- the corresponding NB Identification application stage) MDD device X-ray tube assembly Class IIb N/A HD 60147504 0001 0.7/1.2JG326D-265 NB# 0197 X-RAY HIGH VOLTAGE Class IIb N/A HD 60147504 0001 GENERATOR UD150B-40 NB# 0197 X-RAY HIGH VOLTAGE Class IIb N/A HD 60147504 0001 GENERATOR UD150V-40 NB# 0197 X-RAY HIGH VOLTAGE Class IIb N/A HD 60147504 0001 GENERATOR UD150L-40 NB# 0197 X-RAY HIGH VOLTAGE Class IIb N/A HD 60147504 0001 GENERATOR UD150L-40F NB# 0197 X-RAY HIGH VOLTAGE Class IIb N/A HD 60147504 0001 GENERATOR UD150L-40E NB# 0197 X-ray radiography table BK- Class IIb N/A HD 60147504 0001 12HK NB# 0197 X-ray radiography table BK- Class IIb N/A HD 60147504 0001 120MK NB# 0197 X-Ray Radiography Table BK- Class IIb N/A HD 60147504 0001 200 NB# 0197 X-RAY RADIOGRAPHY STAND Class IIb N/A HD 60147504 0001 BR-120 NB# 0197 X-ray Radiography Stand BR- Class IIb N/A HD 60147504 0001 120T NB# 0197 X-RAY RADIOGRAPHY STAND Class IIb N/A HD 60147504 0001 BR-120M NB# 0197 X-RAY TUBE STAND FH-20HR Class IIb N/A HD 60147504 0001 NB# 0197 X-RAY TUBE STAND FH-21HR Class IIb N/A HD 60147504 0001 NB# 0197 Ceiling Type X-ray Tube Support Class IIb N/A HD 60147504 0001 CH-200M NB# 0197 CEILING TYPE X-RAY TUBE Class IIb N/A HD 60147504 0001 SUPPORT CH-200 NB# 0197 COLLIMATOR TYPE R-300 Class IIb N/A HD 60147504 0001 NB# 0197 Collimator Type R-20J Class IIb N/A HD 60147504 0001 NB# 0197 Radiography System RADspeed Class IIb N/A HD 60147504 0001 fit NB# 0197 GENERAL RADIOGRAPHIC Class IIb N/A HD 60147504 0001 SYSTEM EZy-Rad Pro NB# 0197 Mobile X-ray System MUX-10 Class IIb N/A HD 60147504 0001 NB# 0197 Mobile X-ray System MobileDaRt Class IIb N/A HD 60147504 0001 Evolution NB# 0197 Mobile X-ray System MobileArt Class IIb N/A HD 60147504 0001 Evolution NB# 0197 FDR Visionary Suite Class IIb N/A HD 60147504 0001 NB# 0197 Mobile X-ray System FDR Go Class IIb N/A HD 60147504 0001 NB# 0197 Mobile X-ray System Mobirex i9 Class IIb N/A HD 60147504 0001 NB# 0197 SURGICAL MOBILE C-ARM Class IIb N/A HD 60147504 0001 IMAGING SYSTEM OPESCOPE NB# 0197 ACTENO MS-0048822, rev.1  -4- Device name or Basic UDI-DI MDR Device If the MDR device MDD Certificate (under MDR application) classification (as is a substitute Reference(s) of the proposed by the device, devices under MDR manufacturer and identification of application, and the verified at the pre- the corresponding NB Identification application stage) MDD device REMOTE-CONTROLLED R/F Class IIb N/A HD 60147504 0001 SYSTEM FLEXAVISION NB# 0197 X-RAY R/F SYSTEM Class IIb N/A HD 60147504 0001 FLUOROspeed NB# 0197 X-ray tube assembly 1.2U161CS- Class IIb N/A HD 60147504 0001 31 NB# 0197 X-ray tube assembly 0.7U161CS- Class IIb N/A HD 60147504 0001 36 NB# 0197 X-ray tube assembly 0.7U163CS- Class IIb N/A HD 60147504 0001 36 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.7/1.3U163C-36 NB# 0197 X-ray tube assembly 0.6/1J327C- Class IIb N/A HD 60147504 0001 280 NB# 0197 X-ray tube assembly 0.6/1J317C- Class IIb N/A HD 60147504 0001 282 NB# 0197 X-ray tube assembly 0.6/1J317C- Class IIb N/A HD 60147504 0001 285 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P326D-150 NB# 0197 X-ray tube assembly Class IIb N/A HD 60147504 0001 0.6/1.2P366D-150 NB# 0197 Confirmation Letter Revision History Date NB internal reference Action traceable to each version of the letter 2024-04-11 SHIMA_CL607_2024-04-11 Initial issue MS-0048822, rev.1  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:12:27 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ  M517-V060C Jul. 2024 Digitally signed by Botnaru Andrei Date: 2025.01.14 09:04:47 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ Surgical Mobile C-arm Imaging System Instruction Manual Read this manual thoroughly before you use the product. Keep this manual for future reference. About the Symbols Appearing in This Instruction Manual Throughout the text in this manual, warnings and other information essential when using this unit such as cautionary or prohibited items, appear classified as the following: Mark Description Indicates an imminently hazardous situation which, if not DANGER avoided, will result in serious injury or death. Indicates a potentially hazardous situation which, if not WARNING avoided, could result in serious injury or possibly death. Indicates a potentially hazardous situation which, if not CAUTION avoided, may result in minor to moderate injury or equipment damage. States information which helps to use the equipment NOTE correctly. Indicates references. Gives information to make using the Opescope easier. Gives information for reference when using the Opescope. Revision History Revision Date Changes First edition Oct. 2022 First edition released Modify the description and add a warning on the laser beam. Add how to use each type of the caster to the A Apr. 2023 Moving the Monitor Cart. Changed some specifications and initial setting values for APR. Changed description for the anti-virus software. Added description to the message display of the live monitor. B Oct. 2023 Added a note to the monitor clone display. Added the offset calibration action to the starting inspection checklist. Revision Date Changes Modify the description of Intended use and Indications for use, the Cautions on Cleaning and Disinfection, the Regulatory Information, and the Company's Quality System. Add a note to the Regulatory Information. C Jul. 2024 Change the CE label, add the UDI label, and delete some labels. Update some international standards. Add errors to "Errors That Can Recovered by the User" of the Reference Monitor. This page is intentionally left blank.  Introduction Thank you for selecting the Surgical Mobile C-arm Imaging System OPESCOPE ACTENO FD type (hereafter “the equipment”). Before using the equipment, read the instruction manual and make sure you understand its contents. This manual should be kept available for future reference. If the user or usage location changes, ensure that this instruction manual is always kept together with the equipment. Periodically check to be sure that the instruction manual and the warning labels are not missing or damaged. If they are, contact your Shimadzu service representative for replacement. Original version is approved in English. Notice • All copyrights regarding this manual are property of Shimadzu Corporation. Neither all nor part of these contents shall be reproduced or duplicated without the express permission of Shimadzu Corporation. • Content of this manual may be changed for improvement without notice. Although every possible effort has been made to avoid errors while creating this manual, immediate revision may not be possible in the event that errors or missing information are detected. • Screen images and illustrations contained in this manual may differ from those in actual use, and are intended for example purposes only. Illustrations may also use partial images. • Other company names and product names mentioned in this manual are trademarks or registered trademarks of their respective companies. • The TM and  symbols are omitted in this manual. ©Shimadzu Corporation. All rights reserved. Introduction Operating Precautions “Operating Precaution (for Both the Safety and the Prevention of Danger) in the Use of Electric Medical Equipment” 1. Nobody without the following experience and knowledge should use the equipment. (1) Medical (radiographic) training (if particular qualifications are required in the country concerned, those qualifications must be held). (2) The capacity to read and understand the instruction manual. 2. When installing the equipment, pay attention to the following items: (1) Do NOT install it near water faucet or similar equipment. (2) Install it away from potential sources of problems such as abnormal pressure, temperature or humidity, drafts, direct sunlight, dust, or locations where the air has a high concentration of salt or sulfur. (3) During transportation and operation of the equipment, avoid tilting, vibration and sharp impact against it. (4) Keep the equipment away from the areas where chemicals or gases are stored. (5) Use only the correct electrical power source with matching frequency, voltage and current (or wattage). (6) Check the conditions of the battery power source (power and polarity) before operating the equipment. (7) Properly ground the equipment. 3. Before operating the equipment, pay attention to the following items: (1) Check the conditions of switch contacts, polarity, dial settings, and meters, and make sure the equipment performs correctly. (2) Confirm that the ground is connected properly. (3) Check all wiring for proper and correct connections. (4) Pay attention when using more than one unit at a time, because it may lead to an incorrect diagnosis and cause danger. (5) Check the condition of the external electric circuit that will be directly connected to a patient. (6) Check the condition of the battery power source. 4. While operating the equipment, pay attention to the following items: (1) Do NOT over-exceed time or the amount of equipment use needed for diagnosis or therapy. (2) Observe the equipment and patient continuously for early detection of problems. (3) When a problem is detected with the equipment or patient, take proper action to stop the equipment without harming the patient. (4) Do NOT let the equipment touch the patient. Introduction-2 OPESCOPE ACTENO FD type Instruction Manual  Introduction 5. After operating the equipment, pay attention to the following items: (1) Turn off the switches and return the dial to their original before use in the prescribed order. Then, turn off the main power switch. (2) Do NOT pull the power cable forcibly from the outlet. (3) When storing the equipment, pay attention to the following items: (i) Keep it away from the water. (ii) Store it away from the potential causes of problems such as abnormal pressure, temperature and humidity, draft, direct sunlight, dust, or locations where the air has a high concentration of salt or sulfur. (iii) During transportation and storage of the equipment, avoid tilting, vibration and sharp impact against it. (iv) Store the equipment away from areas where chemicals and gases are stored. (4) Clean all attachments, cables and contacts, and store them in one place. (5) Keep the equipment clean to avoid problems during the next use. 6. When the equipment is found to be out of order, do not try to repair it. Display an appropriate sign to indicate that the equipment is out of order, and contact your Shimadzu Service Representative for repair. 7. Do NOT modify any part of the equipment. 8. Preventive maintenance (1) The equipment and its parts should be periodically checked. (2) If the equipment has not been in operation for an extended period of time, test it prior to actual operation to make sure it works correctly and safely. 9. Concerning other items, operate properly according to the instruction manual. OPESCOPE ACTENO FD type Instruction Manual Introduction-3 Introduction Precautions for Use WARNING The responsibility for management of use and maintenance of medical equipment lies with the user. This equipment is restricted to use by, or under supervision of, a diagnostic radiology technician or a person with a certificate indicating equal proficiency. Repair and inspection of the inside of the equipment is dangerous. Be sure to contact your Shimadzu service representative for repair and inspection. WARNING Never modify the equipment. In general, modifications are strictly prohibited by the Regulatory requirements of the law of the country where the device is installed. Please contact your Shimadzu service representative if it is necessary to modify the equipment. WARNING Perform periodic inspection. Preventive maintenance is required to maintain long-term safety and performance of the equipment. The 6 "Maintenance and Inspections" chapter in this manual gives detailed descriptions of daily and periodic maintenance and inspection that a user should perform. As for the maintenance and inspection that only specially trained experts can perform, utilize the maintenance agreement program offered by Shimadzu. WARNING Repair and maintenance of the inside of the equipment can only be performed by engineers assigned by Shimadzu. Maintenance must be assigned to specially trained experts. Contact your Shimadzu service representative for repair and maintenance. Introduction-4 OPESCOPE ACTENO FD type Instruction Manual  Introduction WARNING Prepare another OPESCOPE ACTENO or alternative fluoroscopic system with specifications greater than or equal to the OPESCOPE ACTENO, in case any trouble happens and fluoroscopy/radiography can not be operated normally. WARNING Do not use this equipment alone for diagnosis. Make a diagnosis based on not only the output image of the equipment but also multiple test results. CAUTION If the operator has no experience in operating the equipment, be sure that he or she receives instruction on how to operate it from Shimadzu service personnel or someone who has adequate experience in using the equipment. In order to operate the equipment safely, an explanation of the operation needs to be given. When installing the equipment, Shimadzu service personnel explain the operating procedure using this instruction manual. Follow their directions and operate the equipment correctly. 1.7 "Operator Profile" (page 1-11) OPESCOPE ACTENO FD type Instruction Manual Introduction-5 Introduction Be Sure to Read the Following to Prevent Explosion, Electric Shock, or Injury DANGER Do NOT use any potentially flammable or explosive gas, such as disinfectant sprays, near the equipment. Use of such gas may cause an explosion. WARNING Check the condition of the patient before conducting a study. If equipment usage is deemed to put the patient at risk due to the his or her condition, refrain from conducting the study or treatment. WARNING Do NOT use the equipment at places where the liquid may enter. Do NOT spill liquids onto the surface or the inside of the equipment. Otherwise, electric shock may occur. In case of liquid spillage to the equipment, immediately turn off the power, and contact your Shimadzu service representative. WARNING If an abnormality occurs during operation, or if an unusual odor or smoke is emitted during operation, stop using the equipment immediately and contact your Shimadzu service representative. Continued use may damage the equipment and cause injury. Introduction-6 OPESCOPE ACTENO FD type Instruction Manual  Introduction WARNING Do NOT open the covers of the equipment. Otherwise, electric shock may result. When opening the covers for maintenance, contact your Shimadzu service representative. WARNING Always be very careful when moving the equipment to avoid contact with the patient or operator and to ensure that the patient or operator does not become caught between the equipment and any neighboring devices. Otherwise, it may cause injury. WARNING When performing CPR, immediately move this equipment away so it does not obstruct CPR. CAUTION When moving the C-arm, hold each of the handles to operate it. Otherwise, you may trap your fingers, causing injury. 3.6 "Operating the C-arm" (page 3-24) OPESCOPE ACTENO FD type Instruction Manual Introduction-7 Introduction CAUTION When opening and closing the monitors, be careful not to trap your fingers. Otherwise, it may cause injury. Introduction-8 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION Do NOT place peripheral devices or any other object within the range of motion of the equipment. If you place peripheral devices such as monitors within the range indicated below, the equipment could strike or contact them. (Units: mm) OPESCOPE ACTENO FD type Instruction Manual Introduction-9 Introduction WARNING Do Not perform any maintenance work for the equipment while conducting a study. Doing so may cause injury to the patient. Cautions on Environmental Conditions WARNING Use the equipment in an environment that meets the stipulations stated here. Use the equipment only in a room or area that conforms to the laws (or regulations with legal force) that govern the electrical safety of this kind of equipment. WARNING Do NOT use the equipment in an oxygen-rich environment. The use in an oxygen-rich environment may cause fatal or serious injuries or damage to the equipment due to easy ignition. WARNING Be sure to connect the equipment only to a (commercial) power outlet with a ground terminal. Do NOT connect the equipment to power stripes, extension cords, or overloaded electrical circuits. Doing so may cause the electric shock. Introduction-10 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION Be sure to use the equipment under the following environmental conditions: The installation of a dedicated air-conditioner in the examination room is recommended if the building air-conditioner cannot meet the necessary environmental conditions. • Atmosphere: No explosive or corrosive gases • Ambient temperature: 10 °C to 35 °C • Relative humidity: 30 % to 80 % (no condensation) • Atmospheric pressure: 800 hPa to 1060 hPa (800 mbar to 1060 mbar) • Environment luminosity: 150 lx to 500 lx • Ambient noise level: Under 70 dB Note also that there must be no sudden change in temperature or humidity. This causes condensation, which can lead to equipment failure. CAUTION Provide the equipment with a suitable ground. The equipment needs a ground. An unsuitable ground could cause electric shocks. See 1.4 "Environmental Conditions" (page 1-5). Cautions on Radiography DANGER Restrict all persons other than the patient from accessing the equipment in accordance with local regulations. To avoid unnecessary exposure, acceptable distances (maximum access values) to the equipment by any person other than the patient are defined for each region. OPESCOPE ACTENO FD type Instruction Manual Introduction-11 Introduction WARNING The equipment must only be operated by qualified personnel, such as radiology technicians or those with equivalent qualifications. WARNING Perform X-ray irradiation carefully and according to the doctor's directions when using the equipment with expectant mothers, women who suspect they are pregnant, lactating women, or children. Particular ways of using the equipment may increase the scatter dose absorbed into the patient, which may cause a radiation hazard. WARNING During X-ray irradiation, ensure that the X-rays irradiate the necessary region only. To avoid unnecessary exposure, narrow down the collimator and take protection measures, such as wearing a protective apron. WARNING Do NOT place any unnecessary object in the location within the X-ray exposure region. Doing so may result in unnecessary radiation exposure to the patient. Introduction-12 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION Be sure to warm-up the equipment (running-in operation of the X-ray tube unit) before fluoroscopy or radiography. If the equipment is not used for a prolonged period, perform warm-up (running-in operation of the X-ray tube unit) periodically (approximately once a week). See 3.5 "Warm-Up" (page 3-23). CAUTION Perform the warm-up if an arc occurs. Suddenly using the X-ray tube unit near the nominal X-ray tube voltage (above 100 kV) after using the unit at a relatively low tube voltage (80 kV max.) for a prolonged period may result in arc. This arc occurs due to loss of the warm-up effect at high tube voltage after the X-ray tube unit is used at a relatively low tube voltage for a prolonged period. In this case, warm-up the X-ray tube unit by referring to the procedure described in the X-ray high voltage generator operation manual. CAUTION Do NOT perform unnecessary standby operations. If standby status continues after the radiography preparation switch is pressed, wire disconnection or withstand voltage failure may occur due to the evaporation of the X-ray tube filament. CAUTION In order to minimize the radiation dose on the patient, make the distance between the focus and the patient’s body surface as long as possible (Minimum 45 cm). The shorter the distance becomes, the greater the amount of scatter dose absorbed into the patient, which may cause a radiation hazard. OPESCOPE ACTENO FD type Instruction Manual Introduction-13 Introduction CAUTION Do NOT confuse the fluoroscopy and radiography. If the radiography mode is misused on purpose by the operator for real-time imaging, the image display delay may be longer than in the fluoroscopy. CAUTION Pay extra attention when irradiating X-rays for a long time or repeatedly. It may cause a radiation hazard. NOTE Objects such as the operating table or surgical instruments in the X-ray exposure area may adversely affect the image quality or dose. NOTE The radiation dose changes when changing tube voltage, dose settings, pulse rate, etc. Introduction-14 OPESCOPE ACTENO FD type Instruction Manual  Introduction Cautions Relating to the Laser Beam The laser beam emitted from the laser pointer (option) on the X-ray tube assembly and FPD sides is categorized as a class 1 laser by the IEC 60825-1:2014, 3rd Edition (effective on 2014-05-15). WARNING Never look directly into the laser beam. Doing so can cause injuries such as damage to the eyes. The laser pointer (option) can be used only under the supervision of a person with medical knowledge who understands the dangers associated with using a laser beam. Only switch the laser pointer ON when necessary. Avoid unnecessary irradiation. Do NOT attempt any operation, adjustment or procedure that is not described in this manual. This could result in dangerous laser radiation. WARNING Do not let any laser beam enter the patient's eyes. Prolonged exposure of the eyes of an anesthetized patient may lead to potentially dangerous exposure if the patient does not close the eyes. OPESCOPE ACTENO FD type Instruction Manual Introduction-15 Introduction Cautions on Moving the Equipment WARNING Take care to avoid impacts and overturning of the equipment. The unit alone weighs more than 200 kg. Impacts and overturning will not only damage the equipment, but could also cause serious injuries. When moving the equipment, pay attention to the following points. • When moving the C-arm between rooms, make sure the C-arm is at its home position. • Check that the cable work has been done correctly. • When traversing slopes and entrances, and negotiating obstacles, move the equipment as gently as possible. Take particular care on steep slopes. • Always apply the brake after you stop moving the equipment. • Do NOT move the equipment over any steps or bumps greater than 2 cm, or Do NOT use the equipment on a floor that is sloped more than 5 degrees. • Always stop the equipment on a level surface and avoid sloped surfaces. Failure to do so may cause the equipment to roll down the slope or tip over. • In places where moving the equipment generates strong vibrations, for example outdoor paths, avoid rapid progress, deep steps, and steep slopes. Do NOT stop moving on inclined routes. • While wheeling the equipment, watch out for obstacles ahead. Measurement Accuracy WARNING Values are displayed as "mm" and "deg" when the DR measurement function is used. Do NOT attempt to use the measurement function for purposes other than references for evaluation because precise image measurement is not possible. Introduction-16 OPESCOPE ACTENO FD type Instruction Manual  Introduction Cautions on the System and Software CAUTION Observe the following precautions: • Do NOT attempt to alter any system software. Doing so could disrupt the functioning of the system and result in loss of images. • Do NOT attempt to alter any system hardware components. Doing so could disrupt the functioning of the system and result in loss of images. Use of any hardware components not provided by Shimadzu is strictly prohibited. This includes peripherals (mouse, keyboard, monitor, etc.). • Pay careful attention to other high frequency-generating equipment in the room. The monitor cart should be as far as possible from any such device to prevent noise from affecting the image video signal. • Do NOT disconnect the cables connected to this system. Otherwise the image may not be displayed, the data may be damaged and the system may fail to start up. • Do NOT move any system component. If necessary, move it carefully to avoid damage. • Do NOT apply any shocks to the system components. • Do NOT place anything which may generate magnetic fields near the system components. • Do NOT alter the system setting. Do NOT install any software to the system other than that provided by Shimadzu for this system. Otherwise, the system may fail to start up. • Do NOT allow anyone to touch the equipment except those who have received permission from the equipment manager. Personal information is stored in this equipment. Do not let unauthorized persons touch the equipment during use or storage. NOTE • Before performing an exposure, always identify the patient based on the patient information displayed on the equipment. • Do NOT delete the program conditions or move the saved location. The program conditions set on the X-ray high voltage generator are linked with the DR console. If you do delete them, a system malfunction may occur. OPESCOPE ACTENO FD type Instruction Manual Introduction-17 Introduction Cautions on Data Loss CAUTION The important image data or original data should be archived (backup) in an external file system such as an optical magnet disc. A system hard ware failure, misoperation, or contingent accidents may cause loss of, or damage to the image data or the original data stored in the magnetic disc of the equipment. • Shimadzu accepts no responsibility for loss or damaged image data or original data. • Shimadzu accepts no responsibility whatsoever for incidental, consequential, or indirect damages (destruction to property, loss of opportunities, tangible and intangible damages such as lost profits, etc.) resulting from or arising out of using, not using, or inability to use the equipment. • External file systems, such as media, could also be damaged. Create multiple backups to avoid data loss. CAUTION Do not disconnect the wired or wireless LAN while the equipment is communicating. Data in communication or data in the equipment may be abnormal or damaged. Introduction-18 OPESCOPE ACTENO FD type Instruction Manual  Introduction Cautions on Network Connections The equipment connects to the network to obtain patient information and study information from external devices and to output data such as study images to external devices. The equipment shall be connect to the network supporting 1000 Base-T/100 Base-T/10 Base-T based on the IEEE standard. The LAN cable shall be compatible with UTP that is rated for CAT 5e or higher. You can also use a wireless LAN unit to wirelessly connect the device to the network. When using the wireless LAN unit, keep it away from the channels used by other devices. If the operating frequency overlaps with that of another device, the communication quality may be degraded. Even if the wireless connection is fully connected, communication might fail due to the environmental influence. In this case, try communicating again. If retrying fails, check the network status. Intended information flow Connection Typical information destination Imager Study image data Patient information, Study information, Study record RIS server information, and Dose information Storage server Study image data CAUTION The wireless LAN unit uses radio waves to exchange information. Failure to implement appropriate security measures may result in the interception of communication data by a malicious third party or unauthorized access. When using the wireless LAN unit, it is the customer's responsibility to implement security measures. If you communicate over a network that is not under security control, information leakage might occur due to network eavesdropping or falsification of communication data, or due to source or destination address spoofing. Do not communicate over an unsecured network. OPESCOPE ACTENO FD type Instruction Manual Introduction-19 Introduction CAUTION The following hazardous situation may occur in the event of a network outage. • Imager: Study images cannot be printed. • RIS server: Patient information and study information cannot be obtained and study record information and dose information cannot be sent. • Storage server: Study images cannot be sent, and past study images cannot be obtained. CAUTION Shimadzu accepts no responsibility for any of the following items due to infection by malware (i.e. malicious software, including computer viruses and worms, which cause damage to the infected computer): • Loss, alteration, and leakage of data, including images, recorded on this equipment • Accidents due to the malfunction of this equipment • Infection of other equipment via this equipment and any damages incurred due to the infection • Other issues including all events caused by malware infection Introduction-20 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION When using the networks described below, the customer must implement security measures to prevent infection by malware (i.e. malicious software, including computer viruses and worms, which causes damage to the infected computer) or a malicious attack on the system. • Networks that lack security management • Networks that may be subject to malware intrusion • Networks that are connected to or have the ability to connect to the following devices (1) Devices that lack security management by the customer (2) Devices that can be used by persons unauthorized by the customer (3) Wireless communication devices Examples of security management are as follows; • NOT connecting to networks that lack security management • NOT connecting to the internet • Checking whether media (such as CDs, DVDs, and external storage devices) are infected with malware before use. • Avoiding actions that may result in malware infection • NOT connecting to the network of another PC connectable to the internet. If security measures are not implemented, any virus infection, or leakage or falsification of hospital and patient information is not covered under warranty. OPESCOPE ACTENO FD type Instruction Manual Introduction-21 Introduction CAUTION The customer should identify, analyze, evaluate and control RISK by Network. The customer connection of this machine to a NETWORK that includes other equipment could result in previously unidentified RISKS to PATIENTS, OPERATORS or third parties; Subsequent changes to the NETWORK could introduce new RISKS and require additional analysis. Changes to the NETWORK include: • Changes in NETWORK configuration • Connection of additional items to the NETWORK • Disconnecting items from the NETWORK • Update of equipment connected to the NETWORK • Upgrade of equipment connected to the NETWORK Cautions on Cleaning and Disinfection WARNING Be sure to turn the equipment power OFF before cleaning and disinfecting the equipment. Otherwise, a malfunction may occur in the equipment, or the equipment may operate in an unintended way. Also, thoroughly ventilate the room before turning ON the power after disinfection work is complete. If flammable gases remain in the room and the system is turned on, fire, smoke, explosion or electric shock may occur. CAUTION Be sure to clean and disinfect the equipment. Cleaning and disinfection is very important to ensure that the equipment can be used hygienically and safely. Strictly follow the methods prescribed. Introduction-22 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION Clean the equipment surface before using disinfectant. Clean the surface with a lint-free cloth or a soft toothbrush that does not scratch the surface. If it is difficult to remove dirt, please use dishwashing detergent or soap diluted with lukewarm water. Be sure to wipe off any dishwashing detergent or soap used for cleaning before disinfection. CAUTION Do not spray disinfectant or water directly on the equipment. Wipe the surface of the equipment with a cloth soaked with disinfectant. If disinfectant gets inside the equipment, it can cause failure or accidents. CAUTION The following disinfectants (intermediate level disinfectant) are available:. However, depending on the object, there are restrictions on the disinfectant that can be used. Please wipe off the disinfectant after disinfection. (A) Chlorine disinfectants∗1 • Sodium dichloroisocyanurate solution (1% maximum) • Sodium hypochlorite solution (1% maximum) (B) Alcohol disinfectants∗2 • Commercially available isopropyl alcohol sodium (up to 99 wt% can be used) • Rubbing alcohol (76.9 - 81.4 vol% Ethanol, isopropyl alcohol as an additive) *1 : Do not use on unpainted metal parts. Using chlorine disinfectant may cause corrosion. *2 : Do not use for plastic parts, especially the following acrylic parts:. Alcohol-based disinfectants may deteriorate. (i) Transparent resin part of laser light transmitting part (ii) Touch panel (iii) Front resin part of the FPD OPESCOPE ACTENO FD type Instruction Manual Introduction-23 Introduction CAUTION Do NOT use the following disinfectants: The use of these disinfectants cannot guarantee the performance and safety of the equipment. • Disinfectants that corrode metals, plastics, rubber, or paint • Disinfectants unsuitable for metals, plastics, rubber, or paint • Spray-gas type disinfectants • Volatile disinfectants • Disinfectants that may enter the equipment CAUTION Do NOT use an organic solvent. Organic solvents may change the surface color. If an organic solvent adheres to the surface, wipe it off immediately. CAUTION Use disinfectants at a minimum. Repeated disinfection over a long time may lead to discoloring and cracking on the equipment shape or resin. For example, rubber and plastic may deteriorate. If any abnormality is found on the equipment after disinfection, stop using the equipment immediately. Contact your Shimadzu service representative for repair. Introduction-24 OPESCOPE ACTENO FD type Instruction Manual  Introduction CAUTION Observe the following precautions when cleaning and disinfecting the touch panel: • Disconnect the main power cable before cleaning and disinfecting. • Clean and disinfect the touch panel periodically. The applicable cleaners include, isopropyl alcohol (abrasive free), glass cleaner (non ammonia-based), water solution of neutral detergent. • Handle the touch panel with care when cleaning and disinfecting. Do NOT rub or hit the panel surface because it tends to scar easily. • Wipe gently with moistened soft close to remove the dust from the panel surface. CAUTION Before a study or operation, remove the dust from the C-arm, X-ray tube assembly, and the periphery. Cautions Relating to Cellular Telephones WARNING Do NOT bring any cellular telephones or related devices into the examination room with their power ON. Such devices can exceed the EMC standard limitations, and under some conditions this can impair the proper functioning of the equipment. In the worst case, this can cause serious injuries or clinical errors. OPESCOPE ACTENO FD type Instruction Manual Introduction-25 Introduction Cautions on Electromagnetic Compatibility (EMC) WARNING This equipment needs special precautions regarding EMC. Install and use the equipment according to the EMC information provided in this instruction manual. See 8.1 "Environmental Conditions of EMC (Electromagnetic Compatibility)" (page 8-2). WARNING Make sure that electromagnetic compatibility is obtained. All peripheral devices must satisfy EMC standards regarding emission of electromagnetic energy and susceptibility to electromagnetic environment. Devices that do not satisfy these standards may disturb the correct functioning of the equipment. In the worst case, this can cause serious injuries or clinical errors. See 8.1 "Environmental Conditions of EMC (Electromagnetic Compatibility)" (page 8-2). WARNING Do NOT use this equipment adjacent to, or stacked with, other equipment. If adjacent or stacked use is necessary, check to be sure that this equipment works properly in the environment. See 8.1 "Environmental Conditions of EMC (Electromagnetic Compatibility)" (page 8-2). Introduction-26 OPESCOPE ACTENO FD type Instruction Manual  Introduction WARNING Portable RF communications equipment (including peripherals such as antenna cables and external antennas) should not be used no closer than 30 cm (12 inches) to any part of the Surgical Mobile C-arm Imaging System OPESCOPE ACTENO FD type, including cables specified by the manufacturer. Otherwise, degradation of the performance of this equipment could result. Cautions When Irradiating Consecutive Pulse X-rays WARNING Observe the following precautions when irradiating consecutive pulse X-rays: • Conducting studies involving irradiating consecutive pulse X-rays onto the region where an implantable pacemaker or defibrillator is implanted may cause these devices to malfunction. • Refer to the "Important General Cautions," "Interactions," or other relevant sections in the digitized accompanying documentation of the implantable pacemaker or defibrillator and take the prescribed measures before irradiating the implanted region of these devices with consecutive pulse X-rays. Fluoroscopy or radiography performed by irradiating consecutive pulse X-rays (such as serial radiography with a few second intervals, pulsed fluoroscopy, digital angiography, DSA, or cineradiography) can adversely affect the CMOS circuit in implantable pacemakers and defibrillators. Such affects may cause oversensing in these devices that can temporarily inhibit pacing pulse output and result in an inappropriate heart rate. OPESCOPE ACTENO FD type Instruction Manual Introduction-27 Introduction Warranty The system is warranted to be free from defects in material and workmanship for one year from the date of delivery. If found to be defective, the system must be offered to Shimadzu for inspection and examination. Upon examination, Shimadzu, at its sole option, will repair or replace at no charge, the system or any part found to be defective. Components which wear are not warranted. This warranty extends to original purchaser or the lessee of the new system only. If the system is to be resold or delivered to a third party, such third party must be provided with a copy of this manual, the installation manual and the technical manual supplied with the system. This warranty does not apply to the following: 1. Failure or damage due to any installation, relocation, or service not provided by your Shimadzu service representative or a SHIMADZU designated contractor. 2. Failure or damage caused by the product of other companies (except those purchased from SHIMADZU). 3. Failure or damage due to repairs using non-SHIMADZU certified service parts. 4. Failure or damage due to non-compliance with the notices and procedures set forth in this manual. 5. Failure or damage due to any operating environment deviating from the requirements set forth in this manual. 6. Failure or damage due to natural disasters such as power surge, rain, fire, earthquake, flood, and thunder. 7. Failure or damage due to installation on non-SHIMADZU approved vehicle, ship, aircraft, or others. 8. Failure or damage due to use in non-SHIMADZU certified countries. 9. Failure or damage in case of purchase from entity other than SHIMADZU or Shimadzu service representative. 10. Failure or damage due to impact, drop, or shock. Service after the expiration of the warranty is available at a reasonable cost and should be performed by your Shimadzu service representative. IN NO EVENT SHALL SHIMADZU AND ITS AFFILIATED ENTITIES BE LIABLE TO ANY PERSON OR ENTITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, ANY DAMAGES RESULTING FROM LOSS OF USE, BUSINESS INTERRUPTION, LOSS OF PROFITS, LOSS OF SAVINGS, THE COST OF PROCUREMENT OF SUBSTITUTED GOODS, SERVICES OR TECHNOLOGIES OR FOR ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THE USE OR INABILITY TO USE THE SYSTEMS. In some jurisdictions, some of the foregoing warranty disclaimers or damage limitations may not apply. Introduction-28 OPESCOPE ACTENO FD type Instruction Manual  Introduction Shimadzu will be indemnified for any claim, liability, or damage arising out of the misuse or non-compliance with this manual by the purchaser or lessee of the system. Software License Agreement NOTE 1. Definition of licensed software The licensed software ("software") refers to all computer programs used by the product, in addition to all related documentation. 2. Ownership of license The software used in this product is copyrighted by Shimadzu Corporation ("Shimadzu") who possesses all rights, including sublicenses for those rights (for copyrights, etc.) held by third parties. The equipment with the installed software is sold on the basis of Shimadzu licensing the software ownership to the customer. Accordingly, when the customer uses the software, the customer must observe the items outlined below: (1) The customer shall only use the software for use with a single equipment. (2) The intellectual property rights for the software are not transferred to the customer. (3) The customer, or any third party, is prohibited from performing any of the following actions: • Duplicating the software. • Changing the software, in whole or part. • Transferring, loaning, or sublicensing the software. • Transferring the software outside Japan without prior permission of the Japanese or U.S. government. Service Life The equipment lifetime is 10 years (based on Shimadzu's criteria) assuming the specified maintenance checks are performed. OPESCOPE ACTENO FD type Instruction Manual Introduction-29 Introduction Disposal Precautions CAUTION When disposing of the equipment, contact your Shimadzu service representative. An improper disposal of this equipment may pollute the environment by substances contained in parts. Action for Environment (WEEE) To all user of Shimadzu equipment in the European Union: Equipment marked with this symbol indicates that it was sold on or after 13th August 2005, which means it should not be disposed of with general household waste. Note that our equipment is for industrial/professional use only. Fig. Introduction-1 WEEE Mark Contact your Shimadzu service representative when the equipment has reached the end of its life. They will advise you regarding the equipment take-back. With your co-operation we are aiming to reduce contamination from waste electronic and electrical equipment and preserve natural resource through re-use and recycling. Do not hesitate to ask your Shimadzu service representative, if you require further information. Environment-friendly usage When not in use, turning off the power can reduce the influence on the environment. However, please decide whether to reduce the impact on the environment or not by comparing the benefit of reducing the impact on the environment and the risk of loss of a patient examination opportunity due to the start up time from the power on. Introduction-30 OPESCOPE ACTENO FD type Instruction Manual  Introduction Software This manual is compatible with the software version 01. Activation This equipment must be activated in the installation. Activation requires authentication by your Shimadzu service representative. Warning and Caution Labels The following safety labels, which describe handling precautions, are attached to the equipment. With adequate understanding of the contents on these labels and the warning/caution items in this manual, operate the equipment safely. Inspect the safety labels periodically (once a year). If any label is peeled or unreadable by stain or scratch, replace it with a new one. For new labels, contact your Shimadzu service representative. (1) (5) (2) (3) (4) (6) (9) C-arm Rear of monitor cart OPESCOPE ACTENO FD type Instruction Manual Introduction-31 Introduction (8) (7) Front of monitor cart Fig. Introduction-2 Warning labels (1) (2) (3) (4) Introduction-32 OPESCOPE ACTENO FD type Instruction Manual  Introduction (5) (6) (Option) (7) (Option) (8) (Option) (9) OPESCOPE ACTENO FD type Instruction Manual Introduction-33 Introduction Organization of This Manual and How to Use It The chart below shows how this manual is organized and how to use it. Introduction First use Chapter 1 Overview of the OPESCOPE ACTENO When assuring operating safety FD type Chapter 2 Configuration of the Equipment Chapter 3 Basic Operation When using the equipment Chapter 4 Image Processing Chapter 7 Options When troubleshooting Chapter 5 Troubleshooting Chapter 6 Maintenance and When carrying out maintenance Inspections and inspection Chapter 7 Options When looking for technical information Chapter 8 Technical Data Introduction-34 OPESCOPE ACTENO FD type Instruction Manual  Introduction Related Instruction Manuals Document Name Document No. SDR120F Reference Guide M517-V062 Abbreviations Abbreviations Description APR Anatomical Program BH filter Beam Hardening Filter CPR Cardiopulmonary resuscitation DR Digital Radiography DSA Digital Subtraction Angiography EMC Electro Magnetic Compatibility FPD Flat Panel Detector HU Heat Unit IBS Image Brightness Stabilizer LCD Liquid-Crystal Display LED Light-Emitting Diode LIH Last Image Hold Options The "Options" described in this manual may be provided as standard, or may be unavailable, depending on the sales format. OPESCOPE ACTENO FD type Instruction Manual Introduction-35 Introduction This page is intentionally left blank. Introduction-36 OPESCOPE ACTENO FD type Instruction Manual  Contents Contents Introduction Operating Precautions . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-2 Precautions for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-4 Warranty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-28 Software License Agreement . . . . . . . . . . . . . . . . . . . Introduction-29 Service Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-29 Disposal Precautions . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-30 Action for Environment (WEEE) To all user of Shimadzu equipment in the European Union: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-30 Environment-friendly usage . . . . . . . . . . . . . . . . . . . . Introduction-30 Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-31 Activation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-31 Warning and Caution Labels . . . . . . . . . . . . . . . . . . . Introduction-31 Organization of This Manual and How to Use It . . . . Introduction-34 Related Instruction Manuals . . . . . . . . . . . . . . . . . . . Introduction-35 Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-35 Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction-35 Chapter 1 Overview of the OPESCOPE ACTENO FD type 1.1 Application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-2 1.1.1 About the OPESCOPE ACTENO FD type . . . . . . . . . . . 1-2 1.2 Features . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-3 1.3 Principle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-4 1.4 Environmental Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . 1-5 1.4.1 Operation Environment . . . . . . . . . . . . . . . . . . . . . . . . . 1-5 1.4.2 Transportation and Storage Environment . . . . . . . . . . . 1-6 1.4.3 Power Supply . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-6 1.4.4 Grounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-7 1.4.5 Network/Security . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-7 1.5 Classification of Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 1-8 OPESCOPE ACTENO FD type Instruction Manual i Contents 1.6 Symbols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-10 1.7 Operator Profile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-11 Chapter 2 Configuration of the Equipment 2.1 Standard Configuration . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2 2.1.1 C-arm Cart . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2 2.1.2 Configuration of the Monitor Cart . . . . . . . . . . . . . . . . . . 2-7 2.2 Main Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-11 2.2.1 Function of Each Switch . . . . . . . . . . . . . . . . . . . . . . . . 2-11 2.2.2 LCD Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-13 2.3 Side Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-23 2.3.1 C-arm Lock Switch . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-23 2.3.2 Control Switch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-24 2.4 Live Monitor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-25 2.5 Reference Monitor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-28 2.5.1 Screen Configuration . . . . . . . . . . . . . . . . . . . . . . . . . . 2-28 2.5.2 Study List Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-31 2.5.3 Image List Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-32 2.5.4 Study Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-34 2.5.5 Image Edit Window . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-35 2.5.6 Print Edit Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-36 Chapter 3 Basic Operation 3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-2 3.2 Transport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-3 3.2.1 Moving the C-arm Cart . . . . . . . . . . . . . . . . . . . . . . . . . . 3-4 3.2.2 Moving the Monitor Cart . . . . . . . . . . . . . . . . . . . . . . . . . 3-9 3.3 Connecting and Dismantling the System . . . . . . . . . . . . . 3-12 3.3.1 System Connections . . . . . . . . . . . . . . . . . . . . . . . . . . 3-12 3.3.2 Disconnection Procedure . . . . . . . . . . . . . . . . . . . . . . . 3-14 3.4 Turn the Power ON / OFF . . . . . . . . . . . . . . . . . . . . . . . . . 3-15 3.4.1 Turning the Power ON . . . . . . . . . . . . . . . . . . . . . . . . . 3-15 3.4.2 Fluoroscopy outside of Study . . . . . . . . . . . . . . . . . . . . 3-18 3.4.3 Turning the Power OFF . . . . . . . . . . . . . . . . . . . . . . . . 3-20 ii OPESCOPE ACTENO FD type Instruction Manual  Contents 3.5 Warm-Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-23 3.6 Operating the C-arm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-24 3.6.1 C-arm Longitudinal Movement . . . . . . . . . . . . . . . . . . . 3-28 3.6.2 C-arm Forward/Back and Lateral Swiveling Movement 3-29 3.6.3 C-arm Slide Motion . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-30 3.6.4 C-arm Rotational Motion . . . . . . . . . . . . . . . . . . . . . . . 3-30 3.6.5 Lock Release Switches on the Doctor handle . . . . . . . 3-31 3.6.6 About the Scales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-32 3.7 Operating Study List Window . . . . . . . . . . . . . . . . . . . . . . 3-33 3.7.1 Registering New Study . . . . . . . . . . . . . . . . . . . . . . . . 3-38 3.7.2 Checking Study Information . . . . . . . . . . . . . . . . . . . . . 3-43 3.7.3 Updating Study Information . . . . . . . . . . . . . . . . . . . . . 3-46 3.7.4 Deleting Registered Study . . . . . . . . . . . . . . . . . . . . . . 3-48 3.7.5 Filtering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-49 3.8 Starting Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-53 3.8.1 Starting New Study . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-53 3.8.2 Restarting Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-54 3.8.3 Emergency Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-55 3.9 Operating Study Window . . . . . . . . . . . . . . . . . . . . . . . . . 3-57 3.10 Selecting the APR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-64 3.11 Fluoroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-73 3.12 Changing Field Size (Zooming-up Images) . . . . . . . . . . . 3-80 3.13 Image Rotation and Reverse, Collimator, Compensating Filter Operation . . . . . . . . . . . . . . . . . . . . . 3-81 3.13.1 Image Rotation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-81 3.13.2 Image Reverse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-82 3.13.3 Collimator and Compensating Filter Operation . . . . . . 3-83 3.13.4 Setting the Beam Hardening Filter . . . . . . . . . . . . . . . . 3-86 3.14 Radiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-87 3.15 Removing and Mounting Grid . . . . . . . . . . . . . . . . . . . . . . 3-95 3.15.1 Removing the Grid . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-95 3.15.2 Mounting the Grid . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-97 3.16 Useful Functions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-99 3.16.1 Smart C Memory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-99 OPESCOPE ACTENO FD type Instruction Manual iii Contents 3.16.2 Live Monitor Image Display on the C-arm Main Panel (Option) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-101 3.16.3 Image Lock on the Reference Monitor . . . . . . . . . . . . 3-102 3.16.4 Touch Focus Function (Option) . . . . . . . . . . . . . . . . . 3-104 3.17 System Settings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-109 3.17.1 Guidance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-110 3.17.2 Default Settings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-111 3.17.3 Touch Panel Calibration . . . . . . . . . . . . . . . . . . . . . . . 3-116 3.18 Ending the Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-118 3.19 Dose Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-119 Chapter 4 Image Processing 4.1 Adjusting Fluoroscopy Contrast and Brightness (C-arm Main Panel) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-2 4.2 Saving/Selecting/Navigating Images . . . . . . . . . . . . . . . . . . 4-3 4.2.1 Saving Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-3 4.2.2 Selecting/Navigating the Images . . . . . . . . . . . . . . . . . . 4-7 4.3 Operating Image List Window . . . . . . . . . . . . . . . . . . . . . . . 4-8 4.3.1 Enabling and Disabling File Protection . . . . . . . . . . . . . 4-20 4.3.2 Deleting Files . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-21 4.3.3 Revising Patient Information . . . . . . . . . . . . . . . . . . . . 4-22 4.3.4 Dividing Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-23 4.3.5 Combining Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-25 4.3.6 Anonymous . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-27 4.3.7 About Image Files In Use . . . . . . . . . . . . . . . . . . . . . . . 4-28 4.3.8 Filtering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-28 Chapter 5 Troubleshooting 5.1 Measures for Power Outages . . . . . . . . . . . . . . . . . . . . . . . 5-2 5.2 When DR Software, SDR-120F, Does Not Respond . . . . . 5-3 5.2.1 When the screen freezes and does not respond . . . . . . 5-3 5.2.2 When the monitor goes off and does not respond . . . . . 5-3 5.3 LCD Display or Switch on C-arm Cart Does Not Respond . 5-4 5.4 When System Switch Does Not Respond . . . . . . . . . . . . . . 5-5 iv OPESCOPE ACTENO FD type Instruction Manual  Contents 5.5 When Message of Mother Board Battery Replacement Appears on Reference Monitor . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-6 5.6 Responding to Problems . . . . . . . . . . . . . . . . . . . . . . . . . . 5-7 5.7 Where Errors are Displayed . . . . . . . . . . . . . . . . . . . . . . . . 5-9 5.7.1 C-arm Main Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-9 5.7.2 Reference Monitor . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-12 Chapter 6 Maintenance and Inspections 6.1 Maintenance and Inspections . . . . . . . . . . . . . . . . . . . . . . . 6-2 6.2 Daily Inspections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-3 6.3 Cleaning and Disinfection . . . . . . . . . . . . . . . . . . . . . . . . . . 6-4 6.4 Inspection for Warning and Caution Labels . . . . . . . . . . . . 6-7 6.5 Checking organization of the dose information . . . . . . . . . . 6-8 6.6 Periodic Inspections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-10 6.7 Regularly Replaced Components . . . . . . . . . . . . . . . . . . . 6-10 Chapter 7 Options 7.1 Laser Pointer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-2 7.2 Fitting and Removing the Cover . . . . . . . . . . . . . . . . . . . . . 7-3 7.3 External Video Output . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-4 7.3.1 How to Connect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-5 7.3.2 External Video Output Settings . . . . . . . . . . . . . . . . . . . 7-6 7.3.3 Clone Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-9 7.4 Hand Switch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-13 7.5 Wireless Hand Switch . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-15 7.5.1 Using the Wireless Hand Switch . . . . . . . . . . . . . . . . . 7-17 7.5.2 Operable Range of the Wireless Hand Switch . . . . . . 7-18 7.5.3 Replacing Batteries . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-19 7.6 Long Cable Foot Switch . . . . . . . . . . . . . . . . . . . . . . . . . . 7-21 7.6.1 Connecting Long Cable Foot Switch . . . . . . . . . . . . . . 7-21 7.6.2 Fluoroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-22 7.6.3 Digital Radiography . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-22 7.7 Wireless LAN Kit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-23 OPESCOPE ACTENO FD type Instruction Manual v Contents Chapter 8 Technical Data 8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) . . . . . . . . . . . . . . . . . . . . . 8-2 8.2 Statement of Compliance [For Europe] . . . . . . . . . . . . . . 8-11 8.2.1 Regulatory Information . . . . . . . . . . . . . . . . . . . . . . . . 8-11 8.2.2 Company's Quality System . . . . . . . . . . . . . . . . . . . . . 8-11 8.2.3 International Standards . . . . . . . . . . . . . . . . . . . . . . . . 8-12 8.2.4 Protection Against Radiation . . . . . . . . . . . . . . . . . . . . 8-12 8.3 Statement of Compliance with Standards . . . . . . . . . . . . 8-12 8.4 Manufacturer Information . . . . . . . . . . . . . . . . . . . . . . . . 8-13 8.5 Specifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-14 8.6 Initial Setting Values for APR . . . . . . . . . . . . . . . . . . . . . 8-26 8.7 Conditions for Installation and Use . . . . . . . . . . . . . . . . . 8-36 8.8 Storage Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-36 8.9 KV-mA Curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-37 8.10 Information on Radiation . . . . . . . . . . . . . . . . . . . . . . . . . 8-39 8.10.1 Radiation Protection . . . . . . . . . . . . . . . . . . . . . . . . . . 8-39 8.10.2 Stray Radiation in the Significant Zone of Occupancy 8-40 8.10.3 Test Report Stray Radiation for OPESCOPE ACTENO FD type . . . . . . . . . . . . . . . . . 8-43 8.10.4 Deterministic Effect . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-45 8.10.5 Reference Air Kerma (Rate) . . . . . . . . . . . . . . . . . . . . 8-46 8.10.6 Distribution Map of Stray Radiation . . . . . . . . . . . . . . 8-52 8.11 Labels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-56 Chapter 9 Appendix 9.1 Starting Inspection Checklist . . . . . . . . . . . . . . . . . . . . . . . 9-2 9.2 Ending Inspection Checklist . . . . . . . . . . . . . . . . . . . . . . . 9-5 vi OPESCOPE ACTENO FD type Instruction Manual Chapter 1 Overview of the OPESCOPE ACTENO FD type 1 Chapter 2 Configuration of the Equipment 2 Chapter 3 Basic Operation 3 Chapter 4 Image Processing 4 Chapter 5 Troubleshooting 5 Chapter 6 Maintenance and Inspections 6 Chapter 7 Options 7 Chapter 8 Technical Data 8 Chapter 9 Appendix 9 OPESCOPE ACTENO FD type Instruction Manual vii  This page is intentionally left blank. viii OPESCOPE ACTENO FD type Instruction Manual  Chapter 1 Overview of the OPESCOPE ACTENO FD type This chapter gives an overview of the OPESCOPE ACTENO FD type and describes its characteristics and the environmental conditions in which it should be used. Chapter 1 Overview of the OPESCOPE ACTENO FD type 1.1 Application ■ Intended use This equipment is a mobile imaging system for X-ray fluoroscopy, radiography and angiography to be used during surgery as well as in X-ray examination rooms. ■ Indications for use This equipment is used for radiographic and fluoroscopy examinations of whole body except mammography, and interventional procedures. This equipment must only be operated by qualified personnel, such as radiography technicians or those with equivalent qualifications. This equipment is used for total patient population including pediatric examinations. 1.1.1 About the OPESCOPE ACTENO FD type For details on the function of each part, see Chapter 2 "Configuration of the Equipment". Doctor handle Live monitor Reference monitor C-arm FPD X-ray tube assembly C-arm cart Monitor cart Fig. 1.1 System overall 1-2 OPESCOPE ACTENO FD type Instruction Manual  1.2 Features 1.2 Features This unit incorporates the following support features to allow smooth fluoroscopy and radiography while ensuring the functionality and safety required in operating 1 theaters and E.R. facilities. ♦ High image quality 1. The 8-inch FPD and digital image processing enable the acquisition of high-quality diagnostic images. 2. When you select the Boost pulse mode in pulsed fluoroscopy, you can obtain high-quality images at a continuous fluoroscopy dose lower than the standard. 3. The large 19 inch LCD monitor offers a wide viewing angle so the display is easy to see from anywhere. ♦ Dose Reduction 1. A “last image hold” (LIH) function is provided for cases where fluoroscopy is not necessary for confirmation. 2. The virtual rotation function and virtual collimator function allow you to rotate, and perform virtual collimator and compensating filter operations on, the last image hold (LIH) image and loop memory images. 3. Pulsed fluoroscopy generates reduced radiation since the X-rays are emitted in pulse form. You can obtain high-resolution images in pulsed fluoroscopy at the maximum frame rate (15 fps). 4. The radiation exposure can be reduced by switching the filters. ♦ Speedy 1. The C-arm is a manually-operated, balanced type and the brake is an electromagnetic locking type. 2. The freedom of motion makes it easy to position the equipment for work on any limb or on the spinal cord, which helps to reduce both the positioning time and the time required for surgery. 3. There is a C-arm lock switch located on the Doctor handle. This allows the physician to release the lock quickly. 4. The “touch panel” format is adopted for the C-arm main panel. An intuitive and easy to understand GUI is used. To operate it all you have to do is directly press the buttons that appear on the screen. 5. From the C-arm main panel, you can perform operations such as image transmission. You can perform almost all operations during examinations from the C-arm. OPESCOPE ACTENO FD type Instruction Manual 1-3 Chapter 1 Overview of the OPESCOPE ACTENO FD type 6. By using APRs (anatomical programs), you can call up the optimum fluoroscopy and radiography conditions for each part of the body in a one-touch operation. ♦ Compact and light 1. Because the equipment is compact and lightweight, it is easy to set up in all kinds of locations. 2. The large wheels equipped with cable guards allow the unit to be moved easily even in confined spaces. ♦ Clean 1. The cables are incorporated into the C-arm, so they will not come into contact with the patient or surgical instruments, allowing the equipment to be used safely. 2. The design is rounded and simple. Care work such as cleaning and disinfection can be done easily, ensuring continued hygiene. 1.3 Principle • This equipment irradiates X-rays from an X-ray tube assembly. The X-ray absorption data after the human body is penetrated is detected and converted into digital image data by the FPD, and imported into an image processor. • The image processor displays digitally processed images on a monitor, records the imported images and transfers them via a network. 1-4 OPESCOPE ACTENO FD type Instruction Manual  1.4 Environmental Conditions 1.4 Environmental Conditions To obtain proper performance, be sure to use the equipment under the specified environmental conditions. 1 1.4.1 Operation Environment Use the equipment under the environmental conditions listed below: The installation of a dedicated air-conditioner in the examination room is recommended if the building air-conditioning cannot meet the necessary environmental conditions. WARNING Do NOT use the equipment in an oxygen-rich environment. The use of the equipment in an oxygen-rich environment may cause fatal or serious injuries or damage to the equipment due to easy ignition. CAUTION Even under the prescribed conditions, avoid rapid changes of temperature or humidity. Condensation may occur and cause failure. Also, rust or corrosion may occur inside the equipment. Item Specifications Atmosphere No explosive or corrosive gases Ambient temperature 10 °C to 35 °C Relative humidity 30 % to 80 % (no condensation) Atmospheric pressure 800 hPa to 1060 hPa (800 mbar to 1060 mbar) Environment luminosity 150 lx to 500 lx Ambient noise level Under 70 dB OPESCOPE ACTENO FD type Instruction Manual 1-5 Chapter 1 Overview of the OPESCOPE ACTENO FD type 1.4.2 Transportation and Storage Environment Item Specifications Temperature 0 °C to 40 °C Relative humidity 10 % to 80 % (no condensation) Atmospheric pressure 700 hPa to 1060 hPa (700 mbar to 1060 mbar) Atmosphere No explosive or corrosive gases 1.4.3 Power Supply Item Specifications Phase Single phase AC Frequency 50/60 Hz Standard voltages 100, 110, 120, 200, 220, 230, 240 VAC Permitted voltage range ±10 % of standard voltage Supply capacity 2.0 kVA or more Power supply 100, 110, 120 V : 0.2 Ω max. impedance 200, 220, 230, 240 V : 0.8 Ω max. DANGER Be sure to use the power supply specified in the instruction manual. Using a power supply other than the one specified may cause equipment malfunction or serious accidents such as fire, smoke emission, or explosions. 1-6 OPESCOPE ACTENO FD type Instruction Manual  1.4 Environmental Conditions 1.4.4 Grounding Grounding resistance: less than 100 Ω 1 WARNING Be sure to connect the equipment only to a (commercial) power outlet with a ground terminal. Do NOT connect the equipment to power stripes, extension cords, or overloaded electrical circuits. Doing so may cause the electric shock. 1.4.5 Network/Security Item Description SDR-120F PC Hardware • CPU: 2-core or more Condition • HDD: 500 GB or more Operating • Memory: 8 GB or more Environment Software Condition SDR-120F PC: Windows 10 or later Network Condition 1000Base-T, TCP/IP protocol Security Anti-Virus Equipped Software Software Transmission protocol: DICOM/Storage, Data and Interface DICOM/MWM, DICOM/Print, DICOM/MPPS Interface: 1000Base-T The type/authority of user group • for user: Authority of standard User Access Control • for service: Authority of manager Password protected System Software Windows 10 or later Software Support Software .NET Framework Environment Application Nothing Requirements of Because it’s whitelist, there is no update. Security Software Updates OPESCOPE ACTENO FD type Instruction Manual 1-7 Chapter 1 Overview of the OPESCOPE ACTENO FD type 1.5 Classification of Equipment This equipment is classified as follows, based on safety standards for electrical medical equipment. ♦ Protection Method Against Electric Shock Class I equipment ♦ Classification of Applied Parts No Applied Parts ♦ Operation Mode Continuous operation ♦ Degree of Protection Against Liquid Ingress • Ordinary equipment CAUTION Use the equipment in a location where there is no danger of water entry. If water does enter inside the equipment there will be an electric shock danger. Do NOT allow water to get onto the surface of the equipment or get inside it. If water does get onto the equipment, turn the power OFF immediately and contact your Shimadzu service representative. • Foot switch: IPX8* (immersion beyond 1 m) * : The IPX Waterproof Specification, specified by the International Electrotechnical Commission, indicates waterproof/drip-proof performance on instruments and equipment. 1-8 OPESCOPE ACTENO FD type Instruction Manual  1.5 Classification of Equipment ♦ For Use in an Oxygen-rich Environment WARNING 1 Do NOT use the equipment in an oxygen-rich environment. The use in an oxygen-rich environment may cause fatal or serious injuries or damage to the equipment due to easy ignition. ♦ For Use in Flammable Atmosphere DANGER Do NOT use the equipment in the presence of flammable anesthetic gas. Doing so may cause an explosion. ♦ Classification of Installation Type Mobile equipment OPESCOPE ACTENO FD type Instruction Manual 1-9 Chapter 1 Overview of the OPESCOPE ACTENO FD type 1.6 Symbols The symbols used on the equipment are shown below: Symbol Location Meaning On name plate Alternating current Inside the equipment, where protective earth conductor in power Protective earth ground cord is connected Observe described items, or On warning and caution labels refer to instruction manual. On name plate Refer to instruction manual Potential equalization Potential equalization conductor conductor On name plate Refer to instruction manual On name plate Serial number Year and month of On name plate manufacture On name plate Manufacturer On the back of the monitor cart Refer to instruction manual 1-10 OPESCOPE ACTENO FD type Instruction Manual  1.7 Operator Profile 1.7 Operator Profile Item Details 1 Age that which a person can obtain the license of Radiological Age Technologist or a license equal to it. Sex No limitation Nationality No limitation Radiological Technologist or person who has a license equal to it. Education The capacity to read and understand the instruction manual. Knowledge Radiological Technologist or person who has a license equal to it. Language Can read and understand English. Necessary. Experience Every operator needs to take training for operating the equipment before using the equipment. Corrected eyesight is over 0.7 using the decimal system (70 %). Permissible Impaired by 40 % resulting in 60 % of normal hearing at 500 Hz to impairments 2 kHz. Over 140 cm tall. Others Person who can confirm the safety by looking ahead of the equipment. OPESCOPE ACTENO FD type Instruction Manual 1-11 Chapter 1 Overview of the OPESCOPE ACTENO FD type This page is intentionally left blank. 1-12 OPESCOPE ACTENO FD type Instruction Manual  Chapter 2 Configuration of the Equipment This chapter explains the configuration of the equipment. Chapter 2 Configuration of the Equipment 2.1 Standard Configuration The two major components of the equipment are the C-arm cart and the monitor cart. Both the C-arm cart and the monitor cart are suitable for use in patient environment. 2.1.1 C-arm Cart The C-arm cart can be operated to achieve the most suitable position for fluoroscopy or radiography. The C-arm cart is connected to the monitor cart before using the equipment. (6) C-arm (1) Doctor handle (2) FPD Direction of X-ray beam (7) Main panel (3) Beam limiting device (4) X-ray tube assembly (8) Maneuvering handles (5) Side panel (10) Hand switch (option) (11) Wireless hand switch (option) (9) Brake pedal (12) Connector (14) Long cable (13) Foot switch foot switch Fig. 2.1 C-arm cart 2-2 OPESCOPE ACTENO FD type Instruction Manual  2.1 Standard Configuration (1) Doctor handle This is a handle used by the surgeon to operate the equipment. The handle is provided with a switch for unlocking the C-arm. For details, see 3.6.5 "Lock Release Switches on the Doctor handle" (page 3-31). (2) FPD 2 This is the abbreviation for the Flat Panel Detector. The equipment detects the X-rays, which are radiated from the X-ray tube unit and passed through the patient's body, using the FPD, and converts them into digital image data. (3) Beam limiting device Controls the range of X-ray radiation when performing fluoroscopy or taking a radiograph. (4) X-ray tube assembly This is the unit that generates X-rays. A fixed anode type X-ray tube is used. (5) Side panel It features functions such as lock and unlock of the C-arm, image rotation, image reverse and smart C memory. Fig. 2.2 Side panel For details, see 2.3 "Side Panel" (page 2-23). (6) C-arm The C-arm is balanced and is operated manually. Since the brake is an electromagnetic locking type, it can be switched on and off with one touch. The C-arm can easily be positioned however required. OPESCOPE ACTENO FD type Instruction Manual 2-3 Chapter 2 Configuration of the Equipment (7) Main panel Used to set the loading factor and perform image-processing operations. The unit is equipped with a compact LCD monitor with a touch panel and you can perform operations from this touch panel. Fig. 2.3 Main panel For details, see 2.2.1 "Function of Each Switch" (page 2-11). (8) Maneuvering handles Used to move the C-arm. For details, see 3.2.1 "Moving the C-arm Cart" (page 3-4). (9) Brake pedal This is the brake for the C-arm. Fig. 2.4 Brake pedal For details, see 3.2.1 "Moving the C-arm Cart" (page 3-4). 2-4 OPESCOPE ACTENO FD type Instruction Manual  2.1 Standard Configuration (10) Hand switch (Option) (11) Wireless hand switch (Option) In the Radiography mode Hand switch Type of radiography First level Preparations for radiography Second level Digital Radiography 2 In the Fluoroscopy/Radiography mode Type of fluoroscopy and Hand switch radiography • Continuous fluoroscopy First level • Pulsed fluoroscopy Second level Digital Radiography For details of the Hand switch, see 7.4 "Hand Switch" (page 7-13). For details of the Wireless hand switch, see 7.5 "Wireless Hand Switch" (page 7-15). (12) Connector Opens the connector cover and connect the cart cable from the monitor cart. Fig. 2.5 Connector For details, see 3.4 "Turn the Power ON / OFF" (page 3-15). OPESCOPE ACTENO FD type Instruction Manual 2-5 Chapter 2 Configuration of the Equipment (13) Foot switch (14) Long cable foot switch (Option) Type of fluoroscopy and Foot switch radiography • Continuous fluoroscopy Left foot switch • Pulsed fluoroscopy Right foot switch Digital Radiography For details on the Long cable foot switch, see 7.6 "Long Cable Foot Switch" (page 7-21). Right foot switch Left foot switch (For Digital radiography) (For continuous fluoroscopy, pulsed fluoroscopy) Fig. 2.6 Foot switch Right foot switch Left foot switch (For Digital radiography) (For continuous fluoroscopy, pulsed fluoroscopy) Fig. 2.7 Long Cable Foot switch (option) 2-6 OPESCOPE ACTENO FD type Instruction Manual  2.1 Standard Configuration 2.1.2 Configuration of the Monitor Cart This is the cart on which the monitors are installed. It is used while connected to the C-arm cart and it controls the power supply to the OPESCOPE ACTENO FD type system. The SDR-120F is also installed as a DR software. (1) Live monitor (2) Reference monitor (8) Irradiation indicator 2 (3) Handle for (9) Auxiliary stopper (10) DVI port (option) adjusting monitor position (7) Keyboard (11) LAN port shelf (4) System switch (5) USB Port (For USB memory storage devices) (6) DVD tray (12) Power switch Fig. 2.8 Monitor cart OPESCOPE ACTENO FD type Instruction Manual 2-7 Chapter 2 Configuration of the Equipment NOTE About the monitor display • Depending on the display conditions you may see very small spots or irregularities, but this does not indicate a fault. • Some pixels may exhibit a display defect (they may be missing, or always lit). • In cold locations the image may appear to leave a trace or may look dim, but this is not a fault. The equipment will return to normal once the temperature has risen. • Do NOT leave a still image displayed for a long time since this can cause an afterimage. • The image may appear with different tones of color on the live monitor and the reference monitor. (1) Live monitor The live monitor shows a screen of the DR Software, SDR-120F. A fluoroscopic image during fluoroscopy and last image hold (LIH) image are displayed. For details, see 2.4 "Live Monitor" (page 2-25). (2) Reference monitor The reference monitor shows a screen of the DR Software, SDR-120F. It displays reference images and allows you to register study information and make various settings for study, post-processing, and so on by using the mouse and keyboard. For details, see 2.5 "Reference Monitor" (page 2-28). (3) Handle for adjusting monitor position Grasp this handle and move it upward or downward to adjust the monitor position. 2-8 OPESCOPE ACTENO FD type Instruction Manual  2.1 Standard Configuration (4) System switch Turns the power ON. For details, see 3.4 "Turn the Power ON / OFF" (page 3-15). Switch Status Description 2 Unlit Power OFF Slow blinking The power is only supplied to the monitor (1 second interval) cart. Fast blinking System is shutting down. (0.25 second interval) Lit Power ON (5) USB Port Connects to USB memory storage devices for storing images. NOTE Be sure to remove USB memory storage devices before moving the monitor cart. Otherwise, the patient or operator may be injured or the surroundings may be damaged. NOTE The USB ports are dedicated for USB memory storage devices. Do NOT connect other type of devices to this port. NOTE Before using a USB memory storage device, make sure that it is not infected with a virus using virus scanning software that has been updated to the latest definition file. OPESCOPE ACTENO FD type Instruction Manual 2-9 Chapter 2 Configuration of the Equipment (6) DVD tray Used to save data to CD-R/DVD-R. (7) Keyboard shelf Accommodates the keyboard, mouse, etc. (8) Irradiation indicator The indicator is lit in yellow during X-ray radiation. (9) Auxiliary stopper Fixes the position of the monitor in the vertical direction. To adjust this position, first loosen the auxiliary stopper. (10) DVI port (option) Connects to DVI cable. (11) LAN port Connects to LAN cable. (12) Power switch Closes and opens power supply circuit. For details, see 3.4 "Turn the Power ON / OFF" (page 3-15). 2-10 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel 2.2 Main Panel 2.2.1 Function of Each Switch 7 2 1 1 2 2 8 3 9 4 10 5 11 6 12 Fig. 2.9 Main panel Reference No. Switch Name Description page Fluoroscopy timer Stops the fluoroscopy timer beep sound 1 beep sound reset 3-76 tone switch Presses this switch to start X-ray X-ray exposure 2 fluoroscopy. 3-75 (fluoroscopy) switch X-rays will be radiated. Opens/closes Parallel Parallel compensating 3 the parallel compensating filter filter open/close compensating filter. Parallel compensating Rotates the parallel 4 filter rotation compensating filter. 3-83 Opens/closes the Octagonal collimator 5 octagonal open/close collimator. Octagonal collimator OPESCOPE ACTENO FD type Instruction Manual 2-11 Chapter 2 Configuration of the Equipment Reference No. Switch Name Description page Presses this switch to release the restriction on X-ray fluoroscopy and radiography for X-ray exposure the X-ray exposure switch or the foot 6 restriction releasing 3-74 switch. switch X-rays can be radiated only when the switch is lit. Image display Used to switch the content of the LCD 7 switching switch display (fluoroscopic image / operation 3-101 (option) screen). Automatically adjusts the contrast and Fluoroscopy brightness of the fluoroscopic image in 7 8 brightness adjustment stages (-2 to +4). switch The set image brightness is displayed at the 4-2 top right of the LCD display. Resets the fluoroscopic image brightness 9 Reset switch setting to 0. For frame memory images, selects the saved image. 10 Next/Previous switch For the loop memory images or serial 4-7 , images, switches to the next/previous the image. Starts/stops playback of the series of 11 Playback/Stop switch fluoroscopic images (loop) when the loop 4-7 memory function is selected. You can view the guidance, check and 12 Menu switch change the initial setting and the touch 3-109 panel calibration. CAUTION If you leave the unit for any substantial time, press the X-ray exposure restriction releasing switch to flash in order to prevent malfunction. 2-12 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel 2.2.2 LCD Display A touch panel is incorporated, allowing operation by directly pressing the buttons on the display. Displayed buttons differ depending on the screen. ♦ Startup Screen 2 1 Fig. 2.10 Startup screen No. Description Displays the status of the device. 1 : In preparation : Ready OPESCOPE ACTENO FD type Instruction Manual 2-13 Chapter 2 Configuration of the Equipment ♦ Basic screen There are two modes of operation display as explained below. • Simple mode Mode that uses a large, easy to view screen layout for users who do not change settings frequently. • Expert mode Mode for users who expeditiously change all settings. Simple mode 2 3 4 5 1 6 7 8 9 11 10 18 19 12 13 14 15 16 17 Fig. 2.11 Basic screen (Simple mode) Reference No. Name Description page Switches the X-ray adjustment mode. Auto/Manual switching button 1 (Auto) : Adjust X-rays automatically. 3-79 (Manual) : Adjust X-rays manually. Indicates the tube voltage. The setting range is 40 to 110 kV. Press (+)/ (-) to change the value 2 X-ray tube voltage display - manually. This cannot be changed when auto is set. 2-14 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel Reference No. Name Description page In the fluoroscopy, the tube current is set automatically. This value cannot be changed X-ray tube current display / manually. 3 X-ray tube current product 3-89 When using digital radiography, the tube current display time product (mAs) is displayed during X-ray radiography. Used to select the beam hardening filter. Each time 2 Beam hardening filter switching you press the button the beam hardening filter button changes. 4 Each time you press the button, the beam hardening 3-86 filter display changes in the following order: [NONE] → [Filter 1]→ [Filter 2]→[Filter 3] →[NONE]. Displays the system status. (lits yellow): When X-rays are being radiated (lits green): When fluoroscopy and radiography is possible 5 System status display : Caution. This is not a system failure. - Operation can be continued. Refer to the message on the screen. : The X-ray tube assembly temperature has exceeded the limit value. Fluoroscopy and radiography cannot be performed until the temperature drops. 6 Image brightness display The set image brightness is displayed. 4-2 OPESCOPE ACTENO FD type Instruction Manual 2-15 Chapter 2 Configuration of the Equipment Reference No. Name Description page Indicates the temperature/status of the X-ray tube assembly. (white): Indicates the temperature of the X-ray tube assembly.∗ (yellow): The X-ray radiation will be suspended soon due to the high temperature of the X-ray tube assembly. X-ray tube assembly 7 (red): The X-ray tube assembly - temperature display temperature has exceeded the limit value. Fluoroscopy and radiography cannot be performed until the temperature drops. ∗: Although the memory (white) may be displayed immediately after the equipment starts depending on the room temperature conditions, it is not a failure. Indicates Fluoroscopy time, Reference air kerma 8 Dose display rate, Accumulated reference air kerma and Total 3-119 dose area product. Fluoroscopy mode selection button Displays the fluoroscopy mode selection screen. 3-66 9 Set [Dose], [Pulse rate] and [Loop]. 3-73 APR selection button Displays the APR selection screen. 10 3-65 Select APR or overwrite save. Emergency case The patient ID and patient name are set 3-56 automatically when the study is started. 11 Acquisition mode selection button Displays the acquisition mode selection screen. 3-70 Set [Acq mode] and [Acq Rate]. 3-87 2-16 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel Reference No. Name Description page Zoom button 12 Changes the field size. (The images are zoomed up.) 3-80 Printer button (option) When a printer etc., is connected, the image displayed on the monitor is printed. 13 7-4 * To use this function, contact your Shimadzu service representative. 2 Save button 14 Saves the image to the hard disk. 4-3 Dose Info. button Displays the dose report. Indicates Total dose area product, Accumulated 15 3-119 reference air kerma (AK), and Total fluoroscopy time. Setting screen switch button 16 Switches between Simple mode and Expert mode. - End study button Completes the study and displays the "New study 17 3-118 standby screen". Control monitor switching button Switches the monitor controlled through the C-arm 18 4-7 main panel. Laser pointer button Displays or hides the cross lines from the laser projector. 19 7-2 * To use this function, contact your Shimadzu (Option) service representative. OPESCOPE ACTENO FD type Instruction Manual 2-17 Chapter 2 Configuration of the Equipment ♦ Expert mode 2 3 4 5 1 6 7 8 10 12 9 13 14 11 22 23 24 15 16 17 18 19 20 21 Fig. 2.12 Basic screen (Expert mode) Reference No. Name Description page Switches the X-ray adjustment mode. Auto/Manual switching button 1 (Auto) : Adjust X-rays automatically. 3-79 (Manual) : Adjust X-rays manually. Indicates the tube voltage. The setting range is 40 to 110 kV. Press (+)/ (-) to change the value 2 X-ray tube voltage display - manually. This cannot be changed when auto is set. In the fluoroscopy, the tube current is set automatically. This value cannot be changed X-ray tube current display / manually. 3 X-ray tube current product 3-89 When using digital radiography, the tube current display time product (mAs) is displayed during X-ray radiography. 2-18 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel Reference No. Name Description page Used to select the beam hardening filter. Each time Beam hardening filter switching you press the button the beam hardening filter button changes. 4 Each time you press the button, the beam hardening 3-86 filter display changes in the following order: [NONE] → [Filter 1]→ [Filter 2]→[Filter 3] →[NONE]. 2 Displays the system status. (lits yellow): When X-rays are being radiated (lits green): When fluoroscopy and radiography is possible 5 System status display : Caution. This is not a system failure. - Operation can be continued. Refer to the message on the screen. : The X-ray tube assembly temperature has exceeded the limit value. Fluoroscopy and radiography cannot be performed until the temperature drops. 6 Image brightness display The set image brightness is displayed. 4-2 Indicates the temperature/status of the X-ray tube assembly. (white): Indicates the temperature of the X-ray tube assembly.∗ (yellow): The X-ray radiation will be suspended soon due to the high temperature of the X-ray tube assembly. X-ray tube assembly 7 (red): The X-ray tube assembly - temperature display temperature has exceeded the limit value. Fluoroscopy and radiography cannot be performed until the temperature drops. ∗: Although the memory (white) may be displayed immediately after the equipment starts depending on the room temperature conditions, it is not a failure. OPESCOPE ACTENO FD type Instruction Manual 2-19 Chapter 2 Configuration of the Equipment Reference No. Name Description page Indicates Fluoroscopy time, Reference air kerma 8 Dose display rate, Accumulated reference air kerma and Total 3-119 dose area product. Sets the dose. • [High Quality]: Irradiates a high dose of X-rays to generate a high quality image. • [Normal]: Irradiates a standard dose of X-rays. • [Low Dose 1]: Dose selection button Irradiates a low dose of X-rays to minimize the radiation dose to the patient. • [Low Dose 2]: 9 Irradiates a lower dose of X-rays than in [Low - Dose 1] to minimize the radiation dose to the patient. • [Boost Pulse]: Irradiates a high dose of X-rays to generate a high quality image. There are two types of pulse rate, 7.5 fps and 3.75 fps, and high dose is irradiated with a tube current peak value that is double that of the High Quality mode. For this reason, it is useful for procedures on thick body parts which are moved comparatively less than other parts. Pulse rate selection button Sets the fluoroscopy pulse rate. Select [Continuous] to perform continuous 10 fluoroscopy. Select the [15 fps], [10 fps], [7.5 fps] or - [3.75 fps] button to switch to pulsed fluoroscopy and change the pulse rate to the selected value. Loop button Temporally saves loop memory images (series of 11 4-4 fluoroscopic images). APR selection button Displays the APR selection screen to select an APR 12 3-65 or overwrite save. 2-20 OPESCOPE ACTENO FD type Instruction Manual  2.2 Main Panel Reference No. Name Description page Emergency case The patient ID and patient name are set 3-56 automatically when the study is started. Acquisition mode selection button 2 Sets the acquisition mode. 13 • [Spot]: Radiography with one irradiation • [Serial]: Radiography with continuous irradiation - • [DSA]: DSA radiography Set the acquisition rate only when [Serial] or [DSA] is selected. Density selection button Selects the density ([-3] / [-2] / [-1] / [0] / [+1] / [+2] 14 / [+3]). The higher the number rises, the higher the - dose will be increased. Manual spot radiography mode button Used for the manual spot radiography. 15 ∗: When this function is unnecessary, contact your 3-92 Shimadzu service representative. Zoom button 16 Changes the field size. (The images are zoomed up.) 3-80 Printer button (option) When a printer etc., is connected, the image displayed on the monitor is printed. 17 7-4 * To use this function, contact your Shimadzu service representative. Save button 18 Saves the image to the hard disk. 4-3 Dose Info. button Displays the dose report. Indicates Total dose area product, Accumulated 19 3-119 reference air kerma (AK), and Total fluoroscopy time. Setting screen switch button 20 Switches between Simple mode and Expert mode. - OPESCOPE ACTENO FD type Instruction Manual 2-21 Chapter 2 Configuration of the Equipment Reference No. Name Description page End study button Completes the study and displays the "New study 21 3-118 standby screen". Laser pointer button Displays or hides the cross lines from the laser projector. 22 7-2 * To use this function, contact your Shimadzu (Option) service representative. Control monitor switching button Switches the monitor controlled through the C-arm 23 4-7 main panel. Displayed image lock button Locks the image display on the reference monitor. 24 The acquired image is not displayed during 3-102 radiography. 2-22 OPESCOPE ACTENO FD type Instruction Manual  2.3 Side Panel 2.3 Side Panel 2.3.1 C-arm Lock Switch The C-arm lock switch is used to secure and release the C-arm. 2 1 2 3 4 Fig. 2.13 C-arm lock switch Reference No. Switch Lock location Description page 1 C-arm slide motion 2 C-arm rotary motion Switch lit: The C-arm is unlocked. 3-24 Switch unlit: C-arm forward/back The C-arm is locked. 3 and lateral swiveling movement C-arm longitudinal 4 movement OPESCOPE ACTENO FD type Instruction Manual 2-23 Chapter 2 Configuration of the Equipment 2.3.2 Control Switch 1 2 4 3 Fig. 2.14 Control switch Reference No. Switch Name Description page Used to reverse the image displayed on the monitor. Note that you can only reverse the Monitor image fluoroscopic image in the live monitor 1 3-82 reverse and LIH fluoroscopic image. The subsequent fluoroscopy has the same orientation as the operations used to control it. Used to speed up the rotation operations. Press this switch and then press the 2 Rapid feed 3-81 [Image rotation]. 3 Image rotation Used to rotate the image. 3-81 Used to store the fluoroscopy conditions, the image rotation position, the 4 Smart C memory 3-99 collimator and the compensating filter settings. 2-24 OPESCOPE ACTENO FD type Instruction Manual  2.4 Live Monitor 2.4 Live Monitor The live monitor shows a screen of the DR Software, SDR-120F. 1 2 2 3 11 4 13 5 14 6 16 7 17 18 Fig. 2.15 Live monitor (Before image display) 2 9 3 10 11 4 12 5 15 6 16 7 8 17 19 Fig. 2.16 Live monitor (After image display) OPESCOPE ACTENO FD type Instruction Manual 2-25 Chapter 2 Configuration of the Equipment Reference No. Name Description page 1 Patient information The patient information is displayed. - Accumulated reference air The accumulated reference air kerma of the study 2 3-119 kerma (AK) currently running is indicated. The reference air kerma rate is indicated. It is 3 Reference air kerma rate (AKR) indicated only while fluoroscopy or serial 3-119 radiography is performed. The total dose area product of the study currently 4 Total dose area product (DAP) 3-119 running is indicated. Detachable grid status display 5 : Attached Indicates whether the grid is attached or detached. - : Detached 6 X-ray tube voltage display Indicates the tube voltage. - 7 X-ray tube current display Indicates the tube current. - When using digital radiography, the exposure time 8 Exposure time display 3-89 (ms) is displayed during X-ray radiography. LIH display This is displayed when a fluoroscopy last image hold 3-81 (LIH) image is displayed. 9 Loop memory display This is displayed when the loop memory image is displayed. 4-3 A: Currently displayed image [A/B] B: Total number of recorded images Indicates the frame rate of the image currently 10 Frame rate display - displayed. Loop memory mode display This is displayed when the loop memory mode is 11 4-4 used. This displays the loop memory status. Loop memory status display 4-4 12 : Playback 4-7 / : Paused Clone display*1 13 This is displayed during the clone display. 7-9 2-26 OPESCOPE ACTENO FD type Instruction Manual  2.4 Live Monitor Reference No. Name Description page This is displayed when the following functions are Display during mechanical operating. operation 14 • Collimator 3-81 • BH filter • Compensating filter 15 Display during image saving This is displayed when an image is being saved. 4-3 2 Fluoroscopy brightness display 16 This displays the set fluoroscopic image brightness. 4-2 The total fluoroscopy time of the study currently 3-75 17 Fluoroscopy time running is indicated. 3-119 Displays warning or error message. When you 18 Message display display the offset calibration status, the error - message may appear only briefly. 19 Laser pointer display*2 The cross lines are displayed. 7-2 ∗1: Only displayed when combined with the external video output function (option). ∗2: Only displayed when combined with the laser pointer (option). OPESCOPE ACTENO FD type Instruction Manual 2-27 Chapter 2 Configuration of the Equipment 2.5 Reference Monitor The reference monitor shows a screen of the DR Software, SDR-120F. It allows you to operate a study or saved images. 2.5.1 Screen Configuration The screen has three areas: the main panel area, the operation panel area, and the processing window area. Processing window area (Image display area) Main panel area Operation panel area Fig. 2.17 Reference monitor 2-28 OPESCOPE ACTENO FD type Instruction Manual  2.5 Reference Monitor ♦ Main Panel Area The main panel area is used to switch between windows, and to start up and shut down the system. It is always displayed even though some of the buttons change. 4 1 3 2 2 Fig. 2.18 Main panel area No. Name Description Processes that are not used frequently in system operation are registered in menu format. “SDR-120F Reference Guide” System menu • [Edit Preset]: Edits a preset used for study, such as print and radiography conditions, and a preset used for study registration. 1 • [Utility]: Performs the save screen function to temporarily turn off the screen display, and the SMPTE pattern display function. • [Calibration]: Performs the FPD calibration • [System info.]: Shows the system version. OPESCOPE ACTENO FD type Instruction Manual 2-29 Chapter 2 Configuration of the Equipment No. Name Description Study status display Displays study status. List display Switches to the Study List or Image List window Study button Switches to the Study window. “SDR-120F Reference Guide” 2 Image Edit button Switches to the Image Edit window. “SDR-120F Reference Guide” Print Edit button Switches to the [Print Edit] window. “SDR-120F Reference Guide” Each icon lights or flashes to indicate the system and System/Processing status indicator processing status. Click either icon to check 3 processing details. Some icons has no detail display. “SDR-120F Reference Guide” Current time / Free space Displays the current time and the free space on hard 4 on HDD disk. ♦ Processing Window and Operation Panel The appearances of the processing window and operation panel changes depending on the selection of button on the main panel area. Item Description Processing window Mainly used to display images, and study and image lists. The operation buttons used for processes are displayed Operation panel here. The appearance of the operation panel changes with the selected process. 2-30 OPESCOPE ACTENO FD type Instruction Manual  2.5 Reference Monitor 2.5.2 Study List Window This window is used to manage studies, such as study registration and deletion, and to start a study. 1 2 2 3 5 4 Fig. 2.19 Study List window No. Name Description Image List button Switches to the image list window to manage image files 1 saved on the system's hard disk. Switches to the image list window to manage image files Media button saved on storage medias. “SDR-120F Reference Guide” 2 Eject button Ejects the storage media. Study List operation Displays studies that are categorized in tabs according to 3 area the study status. Study information Displays detailed information about the study selected in 4 details the Study List. Operation panel 5 Operates studies in the Study List. of Study List window OPESCOPE ACTENO FD type Instruction Manual 2-31 Chapter 2 Configuration of the Equipment 2.5.3 Image List Window This window shows all image files saved in the system in the group. 1 3 4 5 Fig. 2.20 Image List window (Hard disc) 1 2 4 5 6 Fig. 2.21 Image List window (Media) 2-32 OPESCOPE ACTENO FD type Instruction Manual  2.5 Reference Monitor No. Name Description Study List button 1 Switches to the Study List window. Image List button Switches to the image list window to manage image files 2 saved on the system's hard disk. Media button Switches to the image list window to manage image files saved on storage medias. 2 “SDR-120F Reference Guide” 3 Eject button Ejects the storage media. Image list operation 4 Lists image files. area Operation panel 5 of Image List Operates images in the Image list. window 6 Disk free space Displays the amount of free space on the storage media. OPESCOPE ACTENO FD type Instruction Manual 2-33 Chapter 2 Configuration of the Equipment 2.5.4 Study Window This window allows you to check study information, close a study, and check and edit a saved image. 1 2 Fig. 2.22 Study window No. Name Description Image and information 1 Displays saved images and information. display area Image and study operation 2 Operates saved images and study. panel 2-34 OPESCOPE ACTENO FD type Instruction Manual  2.5 Reference Monitor 2.5.5 Image Edit Window This window allows you to check and edit a saved image. For details, refer to “SDR-120F Reference Guide”. 2 1 2 Fig. 2.23 Image Edit window No. Name Description 1 Image display area Displays saved images and information. 2 Image operation panel Operates saved images. OPESCOPE ACTENO FD type Instruction Manual 2-35 Chapter 2 Configuration of the Equipment 2.5.6 Print Edit Window This window allows you to print image files or films that are registered for printing, and edit the print format for efficient output. For details, refer to “SDR-120F Reference Guide”. 1 2 Fig. 2.24 Print Edit window No. Name Description 1 Image display area Displays a image to be printed. 2 Print operation panel Operates printing. 2-36 OPESCOPE ACTENO FD type Instruction Manual  Chapter 3 Basic Operation This chapter explains the basic procedure for using the equipment. Chapter 3 Basic Operation 3.1 Introduction NOTE The operating methods and screens displayed on the LCD display differ depending on the screen mode and combination of equipment. This instruction manual explains operations based on the simple mode. This section describes the basic operation flow and provides references. Transport [3.2] / Connection [3.3] Turning the power ON [3.4.1] Positioning (How to operate the C-arm) [3.6] Operating the Study List window [3.7] Starting the study [3.8 ] Operating the Study window [3.9] Selecting the APR [3.10] Study Fluoroscopy [3.11] Digital radiography [3.14] Ending the study [3.18] Turning the power OFF [3.4.3] [ ] indicates the location of a reference. 3-2 OPESCOPE ACTENO FD type Instruction Manual  3.2 Transport 3.2 Transport WARNING Take care to avoid impacts and overturning of the equipment. The equipment weighs more than 200 kg. Impacts and overturning will not only damage the equipment, but could also cause serious injuries. When moving the equipment, pay attention to the following points. 3 • When moving the C-arm between rooms, make sure the C-arm is at its home position. • Follow the instructions in 3.2.1 "Moving the C-arm Cart" (page 3-4) and 3.2.2 "Moving the Monitor Cart" (page 3-9) to make sure the cable work has been done correctly. • When traversing slopes and entrances, and negotiating obstacles, move the equipment as gently as possible. Take particular care on steep slopes. • Always apply the brake after you stop moving the equipment. • Do NOT move the equipment over any steps or bumps greater than 2 cm, or Do NOT use the equipment on a floor that is sloped more than 5 degrees. • In places where moving the equipment generates strong vibrations, for example outdoor paths, avoid rapid progress, deep steps, and steep slopes. Do NOT stop moving on inclined routes. • While wheeling the equipment, watch out for obstacles ahead. • When driving the equipment where people are present, near equipment, or close to a wall, drive slowly to be able to stop immediately and maintain safety in the surroundings. OPESCOPE ACTENO FD type Instruction Manual 3-3 Chapter 3 Basic Operation 3.2.1 Moving the C-arm Cart 1 Check that the C-arm is at its home position (fixed position). • The home position (fixed position) is the position where all scales register zero. See 3.6.6 "About the Scales" (page 3-32). Fig. 3.1 Home position (fixed position) of the C-arm NOTE If the C-arm is not at its home position (fixed position), turn the power ON and return it to the home position (fixed position). 2 Check that the foot switch is enclosed. Fig. 3.2 3-4 OPESCOPE ACTENO FD type Instruction Manual  3.2 Transport 3 Check that the cart cable is disconnected. See 3.3 "Connecting and Dismantling the System" (page 3-12). 4 Release the brake. • Rear brake Step on the side of the brake pedal to release the brake. 3 Situation with the brake applied Situation with the brake released Fig. 3.3 Brake pedal • Front brake Release the lock on the front caster to release the brake. Lock Fig. 3.4 Front caster OPESCOPE ACTENO FD type Instruction Manual 3-5 Chapter 3 Basic Operation 5 Hold the maneuvering handles while moving the C-arm cart. To change the direction of motion, raise the right maneuvering handle and turn it in the direction you want to go. The rear casters move in accordance with this handle motion. • The maneuvering handles can be fixed at the 0° and 90° positions. Right handle (90°, fixed) Right handle (0°, fixed) Fig. 3.5 Maneuvering handles ♦ To move straight ahead Fig. 3.6 Position of the right handle and direction of motion (straight ahead) 3-6 OPESCOPE ACTENO FD type Instruction Manual  3.2 Transport ♦ To move diagonally 3 Fig. 3.7 Position of the right handle and direction of motion (a diagonal course) ♦ Parallel motion Fig. 3.8 Position of the right handle and direction of motion (parallel) NOTE When the rear casters are oriented at right angles to the direction in which you want to proceed, the casters will stick and it will not be possible to move. If the C-arm cart is difficult to move, check the orientations of the rear casters and the maneuvering handles. OPESCOPE ACTENO FD type Instruction Manual 3-7 Chapter 3 Basic Operation 6 Engage the brake after moving the equipment. • Rear brake Step on the side of the brake pedal to engage the brake. Situation with the brake applied Situation with the brake released Fig. 3.9 Brake pedal • Front brake Lock the front caster and engage the brake. Lock Fig. 3.10 Front caster 3-8 OPESCOPE ACTENO FD type Instruction Manual  3.2 Transport 3.2.2 Moving the Monitor Cart 1 Check that the main power cable and the cart cable are correctly wound on the cable guides of the monitor cart. 2 Release the caster brake. The way to release the brake depends on the type of caster installed, so refer to the following. 3 Name Brake is released. Brake is applied. Caster Type A Caster Type B Fig. 3.11 Shape of caster • Caster Type A Raise here to release the brake. Fig. 3.12 How to release the brake of Caster Type A OPESCOPE ACTENO FD type Instruction Manual 3-9 Chapter 3 Basic Operation • Caster Type B Step on here to release the brake. Fig. 3.13 How to release the brake of Caster Type B 3 Hold the handles and move the monitor cart. 4 After completing the motion, apply the caster brake. The way to apply the brake depends on the type of caster, so refer to the following. Handle Cable guide Casters with brakes Fig. 3.14 Handle, Cable guide, Caster of Monitor Cart 3-10 OPESCOPE ACTENO FD type Instruction Manual  3.2 Transport • Caster Type A Step on here to apply the brake. Fig. 3.15 How to apply the brake of Caster Type A • Caster Type B 3 Step on here to apply the brake. Fig. 3.16 How to apply the brake of Caster Type B Next, 3.3.1 "System Connections" OPESCOPE ACTENO FD type Instruction Manual 3-11 Chapter 3 Basic Operation 3.3 Connecting and Dismantling the System When you have arranged the C-arm cart and the monitor cart in the required positions, make the following power supply connections. 3.3.1 System Connections 1 Connect the cart cable from the monitor cart to the C-arm cart. Turn the knob clockwise until it clicks. Fig. 3.17 Connecting the cart cable 2 Connect the C-arm cart’s potential equalization conductor. WARNING When using an electrocautery knife or an operating table etc., the potential equalization conductor is necessary to ensure the safety of the patient and the operators. Potential equalization conductor Fig. 3.18 Potential equalization conductor 3-12 OPESCOPE ACTENO FD type Instruction Manual  3.3 Connecting and Dismantling the System 3 Connect the monitor cart’s main power cable to the power outlet. 3 Main power cable Cart cable Fig. 3.19 Connection of the main power cable WARNING Be sure to connect the equipment only to a (commercial) power outlet with a ground terminal. Do NOT connect the equipment to power stripes, extension cords, or overloaded electrical circuits. Doing so may cause the electric shock. CAUTION Connect the cart cable to the C-arm cart with the power switch on the back of the monitor cart turned off. NOTE The power to the monitor cart can be turned on even if the cart cable is not connected. In this case, the system switch blinks in 1 second intervals (slow blinking). Next, 3.4.1 "Turning the Power ON" OPESCOPE ACTENO FD type Instruction Manual 3-13 Chapter 3 Basic Operation 3.3.2 Disconnection Procedure To disconnect, follow the connection procedure in reverse. 1 Before moving the C-arm cart, disconnect the main power cable and the cart cable. When the cart cable is released, always the associated cart connector cover should be mounted to protect the connector pin of that cable. Turn the knob counterclockwise. Cart connector cover Fig. 3.20 Disconnecting the cart cable Fig. 3.21 Mounting cart connector cover 2 Wind the main power cable and cart cable onto the cable guides of the monitor cart. Cable guide Fig. 3.22 Cable guide CAUTION Disconnect the cart cable with the power switch on the back of the monitor cart turned off. 3-14 OPESCOPE ACTENO FD type Instruction Manual  3.4 Turn the Power ON / OFF 3.4 Turn the Power ON / OFF To ensure that no trouble occurs with the equipment while examining a patient, always carry out a starting inspection in advance to check that everything is normal for the study. Details of the starting inspection are summarized in Chapter 9 "Appendix" “Starting Inspection Checklist.” Make a copy of this checklist and refer to it while performing inspections. 3 3.4.1 Turning the Power ON CAUTION Strictly follow the prescribed procedure. When turning the power ON, strictly follow the procedure set out below. 1 Turn the power switch at the back of the monitor cart ON. Power switch Fig. 3.23 Power switch OPESCOPE ACTENO FD type Instruction Manual 3-15 Chapter 3 Basic Operation 2 Press the system switch on the front of the monitor cart. • Initialization of the collimator, compensating filter, etc. will continue for about 30 seconds. System switch Fig. 3.24 System switch CAUTION When turning the power OFF and back ON using the power switch and system switch, leave an interval of at least 10 seconds after turning the power OFF before turning the power switch on again. NOTE It takes 3 minutes for the system to start up (before you can start a study). Wait until [In preparation] on the C-arm main panel disappears. 3-16 OPESCOPE ACTENO FD type Instruction Manual  3.4 Turn the Power ON / OFF NOTE The following dialog box may appear if the installation of the equipment is not completed or if the hospital name is changed in the DR. If it appears, contact your Shimadzu service representative. 3 If you forget to return the C-arm to the home position, press the system switch for three seconds to apply power only to the C-arm. Afterward, press the system switch again to end this operation. OPESCOPE ACTENO FD type Instruction Manual 3-17 Chapter 3 Basic Operation 3.4.2 Fluoroscopy outside of Study Even if you do not select a study, you can perform fluoroscopy. NOTE • Mouse and keyboard operations are disabled during fluoroscopy. • You cannot perform fluoroscopy while foreground processing is in progress, such as when saving images to the hard disk or registering images for printing. • If you perform fluoroscopy during background processing except for image playback or media archive, the processing is suspended. • You cannot save a fluoroscopic image that has been acquired outside of study. • The loop memory mode cannot be used during fluoroscopy outside of study. Perform fluoroscopy outside of a study by following the same procedure as normal fluoroscopy as shown below. 1 Turn (X-ray exposure restriction releasing switch) ON (lit). Fig. 3.25 Before starting up 3-18 OPESCOPE ACTENO FD type Instruction Manual  3.4 Turn the Power ON / OFF 2 Press X-ray exposure (fluoroscopy) switch or press the left foot switch. • X-rays for fluoroscopy will be radiated. • During radiation, X-ray exposure (fluoroscopy) switch is lit and (X-rays being radiated) lights yellow. • During radiation, the irradiation indicator on the monitor cart is lit. The fluoroscopic image is displayed on the live monitor. When X-ray exposure (fluoroscopy) switch is pressed: 3 (X-rays being radiated) lights yellow The fluoroscopy time Press is displayed. When the foot switch is pressed: Press Fig. 3.26 Fluoroscopy Next, 3.6 "Operating the C-arm" OPESCOPE ACTENO FD type Instruction Manual 3-19 Chapter 3 Basic Operation 3.4.3 Turning the Power OFF CAUTION You must strictly follow the procedure below to turn the power OFF. After completing the work to be done, always perform an ending inspection. Details of the ending inspection are summarized in Chapter 9 "Appendix" “Ending Inspection Checklist.” Make a copy of this checklist and refer to it while performing inspections. We recommend that you keep the completed checklist for a certain period of time. CAUTION Do NOT turn OFF the power switch on the back of the monitor cart or disconnect the main power cable before shutdown process is completed. Doing so may damage the system and the data. CAUTION Do NOT turn off the power during transfer of image data to media (CD-R/DVD-R) and DICOM storage server. Doing so may cause loss of, or damage to the image data or the original data stored in the magnetic disc of the equipment. 3-20 OPESCOPE ACTENO FD type Instruction Manual  3.4 Turn the Power ON / OFF 1 Check that the C-arm is at its home position. • The home position is the position where all scales register zero. See 3.6.6 "About the Scales" (page 3-32). 3 Fig. 3.27 Home position of the C-arm 2 End the Study See 3.18 "Ending the Study" (page 3-118). 3 Click the [System] button at the top right of the reference monitor. [System] button Fig. 3.28 Turning the power OFF 1 • The system menu is displayed. System menu Fig. 3.29 Turning the power OFF 2 OPESCOPE ACTENO FD type Instruction Manual 3-21 Chapter 3 Basic Operation 4 Click [Shutdown]. Fig. 3.30 Turning the power OFF 3 5 The [Confirmation] dialog box appears. Click [Shutdown] and then [OK]. Fig. 3.31 Turning the power OFF 4 6 Check that the green lamp on the system switch on the front of the monitor cart goes out. 7 Turn the power switch at the back of the monitor cart OFF. Power switch Fig. 3.32 Power switch 8 Disconnect the main power cable. 3-22 OPESCOPE ACTENO FD type Instruction Manual  3.5 Warm-Up 3.5 Warm-Up Warm-up, breaking-in the equipment, is required for the use of X-ray tube unit. Performing fluoroscopy and radiography without warm-up may result in an X-ray tube unit discharge. Before fluoroscopy or radiography, perform warm-up following the procedure below. 1 Turn (X-ray exposure restriction releasing switch) ON (lit). 2 Press (Auto/Manual selection button) to switch the x-ray 3 adjustment mode to manual. 3 Set the fluoroscopy conditions as shown below. • Dose: [Normal] • Pulse Rate: [Continuous] • Fluoroscopy tube voltage: 70 kV Fluoroscopy mode selection screen Fluoroscopy tube voltage (kV) [Dose] [Pulse Rate] Fig. 3.33 Warm-up 4 Perform 10-second fluoroscopy 2 times. Also perform 10-second fluoroscopy 2 times at tube voltages of 90 kV and 110 kV. For details, see 3.11 "Fluoroscopy" (page 3-73). OPESCOPE ACTENO FD type Instruction Manual 3-23 Chapter 3 Basic Operation 3.6 Operating the C-arm Operate the C-arm to position it for the required fluoroscopy / radiography range. WARNING When moving the C-arm, take care that the C-arm, X-ray generators and FPD at both ends do not strike the patient or peripheral devices. Also, after positioning the C-arm, be sure to press the C-arm lock switch to lock the C-arm. Failure to do so may cause injury or damage to the equipment. CAUTION When moving the C-arm, hold each of the handles to operate it. Otherwise, you may trap your fingers, causing injury. Doctor handle C-arm handle Slide handle Hazardous locations 3-24 OPESCOPE ACTENO FD type Instruction Manual  3.6 Operating the C-arm CAUTION Do NOT place peripheral devices or any other object within the range of motion of the equipment. If peripheral devices such as the monitor cart are placed within the range indicated in the figure below, there will be a danger of collision or contact. (Unit: mm) 3 OPESCOPE ACTENO FD type Instruction Manual 3-25 Chapter 3 Basic Operation 1 Press the lock release switch. • The C-arm is unlocked. (The switch will light.) C-arm lock switch C-arm slide motion C-arm rotary motion C-arm forward/back C-arm longitudinal and lateral swiveling movement movement Fig. 3.34 C-arm lock switch 2 Move the C-arm with its handles. For details on operations, see 3.6.1 "C-arm Longitudinal Movement" (page 3-28) through to 3.6.4 "C-arm Rotational Motion" (page 3-30). 3 When you reach the right position, press the lock switch again. • The C-arm will be locked. (The switch will go out.) 4 Check that the C-arm is locked. NOTE In case of an emergency such as a power failure, the C-arm can be moved by applying a force of 10 kgf or more even when the C-arm is locked. NOTE Even when the lock is released (the LED lights), it will be automatically applied (the LED goes out) if no switch is pressed for the predetermined time (factory default setting: one minute). Next, 3.7 "Operating Study List Window" 3-26 OPESCOPE ACTENO FD type Instruction Manual  3.6 Operating the C-arm Operating the C-arm Without Starting the DR Follow the procedures below when you want to only operate the C-arm, such as for storage when there is no need to perform fluoroscopy. 1 Connect the cart cable and main power cable of the monitor cart. For details, see 3.3.1 "System Connections" (page 3-12). 2 Turn the power switch at the back of the monitor cart ON. 3 Power switch Fig. 3.35 Power switch 3 Press and hold the system switch on the front of the monitor cart for at least 3 seconds. • Power is supplied to the C-arm unit. System switch Fig. 3.36 System switch Power is supplied to the C-arm unit without waiting for the DR to start, and the C-arm can be operated. To turn off the system, press the system switch again. OPESCOPE ACTENO FD type Instruction Manual 3-27 Chapter 3 Basic Operation 3.6.1 C-arm Longitudinal Movement 450 mm Doctor handle Move the C-arm while holding the C-arm handles or slide handles. CAUTION Trapping Fig. 3.37 C-arm longitudinal movement 3-28 OPESCOPE ACTENO FD type Instruction Manual  3.6 Operating the C-arm 3.6.2 C-arm Forward/Back and Lateral Swiveling Movement Move the C-arm while holding the C-arm handles or slide handles. Doctor handle 200 mm 3 CAUTION Trapping Move the C-arm while holding the C-arm handles or slide handles. Doctor handle ±12.5° CAUTION Trapping Fig. 3.38 C-arm forward/back and lateral swiveling movement OPESCOPE ACTENO FD type Instruction Manual 3-29 Chapter 3 Basic Operation 3.6.3 C-arm Slide Motion 30° Move the C-arm while holding the C-arm handles. CAUTION 挟み込み Trapping 90° CAUTION Trapping CAUTION Trapping Fig. 3.39 C-arm slide motion 3.6.4 C-arm Rotational Motion 120° 300° Move the C-arm while holding the C-arm handles. CAUTION Trapping Fig. 3.40 C-arm rotational motion 3-30 OPESCOPE ACTENO FD type Instruction Manual  3.6 Operating the C-arm 3.6.5 Lock Release Switches on the Doctor handle There are two lock release switches on the Doctor handle. On shipment from the factory, these switches are configured so that the forward/ back and lateral swiveling movement or longitudinal movement of the C-arm is released while the switch is held down. NOTE If you need to change the setting, contact your Shimadzu service representative. 3 Switch Lock location Left Switch C-arm forward/back and lateral swiveling movement Right Switch C-arm longitudinal movement Switch Switch Fig. 3.41 Release switches on the Doctor handle OPESCOPE ACTENO FD type Instruction Manual 3-31 Chapter 3 Basic Operation 3.6.6 About the Scales Every moving part features a scale that you can use as a guide during motion. Note that the color of the scale matches the color of the C-arm lock switch. The zero on each scale is the C-arm’s home position. C-arm slide motion C-arm rotary motion C-arm forward/back movement C-arm lateral swiveling movement C-arm longitudinal movement Fig. 3.42 Scale 3-32 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 3.7 Operating Study List Window The Study List window is the first window that appears on the reference monitor when the system starts up. To display the Study List window, click the [Study List] button. If the [Study List] button is not displayed, click the [List] button to display the [List] window, and then switch to the Study List window. NOTE If a large amount of study data is stored, there will be no free space and a study cannot be started. Delete unnecessary data periodically. 3 CAUTION When you obtain study information from the network and store it on this equipment, make sure that the study order does not overlap with those of other devices. [Study List] button [List] button Study List operation area Study information details Operation panel Fig. 3.43 Study List window OPESCOPE ACTENO FD type Instruction Manual 3-33 Chapter 3 Basic Operation ♦ Operation Panel of Study List Window 1 2 3 Fig. 3.44 Operation panel of Study List window No. Item Description Start Study button Starts a study selected in the Study List. A study cannot be started when the cart cable is not connected, during a 1 study, or during background processing (Image send, Image save, Print). Delete button 2 Deletes a study selected in the Study List operation area. Emergency Study Starts an emergency study. The window switches to the button Study window. An emergency study cannot be started 3 when the cart cable is not connected, during a study, or during background processing (Image send, Image save, Print). 3-34 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window ♦ Study List Operation Area You can select multiple studies at the same time by holding down the Ctrl or Shift key while selecting. 4 5 1 2 3 3 Fig. 3.45 Study List Operation Area No. Item Description Displays a Study List by the study status: • Reserve: displays a list of reserved studies. • Today: displays a list of studies that ended today. 1 Tabs • All: displays a list of all completed studies. • MWM: displays a list of studies that are received from the MWM server. SDR -120F Reference Guide Displays the Patient ID, Patient’s name, Accession No, Study start date and time (Reserve and MWM tabs)/Study date and time (Today and All tabs), and APR. Clicking 2 Item item sorts the list in ascending or descending order. The width of each item can be resized by dragging the boundary between each item. Displays the list of studies. If it doesn't fit on the window, 3 Study List a scroll bar appears at the right or bottom of the list. You can scroll the viewing area of the window. Filter button 4 Filters the Study List. OPESCOPE ACTENO FD type Instruction Manual 3-35 Chapter 3 Basic Operation No. Item Description FIlter Cancel button 5 Cancels filtering. ♦ Right-click Menu The Right-click menu is available by clicking a study in the Study List. The menu item depends on the selected study Fig. 3.46 Right-click Menu Menu Item Description Starts a new study of a selected study. The window Start Study switches to the Study window. Restarts a study below: Restart Study • a study in the [Today] tab • a study in the [All] tab that ended today. Edit Edits study information. Delete Deletes the selected study. When the Study List is opened, the list is sorted in the study registration order. Patient’s names are sorted in the character code. It is the same as the Windows standard operation. 3-36 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window ♦ Study Information Details 3 1 2 3 Fig. 3.47 Study Information Details with Reserve or MWM tab 1 2 4 Fig. 3.48 Study Information Details with Today or ALL tab OPESCOPE ACTENO FD type Instruction Manual 3-37 Chapter 3 Basic Operation No. Item Description Study information 1 Displays study information details. details Modify button 2 Modifies information of the selected study. Create Study 3 Creates a new study. Detail button Opens the [Detail] window which shows the study 4 information details. 3.7.1 Registering New Study A new study will be registered in the [Reserve] tab. 1 Click [Create Study] in the Study List window. Fig. 3.49 Registering a new study 3-38 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 2 The Create new study window appears. Enter required items, such as [Patient ID] and [Patient's name]. 1 (required) 2 (required) 3 4 5 6 8 7 3 9 10 11 12 13 14 15 Fig. 3.50 Study Information Details with Today or ALL tab NOTE The patient ID and patient's name must be entered. For example, if the patient ID has not been entered, the following dialog box appears. Be sure to enter them. OPESCOPE ACTENO FD type Instruction Manual 3-39 Chapter 3 Basic Operation No. Item Description Patient ID, Enters new patient ID or display registered it. Up to 64 Complement button characters can be entered. 1 Clicking searches patient registered in the system by the Patient ID, and complements other patient information. Patient's name 2 Enters the patient's name or display registered it. DOB/Age Enters dates of birth and age of patient or display it of 3 registered patients. After entering the date of birth, the patient's age is automatically calculated and displayed. Sex Selects the sex or display registered it. Enter either 4 initials in the sex field. M: Male, F: Female, O: Other Accession No. Enters the accession No. It cannot be entered for a 5 study received from the MWM. Up to 16 characters can be entered. Selects a APR or display the APR registered in the APR presets. If it is blank, start a study with the currently selected APR. An emergency study uses the top APR on the list. APR 6 Modality 7 Selects a image output type. Selects a request department registered in the presets from the list or display it. Request department 8 3-40 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window No. Item Description Selects a physician registered in the presets from the list or display it. Physician 9 Selects a technologist registered in the presets from the list or display it. Technologist 10 3 Comment 11 Enters comments. Up to 64 characters can be entered. Scheduled date Enters the scheduled date. The input order is year, 12 month, day, hour, and minute. Start Study button 13 Starts a study. The Study window appears. OK button 14 Creates the study with entered values. Cancel button Discards entered values. The Create New Study 15 window closes. NOTE Up to 63 characters can be entered in the patient’s name field. OPESCOPE ACTENO FD type Instruction Manual 3-41 Chapter 3 Basic Operation ♦ Complementing Information by the Patient ID After entering the Patient ID, clicking searches patient information registered in the system, and then complements the patient information. • When only one patient is found, the patient information is completed. • When multiple patients are found, the following [Select Patient ID] dialog box appears. Select one patient whose information is used for completing the information. Fig. 3.51 Complementary candidate 3 When you finish entering data, click [OK]. Fig. 3.52 Creating new study • The new study is created, and is displayed in the [Reserve] tab. When patient information is registered for the same patient ID but using a different patient's name, the confirmation dialog box appears. When patient information is registered for the same patient's name but using a different patient ID, a new study is created. 3-42 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 3.7.2 Checking Study Information To edit study information, click [Modify] in the lower left corner of the window, or right-click the selected study and select [Edit]. You can check the information of the reserved study, or the information of the study for which fluoroscopy or photographing was performed. ♦ How to Check the Reserved Study 1 Click [Reserve] tab and the desired study. 3 • The selected study is highlighted. • The study information registered at reservation is displayed in the study information details. Select the desired study. The study information is displayed. Fig. 3.53 Study information of reserved study OPESCOPE ACTENO FD type Instruction Manual 3-43 Chapter 3 Basic Operation ♦ How to Check the Performed Study 1 Click [Today] or [All] tab and the desired study. • The selected study is highlighted. • The study information is displayed in the study information details. The information registered at reservation and performed study contents is displayed. Select the desired study. The study information is displayed. 2 1 3 Fig. 3.54 Study information of performed study No. Item Description Displays the name of the APR and modality at study execution. 1 APR/Modality When the study is performed using a plurality of APR, the conditions of the APR used at first are displayed. 2 Study date Displays the study start and end date and time. Display the total DAP (Dose area product), the total 3 Study Information radiation dose, the total time of fluoroscopy, and the number of exposure of the performed study. 3-44 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 2 Click to show the information details. • The Detail window appears. Performed study details are displayed in addition to the contents in the Study List window. 1 3 2 3 Fig. 3.55 Study information details No. Item Description Displays kV, mA, msec of performed study. 1 Exposure List F: Fluoroscopy R: Radiography Displays DICOM print condition during study in the format below: 2 Print Printed film size | Number of print in that size Example) 14x17 | 3 Close button 3 Closes the [Detail] window. • Click [Close] after checking details. The Detail window closes and the Study List window returns. OPESCOPE ACTENO FD type Instruction Manual 3-45 Chapter 3 Basic Operation 3.7.3 Updating Study Information The information of reserved or performed study can be added or modify and updated. NOTE If you edit study information with this equipment, the information may be different from that of other devices. 1 Click the desired study, and then [Modify]. Select the desired study. Fig. 3.56 Updating study information 3-46 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 2 The Edit window appears. Add to or correct the information of the study. 3.7.1 "Registering New Study" Add or correct information. 3 Click [OK] to save the new changes. *The APR, Modality, and Scheduled date cannot be changed for performed study. Fig. 3.57 Study information edit window 3 Click [OK]. • The study information is updated. The Study List window returns. OPESCOPE ACTENO FD type Instruction Manual 3-47 Chapter 3 Basic Operation 3.7.4 Deleting Registered Study Delete a study from the Study List. The study can be deleted from the [Reserve], [Today] and [All] tabs. The study deleted from the [Today] tab is also deleted from [All] tab. NOTE Once a study is deleted, it cannot be recovered. So, thoroughly check that the information may be deleted before deleting it. The following describes how to delete a study on the [Reserve] tab. It is the same for [Today] and [All] tabs. 1 Click a study to delete from the Study List window. • The selected study is highlighted. Select the desired study. Fig. 3.58 Deleting study 3-48 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window 2 Click [Delete]. • The [Confirm] dialog box appears. 3 Fig. 3.59 Confirmation dialog box 3 Click either [Yes]. • Click [Yes] to delete the study. You can select and delete multiple studies arranged continuously in a block by holding down the Shift key. You can select and delete multiple studies that are not arranged continuously by holding down the Ctrl key. 3.7.5 Filtering The filtering function allows user to find the target study quickly. Even when a part of patient ID and name are unknown, a wild card (*) matching allows user to find patients matching the criteria specified. ♦ Starting Filtering 1 Click . Fig. 3.60 Study List filtering OPESCOPE ACTENO FD type Instruction Manual 3-49 Chapter 3 Basic Operation • The Filter condition settings dialog box appears. 1 2 3 4 5 6 7 Fig. 3.61 Filter condition settings dialog box No. Item Description Checkbox Selects either checkbox of [Patient ID], [Patient's 1 name], or [Date Cond] to input the data or to set date. Patient ID Specifies the Patient ID. A maximum of 64 characters 2 can be inputted. You can use the asterisk (*) character as a wildcard character. Patient's name The name of patient is targeted. You can use the 3 asterisk (*) character as a wildcard character. A wild card character can input to the head or the end of a character string or both. It cannot be inputted in other place. 3-50 OPESCOPE ACTENO FD type Instruction Manual  3.7 Operating Study List Window No. Item Description Specifies a scheduled date on the [Reserve] tab and a study date on the [Today] and [All] tabs and Image List. The initial setting is [Date]. Select the specification method according to the purpose. Selecting [Term] or [Base day] changes the display. [Date] Specifies a date to set condition. Date Cond 3 4 [Term] Specifies a start and end date to set condition. [Base Day] Specifies the base day and target term, [Before] or [After] the base day, to set condition. Search button Cancels previous search result and filters by new 5 conditions. Extraction button 6 Further filters the search result by new conditions. Cancel button Closes the Filter condition settings dialog box to cancel 7 a filtering temporarily. OPESCOPE ACTENO FD type Instruction Manual 3-51 Chapter 3 Basic Operation ♦ Cancelling Filtering When performing a filtering, only the item matching the filtering condition is displayed. There are the following two methods to cancel the filtering state after the filtering or in the middle of a filtering. • Click . • Switch the tab. Click it. Fig. 3.62 Cancelling filtering Switch tab. Fig. 3.63 Switching tab 3-52 OPESCOPE ACTENO FD type Instruction Manual  3.8 Starting Study 3.8 Starting Study The study can be started by one of the following methods: • Start a new study. • Restart a performed study. • Start a emergency study. This section describes these method. NOTE 3 A study cannot be started when the cart cable is not connected. 3.8.1 Starting New Study 1 Start a new study by either method: a. Create a new study and click [Start Study]. b. Select a reserved study or MWM-registered study and click [Start Study]. Select the study. Fig. 3.64 Starting study • The window switches to the Study window. OPESCOPE ACTENO FD type Instruction Manual 3-53 Chapter 3 Basic Operation 3.8.2 Restarting Study The performed study can be restarted when addition image acquisition is required after study has ended on the current day, which is displayed in [Today] or [All] tab. ♦ Restarting Study in the Today or All tab 1 Click [Today] or [All] tab. 2 Select the desired study that has ended on the current day. • The selected list is highlighted. The [Restart Study] is available. Select the study. Fig. 3.65 Restarting study 3 Click [Restart Study]. • The window switches to the Study window. NOTE While the images are displayed in the Image Edit window, the study that contains those images cannot be restarted and the following dialog box appears. Close the Image Edit window before restarting the study. 3-54 OPESCOPE ACTENO FD type Instruction Manual  3.8 Starting Study 3.8.3 Emergency Study At emergency studies for emergency patients, etc., a emergency study can be started with automatically generated information. 1 Click [Emergency Study] in the Study List window on the reference monitor. 3 Fig. 3.66 Emergency Study • The window switches to the Study window. The patient ID and patient's name are automatically input. You can start an emergency study by pressing [Emergency case] on the C-arm main panel when the Study list window is displayed on the reference monitor. Fig. 3.67 Registration of an emergency case (C-arm main panel) OPESCOPE ACTENO FD type Instruction Manual 3-55 Chapter 3 Basic Operation • For an emergency study, the patient ID and patient's name are automatically generated as follows. Item Description The Patient Last Name is generated using the year/month/ date at emergency study start. Patient Last name LN+ year/month/date Example) September 3, 2012, Patient Last Name will be LN20120903. The Patient First Name is generated using the hour/minute/ second at emergency study start. Patient First name FN+hour/minute/second Example) 14:15:30 Patient Last Name will be FN141530. The patient ID is generated using the year/month/date-hour/ minute/second at emergency study start. Patient ID Example) 14:15:30 on September 3, 2012, Patient ID will be EPID20120903-141530. The ended emergency study is displayed in the [Today] and [All] tabs. In order to edit the information of the emergency study, select it and click [Modify] at the button of the window. The [Revise patient information] of the Image List window can also edit patient information. An emergency study uses the Standard APR. 3-56 OPESCOPE ACTENO FD type Instruction Manual  3.9 Operating Study Window 3.9 Operating Study Window The study is started in the Study window on the reference monitor. The radiography condition is pre-selected on the reference monitor or the C-arm main panel. The acquired image is displayed on the live monitor real time. To open the Study window, operate the reference monitor or the C-arm main panel. 1 Start a study. 3 1 2 3 Fig. 3.68 Study window 1 2 3 Fig. 3.69 Patient information NOTE Make sure that the patient information matches that of the patient to be examined. OPESCOPE ACTENO FD type Instruction Manual 3-57 Chapter 3 Basic Operation No. Item Description 1 Patient ID Displays the patient ID. 2 Patient’s Name Displays the patient’s name. Displays the Patient’s sex and age. 3 Sex / Age M: Male / F: Female / O: Other The live monitor also shows patient information. Fig. 3.70 Live monitor 3-58 OPESCOPE ACTENO FD type Instruction Manual  3.9 Operating Study Window ♦ Operation Panel of Study Window (Acq Condition Tab) 3 1 2 3 4 5 7 6 8 9 10 Fig. 3.71 Operation panel OPESCOPE ACTENO FD type Instruction Manual 3-59 Chapter 3 Basic Operation No. Item Description Switches the tab between the Acq, Thumbnail and Edit. • Acq tab: displays APR and image information Acq/Thumbnail/Edit tab on the live monitor. 1 • Thumbnail tab: displays a thumbnail (reduced) list of study images saved on the hard disk. Switches the displayed image. • Edit tab: edits images saved on the hard disk. “SDR -120F Reference Guide” APR Display / Selection Displays the current APR. If you change the APR, 2 select it from the list. The list shows the APRs registered in the APR preset edit. Radiography mode Displays the current radiography mode. It is 3 switched by changing the APR or setting on the C-arm main panel. Nega/Posi 4 Shows the polarity setting in the current APR. Image Reverse Shows the reverse state of the fluoroscopy or LIH 5 image. It corresponds to the reverse switch on the C-arm's side panel. Switch Page buttons Switches to the previous/next image when a study 6 or series selected contains multiple image files. Display Image Information button Turns the image information display over the image 7 on or off. Image Sequence buttons Plays sequences of a multi-frame image obtained 8 with serial radiography. DICOM Print button Registers the selected image file for print edit. 9 “SDR -120F Reference Guide” End Study button Ends the current study and switches to the Study 10 List window. 3-60 OPESCOPE ACTENO FD type Instruction Manual  3.9 Operating Study Window ♦ Thumbnail Tab The displayed image is surrounded by a selection frame. Fig. 3.72 Thumbnail tab 3 Item Description Moves to the last image of list. Moves downward on the list by one low (by two images). Moves upward on the list by one low (by two images). Moves to the top image of list. 2 When you save the fluoroscopic image or acquire image, the image is displayed. Image is displayed. Fig. 3.73 Study window showing study image OPESCOPE ACTENO FD type Instruction Manual 3-61 Chapter 3 Basic Operation ♦ Image Information 1 9 2 10 4 3 11 5 6 12 7 13 14 8 15 16 No. Item Description 1 Patient Name The patient's name is displayed. 2 ID The patient ID is displayed. The patient's sex and age are displayed. 3 Sex/Age M: Male; F: Female; O: Other. The acquisition date is displayed in the “year/ 4 Acquisition Date month/day” format. The acquisition time is displayed in the 5 Acquisition Time "hour:minute:second" format. The cumulative reference air kerma of all fluoroscopy performed after closing the previous Cumulative Reference Air study and all radiography within the current study 6 Kerma (AK) is displayed. When a value is less than 0.0005, it may be displayed as "0.000" though the exact value is stored in the system. The cumulative dose area product of all fluoroscopy performed after closing the previous study and all radiography within the current study 7 Dose Area Product (DAP) is displayed. When a value is less than 0.0005, it may be displayed as "0.000" though the exact value is stored in the system. 3-62 OPESCOPE ACTENO FD type Instruction Manual  3.9 Operating Study Window No. Item Description The X-ray conditions below are displayed. kV : Tube voltage at the irradiation 8 X-ray Condition mA : Tube current at the irradiation msec : Irradiation duration per 1 frame in millisecond units The numbers related to the displayed image are Image number: Frame displayed as shown below: 9 number/Total number of Image number: Frame number/Total number of frames frames Ex. 1: 1/2 10 Radiography Mode The radiography mode: SPOT, SERIAL, or DSA, is displayed. 3 11 Acquisition Rate The acquisition rate is displayed. The mark is displayed when the displayed image is 12 Reverse mark reversed by the image reverse operation. 13 Enlargement Factor (xN) The enlargement factor is displayed. Window Width (W) The window width value is displayed. 14 Window Level (L) The window level value is displayed. 15 Gamma (G) Gamma type and level are displayed. 16 Edge (E) Edge type and level are displayed. Items not registered at the time of radiography are not displayed. OPESCOPE ACTENO FD type Instruction Manual 3-63 Chapter 3 Basic Operation 3.10 Selecting the APR The optimum fluoroscopy and radiography (acquisition) conditions for each part of the body are preset in APR. By selecting an APR, the necessity for manual adjustment is cut to a minimum. The following is an explanation of the operation at the C-arm main panel. For details on the operation at the reference monitor, see 3.9 "Operating Study Window" (page 3-57). NOTE APR is set using Shimadzu recommended values. If the values are not appropriate for your specific needs, please change the values. "To Change Fluoroscopy APR" (page 3-66) "To Change Acquisition APR" (page 3-70) 3-64 OPESCOPE ACTENO FD type Instruction Manual  3.10 Selecting the APR ♦ Selecting APR from the Basic Screen 1 Press the APR selection button. • The APR selection screen is displayed. Basic screen 3 Fig. 3.74 Selecting the APR 1 2 Select the APR. • The basic screen is displayed. APR selection screen APR Fig. 3.75 Selecting the APR 2 The parameters registered in the APR are loaded. Next, 3.11 "Fluoroscopy" OPESCOPE ACTENO FD type Instruction Manual 3-65 Chapter 3 Basic Operation To Change Fluoroscopy APR 1 Press the fluoroscopy selection button. • The fluoroscopy mode selection screen is displayed. Basic screen Fig. 3.76 Changing the fluoroscopy APR 1 2 Set [Dose], [Pulse Rate] and [Loop], and press [Close]. • The basic screen is displayed. Fluoroscopy mode selection screen [Loop] [Close] [Dose] [Pulse Rate] Fig. 3.77 Changing the fluoroscopy APR 2 3-66 OPESCOPE ACTENO FD type Instruction Manual  3.10 Selecting the APR Item Description • [High Quality]: Irradiates a high dose of X-rays to generate a high quality image. • [Normal]: Irradiates a standard dose of X-rays. • [Low Dose 1]: Irradiates a low dose of X-rays to minimize the radiation dose to the patient. • [Low Dose 2]: Irradiates a lower dose of X-rays than in [Low Dose 1] [Dose] • to minimize the radiation dose to the patient. [Boost Pulse]: 3 Irradiates a high dose of X-rays to generate a high quality image. There are two types of pulse rate, 7.5 fps and 3.75 fps, and high dose is irradiated with a tube current peak value that is double that of the High Quality mode. For this reason, it is useful for procedures on thick body parts which are moved comparatively less than other parts. Selects [Continuous] to perform continuous fluoroscopy. Select the [15 fps], [10 fps], [7.5 fps] or [3.75 fps] button to [Pulse Rate] switch to pulsed fluoroscopy and change the pulse rate to the selected value. Saves loop memory images (a series of fluoroscopic [Loop] images). OPESCOPE ACTENO FD type Instruction Manual 3-67 Chapter 3 Basic Operation • To overwrite save in an existing APR The changes you made on fluoroscopy APR are temporary. Overwrite save in an existing APR following the steps below if it is necessary. 1 Press the APR selection button. • The APR selection screen is displayed. Basic screen Fig. 3.78 Overwriting the APR 1 2 Press [Setting change]. • The overwrite confirmation screen is displayed. APR selection screen Fig. 3.79 Overwriting the APR 2 3-68 OPESCOPE ACTENO FD type Instruction Manual  3.10 Selecting the APR 3 Press [OK]. • APR is overwritten and saved, and the basic screen is displayed. Overwrite confirmation screen 3 Fig. 3.80 Overwriting the APR 3 OPESCOPE ACTENO FD type Instruction Manual 3-69 Chapter 3 Basic Operation To Change Acquisition APR 1 Press the acquisition mode selection button. • The acquisition mode selection screen is displayed. Basic screen Fig. 3.81 Changing acquisition APR 1 2 Set [Acq Mode] and [Acq Rate], and press [Close]. • The basic screen is displayed. Acquisition mode selection screen [Close] [Acq Mode] [Acq Rate] Fig. 3.82 Changing acquisition APR 2 3-70 OPESCOPE ACTENO FD type Instruction Manual  3.10 Selecting the APR Item Description • [Spot]: Radiography with one irradiation [Acq Mode] • [Serial]: Radiography with continuous irradiation • [DSA]: DSA radiography Each time the button is pressed, the acquisition rate switches [Acq Rate] in the following order: [7.5 fps] → [5 fps] → [3.75 fps] → [3 fps] → [2 fps] → [1 fps] → [0.5 fps]. • To overwrite save in an existing APR The changes you made on fluoroscopy APR are temporary. Overwrite save in an existing APR following the steps below if it is necessary. 3 1 Press the APR selection button. • The APR selection screen is displayed. Basic screen Fig. 3.83 Overwriting the APR 1 OPESCOPE ACTENO FD type Instruction Manual 3-71 Chapter 3 Basic Operation 2 Press [Setting change]. • The overwrite confirmation screen is displayed. APR selection screen Fig. 3.84 Overwriting the APR 2 3 Press [OK]. • APR is overwritten and saved, and the basic screen is displayed. Overwrite confirmation screen Fig. 3.85 Overwriting the APR 3 3-72 OPESCOPE ACTENO FD type Instruction Manual  3.11 Fluoroscopy 3.11 Fluoroscopy NOTE • Mouse and keyboard operations and printing are disabled during fluoroscopy. • You cannot perform fluoroscopy while foreground processing is in progress, such as when saving images to the hard disk or registering images for printing. • If you perform fluoroscopy during background processing except for image 3 playback or image writing to media, only the processing in progress will be completed, and the processing in the queue is paused. CAUTION A sudden temperature change in the FPD may cause a density difference or artifacts in images in the following cases: In this case, allow about two minutes for the problem to resolve. • When fluoroscopy/radiography is performed immediately after turning on the power. • When fluoroscopy/radiography is repeated for a long time without an interval of more than 30 seconds • When fluoroscopy/radiography is performed for a long time. 1 Check the fluoroscopy conditions. • The fluoroscopy conditions are set automatically in accordance with the selected APR. • Check the Dose control mode (Auto/Manual). (Auto): Tube voltage falls within a range of 40 to 110 kV automatically. (Manual): Tube voltage can be changed manually. ( page 3-79) "Changing the Fluoroscopy Conditions 1 (Dose)" (page 3-77) "Changing the Fluoroscopy Conditions 2 (Pulse rate)" (page 3-78) "Changing the Fluoroscopy Conditions 3 (Fluoroscopy Tube Voltage)" (page 3-79) OPESCOPE ACTENO FD type Instruction Manual 3-73 Chapter 3 Basic Operation Fluoroscopy mode selection screen Tube voltage (kV) Tube current (mA) Dose control mode [Dose] [Zoom] [Pulse Rate] [Loop] Fig. 3.86 Checking the fluoroscopy conditions 2 If the X-ray exposure restriction releasing switch is flashing, turn (X-ray exposure restriction releasing switch) ON (lit). • It is only possible to radiate X-rays when the X-ray exposure restriction releasing switch is lit. X-ray exposure restriction releasing switch Fig. 3.87 X-ray exposure restriction releasing switch CAUTION If you leave the unit for any substantial time, press the X-ray exposure restriction releasing switch to flash in order to prevent malfunction. 3-74 OPESCOPE ACTENO FD type Instruction Manual  3.11 Fluoroscopy 3 Press X-ray exposure (fluoroscopy) switch or press the left foot switch. • X-rays for fluoroscopy will be radiated. • During radiation, X-ray exposure (fluoroscopy) switch is lit and (X-rays being radiated) lights yellow. • During radiation, the irradiation indicator on the monitor cart is lit. The fluoroscopic image is displayed on the live monitor. When X-ray exposure (fluoroscopy) switch is pressed: 3 (X-rays being radiated) lights yellow The fluoroscopy time Press is displayed. When the foot switch is pressed: Press Fig. 3.88 Fluoroscopy NOTE When using pulsed fluoroscopy, continue pressing the left foot switch and the X-ray irradiation will automatically stop after 20 seconds. An alarm sounds approximately 3 seconds before irradiation stops. To continue performing boost pulsed fluoroscopy, release the left foot switch and press the left foot switch again. OPESCOPE ACTENO FD type Instruction Manual 3-75 Chapter 3 Basic Operation NOTE If the fluoroscopy timer preset time is exceeded, a beep sounds. You can continue fluoroscopy during the time that the beep sound is sounding. However, fluoroscopy can be continued for a maximum of ten minutes only; on exceeding this limit X-ray radiation is automatically stopped. • If you want to restart fluoroscopy, release the left foot switch or the X-ray exposure (fluoroscopy) switch on the C-arm main panel. After that, you will be able to start fluoroscopy again. • You can stop the beep sound sounding by pressing Fluoroscopy timer beep sound reset switch. Fluoroscopy timer beep sound reset switch Fig. 3.89 Fluoroscopy timer beep sound reset switch For details on setting the timer value, see 3.17.2 "Default Settings" (page 3-111). NOTE After radiography, it is not possible to perform boost pulsed fluoroscopy while a radiography pause message is displayed on the C-arm main panel. When performing fluoroscopy, select a dose setting other than boost pulse while a radiography pause message is displayed. 3-76 OPESCOPE ACTENO FD type Instruction Manual  3.11 Fluoroscopy Changing the Fluoroscopy Conditions 1 (Dose) NOTE Changes made from the C-arm main panel are temporary, so the values after the change are not saved. To save changes, press [Overwrite & Upload] in the APR selection screen. "To Change Fluoroscopy APR" (page 3-66) 1 Select [Dose]. 3 • The selected button will be highlighted. Fluoroscopy mode selection screen [Dose] Fig. 3.90 Changing the dose Item Description Irradiates a high dose of X-rays to generate a high quality [High Quality] image. [Normal] Irradiates a standard dose of X-rays. Irradiates a low dose of X-rays to minimize the radiation [Low Dose 1] dose to the patient. Irradiates a lower dose of X-rays than in [Low Dose 1] to [Low Dose 2] minimize the radiation dose to the patient. Irradiates a high dose of X-rays to generate a high quality image. There are two types of pulse rate, 7.5 fps and 3.75 fps, and [Boost Pulse] high dose is irradiated with a tube current peak value that is double that of the High Quality mode. For this reason, it is useful for procedures on thick body parts which are moved comparatively less than other parts. OPESCOPE ACTENO FD type Instruction Manual 3-77 Chapter 3 Basic Operation Changing the Fluoroscopy Conditions 2 (Pulse rate) NOTE Changes made from the C-arm main panel are temporary, so the values after the change are not saved. To save changes, press [Overwrite & Upload] in the APR selection screen. "To Change Fluoroscopy APR" (page 3-66) 1 Press or to select the fluoroscopy pulse rate. • Select [CONTINUOUS] for continuous fluoroscopy. If you select [15 fps], [10 fps], [7.5 fps] or [3.75 fps], pulsed fluoroscopy will be executed, and the pulse rate will be changed to the selected value. Fluoroscopy mode selection screen Fig. 3.91 Changing the pulse rate NOTE You cannot switch the pulse rate while continuing fluoroscopy. You must stop fluoroscopy before making this change. NOTE When [Boost] is selected in [Dose], only [7.5 fps] or [3.75 fps] can be selected for the pulse rate. 3-78 OPESCOPE ACTENO FD type Instruction Manual  3.11 Fluoroscopy Changing the Fluoroscopy Conditions 3 (Fluoroscopy Tube Voltage) 1 Press the Auto/Manual switching button to switch to the manual mode. • lights. Basic screen Auto/Manual switching button 3 Fig. 3.92 Changing the fluoroscopy tube voltage 1 2 Press or to select the tube voltage. Basic screen (manual) Fig. 3.93 Changing the fluoroscopy tube voltage 2 OPESCOPE ACTENO FD type Instruction Manual 3-79 Chapter 3 Basic Operation 3.12 Changing Field Size (Zooming-up Images) Press (Zoom button) to change the field size. (The images are zoomed up.) Field size Button (color) Normal 8 × 8” (20.5 × 20.5 cm) (Gray) Zoomed 6” (15.5 cm) (Blue) NOTE When the field size is Zoomed, a circular shutter (filled with black) is displayed outside the field of view. NOTE If you change the field size during the fluoroscopy with the loop memory mode, the circular shutter is not displayed on the image after playback, frame-by-frame advance after fluoroscopy, or image after the save. 3-80 OPESCOPE ACTENO FD type Instruction Manual  3.13 Image Rotation and Reverse, Collimator, Compensating Filter Operation 3.13 Image Rotation and Reverse, Collimator, Compensating Filter Operation You can use the following functions during fluoroscopy and while a fluoroscopic image is displayed. 3.13.1 Image Rotation 3 Rapid feed Image rotation Fig. 3.94 Image rotation A live monitor image can be rotated. Pressing the Image rotation switch on the side panel causes the image to rotate. The Rapid feed switch is used to speed up the image rotation. When you press this switch, it is lit and enabled. Pressing the Image rotation switch while the Rapid feed switch is lit causes the image to rotate quickly. NOTE When the image is rotated or reversed during fluoroscopy in the loop memory mode, it is recorded from the image after the last rotation or last reverse. OPESCOPE ACTENO FD type Instruction Manual 3-81 Chapter 3 Basic Operation 3.13.2 Image Reverse V reverse H reverse (vertical reverse) (horizontal reverse) Fig. 3.95 Image reverse A live monitor image can be reversed. Pressing this switch on the side panel causes the image to be reversed. Fluoroscopy acquisition is performed based on the status of the image reverse switch (lit or unlit). • Fluoroscopy in progress: The fluoroscopic image is reversed. • fluoroscopic image applied: The fluoroscopic image is reversed. The next fluoroscopy acquisition is done in this reversed status. • During acquisition: Reverse operations are not possible. H reverse (horizontal reverse) V reverse (vertical reverse) 3-82 OPESCOPE ACTENO FD type Instruction Manual  3.13 Image Rotation and Reverse, Collimator, Compensating Filter Operation 3.13.3 Collimator and Compensating Filter Operation Press the switches on the C-arm main panel to open/close and rotate the octagonal collimator and the parallel compensating filter. (display during mechanical operation) is displayed on the right side of the live monitor during operation of the following functions. 3 1 2 3 Fig. 3.96 Collimator and compensating filter operation Item Description Pressing the switch opens the parallel compensating Parallel filter. 1 compensating filter open/close Pressing the switch closes the parallel compensating filter. Pressing the switch rotates the parallel Parallel compensating filter counter-clockwise. 2 compensating filter Pressing the switch rotates the parallel rotation compensating filter clockwise. The parallel compensating filter can be rotated endlessly. Octagonal collimator Pressing the switch opens the octagonal collimator. 3 open/close Pressing the switch closes the octagonal collimator. To Rotate the Parallel Compensating Filter To comply with IEC 60601-2-54:2009+A1:2015+A2:2018, rotating the parallel compensation filter simultaneously opens and closes the octagonal collimator depending on the angle. OPESCOPE ACTENO FD type Instruction Manual 3-83 Chapter 3 Basic Operation ♦ Operations During Fluoroscopy During fluoroscopy, collimator adjustments and rotation follow the collimator and compensating filter operations. ♦ Virtual collimator If you perform any collimator or compensating filter operation, the positions of the octagonal collimator and parallel compensating filter are indicated by lines on the live monitor. (Octagonal collimator: circular indication, Parallel compensating filter: two-line indication) NOTE If you start fluoroscopy acquisition immediately after releasing the switch, collimator and compensating filter open/close operation or rotation may still be in progress. Octagonal collimator Parallel compensating filter NOTE The virtual collimator is displayed based on the set fluoroscopy conditions. Therefore, if you change the field of view of the fluoroscopy last image hold (LIH) image or the loop memory image displayed on the live monitor, the position of the virtual collimator on the image will be different from the actual position. You can change the display time of the virtual collimator. To change it, contact your Shimadzu service representative. 3-84 OPESCOPE ACTENO FD type Instruction Manual  3.13 Image Rotation and Reverse, Collimator, Compensating Filter Operation 3 Fig. 3.97 Virtual Collimator OPESCOPE ACTENO FD type Instruction Manual 3-85 Chapter 3 Basic Operation 3.13.4 Setting the Beam Hardening Filter ♦ Types of Beam Hardening Filter Display Material Applications NONE - - Filter 1 Cu0.1 mm The limbs, etc. Filter 2 Cu0.2 mm Trunk, vertebral body, etc. Filter 3 Cu0.3 mm Chest, abdomen, etc. ♦ Selecting a Beam Hardening Filter Press the beam hardening filter selection button. Each time you press the button, the beam hardening filter display changes in the following order: [NONE] → [Cu0.1 mm] → [Cu0.2 mm] → [Cu0.3 mm] → [NONE]. Beam hardening filter selection button Fig. 3.98 Selecting a beam hardening filter 3-86 OPESCOPE ACTENO FD type Instruction Manual  3.14 Radiography 3.14 Radiography In the digital photography, acquired images are automatically saved to the hard disk. The image appears on the live monitor during acquisition, and the saved image appears on the reference monitor acquisition. NOTE • The digital radiography conditions are set automatically based on the last fluoroscopy conditions. For this reason, before taking a radiograph you should set the X-ray adjustment mode to “Auto” and perform fluoroscopy to 3 confirm that an adequate fluoroscopic image is acquired. • Mouse and keyboard operations and printing are disabled during radiography. • You cannot perform radiography while foreground processing is in progress, such as when saving images to the hard disk or registering images for printing. • If you perform radiography during background processing except for image playback or image writing to media, only the processing in progress will be completed, and the processing in the queue is paused. CAUTION A sudden temperature change in the FPD may cause a density difference or artifacts in images in the following cases: In this case, allow about two minutes for the problem to resolve. • When fluoroscopy/radiography is performed immediately after turning on the power. • When fluoroscopy/radiography is repeated for a long time without an interval of more than 30 seconds • When fluoroscopy/radiography is performed for a long time. When the [Image Dest], [Print Preset], or [Media Archive] is set in the [Auto. Processing] of the APR setting, these processing will be applied to all the acquired frames when the study is ended. OPESCOPE ACTENO FD type Instruction Manual 3-87 Chapter 3 Basic Operation 1 Press the acquisition mode selection button. Basic screen Fig. 3.99 Digital radiography 1 2 Check the radiography conditions. Acquisition mode selection screen [Acq Mode] [Acq Rate] [Density] Fig. 3.100 Digital radiography 2 NOTE [Acq Rate] is only displayed when a technique that involves serial radiography, such as [Serial] or [DSA], is selected. 3-88 OPESCOPE ACTENO FD type Instruction Manual  3.14 Radiography 3 Press the right foot switch. • During X-ray irradiation, the radiography image is displayed on the live monitor, after which the same image is displayed on the reference monitor. • X-ray emission is stopped and image acquisition ends when the radiography button is released midway during irradiation or when the preset number of frames are completed to be acquired. 3 Press Fig. 3.101 Digital radiography 3 NOTE Releasing your foot from the foot switch during irradiation will end X-ray irradiation partway through and stop radiography. In that case, the last frame may not have enough brightness. In serial radiography, X-ray emission is stopped and image acquisition ends when the preset number of frames are acquired. Acquisition mode selection screen (during X-ray irradiation) Tube voltage Tube current (kV) time product (mAs)∗ Fig. 3.102 Digital radiography 4 ∗ The tube current time product (mAs) is only displayed during radiographic exposure. OPESCOPE ACTENO FD type Instruction Manual 3-89 Chapter 3 Basic Operation To Change the Acq Mode NOTE Changes made from the C-arm main panel are temporary, so the values after the change are not saved. To save changes, press [Overwrite & Upload] in the APR selection screen. "To Change Acquisition APR" (page 3-70) NOTE When the Acq mode is changed, the acq rate hold in the X-ray generator is set. 1 Select [Acq Mode]. Acquisition mode selection screen [Acq Mode] The selected [Acq Mode] is displayed. Fig. 3.103 Changing the Dose Item Function [Spot] Radiography is performed with 1 irradiation. [Serial] Radiography is performed with continuous irradiation. [DSA] DSA radiography is performed. 3-90 OPESCOPE ACTENO FD type Instruction Manual  3.14 Radiography To Change the Acquisition Rate 1 Press or to select the acquisition rate. • Each time you press the button, the acquisition rate changes in the following order: [7.5 fps] → [5 fps] → [3.75 fps] → [3 fps] → [2 fps] → [1 fps] → [0.5 fps] Acquisition mode selection screen 3 Fig. 3.104 Changing the acquisition rate NOTE [Acq Rate] is only displayed when a technique that involves serial radiography, such as “Serial” or “DSA”, is used. OPESCOPE ACTENO FD type Instruction Manual 3-91 Chapter 3 Basic Operation To Perform the Manual Spot Radiography The Manual spot radiography allows manual adjustment of the tube voltage (kV) value and tube current time product (mAs) for DR radiography. 1 When in simple mode, press the setting screen switch button to switch to the expert mode. Basic screen Setting screen switch button Fig. 3.105 Manual spot radiography 1 2 Press (Manual spot radiography mode button). Basic screen (expert mode) Manual spot radiography mode button Fig. 3.106 Manual spoor radiography 2 3 Press / to adjust the tube voltage (kV) value and the tube current time product (mAs) value. 3-92 OPESCOPE ACTENO FD type Instruction Manual  3.14 Radiography Manual spot radiography screen Tube voltage Tube current (kV) time product (mAs) 3 Fig. 3.107 Manual spoor radiography 3 NOTE In the Manual spot radiography mode, fluoroscopy and serial radiography are not available. 4 Press the right foot switch. Press Fig. 3.108 Manual spot radiography 4 5 Continue pressing the right foot switch. • X-rays will be radiated. During radiation the irradiation indicator (on the monitor cart) is lit. NOTE Keep pressing the foot switch until X-ray radiation is completed. If you release it halfway, the X-ray radiation will terminate prematurely. 6 Check that the X-ray radiation is completed and finish radiography. Press (Manual spot radiography mode button) or (Expert mode) to return to the basic screen. OPESCOPE ACTENO FD type Instruction Manual 3-93 Chapter 3 Basic Operation To Change the Density 1 Press the Density button. Acquisition mode selection screen Fig. 3.109 Changing the density 1 2 Set the density. • Select the density ([-3] / [-2] / [-1] / [0] / [+1] / [+2] / [+3]). Acquisition mode selection screen Fig. 3.110 Changing the density 2 NOTE The dosage becomes higher with a higher density value. 3-94 OPESCOPE ACTENO FD type Instruction Manual  3.15 Removing and Mounting Grid 3.15 Removing and Mounting Grid The grid can be removed when the exposure level must be reduced to perform radiography for infants, etc. CAUTION Be careful not to confuse these parts with similar products of another company. Misuse of these parts may cause the accident. 3 3.15.1 Removing the Grid 1 Rotate the C-arm so that the grid faces up. Grid Fig. 3.111 C-arm rotation See 3.6.4 "C-arm Rotational Motion" (page 3-30). WARNING When moving the C-arm, take care that the C-arm, X-ray generators and X-ray FPD at both ends do not strike the patient or peripheral devices. Also, after positioning the C-arm, be sure to press the C-arm lock switch to lock the C-arm. Failure to do so may cause injury or damage to the equipment. OPESCOPE ACTENO FD type Instruction Manual 3-95 Chapter 3 Basic Operation CAUTION When moving the C-arm, hold each of the handles to operate it. Otherwise, you may trap your fingers, causing injury. 2 Place your thumb in the pull handle and pull the cover down to open the cover. Cover Pull Handle Fig. 3.112 Opening cover 3 While sliding the lever in the direction of the arrow, grasp the part marked “Grid” and pull out the grid to remove it. Lever Fig. 3.113 Unlocking lever “Grid” Fig. 3.114 Removing grid 3-96 OPESCOPE ACTENO FD type Instruction Manual  3.15 Removing and Mounting Grid 4 Lift the cover up until it clicks to close it. CAUTION Make sure that the cover is securely fastened. Otherwise, it may come off during use. 3 Cover Pull Handle Fig. 3.115 Closing cover 3.15.2 Mounting the Grid 1 Place your thumb in the pull handle and pull the cover down to open the cover. Cover Pull Handle Fig. 3.116 Opening cover OPESCOPE ACTENO FD type Instruction Manual 3-97 Chapter 3 Basic Operation 2 Insert the grid into the rail groove and push it all the way in. Rail “Grid” Fig. 3.117 Mounting grid CAUTION Insert the grid with the orientation shown in the figure. If the grid orientation is incorrect, the grid cannot be fully inserted. CAUTION Be sure to insert the grid all the way in. If the grid is not secured properly, it may fall off during use. Also, if it is not inserted all the way in, the correct image cannot be obtained. 3 Lift the cover up until it clicks to close it. Cover Pull Handle Fig. 3.118 Closing cover CAUTION Make sure that the cover is securely fastened. Otherwise, it may come off during use. 3-98 OPESCOPE ACTENO FD type Instruction Manual  3.16 Useful Functions 3.16 Useful Functions 3.16.1 Smart C Memory Store the fluoroscopy conditions, the rotational position of the image, the collimator, compensating filter position, the loading factor and other information. NOTE • This operation is not possible during fluoroscopy. 3 • You cannot do this when X-ray exposure (fluoroscopy) switch is pressed. • The information stored with this function is reset when the power is turned OFF. The following conditions can be stored. • Fluoroscopy conditions • Rotational position of image • Open/close position and rotational angle of the collimators and compensating filter • Image reverse • Filter • Field size If you want to change the stored condition, contact your Shimadzu service representative. Smart C memory [F] Smart C memory [L] Fig. 3.119 Smart C memory 1 Hold down Smart C memory (for about 1 second). • The current conditions are stored. When storing is completed the switch lights. OPESCOPE ACTENO FD type Instruction Manual 3-99 Chapter 3 Basic Operation NOTE If any condition is changed from the stored condition in smart C memory, the smart C memory starts blinking. 2 Press the blinking Smart C memory, briefly. • The conditions stored in the Smart C memory will be called up. At the same time, the switch will change from blinking to continuously lit. To Differentiate the Use of Two Smart C Memory Lit 1 Hold down (smart C memory [F]), for about 1 second. • The current conditions will be stored in smart C memory [F]. When storing is completed the switch lights. Blink 2 Change conditions such as the rotational position of the image. • Smart C memory [F] will blink. Lit 3 Briefly hold down (smart C memory [L]), for about 1second. • The changed conditions are stored in smart C memory [L]. When storing is completed the switch lights. • Smart C memory [F] goes off. Lit 4 Press (smart C memory [F]), briefly. • Smart C memory [F] will light, and the equipment will return to the conditions stored in smart C memory [F]. • Smart C memory [L] will go off. Lit 5 Press (smart C memory [L]), briefly. • Smart C memory [L] will light, and the equipment will adopt the conditions stored in smart C memory [L]. • Smart C memory [F] goes off. 3-100 OPESCOPE ACTENO FD type Instruction Manual  3.16 Useful Functions 3.16.2 Live Monitor Image Display on the C-arm Main Panel (Option) By pressing (Image display switch), the image on the live monitor is displayed on the LCD display of C-arm main panel. NOTE This function is available only when the image display function (option) is combined. The following live monitor display elements, however, are not 3 displayed on the LCD display. • Lines of virtual collimation • Annotation Basic screen Image display switch Image display Fig. 3.120 Switching the LCD display OPESCOPE ACTENO FD type Instruction Manual 3-101 Chapter 3 Basic Operation 3.16.3 Image Lock on the Reference Monitor The image lock function keeps an image displayed on the reference monitor. It could be useful for fluoroscopy referring to an another image even during radiography or image saving. The image lock function is available for the Study window only. 1 Press the setting screen switch button to switch to expert mode. Basic screen Setting screen switch button Expert mode screen 3-102 OPESCOPE ACTENO FD type Instruction Manual  3.16 Useful Functions 2 Press (Image lock button). • The [Lock] appears on the reference monitor and the image being displayed is locked. Expert mode screen 3 Image lock button • Press the image lock button again to release the lock. NOTE The image lock button is displayed only on the expert mode. NOTE When performing radiography during the image lock, an image appears on the live monitor for a moment and the image display is not updated on the reference monitor. Use the Next/Previous switch to display the acquired image. For details on operations, see 4.2.2 "Selecting/Navigating the Images" (page 4-7). NOTE The loop memory images or the serial images cannot be played back during the image lock. Release the image lock to play back the images. OPESCOPE ACTENO FD type Instruction Manual 3-103 Chapter 3 Basic Operation 3.16.4 Touch Focus Function (Option) The touch focus function is to adjust the brightness inside a user-defined photometry area on a fluoroscopic image with the touch panel operation on the C-arm main panel. Appropriate brightness is achieved every defining the area. Through the brightness inside the area varies, the brightness adjustment does not follow the variation. 1 Press the Image display switch on the C-arm main panel with the basic screen displayed. • The image currently displayed on the live monitor is displayed on the LCD display. For details, see 3.16.2 "Live Monitor Image Display on the C-arm Main Panel (Option)" (page 3-101). NOTE This touch focus function is available while the image on the live monitor is also displayed on the C-arm main panel. With the basic screen, the photometry area is positioned at the center of a fluoroscopic image, and cannot be changed. 3-104 OPESCOPE ACTENO FD type Instruction Manual  3.16 Useful Functions Basic screen 3 Image display switch 2 Press any position within the field to specify a photometry area. • Appropriate brightness is achieved inside the area specified with fluoroscopy. NOTE You cannot specify an area that will not be displayed due to image rotation or an area outside the display area for a small field. When these area are specified, the photometry area marker flashes red. OPESCOPE ACTENO FD type Instruction Manual 3-105 Chapter 3 Basic Operation Touch Focus Screen 3 1 2 No. Name Description Switches the X-ray adjustment mode. Auto/Manual switching button (Auto): Adjust X-rays automatically. 1 (Manual): Adjust X-rays manually. * The touch focus function is available with the Auto mode. Turns OFF the touch focus function. The photometry area marker disappears from the 2 Touch focus off button screen and an image is displayed according to fluoroscopy conditions. 3 Photometry area marker The area inside the marker is adjusted. 3-106 OPESCOPE ACTENO FD type Instruction Manual  3.16 Useful Functions 3 Appropriate brightness is achieved once every defining the photometry area with the touch panel of the C-arm main panel. Then, if the brightness in the photometry area marker changes due to a change in the subject, the photometry area marker will turn yellow, but the brightness will not be adjusted automatically. When the photometry area marker is yellow, press the same spot again to adjust the brightness again. Until appropriate brightness is achieved for a new photometry area, the photometry area marker is blanking green. OPESCOPE ACTENO FD type Instruction Manual 3-107 Chapter 3 Basic Operation ♦ Operation When Touch Focus Function is Turned OFF Press the touch focus off button to turn off the touch focus function. When the X-ray adjustment mode is the Auto, brightness will be adjusted inside the photometry area according to a currently selected APR. When the X-ray adjustment mode is the Manual, an image with the brightness according to the current X-ray conditions is displayed. Press any position to turn on the touch focus function. NOTE With the fluoroscopic image display, the X-ray condition controls listed below are not available: - Fluoroscopy pulse rate (switching between the DC fluoroscopy and the Pulsed fluoroscopy) - Fluoroscopy dose switching - BH filter switching - APR change - Loop memory ON/OFF NOTE When the field is switched, the photometry area marker remains at the current coordinate position on the C-arm main panel. Set up a new photometry area marker for a new field. 3-108 OPESCOPE ACTENO FD type Instruction Manual  3.17 System Settings 3.17 System Settings You can view the guidance, check and change the initial setting and the touch panel calibration. NOTE The changes you make to the unit settings remain effective even if you restart (they are not reset by turning the power OFF). 3 1 Press (Menu switch). • The system setting menu screen is displayed. 2 Select the button for each menu. Basic screen Menu switch Setting menu screen Fig. 3.121 Setting menu screen OPESCOPE ACTENO FD type Instruction Manual 3-109 Chapter 3 Basic Operation 3.17.1 Guidance 1 Press [Guidance]. • The guidance screen is displayed. Setting menu screen [Guidance] Fig. 3.122 Guidance 2 Press the button representing the control part. • The guidance of the control part is displayed. No. Screen Item Description The C-arm main panel 1 [Main Panel] guidance is displayed. The C-arm side panel 2 [Side Panel] guidance is displayed. 3-110 OPESCOPE ACTENO FD type Instruction Manual  3.17 System Settings No. Screen Item Description The LCD display 3 [Display] guidance is displayed. 3.17.2 Default Settings 3 1 Press [Default Settings]. • The default settings screen is displayed. Setting menu screen [Default Settings] Fig. 3.123 Default Settings 1 OPESCOPE ACTENO FD type Instruction Manual 3-111 Chapter 3 Basic Operation 2 Check the following items and change if necessary. Default settings screen Fig. 3.124 Default settings 2 ♦ Monitor Setting Screen 2 1 3 No. Item Description 1 [Default Mode] Selects the default display ([Simple] or [Expert]). 2 [Brightness] Adjusts the monitor brightness. [Tube Current Sets the tube current display value ([Peak] or [Average]) for 3 Indication] fluoroscopy. NOTE The default configuration does not provide the tube current indication. To use this setup, contact your Shimadzu service representative. 3-112 OPESCOPE ACTENO FD type Instruction Manual  3.17 System Settings ♦ Sound Setting Screen 1 2 3 3 No. Item Description [Operation 1 Adjusts [Operation sound] using [−] and [+]. Sound] 2 [Beep Sound] Adjusts [Beep sound] using [−] and [+]. [Fluoroscopy 3 Adjusts [Fluoroscopy sound] using [−] and [+]. Sound] CAUTION The fluoroscopy sound requires careful adjustment. It should be audible since it is produced to inform a user that X-rays are being generated. OPESCOPE ACTENO FD type Instruction Manual 3-113 Chapter 3 Basic Operation ♦ Operation Setting Screen 1 2 No. Item Description Adjusts the time of the fluoroscopy timer preset using [−] [Fluoroscopy and [+]. 1 Timer] • You can make changes in 30-second increments. • The maximum setting is 5 minutes. (Checked): Default setting The image rotation, collimator, filter, and image reverse settings remain even when the APR is changed. Only X-ray 2 [APR Setting] conditions and image processing parameters are changed. (Cleared) All APR settings are changed when the APR is changed. 8.6 "Initial Setting Values for APR" (page 8-26) 3-114 OPESCOPE ACTENO FD type Instruction Manual  3.17 System Settings * The following additional screen is displayed only with the external video output function (option). 1 2 3 No. Item Description 1 [Monitor Setting] Sets the monitor display (Standard or Clone). [Video Output 1] 2 Sets the external video output function ([LIVE] or [REF]). [Video Output 2] CAUTION The video output by the external video output function is for reference. Do not use for diagnostic purposes. To use the Video Output 2, contact your Shimadzu service representative. OPESCOPE ACTENO FD type Instruction Manual 3-115 Chapter 3 Basic Operation 3.17.3 Touch Panel Calibration 1 Press [Calibration]. • The calibration screen is displayed. Setting menu screen [Calibration] Fig. 3.125 Calibration 1 2 Follow the on-screen messages and calibrate the touch panel. • Press (reset switch) while holding down at the lower right of the screen. Calibration screen (start) Reset Key Fig. 3.126 Calibration 2 3-116 OPESCOPE ACTENO FD type Instruction Manual  3.17 System Settings • Press (reset switch) while holding down at the upper left of the screen. Calibration is completed. Calibration screen (complete) 3 Reset Key Fig. 3.127 Calibration 3 OPESCOPE ACTENO FD type Instruction Manual 3-117 Chapter 3 Basic Operation 3.18 Ending the Study 1 Release your foot from the foot switch. 2 Press (End study button). • The “New study standby screen” is displayed. Fig. 3.128 Ending the study You can also end study from the monitor cart (reference monitor). When the [Image Dest], [Print Preset], or [Media Archive] is set in the [Auto. Processing] of the APR setting, these processing is performed at the end of the study. In such cases, it usually takes a few tens of seconds to complete the study, or a few minutes if there are many images. 3-118 OPESCOPE ACTENO FD type Instruction Manual  3.19 Dose Display 3.19 Dose Display Fluoroscopy time, reference air kerma rate, accumulated reference air kerma and total dose area product are indicated on the C-arm main panel and the live monitor. Basic screen 1 4 3 2 3 Fig. 3.129 Main pane 3 2 4 1 Fig. 3.130 Live monitor OPESCOPE ACTENO FD type Instruction Manual 3-119 Chapter 3 Basic Operation The dose report is displayed when [Dose Info.] on the C-arm main panel is pressed. Dose report screen 4 1 3 [Dose info.] Fig. 3.131 Live monitor No. Item Description The total fluoroscopy time of the study 1 Total fluoroscopy time currently running is indicated. The reference air kerma rate* is indicated. It is 2 Reference air kerma rate (AKR) indicated only while fluoroscopy or serial radiography is performed. Accumulated reference air The accumulated reference air kerma* of the 3 kerma (AK) study currently running is indicated. The total dose area product of the study 4 Total dose area product (DAP) currently running is indicated. ∗ The air kerma (rate) at the position 51.5 cm above the focus. NOTE The unit of the Total dose area product value can be selected from the following. Contact your Shimadzu service representative if you need to make any changes. • mGy・m2 • Gy・cm2 • μGy・m2 • mGy・cm2 3-120 OPESCOPE ACTENO FD type Instruction Manual  3.19 Dose Display NOTE When the study is closed, all the indicated values are reset. NOTE The indicated value of Dose Area Product has the maximum error of 35 %. However, the error may be 35 % or more in AKR of less than 6 mGy/min and Accumulated Reference Air Kerma of less than 100 mGy. (It is based on the IEC-60601-2-54 clause 203.6.4.5.) 3 OPESCOPE ACTENO FD type Instruction Manual 3-121 Chapter 3 Basic Operation This page is intentionally left blank. 3-122 OPESCOPE ACTENO FD type Instruction Manual  Chapter 4 Image Processing This chapter explains how to perform image processing. Chapter 4 Image Processing 4.1 Adjusting Fluoroscopy Contrast and Brightness (C-arm Main Panel) Image brightness display 1 2 Fig. 4.1 Adjusting contrast and brightness No. Item Description Automatically adjusts the contrast and brightness of the fluoroscopic image in 7 Fluoroscopy brightness stages (-2 to +4). 1 adjustment switch The set fluoroscopic image brightness is displayed at the top right of the LCD display and the monitor. Resets the fluoroscopic image brightness 2 Reset switch setting to 0. NOTE All the above operations can only be performed on the fluoroscopic images displayed on the live monitor. 4-2 OPESCOPE ACTENO FD type Instruction Manual  4.2 Saving/Selecting/Navigating Images 4.2 Saving/Selecting/Navigating Images 4.2.1 Saving Images This section explains how to save the fluoroscopic images. When the saved fluoroscopic image is displayed on the reference monitor, the AK (accumulated reference air kerma), the DAP (Total dose area product), and the msec (exposure time) in the image information are not recorded. The kV (tube voltage) and the mA (tube current) are not recorded for images stored during fluoroscopy. NOTE When you start or end the study or shut down the PC, the images that are not 4 saved on the hard disk are deleted. The maximum number of saved frames for loop memory images is 300 frames. The larger the number of frames, the longer it will take to save. To change the number of frames, use the Edit APR Preset window. “SDR-120F Reference Guide” ♦ Frame Memory Function NOTE You cannot perform fluoroscopy or radiography while saving an image, except when saving a fluoroscopic image in the frame memory mode. You can save the currently displayed images. (display during image saving) is displayed on the monitor while an image is being saved. The frame memory function can save a fluoroscopic image (frame) during fluoroscopy and a last image hold (LIH) image after fluoroscopy is ended. When an image is saved by the frame memory function during fluoroscopy, X-ray information such as a dose and X-ray conditions is not input in the DICOM header. OPESCOPE ACTENO FD type Instruction Manual 4-3 Chapter 4 Image Processing Basic screen [Save] Fig. 4.2 Frame memory Press [Save] to save the fluoroscopic image (frame) to the hard disk. After fluoroscopy, a LIH fluoroscopic image appears. ♦ Loop Memory Function You can save loop memory images (a series of fluoroscopic images). NOTE The loop memory function is enabled only during a study. 1 Select [Loop] in the fluoroscopy mode selection screen. • (loop memory display) is displayed on the monitor. Fluoroscopy mode selection screen [Loop] Fig. 4.3 Loop memory 1 4-4 OPESCOPE ACTENO FD type Instruction Manual  4.2 Saving/Selecting/Navigating Images 2 Perform fluoroscopy. For details, see 3.11 "Fluoroscopy" (page 3-73). • The loop memory images are temporarily held from when the X-ray irradiation (fluoroscopy) switch or the left foot switch is pressed until the switch is released. NOTE Loop memory images can be held temporarily only once, regardless of fluoroscopy time (number of frames). The loop memory images can be played back automatically after fluoroscopy is performed. If you need to change the setting, contact your Shimadzu service representative. 4 3 Press [Save] to save the loop memory images to the hard disk drive. • (display during image saving) is displayed on the monitor while an image is being saved. The [Save] button is not available while in loop fluoroscopy. Saving the loop memory images in the hard disk drive enables you to refer to the past loop memory images even after saving the newer images. Basic screen [Save] Fig. 4.4 Loop memory 2 OPESCOPE ACTENO FD type Instruction Manual 4-5 Chapter 4 Image Processing NOTE You cannot save images or perform digital radiography while saving to the hard disk. NOTE When the loop memory images obtained from a single fluoroscopy exceeds set number of frames, the oldest image is automatically deleted as a new image is saved. 4-6 OPESCOPE ACTENO FD type Instruction Manual  4.2 Saving/Selecting/Navigating Images 4.2.2 Selecting/Navigating the Images Press the Next/Previous switch or the Playback/Stop switch on the C-arm main panel to select or navigate the image. 2 3 4 1 Fig. 4.5 Selecting/navigating the images No. Name Description Switches the monitor controlled through the C-arm main Control monitor panel. switching button 1 : Live monitor is selected. : Reference monitor is selected. The switches below are available only when the live monitor is selected and loop memory images or serial images are displayed. No. Name Description Presses the Next/Previous switch to display the next/ Next/Previous 2 previous image in the temporally-held loop memory images switch or serial images. Playback/Stop Presses the Playback/Stop switch to start/stop the playback 3 switch of the saved loop memory images or serial images. The switch below is available only when the reference monitor is selected. No. Name Description Next/Previous Holds down the Next/Previous switch to select the saved 2 switch image. OPESCOPE ACTENO FD type Instruction Manual 4-7 Chapter 4 Image Processing 4.3 Operating Image List Window In the Image List window, you can operate images saved on the hard disk. To display the Image List window, press the [Image List] button. If the [Image List] button is not displayed, press the [List] button to display the List window, and then switch to the Image List window. In some places in this document, the term "image" is used to refer to an image file, whereas in other places it is used to refer to a frame or image. NOTE If a large amount of image data is saved, there will be no available space and a study cannot be started. Delete unnecessary data periodically. Operation Study List button 45 Panel 1 2 3 6 Fig. 4.6 Image List window No. Name Description Two Panes/Three Panes Switch button Switches between the two panes/three panes in the 1 image file list area. 4-8 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window No. Name Description Thumbnail/List Switch button Switches between the list display/thumbnail display 2 in the image pane. All Image Display 3 Switches between all image display on and off. Filter button 4 Displays the [Filter condition settings] dialog box. Filter Cancel button Cancels the filtering. The list returns to the state 5 before a filtering. 6 Image List operation area Displays a list of image files. 4 OPESCOPE ACTENO FD type Instruction Manual 4-9 Chapter 4 Image Processing ♦ File Display Hierarchy in the Image List Screen All the image files saved in the system are classified into three groups: study, series, and image. The Image List window shows the representative information based on the hierarchical structure. Different studies of an identical patient are separated studies. The following diagram shows the files in their hierarchical structure. Study Series Image Study 1 Series 1 Image file Image file Series 2 Image file Image file Study 2 Series 1 Image file Image file Fig. 4.7 Hierarchical structure of files Image files consist of single-frame files (files containing single frame) and multi-frame files (files containing multiple frames). 4-10 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window ♦ File Selection Two or more studies can be selected by holding down the CTRL or SHIFT key. • Selecting Study List A study list is selected. This range is selected. Study 1 Series 1 Image file Image file Series 2 Image file Image file 4 • Selecting Series List A series list is selected. This range is selected. Study 1 Series 1 Image file Image file Series 2 Image file Image file • Selecting Image List This range is selected. Study 1 Series 1 Image file Image file Series 2 Image file Image file OPESCOPE ACTENO FD type Instruction Manual 4-11 Chapter 4 Image Processing • Selecting Multiple Studies Multiple lists are selected. This range is selected. Study 1 Series 1 Image file Image file Series 2 Image file Image file Study 2 Series 3 Image file Image file 4-12 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window ♦ Switching Between Two Panes/Three Panes Display The Image List window can be switched between the two panes display and the three panes display. The default display is the three panes display. 1 Click • Two Panes Display Study pane 4 Image pane Fig. 4.8 Two panes display • Three Panes Display Study pane Series pane Image pane Fig. 4.9 Three panes display OPESCOPE ACTENO FD type Instruction Manual 4-13 Chapter 4 Image Processing ♦ Operation Panel of Image List Window 1 2 3 4 5 Fig. 4.10 Operation panel of Image List window No. Name Description Image Display button Switches to the Image Edit window to display image. 1 “SDR-120F Reference Guide” DICOM Print Output button Registers the selected image file to a print edit. 2 “SDR-120F Reference Guide” Media Archive button Registers image files for writing to a storage media. 3 “SDR-120F Reference Guide” 4-14 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window No. Name Description Send button Sends image files to other devices. 4 “SDR-120F Reference Guide” Delete button Deletes image files. 5 “SDR-120F Reference Guide” ♦ List items of Image List Operation Area Each pane has display items as shown below: List display mode Study pane item 4 Image Series pane pane item Item Fig. 4.11 Display items - List display Thumbnail display mode Study pane item Series pane item Image pane Item Fig. 4.12 Display items - Thumbnail display Study Pane Name Description Pat. ID The patient ID is displayed. Pat. Name The patients' names is displayed. Study Date The date and time of the study are displayed. Label The status of the image files in the study is displayed. DOB The patients' dates of birth is displayed. The patients' sex is displayed. M: Male F: Female O: Other Sex Blank: Unregistered (i.e., not registered at the time of image acquisition) OPESCOPE ACTENO FD type Instruction Manual 4-15 Chapter 4 Image Processing Series Pane (3 pane only) Name Description Ser# The series number is displayed. Series Date The study date and time of the series are displayed. Images The number of images in the series is displayed. Label The status of the image file in the series is displayed. Image Pane Name Description The series number is displayed. Ser# (in List display mode with Two pane) Im# The image number is displayed. Type The image type is displayed. Frames The numbers of frame image registered in the image files is displayed. Label The status of the image file in the image pane is displayed. The tube voltage at the image acquisition is displayed. kV (in List display mode) The tube current at the image acquisition is displayed. mA (in List display mode) The APR at the image acquisition is displayed. APR (in List display mode) The data and time at image acquisition are displayed. Acq. Date (in List display mode with Two pane) ♦ Descriptions of Type and Labels Type Display Name Description SPOT SPOT_R Indicates that an image was acquired in the SPOT acquisition mode. SPOT_P SERIAL Indicates that an image was acquired in the SERIAL acquisition mode. SERIAL_P DSA Indicates that an image was acquired in the DSA acquisition mode. FLUO Indicates a saved fluoroscopic image. "_ R" and "_ P" indicate the type according to the SURE processing. “SDR-120F Reference Guide” 4-16 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window Label of Study and Series Panes Description Name Upper case Lower case Indicates that protection (deletion Indicates that some image files has P/p prohibited) is set for all the image been protected (deletion files in the study or series. prohibited) in the study or series. Indicates that all the image files in Indicates that some image files in the study or series were registered the study or series were registered R/r to this system from a network or a to this system from a network or a storage media, such as a CD-R or storage media, such as a CD-R or DVD-R. DVD-R. Indicates that all the image files in Indicates that some image files in N/n the study or series were sent via the study or series were sent via the network. the network. A/a Indicates that all the image files in the study or series were saved to a Indicates that some image files in the study or series were saved to a 4 storage media, such as a CD-R or storage media, such as a CD-R or DVD-R. DVD-R. Indicates that all the image files in Indicates that some image files in H/h the study or series was the study or series was dicom-printed. dicom-printed. No Indicates image files other than the above. indication Label of Image Pane Name Description P Indicates that protection (deletion prohibited) is set for the image file. Indicates that the image file was registered to this system from a network R or a storage media, such as a CD-R or DVD-R. N Indicates that the image file was sent via the network. Indicates that the image file was registered for storing on a storage media, A such as a CD-R or DVD-R. H Indicates that the image files was dicom-printed. No Indicates the image file other than the above. indication OPESCOPE ACTENO FD type Instruction Manual 4-17 Chapter 4 Image Processing NOTE The "A /a" label indicates that an image has been registered for media storing. When forced termination or abnormal termination of the system occur before writing the image in storage media after registration, the label of "A/a" remains although the image is not written in the media. Please complete image writing. ♦ Operation in Image List Operation Area • Rearranging Items The item names at the top of the lists can be dragged to the left or right. Release the mouse button after moving the item to the desired position. The item will move. • Rearranging Lists The order of the contents of a list can be switched between ascending order and descending order by clicking on an item name at the top of a list. / is displayed for rearranged items. • Scrolling Lists If part of a list is hidden, a scroll bar is displayed either at the bottom or on the right side. The hidden part can be displayed by moving the mouse pointer to the scroll bar and dragging the scroll bar up, down, to the left, or to the right as appropriate. • Right-click Menu Select a displayed image and right-click to display the right-click menu. The menu that appears depends on the selected pane. Fig. 4.13 Right-click menu 1 2 3 4 5 6 10 Fig. 4.14 Right-click menu on Study pane 4-18 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window 1 2 3 Fig. 4.15 Right-click menu on Series pane 1 2 3 7 8 9 10 Fig. 4.16 Right-click menu on Image pane 4 No. Name Description 1 Protect Protects (i.e., prohibit deletion of) the selected image file. Cancels protection (i.e., allow deletion) of the selected 2 Unprotect image file. 3 Delete Deletes the selected image file. Revise patient 4 Updates the patient information. information 5 Combine studies Combines studies that have been divided. Anonymizes information related to personal information 6 Anonymous included in the selected study, and copy images. 7 Divide study Divides an study. Applies the Post Sure processing to a selected image file. 8 Post Sure “SDR-120F Reference Guide” Displays the DICOM tag information of images in the 9 Property image pane. Performs the registered additional function. 10 Special Job “SDR-120F Reference Guide” • Changing Pane Display Size The display size of study, series, and image panes can be changed. When the mouse pointer is moved to the border of a pane, it changes to . With this mouse pointer, dragging the mouse up, down, to the left, or to the right changes the display size of each pane. OPESCOPE ACTENO FD type Instruction Manual 4-19 Chapter 4 Image Processing 4.3.1 Enabling and Disabling File Protection In order to prevent files from being deleted by mistake, protection (i.e., deletion prohibited) can be set for files using the right-click menu. ♦ Protecting Files 1 Select a desired file, and select [Protect] on the right-click menu. • If protection is set for a file, either [P] (upper case) or [p] (lower case) appears in the [Label] column. Indicates that protection (deletion prohibited) is set for all of the data in the subordinate group. Indicates that protection is set for some of the data in the subordinate group. Fig. 4.17 Protect file NOTE If a list including protected files is deleted, unprotected image files in the list are deleted. ♦ Unprotecting Files 1 Select a desired file, and select [Unprotect] on the right-click menu. • The character "P" or "p" disappear from the [Label] column. "P" disappears to indicate that protection that was set to all data in the subordinate is canceled. "p" disappears to indicate that protection that was set to some of the data in the subordinate group is canceled. Fig. 4.18 Unprotect file 4-20 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window 4.3.2 Deleting Files Delete a image file on the disk using the procedure described below. NOTE Once a file is deleted, it cannot be restored. Be sure to check that a file is not needed before deleting it. 1 Select a file to be deleted. 2 Either click [Delete] on the operation panel or [Delete] on the right-click menu. 4 Fig. 4.19 Delete button • A [Confirm] dialog box appears. Fig. 4.20 Confirmation dialog box 3 Click [Yes]. • Click [Yes] to display a dialog box showing that deletion is in progress, and then the selected image file will be deleted. When a study or series specified to be deleted contains a file in use, it will not be deleted and remain after the delete. OPESCOPE ACTENO FD type Instruction Manual 4-21 Chapter 4 Image Processing 4.3.3 Revising Patient Information You can change and update the patient information, such as when you want to change the patient name of the acquired image. NOTE If you edit patient information with this equipment, the information may be different from that of other devices. 1 Select and right-click a desired study in the study pane. • The right-click menu is displayed. Fig. 4.21 Revise patient information Revising the patient information fails when the image included in the selected study is still in use. 2 Click [Revise patient information]. • The Patient Information Update dialog box appears. Fig. 4.22 Patient Information Update dialog box 4-22 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window 3 Edit desired items. For details, see 3.7.1 "Registering New Study" (page 3-38). 4 Click [Update]. • Clicking [Update] overwrites the patient information with the new changes. 4.3.4 Dividing Study Studies can be divided, for example, when you have mistakenly forgotten to end the previous study and continued with study of the next patient. 1 Select the image file to be divided in the image pane. • The selected image is highlighted. 4 • The selected thumbnail image is surrounded with the selection border. Select the image to be divide. Fig. 4.23 Select file to be divided 2 Right-click inside the image pane. • The right-click menu is displayed. 3 Click [Divide study]. Fig. 4.24 Dived study OPESCOPE ACTENO FD type Instruction Manual 4-23 Chapter 4 Image Processing • The [Confirm] dialog box appears. Fig. 4.25 Confirmation dialog box 4 Click [Yes]. • Click [Yes] to divide the study. Division of studies fails when the selected image contains an image in use. ♦ List and Patients' Names After Division of Study When a single study is divided, the new divided study is generated and appears below the original study. The default name of the new divided study is "Separated Study". The name "Separated Study" can be renamed as appropriate by updating the patient information. 4-24 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window 4.3.5 Combining Study The divided study can be combined into a single study. NOTE Once divided studies can be combined. Combining different studies fails. 1 Select two studies that were divided. • They are highlighted. Select 4 divided two studies. Fig. 4.26 Select divided studies 2 Right-click inside the study pane. • The right-click menu is displayed. 3 Click [Combine studies]. Fig. 4.27 Combine study • The [Combine Studies] dialog box appears. OPESCOPE ACTENO FD type Instruction Manual 4-25 Chapter 4 Image Processing Fig. 4.28 Combine Studies dialog box 4 Select one of these studies as the combine destination. • The selected study is highlighted. 5 Click [Perform]. • Click [Perform] to start combining. Combining of studies fails when the images included in the two selected studies is still in use. 4-26 OPESCOPE ACTENO FD type Instruction Manual  4.3 Operating Image List Window 4.3.6 Anonymous A study can be copied after personal information is removed. 1 Select a study to be anonymized and right-click it to open the right-click menu. Click [Anonymous]. Fig. 4.29 Anonymize study 4 2 The Anonymous dialog box appears. Edit desired items, if necessary. Fig. 4.30 Anonymous dialog box 3 Click [Execute]. • Click [Execute] to start anonymous. When the anonymous is executed, the new study file without personal information is generated and appears in the Image List window. OPESCOPE ACTENO FD type Instruction Manual 4-27 Chapter 4 Image Processing 4.3.7 About Image Files In Use When an image file is in one of the following states, that file is defined as being "in use". • Image is currently displayed. • Image is currently registered to the [Print Edit] window. • Image is currently registered during a save. • Image is currently being send. Image delete, patient information update, division of study, and combining of studies cannot be performed on image files in use or on studies that include image files in use. To disable the "in use" state of an image file, perform one of the operations below according to the above states: • Image is currently displayed. Exit the image display. • Image is currently registered to the [Print Edit] window. Execute printing. • Image is currently registered for image saving. Either wait for registration to complete or cancel it. • Image is currently being send. Either wait for image sending to complete or cancel it. 4.3.8 Filtering The filtering function allows user to find the target study quickly. Even when a part of patient ID and name are unknown, a wild card (*) matching allows user to find patients matching the criteria specified. For details, see 3.7.5 "Filtering" (page 3-49). 4-28 OPESCOPE ACTENO FD type Instruction Manual  Chapter 5 Troubleshooting This chapter explains the corrective action to take if the equipment develops trouble. When trouble occurs, take action calmly and deliberately. Chapter 5 Troubleshooting 5.1 Measures for Power Outages ♦ C-arm Cart To operate the C-arm during a power cut, operate it manually. Release the front and rear brakes of the C-arm unit to move it. C-arm Front brake Rear brake Fig. 5.1 C-arm cart ♦ Monitor Cart When emergency power can be used during a power cut, connect the emergency power to the monitor cart. Under emergency power, etc., to restart the device after power has been restored, press the system switch on the front of the monitor cart. All functions can be used after power has been restored. System switch Fig. 5.2 Monitor cart 5-2 OPESCOPE ACTENO FD type Instruction Manual  5.2 When DR Software, SDR-120F, Does Not Respond 5.2 When DR Software, SDR-120F, Does Not Respond 5.2.1 When the screen freezes and does not respond 1 Press and hold the system switch for more than 3 second. • The system shuts down. System switch 5 Fig. 5.3 System switch 2 Wait for the system switch to stop flashing, and then turn the system switch ON. (Normal Procedure) • It takes approximately 3 minutes to be able to perform fluoroscopy from when the system is shut down. 3 Turn (X-ray exposure restriction releasing switch) ON (lit). For details, see 3.4.2 "Fluoroscopy outside of Study" (page 3-18). 4 Select the APR. • Fluoroscopy can be performed outside of study. 5.2.2 When the monitor goes off and does not respond • If the monitor's power lamp is off, make sure that the power switches on the front and back of the monitor are turned ON. • If the power switches are ON, wait 20 seconds and press the system switch. OPESCOPE ACTENO FD type Instruction Manual 5-3 Chapter 5 Troubleshooting 5.3 LCD Display or Switch on C-arm Cart Does Not Respond 1 Press and hold the system switch for more than 3 second. • The system shuts down. System switch Fig. 5.4 System switch 2 Wait for the system switch to stop flashing, and then turn the system switch ON. (Normal Procedure) • It takes approximately 3 minutes to be able to perform fluoroscopy from when the system is shut down. 3 Turn (X-ray exposure restriction releasing switch) ON (lit). For details, see 3.4.2 "Fluoroscopy outside of Study" (page 3-18). 4 Select the APR. • Fluoroscopy can be performed outside of study. NOTE This operation is also effective in the following case: X-rays are not emitted and no error is displayed when you perform fluoroscopy or radiography operation with the X-ray exposure restriction released and the LCD display allowing you to perform fluoroscopy or radiography. 5-4 OPESCOPE ACTENO FD type Instruction Manual  5.4 When System Switch Does Not Respond 5.4 When System Switch Does Not Respond • Make sure the power is connected properly. • Check that the power switch on the back of the monitor cart is ON. • If both are normal, turn off the power switch on the back of the monitor carts, turn it on after 5 seconds, and try again. 5 OPESCOPE ACTENO FD type Instruction Manual 5-5 Chapter 5 Troubleshooting 5.5 When Message of Mother Board Battery Replacement Appears on Reference Monitor When a message of mother board battery replacement and the icon of low battery appear on the reference monitor at the start of the equipment, contact your Shimadzu service representative immediately. Icon of low battery Message Fig. 5.5 Message of mother board battery replacement NOTE If the equipment is left for a long time after the message above appears without taking appropriate actions by your Shimadzu service representative, the DR may fail to start up normally. When the message “LOW BATTERY” appears on the BIOS screen at the start of the DR, shut down the DR according to the instruction displayed, and contact your Shimadzu service representative. 5-6 OPESCOPE ACTENO FD type Instruction Manual  5.6 Responding to Problems 5.6 Responding to Problems When a problem occurs with the equipment, take action by following the steps in the "Corrective Procedure Flowchart" (page 5-8). WARNING If you have any doubts about how to proceed, contact your Shimadzu service representative. WARNING If you feel there is something wrong with the equipment, stop using it immediately. If you notice an abnormal operation or sound, stop using the equipment immediately and contact your Shimadzu service representative. 5 WARNING Repair and maintenance of equipment can only be performed by engineers to whom Shimadzu assigns. Maintenance must be assigned to specially trained experts. Contact your Shimadzu service representative for repair and maintenance. OPESCOPE ACTENO FD type Instruction Manual 5-7 Chapter 5 Troubleshooting ♦ Corrective Procedure Flowchart Occurrence of a problem Is a message displayed? Refer to 5.7 "Where Errors are Displayed". Have you remedied the problem? No. Yes End Telephone your Shimadzu service representative. 5-8 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed 5.7 Where Errors are Displayed 5.7.1 C-arm Main Panel When the equipment’s self-diagnosis circuit detects an abnormality, a dialog that displays the nature of the abnormality appears on the LCD. This dialog indicates two levels of abnormality: “warning” and “error”. A dialog indicating details of the abnormality is also displayed on the reference monitor on the monitor cart. ♦ Caution This is not an equipment malfunction. You can reset and continue operation by following the instructions displayed on the screen. Example: 5 Fig. 5.6 Caution screen 1 Press [OK]. 2 Continue to operate the equipment by following the instructions displayed on the screen. OPESCOPE ACTENO FD type Instruction Manual 5-9 Chapter 5 Troubleshooting ♦ Error You may or may not be able to reset and continue operation by following the instructions displayed on the screen. Operation can be continued You can reset and continue operation by following the instructions displayed on the screen. After the end of operation turn the power OFF at the monitor cart and contact your Shimadzu service personnel. Fig. 5.7 Error screen 1 1 Press [OK]. 2 Continue to operate the equipment by following the instructions displayed on the screen. Operation cannot be continued Promptly turn the power OFF at the monitor cart and contact your Shimadzu service personnel. Fig. 5.8 Error screen 2 5-10 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed Error (Caution) Cause of error (caution) Action Number 1 to 9 Errors associated with CPU error Errors associated Internal power supply 100 to 199 error 200 to 299 Errors associated Control circuit error Errors associated High voltage 300 to 399 Contact your Shimadzu generating control system error service representative. Errors associated with temperature 400 to 499 detection and communications Errors associated with the mechanical 500 to 599 control system, e.g. the collimator 600 to 613 Errors associated with the system Change APR, start or end a study. If it occurs Errors associated with exposure 614 and 615 repeatedly, contact condition setting your Shimadzu service representative. 5 Contact your Shimadzu 616 to 699 Errors associated with the system service representative. Contact your Shimadzu 800 Errors associated with the monitor cart service representative. Incompatibility of the combination of Check the combination 801 the monitor cart and C-arm unit when of the monitor cart and two or more instruments are owned C-arm unit. Exposure is prohibited because only the This is not a 802 C-arm unit is started malfunction. 803 to 899 Errors associated with the monitor cart Contact your Shimadzu 900 to 999 Errors associated with the DR service representative. X ray tube assembly high temperature, 1000 to Follow the instructions HU over, HU over warning, door open, (CAUTION) displayed on the screen. etc. OPESCOPE ACTENO FD type Instruction Manual 5-11 Chapter 5 Troubleshooting 5.7.2 Reference Monitor NOTE When a displayed error is not included in this list, or the same error message is displayed after the remedy, contact your Shimadzu service representative. ♦ Errors That Can Recovered by the User The errors described in the following table can be recovered by the user. Follow the specified remedy to recover these errors. If an error cannot be recovered by the specified method, contact your Shimadzu service representative. Message Remedy The connection to the system control board (WHA) was broken. Please make sure that the cart cable is connected. If there is Check the message on the C- arm main nothing wrong with the cart cable, follow panel. the message displayed on the C-arm main panel to restore the system. The connection to the image acquisition component was broken. Please reboot the Follow the on-screen instructions. system. If the system is in the study now, please end it. The connection to the system control board (WHA) was broken.Follow the message Check the message on the C- arm main displayed on the C-arm main panel to panel. restore the system. There is no response from the communication control component. Please reboot the system.You will not be able to Follow the on-screen instructions. start fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. A few images failed to be collected during fluoroscopy/radiography (unmatched acquisition number). Please reboot the Follow the on-screen instructions. system.You may continue to use the system only in an emergency, but this may cause the system to become unstable. To perform fluoroscopy recording, loop memory mode fluoroscopy and This is a guide message and is normal. radiography, please start the study. 5-12 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed Message Remedy The image acquisition component is being Please wait for about 30 seconds. If the prepared. You will not be able to start fluoroscopy/radiography or study cannot fluoroscopy, radiography and study until be started after that, restart the system. the preparation is complete. The image acquisition component has not responded to the completion of fluoroscopy/radiography. If this error Follow the on-screen instructions. occurs continuously, please reboot the system. Failed to save image. Please reboot the system as it appears to be operating abnormally. You may continue to use the system only in an emergency, but You will Follow the on-screen instructions. not be able to do the fluoroscopy recording, radiography and starting study until the system reboot. If the system is in the study now, please end it. The image acquisition component is being prepared. Please wait for a while and then try again. You will not be able to start 5 fluoroscopy, radiography and study until Follow the on-screen instructions. the preparation is complete. If it does not recover after some time, please reboot the system. The image is being saved. Fluoroscopy recording and radiography are not Wait until the image saving icon available until the image saving icon disappears. disappears. A fatal error has occurred in the image acquisition component. Please reboot the system. You will not be able to start Follow the on-screen instructions. fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. Image processing of the image processing board has timed out. Please reboot the system. You will not be able to start Follow the on-screen instructions. fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. The FPD connection was disconnected. Please make sure that the cart cable is Follow the on-screen instructions. connected. If there is nothing wrong with the cart cable, please reboot the system. OPESCOPE ACTENO FD type Instruction Manual 5-13 Chapter 5 Troubleshooting Message Remedy The FPD preparation process failed. Please reboot the system. You will not be able to start fluoroscopy, radiography and study Follow the on-screen instructions. until the system reboot. If the system is in the study now, please end it. The FPD connection was disconnected.Please wait for a while and then try again. If you are still unable to Follow the on-screen instructions. operate the system after some time, please reboot the system. The FPD is not responding. Please reboot the system. You will not be able to start fluoroscopy, radiography and study until Follow the on-screen instructions. the system reboot. If the system is in the study now, please end it. A few images failed to be collected during fluoroscopy/radiography. Please reboot down the system.You may continue to use Follow the on-screen instructions. the system only in an emergency, but this may cause the system to become unstable. Failed to change the FPD settings. Please reboot the system. You will not be able to start fluoroscopy, radiography and study Follow the on-screen instructions. until the system reboot. If the system is in the study now, please end it. The FPD is hot. Please shut down the system and check for any abnormalities in the surrounding environment. You may Follow the on-screen instructions. continue to use the system only in an emergency, but It may damage the FPD. The board temperature of the image processing board is rising. Please shut down the system and check for any abnormalities in the surrounding Follow the on-screen instructions. environment. You may continue to use the system only in an emergency, but fluoroscopy/radiography may terminate suddenly. The cooling fan of the image processing board stopped. Please reboot the system. You may continue to use the system only Follow the on-screen instructions. in an emergency, but fluoroscopy/ radiography may terminate suddenly. The connection to the image processing board has been broken. Waiting for the Follow the on-screen instructions. image processing board reconnection. 5-14 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed Message Remedy The connection to the image processing board has been recovered. If issues Follow the on-screen instructions. continue to occur, please restart the system as it may be operating unstably. The connection to the image processing board has been broken. Please reboot the system. You will not be able to start Follow the on-screen instructions. fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. An error has occurred in the connection to the image processing board. Please reboot the system. You will not be able to start Follow the on-screen instructions. fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. The image processing board has become hot. Please shut down the system immediately and check for any abnormalities in the surrounding Follow the on-screen instructions. 5 environment. If the system is in the study now, please end it. The processing error has occurred on the image processing board (XXXXX). Please reboot the system. You will not be able to Follow the on-screen instructions. start fluoroscopy, radiography and study until the system reboot. If the system is in the study now, please end it. The connection to the system control board (FPD) was broken. Please reboot the Check the message on the C- arm main system according to the message displayed panel. on the C-arm main panel. The connection to the system control board (MC) was broken. Please reboot the Check the message on the C- arm main system according to the message displayed panel. on the C-arm main panel. Expiration date of the calibration has Perform the FPD calibration. expired. Error during system startup! Try restarting the system. System will shut down. No response from DICOM Export job. Try restarting the system. DICOM export may fail. No response from Print job. Try restarting the system. Print may fail. OPESCOPE ACTENO FD type Instruction Manual 5-15 Chapter 5 Troubleshooting Message Remedy No response from Store Media job. Try restarting the system. Store Media may fail. Background processing is still active, or a To forcibly shut down the system, press queue is still unprocessed. the [OK] button. Unprocessed processes will be lost if the To cancel forcible shutdown of the system, system is shut down now. press the [Cancel] button. Image file has not yet been written to To cancel writing of the data, press the media after storing. [OK] button. The data to be stored will be cleared if it is To write the data, press the [Cancel] button not written to media. and perform writing to the media. To cancel printing, press the [OK] button. Some Print jobs are not yet completed. To print the data, press the [Cancel] button They will be lost if the system is shut down and perform printing from the print edit now. job. Unable to restart study because study data Finish processing the images included in is being processed. Please check the the target study. processing status. The operation has been canceled due to Delete unwanted images in HDD. disk space shortage to save new image(s). There is no response from acquisition control process. Try restarting the system. It might be impossible to acquire the image. The number of studies reached the Delete unwanted registration information maximum. on the [All] tab. No new data can be registered. The number of the reserved studies Delete unwanted registration information reached the maximum. on the [Reserve] tab. It is not possible to register a new item. Some data is not displayed as the number Delete unwanted registration information of display data reached the maximum. on the [All] tab. Failed to acquire data from the MWM Check the MWM connection and start server. query again. Destination is not selected. Set a desired server of the [MWM Query Please try again after selecting the Condition Setting] window and start query destination. again. Failed to notify Study Start message to the Check the MPPS connection. The Study MPPS server. Start message can be notified after Continue starting study? continuing a study. The maximum length for the item is 64 characters. Edit the entry in question. (Include space character) 5-16 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed Message Remedy Entry contains illegal characters. Edit the entry in question. Please input the patient's name. Enter a patient name. When the image is under used with another Failed to add to print edit. job, stop the job and register it to print again. Unable to add print edit, due to unknown Restart the system and register it to print error. again. Perform the measurement calibration and Unable setting as no Image size data. retry. Replace with other storage media and Failed to mount media. check again or restart the system and retry. Media is not inserted. Insert the storage media and retry. Restart the system, or replace the storage Failed to access media. media. Insert supported storage media (CD-R or Detected media is not supported. DVD-R) and perform archiving. Cannot store on media containing 5 Replace the storage media and perform data other than images. archiving. Replace media. Insert writable storage media, and perform Insert writable media. archiving. Either reduce the number of images to Not enough free space on media to archive, or insert storage media with store selected image(s). sufficient free space. Media has been stored Replace the storage media and perform on non-Shimadzu instruments. storing. Media is not inserted. Replace the storage media and press the Insert writable media and select [Execute]. [Execute] button. The postscript writing in this media is Insert recordable storage media, and retry prohibited. it. Unable to archive, due to unknown error. Restart the system and retry archiving. Wait for archiving completed and retry Cannot add any image during writing. archiving. Either reduce the number of images to Cannot add any image due to the lack of archive, or insert storage media with free space. sufficient free space. Registration for archive was failed because Replace the blank media or media having the current media has the images applied only unprocessed images and retry it. their processing parameters. OPESCOPE ACTENO FD type Instruction Manual 5-17 Chapter 5 Troubleshooting Message Remedy Cannot access media because of post Wait for currently executing processes to writing. end and retry it. Unable to retrieve, due to unknown error. Restart the system and retry archiving. Eject the storage media by the eject button Failed to eject media. on the drive. Cancel use of data to be processed and Failed to protect image. retry it. Cancel use of data to be processed and Failed to unprotect image. retry it. If the protected image is selected, cancel It was failed to revise the study the protection. information. Or, cancel use of data to be processed and retry it. Please select only one study to execute a Re-select one study and retry it. process. Re-select the image to be divided so that Cannot divide re-combined image and both the original image and the original image. re-combined image are completely included. To combine the studies, please select two Re-select two studies for combining. studies. If the protected image is selected, cancel the protection. It was failed to divide the study. Or, cancel use of data to be processed and retry it. Only the divided studies can be combined. It was failed to combine the studies. Select them and retry it. Cancel use of data to be processed. The file to be processed is in use. Or, wait for currently executing processes Failed to combine studies. (e.g. printing or transfer) to end. Cancel use of data to be processed. The file for processing is now using. Or, wait for currently executing processes It was fail to divide the study. (e.g. printing or transfer) to end. Cannot combine studies with different Select studies having the same date. dates. The protected image cannot be combined. Cancel the protection and retry it. The protected image cannot be divided. Cancel the protection and retry it. Please select only one study to execute a Select one study and retry it. process. Delete unnecessary fixed text and register No more template is able to register. new one. 5-18 OPESCOPE ACTENO FD type Instruction Manual  5.7 Where Errors are Displayed Message Remedy The value for the calibration is too short. Edit it. Please correct the value. The value for the calibration is too long. Edit it. Please correct the value. No title is entered in Preset Title field. Set the preset title. Same Preset Title already exists. Set a title different from other preset titles. Detected unsupported character(s) in the study information, and has been replaced Check alternatives character(s). with alternatives character(s). Detected unsupported character(s) in the image information, and has been replaced Check alternatives character(s). with alternatives character(s). The operation has been canceled due to Delete unnecessary images in HDD and disk space shortage to save new image(s). retry it Can not be processed because it contains Close the study and retry it. the image file during the study. Can not be processed because it contains Cancel use of data to be processed. 5 Or, wait for currently executing processes the image file using by other process. (e.g. printing or transfer) to end. Cancel use of data to be processed. The file to be processed is in use. Or, wait for currently executing processes Failed to update the data. (e.g. printing or transfer) to end. ♦ Errors That Cannot Be Recovered by the User The errors described in the following table cannot be recovered by the user. Contact the service personnel. Window Error Message Failed to authenticate license. During system startup System will shut down. Screen resolution is invalid. Image list Failed to register media archive job. Print Preset window No available printer is registered. OPESCOPE ACTENO FD type Instruction Manual 5-19 Chapter 5 Troubleshooting ♦ Error Nos. and Remedies This section describes possible causes of errors and how to remedy them. Follow the specified remedy to recover these errors. NOTE If a displayed error is not included in this list, restart the system and check that the system has recovered from the error. If the system does not recover from the error, contact your Shimadzu service representative. Displayed Window Possible Cause User Remedy Error No. Transmission Processing destination Make sure that the computer at status computer has not 1B020 the transmission destination window, started up, or the has started, and retry restarting. [Send] tab LAN connection is abnormal. When this error occurs during retrieving, secure sufficient D0006 Image copy error. Processing free space on the main hard status disk, and try a restart. window, Defective storage media or [Media] tab CD-R or DVD-R faulty drive D0020 writing error. Replace with new storage media. Transmission Processing destination imager Make sure that the imager at status 1B020 has not started up, or the transmission destination window, the LAN connection has started, and retry restarting. [Print] tab is abnormal. 5-20 OPESCOPE ACTENO FD type Instruction Manual  Chapter 6 Maintenance and Inspections This chapter describes the daily and periodic inspections. The inspections must be carried out in order to maintain the performance of the equipment and ensure safety. Chapter 6 Maintenance and Inspections 6.1 Maintenance and Inspections By reliably maintaining the performance of the equipment, you can assure the safety of the operator and the patients, and efficiently provide images of exceptional diagnostic value. Our thorough quality control and inspection procedures ensure that the equipment is shipped in the optimum condition. In order to maintain this optimum condition, you must implement maintenance and inspection in a deliberate way. The maintenance and inspections for the equipment are classified as follows. . Type of maintenance/ Inspection Implemented by inspection interval Starting At the start of Operator or equipment manager inspection work every day Daily inspections Ending At the end of Operator or equipment manager inspection work every day Cleaning and disinfection Operator or equipment manager As required Inspection for warning and Operator or equipment manager Every year caution labels Checking organization of the Operator or equipment manager Every year dose information Your Shimadzu service Periodic inspections Every 6 months representative FPD Calibration* Operator or equipment manager Every 6 months * For the calibration procedure, refer to “M517-V063 Digital Radiography System SDR-120F Reference Guide”. 6-2 OPESCOPE ACTENO FD type Instruction Manual  6.2 Daily Inspections 6.2 Daily Inspections The daily inspections comprise the starting inspections and ending inspections. Daily inspections are necessary in order to keep using the equipment for a long time. Check that all inspections and corrective actions have been completed before using the equipment. Use the “Starting Inspection Checklist” and “Ending Inspection Checklist” in Chapter 9 "Appendix". We recommend that you retain filled out copies of the “Starting Inspection Checklist” and “Ending Inspection Checklist” for a fixed time. CAUTION If an error is found in the inspection, stop using the equipment and contact your Shimadzu service representative. Be careful to ensure the safety when the maintenance and inspection are carried out by the user. Shimadzu accepts no responsibility for any failures and damages caused by the inspection carried out by companies other than your Shimadzu service representative or a SHIMADZU designated contractor. 6 OPESCOPE ACTENO FD type Instruction Manual 6-3 Chapter 6 Maintenance and Inspections 6.3 Cleaning and Disinfection WARNING Be sure to turn the equipment power OFF before cleaning and disinfecting the equipment. Otherwise, a malfunction may occur in the equipment, or the equipment may operate in an unintended way. Also, thoroughly ventilate the room before turning ON the power after disinfection work is complete. If flammable gases remain in the room and the system is turned on, fire, smoke, explosion or electric shock may occur. CAUTION Be sure to clean and disinfect the equipment. Cleaning and disinfection is very important to ensure that the equipment can be used hygienically and safely. Strictly follow the methods prescribed. CAUTION Clean the equipment surface before using disinfectant. Clean the surface with a lint-free cloth or a soft toothbrush that does not scratch the surface. If it is difficult to remove dirt, please use dishwashing detergent or soap diluted with lukewarm water. Be sure to wipe off any dishwashing detergent or soap used for cleaning before disinfection. CAUTION Do not spray disinfectant or water directly on the equipment. Wipe the surface of the equipment with a cloth soaked with disinfectant. If disinfectant gets inside the equipment, it can cause failure or accidents. 6-4 OPESCOPE ACTENO FD type Instruction Manual  6.3 Cleaning and Disinfection CAUTION The following disinfectants are available:. However, depending on the object, there are restrictions on the disinfectant that can be used. Please wipe off the disinfectant after disinfection. (A) Chlorine disinfectants∗1 • Sodium dichloroisocyanurate solution (1% maximum) • Sodium hypochlorite solution (1% maximum) (B) Alcohol disinfectants∗2 • Commercially available isopropyl alcohol sodium (up to 99 wt% can be used) • Rubbing alcohol (76.9 - 81.4 vol% Ethanol, isopropyl alcohol as an additive) *1 : Do not use on unpainted metal parts. Using chlorine disinfectant may cause corrosion. *2 : Do not use for plastic parts, especially the following acrylic parts:. Alcohol-based disinfectants may deteriorate. (i) Transparent resin part of laser light transmitting part (ii) Touch panel (iii) Front resin part of the FPD 6 CAUTION Do NOT use the following disinfectants: The use of these disinfectants cannot guarantee the performance and safety of the equipment. • Disinfectants that corrode metals, plastics, rubber, or paint • Disinfectants unsuitable for metals, plastics, rubber, or paint • Spray-gas type disinfectants • Volatile disinfectants • Disinfectants that may enter the equipment OPESCOPE ACTENO FD type Instruction Manual 6-5 Chapter 6 Maintenance and Inspections CAUTION Do NOT use an organic solvent. Organic solvents may change the surface color. If an organic solvent adheres to the surface, wipe it off immediately. CAUTION Use disinfectants at a minimum. Repeated disinfection over a long time may lead to discoloring and cracking on the equipment shape or resin. For example, rubber and plastic may deteriorate. If any abnormality is found on the equipment after disinfection, stop using the equipment immediately. Contact your Shimadzu service representative for repair. CAUTION Observe the following precautions when cleaning and disinfecting the touch panel: • Disconnect the main power cable before cleaning and disinfecting. • Clean and disinfect the touch panel periodically. The applicable cleaners include, isopropyl alcohol (abrasive free), glass cleaner (non ammonia-based), water solution of neutral detergent. • Handle the touch panel with care when cleaning and disinfecting. Do NOT rub or hit the panel surface because it tends to scar easily. • Wipe gently with moistened soft close to remove the dust from the panel surface. CAUTION Before a study or operation, remove the dust from the C-arm, X-ray tube assembly, and the periphery. 6-6 OPESCOPE ACTENO FD type Instruction Manual  6.4 Inspection for Warning and Caution Labels On completing the work, check the following points before switching the power ON again. • There must be no water or disinfectant adhering to the equipment. • The tools used in cleaning and disinfecting work must be tidied away. See 3.4 "Turn the Power ON / OFF" (page 3-15). WARNING When turning the power ON after cleaning, make sure the examination room is properly ventilated. Turning the power ON while any flammable gas remains in the examination room could lead to fire, smoke, explosion or electrocution. 6.4 Inspection for Warning and Caution Labels Periodically (once a year) inspect the labels attached on the equipment. If any label is peeled or unreadable by stain or scratch, contact your Shimadzu service representative for replacement of a new one. 6 See "Warning and Caution Labels" (page Introduction-31). OPESCOPE ACTENO FD type Instruction Manual 6-7 Chapter 6 Maintenance and Inspections 6.5 Checking organization of the dose information Once a year, use a calibrated dosimeter to check that the accuracy of the dose display is within ±35 %. Contact your Shimadzu service representative if the accuracy is not within ±35 %. When performing measurement, be sure to follow the measurement conditions below. ♦ Measurement Condition (Compliant with IEC 60601-2-54:2009+A1:2015+A2:2018 clause 203.5.2.4.5.102) Anti-scatter grid: Used Phantom: PMMA, min.250 mm x min.250 mm x 200 mm Geometry: Focal Spot Dosimeter Patient Entrance Reference Point (according to the Patient Entrance Reference Point of the C-arm X-ray system with the isocenter.) Phantom Unit: mm Fig. 6.1 Dosimetry Conditions 6-8 OPESCOPE ACTENO FD type Instruction Manual  6.5 Checking organization of the dose information Comparison of dose display values and dosimeter values Fig. 6.2 Accuracy check of dose information 6 OPESCOPE ACTENO FD type Instruction Manual 6-9 Chapter 6 Maintenance and Inspections 6.6 Periodic Inspections This refers to the inspections performed by your Shimadzu service representative. Even without any problem in daily inspection, the following items should be inspected periodically. WARNING Be sure to perform periodic inspection (every 6 months). Failure to do this may cause serious accidents or significantly shorten the lifetime of the equipment. Periodic inspections mainly check the equipment performance and the internal mechanisms. The inspections require good knowledge of the internal mechanisms and can also be dangerous. Contact your Shimadzu service representative to request a periodic inspection. It is recommended to conduct periodic inspections every 6 months. A fee is charged for periodic inspections after expiry of the warranty periods. 6.7 Regularly Replaced Components Some of the components of the equipment must be replaced regularly in order to maintain its performance. These components are called regularly replaced components. The regularly replaced components should be replaced by your Shimadzu service representative. The regularly replaced components are listed below. • List of regularly replaced components Replacement Location Part name Q'ty interval FUSE, 021306.3P 1 1 year FUSE, FLM15 1 1 year Monitor Cart HDD 1 5 year BATTERY FOR 1 5 year MOTHERBOARD C-arm FUSE, 660CF-20 1 1 year 6-10 OPESCOPE ACTENO FD type Instruction Manual  Chapter 7 Options This chapter explains how to handle the options (their operation, maintenance, adjustment, and so on). Chapter 7 Options 7.1 Laser Pointer The laser pointer is constructed out of the laser projector at the X-ray tube side or the FPD side. 1 Press (Laser pointer button) on the C-arm main panel. • The button lights blue. • A laser beam is emitted. 2 Press the button again to stop the laser beam. • The laser beam continues to be emitted while the button lights blue. WARNING Never look directly into the laser beam. NOTE The center of the laser pointer has been adjusted on the C-arm position with the X-ray tube assembly at the lowest position. Some C-arm position may result in the off-center by 10 cm maximum on a subject surface. NOTE The beam from the laser pointer at the FPD side crosses at a certain distance from the FPD cover surface. When using the laser pointer at the FPD side, place a subject more than 25 cm from the FPD cover surface. 7-2 OPESCOPE ACTENO FD type Instruction Manual  7.2 Fitting and Removing the Cover 7.2 Fitting and Removing the Cover CAUTION Wear sterile clothing and gloves. CAUTION When the cover is sterilized, it should be fitted by an operator in a clean area. 1 Mount the C-arm covers. The C-arm cover is rolled. • Use double-sided tape provided on the cover, and attach the cover to the C-arm from the X-ray tube assembly side. 2 Fit the FPD cover (cover D 125 cm). The FPD cover is in the form of a bag. • Put the cover onto the FPD. 3 Fit the tank cover (cover D 105 cm). 7 The tank cover is in the form of a bag. • Put the cover onto the X-ray tube assembly. C-arm cover Unroll and stick the cover. FPD X-ray tube assembly Double-sided tape Fig. 7.1 Mounting the C-arm cover OPESCOPE ACTENO FD type Instruction Manual 7-3 Chapter 7 Options 7.3 External Video Output DVI signals are output to externally connected devices such as an external monitor and a video printer. CAUTION When using the system, only the following electrical devices can be connected to the system's LAN connector, USB connector, and DVI (Digital Visual Interface) connector. • Medical electrical devices which conform to IEC60601-1 • Non-medical electrical devices which conform to related IEC safety standards • Non-medical electrical devices which have safety equal to devices which conform to IEC safety standards In addition, please note the following: 1. When connecting medical electrical devices which conform to IEC60601-1 Connect the system and a connected device with a common protective ground, or connect an additional protective ground of the connected device when that device is in a room not used for treatment and diagnosis (office and storage room, etc.). 2. When connecting other electrical devices (1) Connect an additional protective ground of the connected device, or supply electrical power to the connected device from an isolated power source when the connected device is in the room used for treatment and diagnosis. (2) Connect the system and a connected device with common protective ground, or connect an additional protective ground of the connected device when that device is in a room not used for treatment and diagnosis (office and storage room, etc.). Table. Necessary measures when connecting electrical device to this system Location of Connected Device Connected Device Diagnosis/Treatment Room Other Medical electrical devices which conform to - Common protective ground or IEC60601-1 additional protective Additional protective ground ground or Other electrical devices or power supply from an separation device isolated power source 7-4 OPESCOPE ACTENO FD type Instruction Manual  7.3 External Video Output 7.3.1 How to Connect 1 Connect the DVI cable to the DVI port. • The image is output to the connected external device. DVI Fig. 7.2 DVI port 7 OPESCOPE ACTENO FD type Instruction Manual 7-5 Chapter 7 Options 7.3.2 External Video Output Settings 1 Press (Menu switch). • The system setting menu screen is displayed. For details, see 3.17 "System Settings" (page 3-109) Basic screen Menu switch Setting menu screen Fig. 7.3 Setting menu screen 2 Press [Default Settings]. • The default settings screen is displayed. 7-6 OPESCOPE ACTENO FD type Instruction Manual  7.3 External Video Output Setting menu screen [Default Settings] Fig. 7.4 Default Settings 1 3 Press [Screen 2]. • The Screen 2 is displayed. Default settings screen 7 [Screen 2] Fig. 7.5 Default Settings 2 OPESCOPE ACTENO FD type Instruction Manual 7-7 Chapter 7 Options 4 Select the image to be output. • Select "LIVE" to output the image of the live monitor. • Select "REF" to output the image of the reference monitor. Screen 2 Live monitor Live monitor Reference monitor Reference monitor Fig. 7.6 Video Output Setting NOTE • The default setting is to output the live monitor image. • You can set an image to be output to video output 1 and video output 2 respectively. CAUTION The video output by the external video output function is for reference. Do not use for diagnostic purposes. CAUTION To use the Video Output 2, contact your Shimadzu service representative. 7-8 OPESCOPE ACTENO FD type Instruction Manual  7.3 External Video Output 7.3.3 Clone Display NOTE This function is available only when the external video output function (option) is enabled. NOTE If you notice any abnormalities, exit the clone mode and check the reference monitor for errors. A same image is displayed both on the reference monitor and the live monitor (clone display). Two monitors show any one of the following: • fluoroscopic image • Last image hold image • Loop memory image • Frame memory image 1 Start a study. For details, see 3.8 "Starting Study" (page 3-53). 7 OPESCOPE ACTENO FD type Instruction Manual 7-9 Chapter 7 Options 2 Press (Menu switch). • The system setting menu screen is displayed. Basic screen Menu switch Setting menu screen Fig. 7.7 Setting menu screen 7-10 OPESCOPE ACTENO FD type Instruction Manual  7.3 External Video Output 3 Press [Default Settings]. • The default settings screen is displayed. Setting menu screen [Default Settings] Fig. 7.8 Default Settings 1 4 Press [Screen 2]. • The Screen 2 is displayed. Default settings screen 7 [Screen 2] Fig. 7.9 Default Settings 2 NOTE The Monitor Setting can be switched during the study. OPESCOPE ACTENO FD type Instruction Manual 7-11 Chapter 7 Options 5 Press [Clone]. Screen 2 [Clone] Fig. 7.10 Clone setting 6 A same image is displayed both on the reference monitor and the live monitor (clone display). NOTE The clone display can be available during a study. To end a study with the clone display, press [End study] button on the LCD display of the C-arm main panel. For details, see 3.18 "Ending the Study" (page 3-118). NOTE An acquisition image is not displayed during the clone display. Switch the Monitor Setting to “Standard” to display the acquired image. NOTE The Playback switch and the Next/Previous switch are unavailable for the reference monitor during the clone display. Switch the Monitor Setting to "Standard" to use these switches. 7-12 OPESCOPE ACTENO FD type Instruction Manual  7.4 Hand Switch 7.4 Hand Switch This is the hand switch for X-ray radiation. 1 Press the hand switch (Radiography preparation switch) to the first level. • The preparation for radiography starts. Radiography preparation switch First level Fig. 7.11 Hand Switch 1 • On completion of preparations for radiography, the (standby display lamp) lights up. 2 Press the hand switch (Radiography switch) to the second level. 7 • Digital radiography starts. X-ray exposure switch Second level Fig. 7.12 Hand Switch 2 • During X-ray radiation, the irradiation indicator on the monitor cart will be lit. • (“X-rays being radiated”) is lit in the C-arm main panel. OPESCOPE ACTENO FD type Instruction Manual 7-13 Chapter 7 Options NOTE Be careful when handling the hand switch. Accidental press of the hand switch may cause unnecessary radiation exposure. When X-ray irradiation is unnecessary, turn OFF the X-ray exposure restriction releasing switch. NOTE Continue to hold down the hand switch to the second level until X-ray radiation has finished. If you release it part way through, X-ray radiation will be ended prematurely. NOTE Depending on the setting, the hand switch can be used for fluoroscopy. Consult with the service personnel. In this case, the hand switch can be operated as described below. • When the hand switch is pressed to the first level, fluoroscopy is carried out (X-rays for fluoroscopy will be radiated while the switch is held down). • When the hand switch is pressed to the second level, radiography is carried out. 7-14 OPESCOPE ACTENO FD type Instruction Manual  7.5 Wireless Hand Switch 7.5 Wireless Hand Switch Using the wireless hand switch allows performing fluoroscopy and radiography remotely. When not using the wireless hand switch, set the switch in the holder. NOTE The wireless hand switch does not include a battery. Prepare an appropriate battery before use. A CR123A or CR17345 (or equivalent) primary lithium battery (nominal voltage: 3 VDC) can be used. See 7.5.3 "Replacing Batteries" (page 7-19) ♦ Wireless Hand Switch 1 2 3 4 7 5 Fig. 7.13 Wireless Hand Switch No. Item Description Performs radiography. The main button is a two-position switch. 1 Main Button • First level: Radiography preparation • Second level: Start radiography 2 Sub Button Not used. 3 Battery Cover Removes when replacing the battery. 4 Locking Notch For locking the wireless hand switch. OPESCOPE ACTENO FD type Instruction Manual 7-15 Chapter 7 Options No. Item Description Indicates the pressed state of the main button by color. • Main button pressed to first level: Illuminated green • Main button pressed to second level: Illuminated yellow 5 Ring LED The LED light (green) rotates while blinking for 5 seconds when communication between the wireless hand switch and its holder becomes disconnected. ♦ Wireless Hand Switch Holder 2 1 Fig. 7.14 Wireless Hand Switch Holder No. Name Description 1 Locking Notch For locking the wireless hand switch. POW Illuminates when the system power is ON. (Green) • Blinking: The battery of the wireless hand switch is 2.5 V or lower. BATT • Illuminated: The battery of the wireless hand switch is (Orange) 2.1 V or lower. See 7.5.3 "Replacing Batteries" (page 7-19) and replace the battery promptly. LINK Illuminates when wireless communication is Status (Green) established. 2 Indicator TOUCH LEDs Not used. (Green) BUZZ Not used. (Green) SW1 Illuminates when the main button on the wireless hand (Green) switch is pressed to the first level. Illuminates when the main button on the wireless hand SW2 switch is (Yellow) pressed to the second level 7-16 OPESCOPE ACTENO FD type Instruction Manual  7.5 Wireless Hand Switch 7.5.1 Using the Wireless Hand Switch ♦ Basic Operation 1 Remove the wireless hand switch from the holder. The wireless hand switch can be operated while set in the holder as well. See "Holder Mode" (page 7-18) 2 Hold down the main button on the wireless hand switch to the first level. • The ring LED on the wireless hand switch illuminates green. • On completion of preparations for radiography, the (standby display lamp) lights up. 3 Press the main button on the wireless hand switch to the second level. • During X-ray radiation, the irradiation indicator on the monitor cart will be lit. • (“X-rays being radiated”) is lit in the C-arm main panel. 4 When not using the wireless hand switch, set the wireless hand switch in the wireless hand switch holder. 7 NOTE When the system power is off, the wireless hand switch will be locked if it is set in the holder. Do NOT remove the wireless hand switch forcefully when it is locked. NOTE Be careful when handling the wireless hand switch. Accidental press of the wireless hand switch may cause unnecessary radiation exposure. When X-ray irradiation is unnecessary, turn OFF the X-ray exposure restriction releasing switch. OPESCOPE ACTENO FD type Instruction Manual 7-17 Chapter 7 Options NOTE Continue to hold down the wireless hand switch to the second level until X-ray radiation has finished. If you release it part way through, X-ray radiation will be ended prematurely. NOTE Depending on the setting, the wireless hand switch can be used for fluoroscopy. Consult with the service personnel. In this case, the hand switch can be operated as described below. • When the wireless hand switch is pressed to the first level, fluoroscopy is carried out (X-rays for fluoroscopy will be radiated while the switch is held down). • When the wireless hand switch is pressed to the second level, radiography is carried out. ♦ Holder Mode The state where the wireless hand switch is set in the holder is called the holder mode. The wireless hand switch is operable in the holder mode as well. NOTE • When a pressed wireless hand switch is removed from the holder, operation is canceled. Press the wireless hand switch again if an operation is canceled. • When a pressed wireless hand switch is set in the holder, operation is enabled after 1 second elapses. 7.5.2 Operable Range of the Wireless Hand Switch Operations by the wireless hand switch are possible within approx. 10 meters from the system. NOTE The operable range of the wireless hand switch may be affected by surrounding conditions. 7-18 OPESCOPE ACTENO FD type Instruction Manual  7.5 Wireless Hand Switch 7.5.3 Replacing Batteries Replace the battery of the wireless hand switch when the ring LED on the switch does not illuminate even though the switch is pressed, or when BATT of the status indicator LED on the wireless hand switch holder illuminates. 1 Turn the end cap of the wireless hand switch counterclockwise by 90 degrees. End cap Fig. 7.15 Replacing Batteries 1 2 Pull out the end cap. 7 End cap Fig. 7.16 Replacing Batteries 2 3 Slide the battery cover in the direction of the arrow. Battery cover Fig. 7.17 Replacing Batteries 3 OPESCOPE ACTENO FD type Instruction Manual 7-19 Chapter 7 Options 4 Lift and remove the battery cover. Battery cover Fig. 7.18 Replacing Batteries 4 5 Replace the old battery with a new lithium battery (CR123A or CR17345,1 pce). 6 Attach the battery cover and end cap back on the wireless hand switch. WARNING When not using the wireless hand switch for an extended period, remove the battery from the switch. Otherwise, a battery leak may cause wireless hand switch failure. 7-20 OPESCOPE ACTENO FD type Instruction Manual  7.6 Long Cable Foot Switch 7.6 Long Cable Foot Switch Using the long cable foot switch allows performing fluoroscopy and digital radiography remotely. 7.6.1 Connecting Long Cable Foot Switch Connect the long cable foot switch to the C-arm. 1 Orient the long cable foot switch so that the red circle on the connector matches the red circle on the connector on the C-arm. Red circle 7 Fig. 7.19 Connecting Long Cable Foot Switch OPESCOPE ACTENO FD type Instruction Manual 7-21 Chapter 7 Options 7.6.2 Fluoroscopy 1 Press the left foot switch. • X-rays for fluoroscopy will be radiated. • During radiation, X-ray exposure (fluoroscopy) switch is lit and (X-rays being radiated) lights yellow. • During radiation, the irradiation indicator on the monitor cart is lit. The fluoroscopic image is displayed on the live monitor. Press Fig. 7.20 Fluoroscopy For details on fluoroscopy outside of a study, see 3.4.2 "Fluoroscopy outside of Study" (page 3-18), and for details on fluoroscopy during a study, see 3.11 "Fluoroscopy" (page 3-73). 7.6.3 Digital Radiography 1 Press the right foot switch. • During X-ray irradiation, the radiography image is displayed on the live monitor, after which the same image is displayed on the reference monitor. • X-ray emission is stopped and image acquisition ends when the radiography button is released midway during irradiation or when the preset number of frames are completed to be acquired. Press Fig. 7.21 Digital radiography For details on the digital radiography, see 3.14 "Radiography" (page 3-87). 7-22 OPESCOPE ACTENO FD type Instruction Manual  7.7 Wireless LAN Kit 7.7 Wireless LAN Kit 1 Remove the caps. 2 Remove the bolts and the cable guide. 3 Install the wireless LAN adapter. 4 Bolt the cable guide. 5 Attach the caps. Port for wireless LAN adapter Cable guide Bolt Cap 7 OPESCOPE ACTENO FD type Instruction Manual 7-23 Chapter 7 Options This page is intentionally left blank. 7-24 OPESCOPE ACTENO FD type Instruction Manual  Chapter 8 Technical Data Chapter 8 Technical Data 8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) The equipment satisfies the EMC (Electromagnetic Compatibility) standard below: • IEC 60601-1-2:2014 CAUTION Pay attention to the electromagnetic circumstances at the installation site. The equipment may be affected by the electromagnetic environment at the installation site. Also, the installation of the equipment may affect other existing equipment. ♦ Classification of EMI in Accordance with EN/IEC 60601-1-2:2014 Group 1, Class A The system uses radio-frequency energy only for its internal function and is not intended to deliver energy to the patient. However, even a small amount of radio frequency energy leakage does harm to highsensitive equipment. The system main power line in the clinical site should be connected to the domestic power sources which are separated from the public main network. CAUTION For replacement parts of internal components, make sure to apply the cables supplied by Shimadzu. The use of non-cable devices or cables other than those sold by Shimadzu as replacement parts for the internal components may result in increased emissions or decreased immunity of the equipment. ♦ Performance to Be EMC Immunity Tested (Essential performance) Essential performances of the equipment are as follows: • Positioning of X-ray field • Set of X-ray conditions • X-ray exposure • Recording patient information • Radiography • Displaying images 8-2 OPESCOPE ACTENO FD type Instruction Manual  8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) ♦ List of Cables Cable Remarks Cable Name Shield Length (Manufacturer) Power supply cable 14 m N Shimadzu Cart cable 14 m Y Shimadzu Foot switch cable 4m N Shimadzu Hand switch 4.5 m N Shimadzu Long cable foot switch cable 15 m Y Shimadzu LAN cable 20 m N Shimadzu Cable for external video output 5m Y Shimadzu function NOTE The cables listed above are the parts specified to be compliant with the standards. These parts are not provided to the equipment. ♦ List of Options Option Name Remarks (Manufacturer) Laser pointer Shimadzu Cover Shimadzu 8 Dose area product meter Shimadzu Heat radiation unit Shimadzu External video output function Shimadzu Option software Shimadzu Hand switch Shimadzu Wireless hand switch Shimadzu Long cable foot switch Shimadzu Wireless LAN kit Shimadzu Router Shimadzu OPESCOPE ACTENO FD type Instruction Manual 8-3 Chapter 8 Technical Data ♦ Suitable Environment of the System The professional healthcare facility environment without as follows: • Medical treatment areas with high-powered medical electrical equipment (High frequency surgical equipment, short-wave therapy equipment) • Inside the radio frequency shielded room of an MRI. NOTE The emissions characteristics of the Surgical Mobile C-arm Imaging System OPESCOPE ACTENO FD type make it suitable for use in industrial areas and hospitals (CISPR 11 class A). If it is used in a residential environment (for which CISPR 11 class B is normally required) the Surgical Mobile C-arm Imaging System OPESCOPE ACTENO FD type might not offer adequate protection to radio-frequency communication services. The user might need to take mitigation measures, such as relocating or re-orienting the system. 8-4 OPESCOPE ACTENO FD type Instruction Manual  8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) ♦ Guidance and Manufacturer's Declaration - Electromagnetic Emissions - for all EQUIPMENT and SYSTEMS Guidance and manufacturer's declaration - electromagnetic emissions The OPESCOPE ACTENO FD type is intended for use in the electromagnetic environment specified below. The customer or the user of the OPESCOPE ACTENO FD type should assure that it is used in such an environment Emissions test Compliance Electromagnetic environment - guidance The OPESCOPE ACTENO FD type uses RF RF emissions energy only for its internal function. EN 55011/ Group 1 Therefore, its RF emissions are very low and CISPR 11 are not likely to cause any interference in nearby electronic equipment. RF emissions EN 55011/ Class A CISPR 11 Harmonic emissions The OPESCOPE ACTENO FD type is suitable for use in all establishments other than EN 61000-3-2/ Not applicable domestic and those directly connected to the IEC 61000-3-2 public low-voltage power supply network that Voltage fluctuations/ supplies buildings used for domestic purposes. flicker emissions Not applicable EN 61000-3-3/ IEC 61000-3-3 ♦ Guidance and Manufacturer's Declaration - Electromagnetic Immunity - Guidance and manufacturer's declaration - electromagnetic immunity The OPESCOPE ACTENO FD type is intended for use in the electromagnetic environment specified below. The customer or the user of the OPESCOPE ACTENO FD type should assure that it is used in such an environment. 8 Electromagnetic IEC 60601 test Compliance Immunity test environment - level level guidance ±2 kV, ±4kV, ±2 kV, ±4kV, Recommended floor material is wood, ±6 kV, ±8 kV ±6 kV, ±8 kV Electrostatic concrete or ceramic tile. contact contact discharge (ESD) If the floor is covered EN 61000-4-2/ with synthetic material, ±2 kV, ±4kV, ±2 kV, ±4kV, IEC 61000-4-2 preferred relative ±8 kV, ±15 kV ±8 kV, ±15 kV humidity in the room is air air at least 30%. OPESCOPE ACTENO FD type Instruction Manual 8-5 Chapter 8 Technical Data Guidance and manufacturer's declaration - electromagnetic immunity Electromagnetic IEC 60601 test Compliance Immunity test environment - level level guidance Electrical fast ± 2 kV for power ± 2kV for power Mains power quality transient / burst supply lines supply lines should be that of a EN 61000-4-4/ ± 1 kV for input/ ± 1kV for input/ typical commercial or IEC 61000-4-4 output lines output lines hospital environment. ± 1 kV line(s) ± 1kV line(s) Mains power quality Surge to line(s) to line(s) should be that of a EN 61000-4-5/ ± 2 kV line(s) ± 2kV line(s) typical commercial or IEC 61000-4-5 to earth to earth hospital environment. 0% UT 0% UT (100 % dip in UT) Mains power quality (100 % dip in UT) should be that of a for 0.5, 1 cycle for 0.5, 1 cycle typical commercial or hospital environment. If Voltage dips, 40% UT 40% UT the user of the short (60% dip in UT) (60% dip in UT) OPESCOPE ACTENO interruptions and for 5 cycles for 5 cycles FD type requires voltage variations continued operation on power supply during power mains 70% UT 70% UT input lines interruptions, it is (30% dip in UT) (30% dip in UT) EN 61000-4-11/ recommended that the IEC 61000-4-11 for 25 cycles for 25 cycles OPESCOPE ACTENO FD type be powered from an uninterruptible 0% UT 0% UT power supply or a (100% dip in UT) (100% dip in UT) battery. for 5 sec for 5 sec Power frequency Power frequency magnetic fields should (50/60 Hz) be at levels characteristic magnetic field 30 A/m 30 A/m of a typical location in a EN 61000-4-8/ typical commercial or IEC 61000-4-8 hospital environment. NOTE UT is the a.c. mains voltage prior to application of the test level. 8-6 OPESCOPE ACTENO FD type Instruction Manual  8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) ♦ Guidance and Manufacturer's Declaration - Electromagnetic Immunity- Guidance and manufacturer's declaration - electromagnetic immunity The OPESCOPE ACTENO FD type is intended for use in the electromagnetic environment specified below. The customer or the user of the OPESCOPE ACTENO FD type should assure that it is used in such an environment. IEC 60601 Compliance Electromagnetic environment - Immunity test test level level guidance Portable and mobile RF communications equipment should be used no closer to any part of the OPESCOPE ACTENO FD type, including cables, than the recommended separation distance calculated from the equation applicable to the frequency of the transmitter. Recommended separation distance Conducted RF 3 Vrms 3 Vrms d = 1.2 P EN 61000-4-6/ 150 kHz 150 kHz IEC 61000-4-6 to 80 MHz to 80 MHz The ISM bands between 150 kHz ISM Bands 6 Vrms and 80 MHz are 6Vrms (ISM bands) 6.765 MHz to 6.795 MHz, 13.553 (1 KHz, AM MHz to 13.567 MHz, 26.957 MHz 80%) to 27.283 MHz, and 40.66 MHz to 40.70 MHz. 8 OPESCOPE ACTENO FD type Instruction Manual 8-7 Chapter 8 Technical Data Guidance and manufacturer's declaration - electromagnetic immunity IEC 60601 Compliance Electromagnetic environment - Immunity test test level level guidance Radiated RF 3 V/m 3 V/m d = 1.2 P EN 61000-4-3 80 MHz to 80 MHz 80 MHz to 800 MHz IEC 61000-4-3 2.7 GHz to 2.7 GHz (1 kHz, (See “Table d = 2.3 P AM 80 %) 8.1”) 800 MHz to 2.7 GHz (Refer to where P is the maximum output IEC power rating of the transmitter in 60601-1-2: watts (W) according to the 2014, table transmitter manufacturer and d is 9.) the recommended separation distance in metres (m). Field strengths from fixed RF transmitters, as determined by an electromagnetic site survey*a, should be less than the compliance level in each frequency range*b. Interference may occur in the vicinity of equipment marked with the following symbol: NOTE 1 At 80 MHz and 800 MHz, the higher frequency range applies. NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects and people. *a Field strengths from fixed transmitters, such as base stations for radio (cellular/ cordless) telephones and land mobile radios, amateur radio, AM and FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to fixed RF transmitters, an electromagnetic site survey should be considered. If the measured field strength in the location in which the OPESCOPE ACTENO FD type is used exceeds the applicable RF compliance level above, the OPESCOPE ACTENO FD type should be observed to verify normal operation. If abnormal performance is observed, additional measures may be necessary, such as reorienting or relocating the OPESCOPE ACTENO FD type. *b Over the frequency range 150 kHz to 80 MHz, field strengths should be less than 3 V/m. 8-8 OPESCOPE ACTENO FD type Instruction Manual  8.1 Environmental Conditions of EMC (Electromagnetic Compatibility) Table 8.1 Test specifications for ENCLOSURE PORT IMMUNITY to RF wireless communications equipment Test Test Frequency [MHz] Modulation Level 385 Pulse modulation: 18 Hz*1 27 V/m 450 FM ±5 kHz deviation: 1 kHz sine*2 28 V/m 710 745 Pulse modulation: 217 Hz*1 9 V/m 780 810 870 Pulse modulation: 18 Hz*1 28 V/m 930 1462 Pulse modulation: 217 Hz*1 10 V/m 1720 1845 Pulse modulation: 217 Hz*1 28 V/m 1970 2450 Pulse modulation: 217 Hz*1 28 V/m 5240 5500 Pulse modulation: 217 Hz*1 9 V/m 5785 *1 :The carrier shall be modulated using a 50 % duty cycle square wave signal. *2:As an alternative to FM modulation, 50 % pulse modulation at 18 Hz may be used because while it does not represent actual modulation, it would be worst case. 8 OPESCOPE ACTENO FD type Instruction Manual 8-9 Chapter 8 Technical Data ♦ Recommended Separation Distances between Portable and Mobile RF Communications Equipment and the EQUIPMENT or SYSTEM Recommended separation distances between portable and mobile RF communications equipment and the OPESCOPE ACTENO FD type The OPESCOPE ACTENO FD type is intended for use in an electromagnetic environment in which radiated RF disturbances are controlled. The customer or the user of the OPESCOPE ACTENO FD type can help prevent electromagnetic interference by maintaining a minimum distance between portable and mobile RF communications equipment (transmitters) and the OPESCOPE ACTENO FD type as recommended below, according to the maximum output power of the communications equipment. Separation distance according to frequency of transmitter Rated maximum d (m) output power of 150 kHz 80 MHz 800 MHz transmitter to 80 MHz to 800 MHz to 2.7 GHz P (W) d = 1.2 P d = 1.2 P d = 2.3 P 0.01 0.12 0.12 0.23 0.1 0.38 0.38 0.73 1 1.2 1.2 2.3 10 3.8 3.8 7.3 100 12 12 23 For transmitters rated at a maximum output power not listed above, the recommended separation distance d in metres (m) can be estimated using the equation applicable to the frequency of the transmitter, where P is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer. NOTE 1 At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies. NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects and people. 8-10 OPESCOPE ACTENO FD type Instruction Manual  8.2 Statement of Compliance [For Europe] 8.2 Statement of Compliance [For Europe] 8.2.1 Regulatory Information For Europe: The product complies with the requirement of the REGULATION (EU) 2017/745 on medical devices (abbreviated as MDR) and RoHS Directive 2011/65/EU. Product Name: Surgical X-ray TV System Surgical Mobile C-arm Imaging System Model Name: OPESCOPE ACTENO FD type Parts Number: 566-28800 Manufacturer: SHIMADZU CORPORATION Medical Systems Division Address: 1, NISHINOKYO-KUWABARACHO, NAKAGYO-KU, KYOTO, 604-8511, JAPAN Authorized Representative/Importer SHIMADZU EUROPA GmbH in EU: Address: Albert-Hahn-Strasse 6-10, 47269 Duisburg, Germany NOTE When any serious incident occurred in relation to the system, report that to your Shimadzu service representative and to the competent authority of the Member State in you are established. "Serious incident" means any incident that directly or indirectly led, might have led or might lead to any of the following: 8 (a) the death of a patient, user or other person, (b) the temporary or permanent serious deterioration of patient's, user 's or other person's state of health, (c) a serious public health threat. 8.2.2 Company's Quality System The company's quality management system complies with the requirements of Annex IX (the REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL), which is certified by TÜV Rheinland LGA Products GmbH. (Notified under No.0197) OPESCOPE ACTENO FD type Instruction Manual 8-11 Chapter 8 Technical Data 8.2.3 International Standards This equipment conforms the following international standards • IEC 60601-1:2005+A1:2012 / EN 60601-1:2006+A1:2013+A12:2014 • IEC 60601-1-2:2014 / EN 60601-1-2:2015 • IEC 60601-1-3:2008+A1:2013 / EN 60601-1-3:2008+A1:2013+A11:2016 • IEC 60601-1-6:2010+A1:2013 / EN 60601-1-6:2010+A1:2015 • IEC 60601-2-54:2009+A1:2015+A2:2018 / EN 60601-2-54:2009+A1:2015+A2:2019 • IEC 60601-2-43:2010+A1:2017+A2:2019 / EN 60601-2-43:2010+A1:2018+A2:2020 • IEC 60627:2013 / EN 60627:2015 • ISO 10993-1:2018 / EN ISO 10993-1:2020 • ISO 14971:2019+A11:2011 • IEC 62304:2006+A1:2015 / EN 62304:2006+A1:2015 • IEC 62366-1:2015+A1:2020 / EN 62366-1:2015+A1:2020 • ISO 15223-1:2021 / EN ISO 15223-1:2021 • EN 1041:2008+A1:2013 8.2.4 Protection Against Radiation Refer to the standard about the acceptance and performance testing. (ex. DIN 6868-150:2013-06, DIN 6868-157:2014-11) 8.3 Statement of Compliance with Standards • X-RAY EQUIPMENT for RADIOGRAPHY and RADIOSCOPY... SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO IEC 60601-2-54:2009+A1:2015+A2:2018 • X-RAY EQUIPMENT for RADIOGRAPHY and RADIOSCOPY... SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO EN 60601-2-54:2009+A1:2015+A2:2019 • SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO with radiation protection in accordance with IEC 60601-1-3:2008+A1:2013 • SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO with radiation protection in accordance with EN 60601-1-3:2008+A1:2013+A11:2016 • X-RAY EQUIPMENT for RADIOGRAPHY and RADIOSCOPY... SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO IEC 60601-2-43:2010+A1:2017+A2:2019 • X-RAY EQUIPMENT for RADIOGRAPHY and RADIOSCOPY... SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO EN 60601-2-43:2010+A1:2018+A2:2020 8-12 OPESCOPE ACTENO FD type Instruction Manual  8.4 Manufacturer Information 8.4 Manufacturer Information Manufacturer: SHIMADZU CORPORATION Medical Systems Division Address: 1, NISHINOKYO-KUWABARACHO, NAKAGYO-KU, KYOTO, 604-8511, JAPAN 8 OPESCOPE ACTENO FD type Instruction Manual 8-13 Chapter 8 Technical Data 8.5 Specifications 1. Classification of devices Type of protection against electric shock: Class 1 device Degree of protection against electric shock: No Applied Parts Operation mode: Continuous operation 2. X-ray control unit∗1∗2∗3 Nominal maximum output: 2 kW (100 kV, 20 mA, 0.1 sec) Factor depending on the waveform: 1.00 Nominal tube voltage, and the highest tube current obtainable with that voltage: 200V specification: Short time rating: 110 kV, 16 mA Long time rating: 110 kV, 9.8 mA 100V specification: Short time rating: 110 kV, 16 mA Long time rating: 110 kV, 9.8 mA Highest tube current, and the highest tube voltage obtainable with that tube current: 200V specification: Short time rating: 20 mA, 100 kV Long time rating: 13.5 mA, 80 kV 100V specification: Short time rating: 20 mA, 100 kV Long time rating: 13.5 mA, 80 kV Combination of tube voltage and tube current which results in the highest electric output power. Factor depending on the waveform: 1.00 200V specification: Short time rating: 100 kV, 20 mA Long time rating: 110 kV, 9.8 mA 100V specification: Short time rating: 100 kV, 20 mA Long time rating: 110 kV, 9.8 mA Tube voltage setting range: 40 to 110 kV (1 kV step) Digital radiography: Rating: Memory shot 110 kV, 2.65 mAs (16 mA) Manual SPOT 100 kV, 3.20 mAs (20 mA) 110 kV, 2.50 mAs (16 mA) 8-14 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications mAs setting range: Memory shot 0.30 - 2.65 mAs, 16 mA (Radiographic tube voltage and tube current for the memory shot are automatically calculated by the kV-mA curve and density.) Manual SPOT 0.50 - 3.20 mAs (9 steps) (0.50, 0.60, 0.80, 1.00, 1.25, 1.60, 2.00, 2.50, 3.20) 40 - 49 kV, 0.50 - 2.50 mAs 50 - 100 kV, 0.50 - 3.20 mAs 101 - 110 kV, 0.50 - 2.50 mAs Continuous fluoroscopy: Nominal tube voltage, and the highest peak tube current obtainable with that voltage: 110 kV, 4.9 mA (200 V specification) 110 kV, 3.6 mA (100 V specification) Highest peak tube current, and the highest tube voltage obtainable with that tube current: 6.8 mA, 80 kV (200 V specification) 5 mA, 80 kV (100 V specification) Pulsed fluoroscopy: Pulse rates: 15, 10, 7.5, 3.75 fps Nominal tube voltage, and the highest peak tube current obtainable with that voltage: 110 kV, 4.9 mA Highest peak tube current, and the highest tube voltage obtainable with that tube current: 6.8 mA, 80 kV Boost pulsed fluoroscopy: 8 Pulse rates: 7.5, 3.75 fps Nominal tube voltage, and the highest peak tube current obtainable with that voltage: 110 kV, 9.8 mA Highest peak tube current, and the highest tube voltage obtainable with that tube current: 13.5 mA, 80 kV Continuous fluoroscopy time: 20 seconds Fluoroscopy stop time: 0.047 seconds (time from releasing the X-ray exposure (fluoroscopy) switch or the left foot switch to stopping the X-ray exposure) 0.087 seconds for the wireless hand switch OPESCOPE ACTENO FD type Instruction Manual 8-15 Chapter 8 Technical Data *1: Accuracy of each condition is given below (confirm to IEC standards). Tube voltage (within ±8 %), tube current (within ±20 %) mAs: within ±(10 %+0.2 mAs), time: within ±(10 %+1 ms) *2: X-ray output stability is given below. Variation coefficient: 0.005 or less *3: The X-ray output stability with neighboring setting values satisfies the following formula. K1 K2 --------- + --------- K1 K2 I1 t1 I2 t2 --------- – --------- ≤ 0.2 ------------------------- I1 t1 I2 t2 2 Where K 1, K 2 : Mean value of measured X-ray output values obtained using neighboring setting values I 1, I 2 : Neighboring tube current setting values t 1, t 2 : Neighboring radiography time setting values 3. X-ray tube assembly Model name: AD110P-200H X-ray tube: SDO-0.6 Nominal focal spot: 0.6 mm (IEC 60336) Measuring method of focal spot size: Slit camera method Target angle: 8° Target material: Tungsten Anode type: Stationary anode Nominal anode input power: 2.02 kW Nominal radiographic anode input power: 2.1 kW Nominal X-ray tube voltage: 110 kV Maximum anode heat content: 100,000 HU (71 kJ) Maximum anode heat dissipation rate: 550 W Maximum filament voltage: 4.2 V Maximum filament current: 3.7 A Filament heating frequency: 20 kHz Maximum heat content (X-ray tube assembly): 680 kHU (480 kJ) Maximum heat dissipation rate (X-ray tube assembly):226 HU/s (160 W) X-ray tube assembly inherent filtration: Min. 5.0 mm Al eq/ 75 kV Leakage dose: Leakage radiation in an hour from X-ray tube assembly and collimator is less than 1.0 mGy in an hour at a distance of 1 meter from the focal spot. However, leakage radiation in an hour from the collimator is less than 0.5 mGy. 8-16 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications • Leakage dose measurement conditions Fluoroscopy: 55 kV, 22 mA (121 W) continuous Radiography: 110 kV, 16 mA, 100 ms, 45 frames, exposure time 4.5 seconds, cooling time 60 seconds (average load 123 W) Mass: 15 kg±5 kg 4. Beam limiting device Octagonal collimator: Electrical driven (opening/closing), made of Tungsten Parallel compensating filter: Electrical driven (opening/closing/rotation), made of Cu Beam hardening filter: Electrical driven (filter selection), Made of Cu, 0.1, 0.2, 0.3 mm thick Al equivalent for beam hardening filter (70 kV/HVL, 2.5 mm Al) Beam Cu 0.1 mm Cu 0.2 mm Cu 0.3 mm hardening filter Al equivalent 3 mm Al 3.7 mm Al 3.8 mm Al Inherent filtration: 0 mm Al equivalent. 8 OPESCOPE ACTENO FD type Instruction Manual 8-17 Chapter 8 Technical Data Reference axis∗ Reference axis∗ Focal spot Focal spot UNIT: mm Fig. 8.1 X-ray tube assembly ∗ The reference axis which employed in normal operation of equipment means the incident X-ray axis from X-ray tube unit to FPD vertically as shown above. Fig. 8.2 X-ray tube assembly 8-18 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications X-RAY TUBE ASSEMBLY HEATING AND COOLING CURVE 100 330W 220W 175W 90 160W 80 100W Housing Heat Storage (%) 70 60 50 40 Cooling 30 20 10 0 0 20 40 60 80 100 Time (min) ANODE HEATING AND COOLING CURVE 100 550W 90 80 250W 70 Heat Storage(%) 60 50 100W 40 8 30 20 Cooling 10 0 0 1 2 3 4 5 6 7 8 9 10 Time(min) 04/03/25 OPESCOPE ACTENO FD type Instruction Manual 8-19 Chapter 8 Technical Data SINGLE LOAD RATING CHARTS X-ray tube Current [mA] Time [min] EMISSION AND FILAMENT CHARACTERISTICS X-ray tube Current [mA] Filament Voltage [V] Filament Current [A] 8-20 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications Table A.1 SERIAL LOAD RATING TABLE (For reference use only) Tube load (kW) as a function of the frame rate (fps) Number of exposure in of the individual radiographs of the series Series (exp) 7.5 5 3.75 2 1 10 11.4 10.6 10.1 9.8 9.5 20 10.6 9.8 9.4 9.0 8.8 40 9.8 9.0 8.6 8.3 8.0 60 9.4 8.6 8.1 7.8 7.4 80 9.0 8.3 7.8 7.4 7.0 100 8.8 8.0 7.4 7.0 6.7 150 8.4 7.4 6.9 6.4 6.1 Refer to IEC 60613:2010 5. X-ray tube assembly operating principle Operating principle is as follows. a) The filament is heated by passing an electric current, and then thermo electrons are emitted b) A high voltage is applied between the cathode and anode to accelerate the electrons. c) The accelerated electrons strike the anode target and X-rays are generated. d) The filed size of X-ray beams are limited by the collimator. 8 Fig. 8.3 OPERATING PRINCIPLE OPESCOPE ACTENO FD type Instruction Manual 8-21 Chapter 8 Technical Data 6. C-arm cart SID: 1005 mm Rotation of the C-arm: 120° Rotation of the C-arm’s holder: 300°/120° Longitudinal movement of the C-arm: 450 mm Lateral movement of the C-arm: 200 mm Swing of the C-arm: ±12.5° 7. FPD For details, refer to the following FPD instruction manual: M517-V061 X-ray Flat Panel Detector Mercu0909F Instruction Manual 8. Monitor 19 inch LCD display monitor (Live monitor/Reference monitor)) 9. Grid Ratio 13:1 Line rate 70 lines/cm Intermediate material Fiber 10. Fuse, Breaker Rated Rated Acting Breaking Name Location voltage current speed capacity 250 V Slow Monitor CP32V-15DN 15 1000 AC -Blow Cart 250 V Slow Monitor FLM15 15 10000 AC -Blow Cart 250 V Slow Monitor 021306.3P 6.3 63 AC -Blow Cart 660 V Very C-arm 660CF-20 20 10000 AC, DC Fast Cart 32 V Very C-arm MFU0603FF00500P500 0.5 50 DC Quick Cart 8-22 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications 11. DR a) Fluoroscopy / acquisition mode DC (30fps), Pulse (15/10/7.5/3.75 fps) b) Radiography / acquisition mode Spot, Serial (0.5/1/2/3/3.75/5/7.5 fps), DSA (0.5/1/2/3/3.75/5/7.5 fps) c) Image Processing SCORE PRO Advance (only fluoroscopy), SURE (only SPOT and SERIAL), RSM (DSA post-processing), LUT, Rotation, AWC (Auto Window Control), Edge Enhancement, HV reverse d) DICOM PRINT, STORAGE, RDSR, MWM, MPPS e) Other functions Collimator positioning display DVD-R, CD-R, USB I/F for image export. f) Image save - Image size Fluoroscopy: 1000 × 1000 Radiography (Normal field size): 1000 × 1000 Radiography (Zoomed field size): 744 × 744 - Number of bits 16 bit (pixel value information is 14 bit) - Saved number 30,000 or more (1000 × 1000, 16 bit) g) Image output PRINT, STORAGE: DICOM format (with image processing*) Media output: DICOM format (with image processing*) USB output: JPEG format (with image processing), BMP format (with image processing) * You can switch whether to apply image processing for display. 12. Dose display function 8 Dose calculation (accumulative dose, dose rate) is displayed on the monitor and the LCD on the C-arm main panel. 13. Options a) Laser pointer b) Cover c) Dose area product meter d) Heat radiation unit e) External video output function f) Option software g) Hand switch OPESCOPE ACTENO FD type Instruction Manual 8-23 Chapter 8 Technical Data h) Wireless hand switch i) Long cable foot switch j) Wireless LAN kit k) Router Wireless Hand switch : C2UW-LP-I/C2UW-LU Item Frequency Range Bandwidth Modulation Output Watts Bluetooth 4.1 2402-2480 GHz 2MHz GFSK Max. +3.6mW Low Energy 14. Mass and Size Body of the C-arm cart: 250 kg (option installed: 260 kg) Monitor cart: 140 kg (with maximum load: 155 kg) Fig. 8.4 C-arm Cart 8-24 OPESCOPE ACTENO FD type Instruction Manual  8.5 Specifications Fig. 8.5 Monitor Cart 8 OPESCOPE ACTENO FD type Instruction Manual 8-25 Chapter 8 Technical Data 8.6 Initial Setting Values for APR This is the APR initial setting list. The APR can be changed with the touch panel of the C-arm cart or the DR software SDR-120F. For change with the touch panel, see 3.10 "Selecting the APR" (page 3-64). For change with the SDR-120F, see “SDR-120F Reference Guide”. NOTE • “*1” parameters and image processing parameters can be changed with the SDR-120F. • “*2” parameters only appear for the system with the DSA option. • When you want to change who is responsible for changing the parameters managed by the SDR-120F, contact your Shimadzu service representative. NOTE The Low Dose 2 is intended for people at high risk of exposure, such as children. If necessary, remove the grid to reduce the dose. 8-26 OPESCOPE ACTENO FD type Instruction Manual  8.6 Initial Setting Values for APR 2 3 4 5 1 6 7 8 9 10 11 12 Fig. 8.6 APR Position 1 ♦ Fluoroscopy/Radiography Parameter APR No. 1 2 3 4 Chest APR Name Standard Head/Neck Shoulder (IVH/PMI) Dose*1 Normal Normal Low Dose 1 Normal Pulse rate*1 Continuous 15fps Continuous 15fps X-ray adjustment mode AUTO AUTO AUTO AUTOON Loop memory mode*1 OFF OFF OFF OFF Loop frames*1 200 200 200 200 Start fluoroscopy tube 70 60 60 60 voltage (kV) FPD field size*1 Normal Normal Normal Normal BH filter Filter1 Filter1 Filter1 Filter1 Image rotation angle 0 0 0 0 Parallel compensating filter 0 0 0 0 rotation angle Parallel compensating filter Max Max Max Max width Octagonal collimator width Max Max Max Max 8 Image V reverse*1 OFF OFF OFF OFF Image H reverse*1 OFF OFF OFF OFF Laser pointer (OP) OFF OFF OFF OFF Acquisition mode*1 SPOT SPOT SPOT SPOT Density ±0 ±0 ±0 ±0 SERIAL acquisition rate*1 3fps 3fps 3fps 3fps SERIAL acquisition time*1 16 sec 16 sec 16 sec 16 sec DSA acquisition rate*1 *2 3fps 3fps 3fps 3fps DSA acquisition time*1 *2 16 sec 16 sec 16 sec 16 sec OPESCOPE ACTENO FD type Instruction Manual 8-27 Chapter 8 Technical Data ♦ Image Processing Parameter Type APR No. 1 2 3 4 DC 3 3 3 3 15 fps 3 3 3 3 Recursive 10 fps 3 3 3 3 strength 7.5 fps 3 3 3 3 3.75 fps 3 3 3 3 Noise reduction 2 2 2 2 Line enhancement 3 3 3 3 DR compression 3 3 3 3 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E8 STD-E8 STD-E8 STD-E8 Image Brightness 0 0 0 0 Fluorosc Adjustment*1 opy Brightness 14000/ 14000/ 14000/ 14000/ +4 4000 4000 4000 4000 Brightness 14000/ 14000/ 14000/ 14000/ +3 4500 4500 4500 4500 Brightness 14000/ 14000/ 14000/ 14000/ +2 5000 5000 5000 5000 Width/ Brightness 14000/ 14000/ 14000/ 14000/ Level +1 5500 5500 5500 5500 Brightness 14000/ 14000/ 14000/ 14000/ 0 6000 6000 6000 6000 Brightness 14000/ 14000/ 14000/ 14000/ -1 7000 7000 7000 7000 Brightness 14000/ 14000/ 14000/ 14000/ -2 8000 8000 8000 8000 Nega/Posi Posi Posi Posi Posi WHOLE HEADNE SHOULD SURE Type CHEST BODY CK ER SPOT AWC Type304 Type103 Type203 Type203 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 8-28 OPESCOPE ACTENO FD type Instruction Manual  8.6 Initial Setting Values for APR Type APR No. 1 2 3 4 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF SERIAL AWC Serial2 Serial2 Serial2 Serial2 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF DSA *2 AWC DSA2 DSA2 DSA2 DSA2 Gamma Type-Level STD-G3 STD-G3 STD-G3 STD-G3 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 8 OPESCOPE ACTENO FD type Instruction Manual 8-29 Chapter 8 Technical Data 2 3 4 5 1 6 7 8 9 10 11 12 Fig. 8.7 APR Position 2 ♦ Fluoroscopy/Radiography Parameter APR No. 5 6 7 8 APR Name Arm Hand Spine Hip Joint High Dose*1 Normal Normal Normal Quality Pulse rate*1 15fps 15fps 15fps 15fps X-ray adjustment mode AUTO AUTO AUTO AUTO Loop memory mode*1 OFF OFF OFF OFF Loop frames*1 200 200 200 200 Start fluoroscopy tube 50 50 70 70 voltage (kV) FPD field size*1 Normal Normal Normal Normal BH filter Filter1 Filter1 Filter1 Filter1 Image rotation angle 0 0 0 0 Parallel compensating 0 0 0 0 filter rotation angle Parallel compensating Max Max Max Max filter width Octagonal collimator width Max Max Max Max Image V reverse*1 OFF OFF OFF OFF Image H reverse*1 OFF OFF OFF OFF Laser pointer (OP) OFF OFF OFF OFF Acquisition mode*1 SPOT SPOT SPOT SPOT Density ±0 ±0 ±0 ±0 SERIAL acquisition rate*1 3fps 3fps 3fps 3fps SERIAL acquisition time*1 16 sec 16 sec 16 sec 16 sec DSA acquisition rate*1 *2 3fps 3fps 3fps 3fps DSA acquisition time*1 *2 16 sec 16 sec 16 sec 16 sec 8-30 OPESCOPE ACTENO FD type Instruction Manual  8.6 Initial Setting Values for APR ♦ Image Processing Parameter Type APR No. 5 6 7 8 DC 3 3 4 4 15 fps 3 3 4 4 Recursive strength 10 fps 3 3 4 4 7.5 fps 3 3 4 4 3.75 fps 3 3 4 4 Noise reduction 2 2 2 2 Line enhancement 3 3 2 2 DR compression 3 3 3 3 Gamma Type-Level STD-G9 STD-G9 STD-G8 STD-G8 Edge Type-Level STD-E13 STD-E13 STD-E10 STD-E10 Image Brightness 0 0 0 0 Fluorosc Adjustment*1 opy Brightness 14000/ 14000/ 18000/ 18000/ +4 5000 5000 3000 3000 Brightness 14000/ 14000/ 18000/ 18000/ +3 5500 5500 3500 3500 Brightness 14000/ 14000/ 18000/ 18000/ +2 6000 6000 4000 4000 Width/ Brightness 14000/ 14000/ 18000/ 18000/ Level +1 6500 6500 4500 4500 Brightness 14000/ 14000/ 18000/ 18000/ 0 7000 7000 5000 5000 Brightness -1 14000/ 8000 14000/ 8000 18000/ 6000 18000/ 6000 8 Brightness 14000/ 14000/ 18000/ 18000/ -2 9000 9000 7000 7000 Nega/Posi Posi Posi Posi Posi SURE Type ARM HAND LSPINE HIP SPOT AWC Serial3 Serial3 Type105 Type105 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 OPESCOPE ACTENO FD type Instruction Manual 8-31 Chapter 8 Technical Data Type APR No. 5 6 7 8 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF SERIAL AWC Serial2 Serial2 Serial2 Serial2 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF DSA *2 AWC DSA2 DSA2 DSA2 DSA2 Gamma Type-Level STD-G3 STD-G3 STD-G3 STD-G3 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 8-32 OPESCOPE ACTENO FD type Instruction Manual  8.6 Initial Setting Values for APR 2 3 4 5 1 6 7 8 9 10 11 12 Fig. 8.8 APR Position 3 ♦ Fluoroscopy/Radiography Parameter APR No. 9 10 11 12 Spine/Hip Leg Vascular APR Name Foot (Thick) (Knee) access Dose*1 Boost Pulse Normal Normal Low Dose 1 Pulse rate*1 7.5fps 15fps 15fps Continuous X-ray adjustment mode AUTO AUTO AUTO AUTO Loop memory mode*1 OFF OFF OFF OFF Loop frames*1 200 200 200 200 Start fluoroscopy tube 80 50 50 50 voltage (kV) FPD field size*1 Normal Normal Normal Normal BH filter Filter1 Filter1 Filter1 Filter1 Image rotation angle 0 0 0 0 Parallel compensating filter 0 0 0 0 rotation angle Parallel compensating filter Max Max Max Max width Octagonal collimator width Max Max Max Max 8 Image V reverse*1 OFF OFF OFF OFF Image H reverse*1 OFF OFF OFF OFF Laser pointer (OP) OFF OFF OFF OFF Acquisition mode*1 SPOT SPOT SPOT SPOT Density ±0 ±0 ±0 ±0 SERIAL acquisition rate*1 3fps 3fps 3fps 3fps SERIAL acquisition time*1 16 sec 16 sec 16 sec 16 sec DSA acquisition rate*1 *2 3fps 3fps 3fps 3fps DSA acquisition time*1 *2 16 sec 16 sec 16 sec 16 sec OPESCOPE ACTENO FD type Instruction Manual 8-33 Chapter 8 Technical Data ♦ Image Processing Parameter Type APR No. 9 10 11 12 DC 4 3 3 3 15 fps 4 3 3 3 Recursive strength 10 fps 4 3 3 3 7.5 fps 4 3 3 3 3.75 fps 4 3 3 3 Noise reduction 2 2 2 2 Line enhancement 4 3 3 3 DR compression 3 3 3 3 Gamma Type-Level STD-G9 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E13 STD-E13 STD-E13 STD-E13 Image Brightness 0 0 0 0 Fluorosc Adjustment*1 opy Brightness 14000/ 14000/ 14000/ 14000/ +4 3000 4000 4000 4000 Brightness 14000/ 14000/ 14000/ 14000/ +3 3500 4500 4500 4500 Brightness 14000/ 14000/ 14000/ 14000/ +2 4000 5000 5000 5000 Width/ Brightness 14000/ 14000/ 14000/ 14000/ Level +1 4500 5500 5500 5500 Brightness 14000/ 14000/ 14000/ 14000/ 0 5000 6000 6000 6000 Brightness 14000/ 14000/ 14000/ 14000/ -1 6000 7000 7000 7000 Brightness 14000/ 14000/ 14000/ 14000/ -2 7000 8000 8000 8000 Nega/Posi Posi Posi Posi Posi SURE Type LSPINE KNEE FOOT SHUNT SPOT AWC Type105 Type304 Type304 Serial3 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 8-34 OPESCOPE ACTENO FD type Instruction Manual  8.6 Initial Setting Values for APR Type APR No. 9 10 11 12 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF SERIAL AWC Serial2 Serial2 Serial2 Serial2 Gamma Type-Level STD-G8 STD-G8 STD-G8 STD-G8 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 Nega/Posi Posi Posi Posi Posi Auto play OFF OFF OFF OFF DSA *2 AWC DSA2 DSA2 DSA2 DSA2 Gamma Type-Level STD-G3 STD-G3 STD-G3 STD-G3 Edge Type-Level STD-E4 STD-E4 STD-E4 STD-E4 8 OPESCOPE ACTENO FD type Instruction Manual 8-35 Chapter 8 Technical Data 8.7 Conditions for Installation and Use 1. Environmental conditions Temperature: 10 °C to 35 °C Relative humidity: 30 % to 80 % (to be no condensation) Atmospheric pressure: 800 hPa to 1060 hPa State of the atmosphere: To contain no volatile vapors or corrosive gases Ambient noise level: Under 70 dB 2. Power supply System: Single phase AC Frequency: 50 or 60 Hz Capacity: 2.0 kVA or more Voltage and power supply impedance: 100, 110, 120 V ± 10 %, 0.2 Ω max. 200, 220, 230, 240 V ± 10 %, 0.8 Ω max. Ground: Type D grounding Power supply breaker: Type suited to use with an inverter 3. Power consumption 100/110/120 V 200/220/230/240 V Long time 15 A 10 A Momentary 45 A 20 A 8.8 Storage Conditions Temperature: 0 °C to 40 °C Relative humidity: 10 % to 80 % (to be no condensation) Atmospheric pressure: 700 hPa to 1060 hPa State of the atmosphere: To contain no volatile vapors or corrosive gases 8-36 OPESCOPE ACTENO FD type Instruction Manual  8.9 KV-mA Curve 8.9 KV-mA Curve Initial setting value: 75 kV/Cu 3 mm High Quality: DC fluoroscopy (Power 200V), Pulse fluoroscopy High Quality: DC fluoroscopy (Power 100V) 8 Normal: Power 100V and 200V OPESCOPE ACTENO FD type Instruction Manual 8-37 Chapter 8 Technical Data Low Dose 1: Power 100V and 200V Low Dose 2: Power 100V and 200V BoostPulse: Power 100V and 200V 8-38 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation 8.10 Information on Radiation 8.10.1 Radiation Protection To minimize X-ray exposure on patients and medical staff, the operator must observe the local laws and regulations specified in each region, as well as the following precautions. It is also highly recommended to study and know about the recommendations of the International Commission on Radiological Protection (ICRP). ♦ Principle • Limit X-ray irradiation to the minimum. • Keep the fluoroscopy duration to the minimum and utilize the L.I.H. feature and the virtual collimator. • Use the fluoroscopy mode with low radiation dose. • To avoid unintended X-ray irradiation, turn off the X-ray exposure restriction releasing switch when unnecessary. ♦ For Radiation Protection of Patients • If there is any possibility that the regions easily affected by radiation (eye balls, gonad, etc.) are irradiated by X-ray, be sure to protect those regions. • Adjust X-ray irradiation field appropriately to avoid X-ray irradiation to the area other than the region of interest. • Keep the focus-skin distance as long as possible. • Always check the cumulative dose area product and the cumulative reference Air Kerma displayed in the live monitor. 8 NOTE The precision of the displayed dose value is ±35 %. Periodical calibration is required for the dose area product meter chamber and the dose calculating function. ♦ For Radiation Protection of Medical Staff • Limit the time of staying in the controlled area as short as possible. While in the area, be sure to wear the radiation protective gear, such as protective apron, gloves, glasses, etc. • Keep the distance as far as possible from the X-ray source. The radiation dose is inversely proportional to the square of the distance from the radiation source. • Be sure to use a badge or pocket dosimeter to check your personal exposure dose. OPESCOPE ACTENO FD type Instruction Manual 8-39 Chapter 8 Technical Data 8.10.2 Stray Radiation in the Significant Zone of Occupancy The significant zone of occupancy to be used by the operator and medical staff for examination/medical treatment shall be defined as follows: The operation requiring a work in the significant zone of occupancy are orthopedics surgery, pacemaker placement, etc. Significant Zone of Occupancy Phantom: 350×350×150 Fig. 8.9 Vertical Beam, PA position 8-40 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation Significant Zone of Occupancy Phantom: 350×350×150 8 Fig. 8.10 Vertical Beam, AP position OPESCOPE ACTENO FD type Instruction Manual 8-41 Chapter 8 Technical Data Significant Zone of Occupancy Phantom: 350×350×150 Fig. 8.11 Horizontal Beam 8-42 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation 8.10.3 Test Report Stray Radiation for OPESCOPE ACTENO FD type ♦ Test Method The stray radiation in significant zone of occupancy was measured according to IEC601-1-3 Annex AAA. ♦ Test Conditions 1) X-ray conditions X-ray tube voltage:110 kV X-ray tube current:3 mA 2)Phantom Outside dimensions:35[cm] x 35[cm] x 15[cm] Material:PMMA 3) C-arm Position Vertical Beam, PA position:Refer to Fig. 8.9 Vertical Beam, AP position:Refer to Fig. 8.10 Horizontal Beam:Refer to Fig. 8.11 4) Significant zone of occupancy and Measuring points For detail, refer to Fig. 8.9 to Fig. 8.11 ♦ Test Data 8 Refer to Fig. 8.12 to Fig. 8.14 OPESCOPE ACTENO FD type Instruction Manual 8-43 Chapter 8 Technical Data Fig. 8.12 Vertical Beam PA position Fig. 8.13 Vertical Beam AP position Fig. 8.14 Horizontal Beam 8-44 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation 8.10.4 Deterministic Effect In the examination using this equipment, there is a possibility that the cumulative skin dose during the examination may reach the level that could bring a deterministic effect on the patient. According to the ICRP60, the threshold at which a deterministic effect appears on skin or crystalline lens is 1 to 3 Gy. The following shows an example of X-ray conditions which could bring skin dose of 1 Gy during the examination using this equipment. Example: Performing 25 min of fluoroscopy under the parameters of Fluoroscopy mode: High Quality DC, 110 kV, and 4.9 mA 8 OPESCOPE ACTENO FD type Instruction Manual 8-45 Chapter 8 Technical Data 8.10.5 Reference Air Kerma (Rate) This section describes representative values of reference air kerma rate of fluoroscopy and reference air kerma of radiography. These values might change by X-ray condition, etc. ♦ Measurement Condition (Compliant with IEC 60601-2-54:2009+A1:2015+A2:2018 clause 203.5.2.4.5.102) Anti-scatter grid: Used Phantom: PMMA 400x400x200 mm Geometry: Focal Spot Dosimeter Patient Entrance Reference Point (according to the Patient Entrance Reference Point of the C-arm X-ray system with the isocenter.) Phantom Unit: mm 8-46 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation ♦ Fluoroscopy This unit has three or more fluoroscopy modes. Application and characteristics of each modes are shown below. Mode and Application Low Dose DC/Pulse Pulse (ms) Frame Rate Application For study that needs decreasing DC (Continuous) (Continuous) dose. For study that needs decreasing Pulse 33 15/10/7.5/3.75 dose even more. Normal DC/Pulse Pulse (ms) Frame Rate Application DC (Continuous) (Continuous) For normal study. For normal study that needs Pulse 33 15/10/7.5/3.75 decreasing dose. High Quality DC/Pulse Pulse (ms) Frame Rate Application DC (100 V specification) (Continuous) (Continuous) For study that needs high quality. DC (200 V specification) 8 For study that needs high quality Pulse 33 15/10/7.5/3.75 and decreasing dose. Boost Pulse DC/Pulse Pulse (ms) Frame Rate Application Pulse 66 7.5/3.75 For study that needs high quality. OPESCOPE ACTENO FD type Instruction Manual 8-47 Chapter 8 Technical Data Reference Air Kerma Rate • FOV 8 inch Beam hardening filter (Cu) Dose DC/Pulse Reference AKR None 0.1 0.2 0.3 kV 76 77 77 78 DC mA 1.7 1.7 1.8 1.8 AKR (mGy/min) 11.70 7.05 5.28 4.31 kV 75 75 77 78 15 mA 0.8 0.8 0.8 0.9 AKR (mGy/min) 6.46 3.90 3.02 2.62 kV 74 75 76 77 Low dose 2 10 mA 0.5 0.5 0.6 0.6 AKR (mGy/min) 4.45 2.70 2.07 1.69 kV 76 78 79 80 7.5 mA 0.4 0.5 0.5 0.5 AKR (mGy/min) 3.81 2.45 1.93 1.56 kV 75 76 78 79 3.75 mA 0.2 0.2 0.2 0.2 AKR (mGy/min) 1.77 1.16 0.902 0.765 kV 75 77 78 79 DC mA 2.2 2.4 2.5 2.5 AKR (mGy/min) 16.03 11.00 8.34 6.93 kV 74 75 76 77 15 mA 1.1 1.1 1.2 1.2 AKR (mGy/min) 8.73 5.33 3.94 3.30 kV 74 75 76 77 Low dose 1 10 mA 0.7 0.7 0.8 0.8 AKR (mGy/min) 5.92 3.70 2.78 2.31 kV 74 75 77 78 7.5 mA 0.5 0.6 0.6 0.6 AKR (mGy/min) 4.58 2.90 2.22 1.75 kV 74 76 77 78 3.75 mA 0.3 0.3 0.3 0.3 AKR (mGy/min) 2.33 1.54 1.19 0.981 8-48 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation Beam hardening filter (Cu) Dose DC/Pulse Reference AKR None 0.1 0.2 0.3 kV 76 76 77 79 DC mA 3.6 3.6 3.7 3.9 AKR (mGy/min) 25.10 14.80 11.10 9.26 kV 74 74 76 77 15 mA 1.5 1.6 1.7 1.9 AKR (mGy/min) 12.00 7.45 5.70 4.77 kV 74 74 76 77 Normal 10 mA 1 1.1 1.2 1.2 AKR (mGy/min) 8.07 4.95 4.01 3.27 kV 74 75 76 77 7.5 mA 0.8 0.9 0.9 0.9 AKR (mGy/min) 6.49 4.09 3.14 2.60 kV 74 75 77 78 3.75 mA 0.4 0.4 0.4 0.5 AKR (mGy/min) 3.20 2.17 1.69 1.41 8 OPESCOPE ACTENO FD type Instruction Manual 8-49 Chapter 8 Technical Data Beam hardening filter (Cu) Dose DC/Pulse Reference AKR None 0.1 0.2 0.3 kV 78 79 81 84 DC(400W) mA 4.6 4.8 4.9 4.8 AKR (mGy/min) 37.90 24.80 19.40 16.00 kV 77 77 78 79 DC(550W) mA 6 6 6.3 6.5 AKR (mGy/min) 43.50 25.80 19.40 15.80 kV 75 75 76 77 15 mA 2.7 2.8 2.9 3 AKR (mGy/min) 20.70 12.50 9.40 7.82 High Quality kV 74 74 76 77 10 mA 1.8 1.8 1.9 2 AKR (mGy/min) 13.70 8.11 6.51 5.42 kV 74 75 76 78 7.5 mA 1.3 1.4 1.5 1.6 AKR (mGy/min) 10.70 6.76 5.05 4.44 kV 74 75 77 78 3.75 mA 0.6 0.7 0.7 0.8 AKR (mGy/min) 5.20 3.48 2.74 2.28 kV 64 66 67 69 7.5 mA 1.6 1.8 1.9 2.1 AKR (mGy/min) 17.30 10.18 7.59 6.20 Boost Pulse kV 64 66 67 69 3.75 mA 0.8 0.9 1.0 1.1 AKR (mGy/min) 8.80 5.39 3.96 3.20 Highest Reference Air Kerma Rate 82.1 mGy/min (Boost Pulse, 110 kV, 2.5 mA, 8 FOV, no beam hardening filter) 8-50 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation Radiography Reference Air Kerma • FOV 8 inch Beam X-ray condition Reference AK hardening Tube voltage Tube current Time (msec) (mGy) filter (kV) (mA) None 74 16 166 0.32 Cu 0.1 74 16 166 0.19 Cu 0.2 74 16 166 0.19 Cu 0.3 75 16 166 0.1 Highest Reference Air Kerma 23.52 mGy (110 kV, 16 mA, 166 ms, 8 FOV, no beam hardening filter) 8 OPESCOPE ACTENO FD type Instruction Manual 8-51 Chapter 8 Technical Data 8.10.6 Distribution Map of Stray Radiation ♦ Measurement Condition (Compliant with IEC 60601-2-43:2010+A1:2017+A2:2019 Clause 203.13.4) X-ray condition: 110 kV, 3mA Phantom: PMMA 250 x 250 x 250 mm X-ray field size: 100 cm2 of entrance of phantom Geometry: Fig. 8.15 Vertical Beam, AP position 8-52 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation Fig. 8.16 Horizontal Beam ♦ Test Data Refer to Fig. 8.17 to Fig. 8.20. The unit in figures is [μGy/Gycm2]. NOTE The measurements of stray radiation are normalized to a dose area product of 1 Gycm2. 8 OPESCOPE ACTENO FD type Instruction Manual 8-53 Chapter 8 Technical Data Fig. 8.17 Isokerma map at 100 cm hight (AP position) Fig. 8.18 Isokerma map at 150 cm hight (AP position) 8-54 OPESCOPE ACTENO FD type Instruction Manual  8.10 Information on Radiation Fig. 8.19 Isokerma map at 100 cm hight (Horizontal position) 8 Fig. 8.20 Isokerma map at 150 cm hight (Horizontal position) OPESCOPE ACTENO FD type Instruction Manual 8-55 Chapter 8 Technical Data 8.11 Labels ♦ Manufacturer’s Nameplate (for RoHS is representative) Manufacturer’s nameplates are affixed at the locations indicated below. (1) (2) C-arm cart Monitor cart Fig. 8.21 Position of Labeling (1) (2) Fig. 8.22 Manufacturer’s nameplate 8-56 OPESCOPE ACTENO FD type Instruction Manual  8.11 Labels ♦ Warning and Caution Labels (13) (1) (5) (11) (2) (3) (4) (12) (10) (6) (16) (13) (14) (19) (9)(15) (17) C-arm Rear of monitor cart (8) (7) 8 Front of monitor cart (18) Long cable foot switch (option) Fig. 8-23 Warning, caution and other labels OPESCOPE ACTENO FD type Instruction Manual 8-57 Chapter 8 Technical Data (1) (2) (3) (4) (5) 8-58 OPESCOPE ACTENO FD type Instruction Manual  8.11 Labels (6) (Option) (7) (Option) (8) (Option) 8 (9) OPESCOPE ACTENO FD type Instruction Manual 8-59 Chapter 8 Technical Data ♦ Others (10) (11) (12) (Option) (13) • Label Manual 8-60 OPESCOPE ACTENO FD type Instruction Manual  8.11 Labels (14) Installation and Use Condition label (15) Permanent filter label (16) Earth for potential equalization label (17) Foot switch IPX label (18) Long Cable Foot Switch (option) IPX label 8 (19) UDI label OPESCOPE ACTENO FD type Instruction Manual 8-61 Chapter 8 Technical Data ♦ Package for Transportation The following shows the label on the package for transportation, describing about storage environment and transport environment. Fig. 8.24 Label on package for transport 8-62 OPESCOPE ACTENO FD type Instruction Manual Chapter 9 Appendix Chapter 9 Appendix 9.1 Starting Inspection Checklist Date implemented: Implemented by: Always carry out the inspection described below before using the equipment. 1 Check the following points visually before switching the power ON. Correct any nonconformity. Check points Corrective action Have unnecessary items in the vicinity of the equipment been cleared Clear them away. away? Have previously used contrast media and drugs been removed from the Clean up. equipment? Have you cleared away any rust and metal fragments from the moving Clear them away. parts of the equipment and the floor? Are any cables trapped, twisted, or rubbing against anything? Correct this. Have any cable connectors been wet with water? Clear them away. Contact your Shimadzu Is there any damage to cable insulation? service representative. 2 Check the following points by hands-on examination before switching the power ON. Correct any nonconformity. Check points Corrective action Do the casters, brakes, handles and other parts of the C-arm cart function Contact your Shimadzu correctly? service representative. Contact your Shimadzu Do the brakes of the monitor cart function correctly? service representative. Is the C-arm cart’s brake applied? Apply the brakes. Are the monitor cart’s brakes applied? Apply the brakes. 9-2 OPESCOPE ACTENO FD type Instruction Manual  9.1 Starting Inspection Checklist 3 Check visually that connections have been made correctly before switching the power ON. Correct any nonconformity. Check points Corrective action Is the cart cable connected correctly? Connect it. Is the potential equalization conductor connected correctly? Connect it. Is the main power cable connected correctly? Connect it. 4 Turn the power ON. Check the following points visually and aurally. Correct any nonconformity. Check points Corrective action Contact your Shimadzu Is the operating noise after switching the power ON normal? service representative. Have you checked if an error message is displayed on the C-arm main Contact your Shimadzu panel or on the monitor? service representative. 5 Check the following points while operating the equipment. Correct any nonconformity. Check points Corrective action Contact your Shimadzu Is there an abnormal noise when the C-arm is operated? service representative. Contact your Shimadzu Does the C-arm lock switch function correctly? service representative. Contact your Shimadzu Is the laser pointer (option) focused correctly? service representative. Are there any abnormal shadows or defective pixels when you perform Perform FPD calibration or fluoroscopy and radiography and check these images. offset calibration.* * See "M517-V063 Digital Radiography Device SDR-120F Reference Guide" for instructions 9 OPESCOPE ACTENO FD type Instruction Manual 9-3 Chapter 9 Appendix Check points Corrective action Is the DAP (Total dose area product) value displayed on the live monitor appropriate when an area dosimeter is connected. 1. Fix the C-arm so that the X-ray tube assembly is on the upper side and the FPD is on the lower side. 2. Set the X-ray adjustment mode to the Manual. 3. Set the fluoroscopy mode to Normal, 15 fps, 70 kV. 4. Set the BH filter to NONE. 5. Fully open the X-ray field of the collimator. 6. Fully open the Parallel compensating filter. 7. Perform fluoroscopy for 10 seconds. 8. Observe the DAP value displayed on the live monitor. Check that the difference between this and the DAP value recorded in the "DAP Value Record Column" below is within ± 30%. Contact your Shimadzu 9. Return the IBS to its regular operation setting. service representative. “DAP Value Record Column” After the installation adjustment, as soon as possible, perform fluoroscopy according to the above procedure and record the DAP value displayed on the live monitor in the column below. If you readjust the octagonal collimator or the area dosimeter, remeasure it and update the value. □ mGy・m2 □ Gy・cm2 □ uGy・m2 □ mGy・cm2 9-4 OPESCOPE ACTENO FD type Instruction Manual  9.2 Ending Inspection Checklist 9.2 Ending Inspection Checklist Date implemented: Implemented by: Always check the following points before finishing use of the equipment. 1 Check the following points visually before switching the power OFF. Correct any nonconformity. Check points Corrective action Position it at its home Is the C-arm at its home position (fixed position)? position. 2 Switch the power OFF. Check the following points visually. Correct any nonconformity. Check points Corrective action Have unnecessary items in the vicinity of the equipment been cleared away? Clear them away. Have previously used contrast media and drugs been removed from the Clean up. equipment? Are any cables trapped, twisted, or rubbing against anything? Correct this. Have any cable connectors been wet with water? Clear them away. Contact your Shimadzu Is there any damage to cable insulation? service representative. 3 Check the following points by hands-on examination. Correct any nonconformity. Check points Corrective action 9 Do the casters, brakes, handles and other parts of the C-arm cart function Contact your Shimadzu correctly? service representative. Is the C-arm cart’s brake applied? Apply the brakes. Are the monitor cart’s brakes applied? Apply the brakes. Contact your Shimadzu Do the brakes of the monitor cart function correctly? service representative. 4 As necessary, clean and disinfect the equipment. OPESCOPE ACTENO FD type Instruction Manual 9-5 Chapter 9 Appendix This page is intentionally left blank. 9-6 OPESCOPE ACTENO FD type Instruction Manual  Digitally signed by Botnaru Andrei M517-V063B Aug.2024 Date: 2025.01.14 09:04:26 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ OPESCOPE ACTENO Digital Software SDR-120F Reference Guide Read the instruction manual thoroughly before you use the product. Keep this instruction manual for future reference. About the Symbols Appearing in this Operation Manual Throughout the text in this manual, warnings and other information essential when using this unit, such as cautionary or prohibited items, appear classified as per the following: Mark Description Indicates an imminently hazardous situation which, if not avoided, will result in serious injury or death. Indicates a potentially hazardous situation which, if not avoided, could result in serious injury or possibly death. Indicates a potentially hazardous situation which, if not avoided, may result in minor to moderate injury or equipment damage. States information which helps to use the equipment correctly. Gives information to make using the product easier. Indicates references. Revision History Revision Date Changes First edition Oct. 2022 First edition released A Sep. 2023 Update the offset calibration step. B Aug. 2024 Update the calibration screens. Shimadzu Corporation. All rights reserved. Shimadzu Corporation reserves the copyright of this manual and the whole or a part of the contents may not be copied or reproduced without the company's permission.  Introduction Thank you for selecting the SDR-120F, DR software for the OPESCOPE ACTENO FD type. Before using the equipment, read the instruction manual and the reference guide and make sure you understand its contents. Failure to observe the precautions described in the instruction manual and the reference guide may result in damage to the equipment, the operator and the subject (patient). The instruction manual and the reference guide should be kept available for future reference. If the user or usage location changes, ensure that the instruction manual and the reference guide are always kept together with the equipment. Original version is approved in English. Notice • Content of this reference guide may be changed for improvement without notice. Although every possible effort has been made to avoid errors while creating this reference guide, immediate revision may not be possible in the event that errors or missing information are detected. • Screen images and illustrations contained in this reference guide may differ from those in actual use, and are intended for example purposes only. Illustrations may also use partial images. ©Shimadzu Corporation. All rights reserved. Introduction Abbreviations and Terms Abbreviations and Description Terms Anatomical Program (Optimized fluoroscopy/radiography APR presets for each body part) AWC Auto Window Control (Automatic density adjustment) DICOM Digital Imaging and Communication in Medicine DR Digital Radiography DSA Digital Subtraction Angiography FPD Flat Panel Detector MPPS Modality Performed Procedure Step MWM Modality Worklist Management PACS Picture Archiving and Communication Systems RDSR Radiation Dose Structured Report RSM Realtime Smoothed Mask (Image processing for DSA) SCORE PRO Advance Image processing for fluoroscopy SURE Image processing for radiography An area that X-rays pass through appears bright. Posi The background appears white and the bones appear black. An area that X-rays pass through appears dark. Nega The background appears black and the bones appear white. Introduction-2 SDR-120F Reference Guide  Contents Introduction Contents Chapter 1 Overview 1.1 SDR-120F Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-2 1.1.1 Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-2 1.1.2 Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-2 In Chapter 2 Image Display and Edit In 2.1 Edit Tab on Study Window/Image Edit Window . . . . . . . 2-2 2.1.1 How to Display Edit Tab . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-2 2.1.2 2.1.3 How to Open Image Edit Window . . . . . . . . . . . . . . . . . . . . . 2-2 Closing Image Edit Window . . . . . . . . . . . . . . . . . . . . . . . . . 2-3 In 2.1.4 Operation Panel of Image Edit Window . . . . . . . . . . . . . . . . 2-4 2.1.5 Switching Page/Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-7 2.1.6 Switching Display Mode (Image Edit Window Only) . . . . . . . 2-8 In 2.1.7 Selecting Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-9 2.2 Image Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-13 2.2.1 Enlarging, Reducing, Moving, Reversing, and Rotating Image 2- 13 In 2.2.2 Adjusting Image Intensity . . . . . . . . . . . . . . . . . . . . . . . . . . 2-15 2.2.3 Copying and Pasting Processing Information . . . . . . . . . . . 2-17 2.2.4 Shutter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-19 In 2.2.5 Playing Image Sequences . . . . . . . . . . . . . . . . . . . . . . . . . 2-20 2.2.6 Undoing Image Processes . . . . . . . . . . . . . . . . . . . . . . . . . 2-24 2.2.7 Saving Processes (Image Edit Window Only) . . . . . . . . . . 2-24 2.2.8 Newly Save (Image Edit Window Only) . . . . . . . . . . . . . . . 2-25 In 2.2.9 Area Setting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-26 2.3 DSA Post Processing (Option) . . . . . . . . . . . . . . . . . . . 2-28 2.3.1 Remask and Landmarking . . . . . . . . . . . . . . . . . . . . . . . . . 2-28 In 2.3.2 Re-registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-29 2.3.3 RSM Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-30 2.3.4 Peak Hold (Stacking) Processing . . . . . . . . . . . . . . . . . . . . 2-30 2.4 Radiography SURE Edit and POST SURE Processing 2-33 In 2.4.1 Image List Display Relating to SURE . . . . . . . . . . . . . . . . . 2-33 2.4.2 Radiography SURE Edit . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-34 2.4.3 POST SURE Processing . . . . . . . . . . . . . . . . . . . . . . . . . . 2-44 2.5 Annotations and Measurements . . . . . . . . . . . . . . . . . 2-46 2.5.1 All-frame Display Mode/Specific Frame Display Mode . . . . 2-48 SDR-120F Reference Guide Contents-1 Contents 2.6 Text Annotation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-49 2.6.1 Creating Text Annotation (Free Text by Direct Input) . . . . . 2-49 2.6.2 Creating Text Annotations (Fixed Text/Free Text in Text History) 2-50 2.6.3 Editing Text Annotation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-51 2.7 Pointer Annotations . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-53 2.7.1 Creating New Pointer Annotations . . . . . . . . . . . . . . . . . . . 2-53 2.7.2 Editing Pointer Annotation . . . . . . . . . . . . . . . . . . . . . . . . . 2-54 2.8 Measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-56 2.8.1 Measuring Distance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-56 2.8.2 Measuring Angles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-58 2.8.3 Measurement Calibration . . . . . . . . . . . . . . . . . . . . . . . . . . 2-60 2.9 Deleting Annotations/Measurement Objects . . . . . . . . 2-62 2.10 Registering Annotation Template . . . . . . . . . . . . . . . . . 2-62 2.10.1 Registering/Deleting Annotation Template on Annotation/ Measurement Menu 2-62 2.10.2 Editing Annotation Template From Preset Menu . . . . . . . . 2-64 Chapter 3 Study Information Input/Output 3.1 MWM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-2 3.1.1 Take Orders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-3 3.1.2 Query Condition Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-4 3.1.3 New Study (MWM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-5 3.1.4 Auto Study Start . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-6 3.1.5 Updating Performed Study (MWM) . . . . . . . . . . . . . . . . . . . . 3-6 3.2 MPPS (Option) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-8 3.2.1 Checking MPPS Processing Status . . . . . . . . . . . . . . . . . . . 3-8 Chapter 4 Image Input/Output 4.1 Saving Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-2 4.1.1 Registering Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-2 4.1.2 Canceling Image Registration . . . . . . . . . . . . . . . . . . . . . . . . 4-5 4.1.3 Writing to Storage Media . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-5 4.2 Reading Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-7 4.3 Special Job . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-8 4.3.1 USB Export . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-8 4.4 Sending Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-13 4.5 DICOM RDSR Output (Option) . . . . . . . . . . . . . . . . . . . 4-14 4.5.1 RDSR on Image List Window . . . . . . . . . . . . . . . . . . . . . . . 4-14 Contents-2 SDR-120F Reference Guide  Contents Introduction 4.5.2 Property of RDSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-14 4.5.3 Sending RDSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-15 4.5.4 Operations on RDSR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-15 4.6 Registering Images for Printing . . . . . . . . . . . . . . . . . . 4-16 4.7 Printing Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-18 4.7.1 Print Edit Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-18 4.7.2 Printing Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-21 4.7.3 Editing Print Film . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-24 4.7.4 Editing Print Format . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-27 In 4.7.5 Performing Processes by Right-Clicking . . . . . . . . . . . . . . 4-29 4.7.6 Mouse Wheel Operations . . . . . . . . . . . . . . . . . . . . . . . . . . 4-30 4.7.7 Editing Print Preset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-30 In 4.8 Screen Capture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4-31 Chapter 5 User Utility In 5.1 Icons in Main Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-2 5.1.1 5.1.2 Icons List . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-2 Network Connection Icon . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-3 In 5.1.3 Wireless Network Connection Window (Option) . . . . . . . . . . 5-3 5.1.4 Image Send, Print, and Media Icons . . . . . . . . . . . . . . . . . . 5-4 5.1.5 MPPS Processing Status (Option) . . . . . . . . . . . . . . . . . . . . 5-7 In 5.2 System Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-8 5.3 Save Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-8 5.4 SMPTE Pattern Display . . . . . . . . . . . . . . . . . . . . . . . . . 5-9 In 5.5 OSS License Display . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-9 5.6 FPD Calibration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-10 5.6.1 FPD Calibration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-10 In 5.6.2 Offset Calibration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-14 5.6.3 History of FPD Calibration . . . . . . . . . . . . . . . . . . . . . . . . . 5-15 5.7 Editing Presets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-16 In 5.8 Editing Print Preset . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-17 5.8.1 Print Preset Window . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-17 5.8.2 5.8.3 Registering Preset Title . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-19 Deleting Preset Title . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-20 In 5.8.4 Preset Registration for True Size Print . . . . . . . . . . . . . . . . 5-21 5.9 Editing APR Presets . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-22 5.9.1 Edit APR Preset Window . . . . . . . . . . . . . . . . . . . . . . . . . . 5-22 5.9.2 Fluoroscopy Condition Setting . . . . . . . . . . . . . . . . . . . . . . 5-24 5.9.3 Radiography Condition Setting . . . . . . . . . . . . . . . . . . . . . . 5-27 SDR-120F Reference Guide Contents-3 Contents 5.10 Requesting Department Preset . . . . . . . . . . . . . . . . . . 5-29 5.10.1 Registering Requesting Department Presets . . . . . . . . . . . 5-29 5.10.2 Deleting Requesting Department Presets . . . . . . . . . . . . . . 5-31 5.11 Physician's Name Presets . . . . . . . . . . . . . . . . . . . . . . 5-32 5.12 Technologist's Name Presets . . . . . . . . . . . . . . . . . . . . 5-32 5.13 Annotation Template Preset . . . . . . . . . . . . . . . . . . . . . 5-33 Contents-4 SDR-120F Reference Guide  1 Overview 1.1 SDR-120F Outline 1.1.1 Outline The SDR-120F is digital software that provides the SURGICAL MOBILE C-ARM IMAGING SYSTEM, OPESCOPE ACTENO FD type, with the ability to manage studies, and to read, display, store and output X-ray images. Images are processed and displayed in real time, and recorded as an image database on the internal hard disk. The SDR-120F supports various radiography modes, such as SPOT radiography, SERIAL radiography, and DSA radiography (option) modes. This reference guide explains how to operate the following functions. Image display, Image edit Study and image input/output function User Utilities Preset Edit FPD Calibration Optional software •DSA Post processing •MPPS •RDSR Output •Wireless network connection 1.1.2 Options The "Options" described in this reference guide may or may not be available as standard specifications, depending on how they are sold. 1-2 SDR-120F Reference Guide  2 Image Display and Edit 2.1 Edit Tab on Study Window/Image Edit Window In the Edit tab on the Study window or the Image Edit window, you can display and edit images saved on the hard disk. 2.1.1 How to Display Edit Tab 1 Click [Edit] tab of the operation panel of the Study window. The Edit tab is displayed on the operation panel. Image Display operation Area panel 2.1.2 How to Open Image Edit Window 1 Display the Image List window. 2 Select a desired file. The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the selection border. 3 Click [Disp. Image] on the operation panel. 2-2 SDR-120F Reference Guide  2.1 Edit Tab on Study Window/Image Edit Window 2 The Image Edit window appears and the image of the selected list or selected image is displayed. The operation panel switches to the Image edit operation panel. [Image Edit] 2 Image display area Image edit 2 operation panel 2 2 The image can also be displayed by double-clicking the desired list or thumbnail image. 2.1.3 Closing Image Edit Window 2 1 Click [Exit Edit] in the operation panel. 2 The Image Edit window closes and returns to the Image List window.  In the case that the changes applied to image is not saved. 2 2 When the changes applied to image is not saved, the following dialog box appears. 2 2 1 Click either [Save changes and close] or [Discard changes and close]. 2 2 Click either [Execute] or [Cancel]. If you click [Execute], the appropriate process is performed, and the dialog box is closed. If you click [Cancel], the Image Edit window is returned. 2 SDR-120F Reference Guide 2-3 2.1.4 Operation Panel of Image Edit Window The buttons on the operation panel is used to process or switch an image. 1 1 3 3 **4 2 2 **5 7 11 6 7 6 *8 *8 9 10 11 9 10 **12 13 13 **14 Edit tab of Study window Image Edit window The mark "*" indicates that the appearance changes according to a button selected. The mark "**" indicates that the button appears on the Image Edit window only. 2-4 SDR-120F Reference Guide  2.1 Edit Tab on Study Window/Image Edit Window No. Item Image information display Function 2 1 Displays image information of the image displayed. section 2 Switch Page buttons 2 Switches to the previous/next image of multiple image files. / 2.1.5 "Switching Page/Display" Display Image Information button 3 Turns the image information display over the image on or off. Switch Display Mode button 2 Switches the display mode between the all frame display and the 4 representative frame display. 2.1.6 "Switching Display Mode (Image Edit Window Only)" Switch Display Format button 2 5 Switches the image display format (number of subdivisions) between single-image, 4-on-1 or 16-on-1 display format. Select Image button Selects an image. Used only in 4-on-1 or 16-on-1 display format. 2 2.1.7 "Selecting Images" 2 Enlarge/Reduce/Move button Enlarges, reduces, or moves an image. 2.2.1 "Enlarging, Reducing, Moving, Reversing, and Rotating Image" Adjust Intensity button Adjusts an image intensity. 2 2.2.2 "Adjusting Image Intensity" Shutter button 6 Adjusts an image display area. 2.2.4 "Shutter" 2 Annotation button Inserts footnotes, arrows, lines and other annotations anywhere in an image. 2.5 "Annotations and Measurements" 2 Area Setting button 2 Sets the true size print area. 2.2.9 "Area Setting" DSA button (Option) Performs DSA post-processing. 2 2.3 "DSA Post Processing (Option)" Undo button 7 Cancels previous operations and returns to the state that was saved. 2.2.6 "Undoing Image Processes" 8 Process menu display The display changes in accordance with selection of each image processing button (in "6" row above), enabling the process or operation 2 section allocated to it. 2 SDR-120F Reference Guide 2-5  No. Item Function Peak Hold button (Option) 9 Creates one image showing a flow of the contrast medium. 2.3.4 "Peak Hold (Stacking) Processing" Copy Processing Information button Copies the processing information of the image selected. 10 Paste Processing Information button Pastes the copied processing information to another image selected. 2.2.3 "Copying and Pasting Processing Information" Image Sequence buttons Plays sequences of a multi-frame image obtained with serial 11 radiography. 2.2.5 "Playing Image Sequences" [Save] Saves the results of image processing. 2.2.7 "Saving Processes (Image Edit Window Only)" 12 [Newly Save] Saves a selected frame as an image file. 2.2.8 "Newly Save (Image Edit Window Only)" Print Preset Selects a print preset from the preset list. 4.7.7 "Editing Print Preset" 13 [Print] Registers the file to the print edit in the selected print preset. 4.6 "Registering Images for Printing" [Exit Edit] 14 Closes the Image Edit window and return to the Image List window. 2-6 SDR-120F Reference Guide  2.1 Edit Tab on Study Window/Image Edit Window 2.1.5 Switching Page/Display 2 When there are multiple image files, the image can be switched with the switch page button or scroll operation (Image Edit window only).  Switch Page Button 2 The / are enabled when a file contains multiple image files. Click or 2 to switch the page. 2 Edit tab of Study window Image Edit window 2 Item Function Returns to the previous image. 2 Advances to the next image. 2 • In the Image Edit window, the following diagrams show how / switches the 2 display of 8 images (A to H) in (4-on-1 display) format. 2 Initial state After clicking the downward-pointing After clicking the upward-pointing 2 button button In the 4-on-1 display, the display goes forward/backward by four images each 2 time the button is clicked. 2 Clicking / switches one image in single-window display format, four images in 4-on-1 display format, and 16 images in 16-on-1 display format at a time. 2 SDR-120F Reference Guide 2-7  Scroll (Image Edit Window Only) When a file selected contains multiple image files, the display can be switched by rotating the mouse wheel forward or backward. • In the Image Edit window, the following diagrams show how rotating the mouse wheel switches the display of 6 images (A to F) in (4-on-1 display) format. Direction Direction of mouse of mouse wheel wheel rotation rotation After rotating the After rotating the Initial state wheel downward wheel upward In the 4-on-1 format, the display goes forward/backward by one row (two images) along wheel rotation. Scrolling with the mouse wheel switches the images one row (i.e., one image in single-window display format, two images in 4-on-1 display format, and four images in 16-on-1 display format) at a time. 2.1.6 Switching Display Mode (Image Edit Window Only) The image display modes has two types of modes: all frame display mode and representative frame display mode. Click to switch between them. The appearance of the button changes in accordance with the display mode. The default mode is all frame display mode. Item Function All Frame Display Mode button All frames of the selected file are displayed. Representative Frame Display Mode button A representative frame of the selected file is displayed. In a multi-frame file, the default representative frame is the center frame. 2-8 SDR-120F Reference Guide  2.1 Edit Tab on Study Window/Image Edit Window 2.1.7 Selecting Images 2 Select the image to be processed in the 4-on-1 display and 16-on-1 display formats. Various image processing will be applied to it. 2 The image selection menu can be used in 4-on-1 display and 16-on-1 display formats. In single-window display format, the image displayed is considered to be selected. 2 The Edit tab is the single-window display format, so you can select the image selection menu, 2 but it is not enabled. Click . The process menu display section changes to the image selection menu. 2 2 1 4 Image selection 2 2 menu 3 No. Item Function 2 [Select All Images] 1 Selects all the image files in the study or series opened. [Reverse Selection] 2 2 Reverses the selected state. Selected images will be deselected and unselected images will be selected. 3 [Multi Select] Selects the checkbox to select multiple images in 4-on-1 2 display or 16-on-1 display format. [Not Select All Images] 4 Deselects all selected images. The selection border around the images selected first remains. 2 2 2 SDR-120F Reference Guide 2-9  Focus Border and Selection Border When one or more images are selected, they are enclosed with the focus border or selection border. • Focus Border The "focus border" is the white border line surrounding the image clicked in the 4-on-1 or 16-on- 1 display format. The image with the border is base for page or display format switching or, image selection. • Selection Border The "selection border" is the green border line surrounding the image clicked in the 4-on-1 or 16- on-1 display format, in addition to the focus border. When multiple images are selected, all these image will be surrounded with it. Image processing will be applied to images surrounded with this border.  Selecting and Deselecting All Image All the image files in the selected study or series can be selected or deselected using the procedures described below. 1 Click [Select All Images]. A selection border is displayed around all the images, indicating that they are selected. A selection border is displayed around all the images. 2 Click [Not Select All Images]. The selection border around all the images disappears, indicating that they are no longer selected.  Selecting Multiple Images Multiple images can be selected in 4-on-1 or 16-on-1 display format in two ways: using the image selection menu, and using the mouse and keyboard. • Selecting with the image selection menu 1 Select the [Multi Select] checkbox in 4-on-1 or 16-on-1 display format. Image selection menu [Multi Select] 2-10 SDR-120F Reference Guide  2.1 Edit Tab on Study Window/Image Edit Window 2 Move the mouse pointer to the first image and click it. 2 A selection border is displayed around the image selected. Move the mouse pointer to the next image and click it. Repeat this step to select all target images. Selection borders are displayed around all the images selected. 2 Click the first image to be selected. Click the third image. 2 Click the second image. Click the fourth image. 2 You can deselect a selected image by right-clicking it. 2 • Selecting with mouse and keyboard (two methods) Clear [Multi Select] at first. 2 Clear [Multi Select]. 2 (1) Selecting adjacent images 1 Click the first image. 2 2 Specify the selection range either by clicking the last image while holding down the 2 SHIFT key or by dragging the mouse. The selection border is displayed around all the images in the selected range. Selection by Dragging Selection Using the SHIFT Key 2 First, move the mouse pointer over A. First, select A. 2 Next, click K while holding 2 Next, drag the mouse down the SHIFT key to pointer to K. select images A to K. A,B,C,E,F,G,I,J and K are selected. 2 SDR-120F Reference Guide 2-11  (2) Selecting not-adjacent image 1 Click each image while holding down the CTRL key. Selection borders are displayed around images selected. Click the first image to Click the third image while be selected. holding down the CTRL key. Click the second image while holding down the CTRL key. Click the fourth image while holding down the CTRL key. You can deselect a selected image by reselecting it.  Reversing Selection The selected state can be reversed using the procedure described below. Selected images are deselected and unselected images are selected. 1 Select images. The selected images are surrounded with the selection borders. 2 Click [Reverse Selection]. The selection is reversed. • The selection borders around the previously selected images disappear. • Selection borders appear around the previously unselected images. The previously selected images are deselected. 2-12 SDR-120F Reference Guide  2.2 Image Processing 2.2 Image Processing 2 Various image processing can be applied to an image in the [Edit] tab of the Study window and in the Image Edit window. The image processing result can be displayed in real-time. It is saved automatically in the Study window, or by clicking [Save] or switching a window in the Image Edit window. The image processing applied is reflected in image display or output. 2 2 • In the Image Edit window, image processing can be performed only in single-window display format. Apart from some exceptions ( 2.2.3 "Copying and Pasting Processing Information", 2.2.6 "Undoing Image Processes"), image processing is not possible in 4-on-1 display or 16-on- 2 1 display format. • With a multi-frame file (i.e., a file containing multiple images), even if processing is performed only on one frame, the same processing is applied to all the frames. 2 • The window can be switched in the middle of processing without losing the changes 2 by clicking [Study], [Image Edit], [Print Edit], or [List] on the main panel. • In the Image Edit window, to save the changes made in processing, refer to 2.2.7 "Saving Processes (Image Edit Window Only)". 2.2.1 Enlarging, Reducing, Moving, Reversing, and Rotating Image 2 You can change how an image is displayed using the menu or the mouse. Enlargement/reduction is possible in the range 50% to 400%. 2 1 Click . The process menu display section changes to the enlarge/reduce/move/reverse/rotate menu 2 1 Enlarge/Reduce/Move/ 2 Reverse/Rotate menu 2 3 2 4 2 2 SDR-120F Reference Guide 2-13  No. Item Function Selects the enlargement factors in the list. You can also enter the 1 Enlargement factor enlargement factor directly and press [Enter] key to specify it. Move Image buttons / / / Moves an image in the direction indicated by the mark on the button. 2 Center button Moves an image to the center of the image display area. Reverse Image buttons 3 / Reverses an image horizontally and vertically. Rotate Image button 4 / Rotates an image by 90 degrees to the right or left. • Enlarging/Reducing images with the mouse 1 Move the mouse pointer over the image. The pointer changes to . 2 Click either the left or right button. Each click of the button enlarges or reduces the image in 25% increments based on the clicked position as its center. • Left click enlarges the image. • Right click reduces the image. • Moving an images with the mouse 1 Move the mouse pointer over the image. The pointer changes to . 2 Drag the image in the desired direction. The image moves in the direction in which it is dragged. 2-14 SDR-120F Reference Guide  2.2 Image Processing 2.2.2 Adjusting Image Intensity 2 The image can be brighter or darker for image observation. The image to which the SURE processing has been applied will be displayed differently. 2.4 "Radiography SURE Edit and POST SURE Processing" 2 1 Click . The process menu display section changes to the intensity adjustment menu. 2 2 5 1 2 6 Intensity adjustment 2 menu 3 2 4 No. Item Function 2 Window width value Changes the window width value of the display intensity. 1 Increases the value to reduce the contrast. Decreases the value to increase the contrast. Window level value Changes the window level value of the display intensity. 2 2 Increases the value to make the image darker. Decreases the value to make the image brighter. 2 The window level behavior is inverted for an negative image. Gamma Intensity conversion is performed in accordance with the displayed 3 gamma table. Selects the gamma type and the gamma level. Edge 2 Sharpens the edges of an image. Selects the edge enhancement type and the edge enhancement 4 level. E0: No edge enhancement 2 Edge Weak E1 < E2 < E3 < E4 < E5 < E6 < E7 < E8 < E9 Edge Strong E10 < E11 < E12 < E13 < E14 < E15: High-frequency enhancement 2 2 SDR-120F Reference Guide 2-15  No. Item Function [AWC] Automatically sets the optimum window width value and window level value. In each pattern, the higher the last number, the higher the contrast. 5 NONE: AWC disabled TypeX01 < TypeX02 < TypeX03 < TypeX04 < TypeX05 Serial1 < Serial2 < Serial3 DSA1 < DSA2 < DSA3 < DSA4 < DSA5 Nega button Switches the polarity of the image. 6 Switch to a positive image. Switch to a negative image.  Changing Window Width Value and Window Level Value The window width value and window level value can be changed in two ways: using the intensity adjustment menu and using the mouse. • Adjusting the intensity with the Intensity adjustment menu 1 Increase or decrease with / the window width and window level values or directly enter a numerical value in their fields, and press the [Enter] key. The image intensity changes. • Adjusting the intensity with the mouse 1 Move the mouse pointer over the image. The pointer changes to . 2 Drag horizontally or vertically as appropriate. The image intensity changes in accordance with the direction of movement. Direction of pointer Change in image movement Up The brightness is higher. Down The brightness is lower. Right The contrast is lower. Left The contrast is higher. The rate of change depends on which mouse button you drag. Left Click: 1x, Mouse Wheel: 2x, Right Click: 3x 2-16 SDR-120F Reference Guide  2.2 Image Processing 2  Changing Gamma Table Change the gamma table that maps the change in the pixel values to output luminance levels. Select the type and level in the list. Gamma type Gamma level 2  Changing Edge Enhancement The edges of images can be made more or less distinct. Select the type and level in the list. The higher 2 the number, the stronger the enhancement. Edge type 2 Edge level 2.2.3 Copying and Pasting Processing Information 2 The processing information of a image selected can be applied to another image. 2 Processing informations of enlarging, reducing and moving images, intensity and shutter can be copied and pasted. 2 1 Click the image of the processing information copy source. The image is indicated by the focus border. 2 2 Click . The processing information are copied to the temporary storage area. The is enabled. 2 2 2 2 In the Image Edit window, you can apply processing information to multiple images at once. 2 SDR-120F Reference Guide 2-17  3 Select the copy destination image using . 2.1.7 "Selecting Images" The image is indicated by the selection border •The representative frame display mode makes easier selection operations required for copying and pasting processing information. • is enabled only when an image is selected with . 4 Click . The processing information of the source image is pasted to the image selected. Copying or pasting in multi-frame (files containing multiple images) file is meaningless as all the images in the file are displayed using the same processing information. 2-18 SDR-120F Reference Guide  2.2 Image Processing 2 • The illustration below shows the procedure for copying the processing information of one image (A) and applying it to multiple images (B and D) in the Image Edit window. 2 Click Click Select the image of the Select the copy The processing 2 processing information destination images (B information of A is copy source (A). and D). applied to B and D. A focus border surrounds the image. 2 2.2.4 Shutter The frame surrounding an image is called the "shutter". Adjusting the shutter will facilitate observation of the image. 2 The shutter is applied in parallel with the image edge. If the image is rotated, the shutter will also rotate. 2 1 Click . 2 Move the mouse pointer to one side of the image. 2 The pointer changes to . The shutter can be 2 moved freely. When the mouse pointer 2 is moved within the 2 shutter, it changes to . The shutter can be moved by dragging it. 2 3 Drag the horizontally or vertically to an appropriate position. 2 4 Move the mouse pointer inside the shutter. The pointer changes to . 2 SDR-120F Reference Guide 2-19  5 Move the shutter to an appropriate position by dragging the mouse pointer. The shutter area changes. If is dragged to a point where the shutter extend beyond the image region, the part outside the region is adjusted automatically as shown below. Shutter region Image region The shutter is dragged to a The part outside the region point where the borders is adjusted automatically extend beyond the image before the shutter borders region. are fixed. 2.2.5 Playing Image Sequences This function is used to play sequences of images. The image sequences can be played with various play rates and range. • Image sequences can be played only in single-window display format. They cannot be played in 4-on-1 or 16-on-1 display format. • If you perform fluoroscopy or radiography during playing image sequences, the playing stops automatically. 1 Display a multi-frame file (i.e., a file containing multiple images). The is enabled. *3 *1 *4 2 *5 The mark "*" indicates that the appearance changes according to operation status or a menu selected. 2-20 SDR-120F Reference Guide  2.2 Image Processing No. Item Function 2 Play button Plays image sequences. it changes to . is displayed by default. If it is clicked, 2 *1 Stop button Stops image sequences. If this button is clicked, it changes to button. 2 Go Back One Frame button 2 Goes back one frame. 2 Go Forward One Frame button Goes forward one frame. 2 " Going Forward/Backing One Frame" P.2-22 *3 Select Loop Direction button Selects the loop direction. 2 2 " Loop Direction Selection" P.2-22 Play Rate Selection button *4 Selects the play rate. The default rate is the acquisition rate at the time of radiography. 2 2 " Setting Play Rate" P.2-23 2 Switch Play Range Slider Shows the play range. 2 " Setting Play Range" P.2-23 Indicates that playing image sequence is stopped. 2 *5 Indicates that the image sequence is being played. 2 2 Indicates that playing image sequence is not available. 2 2 2 SDR-120F Reference Guide 2-21  Going Forward/Backing One Frame Go forward or backward one frame. Switch Frame knob Item Function Switch Frame Knob Drag it to a desired frame position to display the frame. While playing image sequence is stopped, it automatically moves to the position corresponding to the frame displayed. • Going Forward One Frame Click . The image sequence goes forward one frame. • Going Backward One Frame Click . The image sequence goes backward one frame. • Moving to a Frame Move to the desired frame by dragging the to the corresponding position.  Loop Direction Selection The loop direction of image sequences can be set. 1 Click . The direction list is displayed. Item Function The image sequence repeats a forward cycle. The image sequence repeats a backward cycle. The image sequence "swings" (i.e., switches between forward and backward directions). is available only when playing image sequence is stopped. 2 Select a desired direction. changes to the selection (e.g., it changes to if the swing loop is selected). 2-22 SDR-120F Reference Guide  2.2 Image Processing 2  Setting Play Rate The play rate can be changed. The play rate can be changed even while an image sequence is being played. 2 1 Click . The list is displayed. 2 2 2 Select a desired rate. changes to the selection (e.g., it changes to if "3.0 fps" is selected). 2 If a high play rate is set, in order to maintain this play rate, some frames may be skipped. 2  Setting Play Range 2 The play range can be set. The play range can be changed only when playing image sequence is stopped. 2 1 1 2 2 3 No. Item Function 1 Frame numbers Displays the frame numbers. 2 Start knob Drag it to the first frame of the range. 2 Finish knob 3 2 Drag it to the last frame of the range. 1 Change the range by dragging or to the left or right as appropriate. The frame number changes to their position. 2 2 SDR-120F Reference Guide 2-23  • The following diagram shows the play range of 5th to 10th. The range is changed by dragging and to the left or right as appropriate. Example: The play range is changed to 5th to 10th. 2.2.6 Undoing Image Processes The image processing can be erased to restore the image older state. The image processing performed before saving the image can be cancelled. Once the image is saved, the image state before saving cannot be restored. When an image process is performed, is enabled. 1 Click on the operation panel. The image processing applied up to that point are erased. 2.2.7 Saving Processes (Image Edit Window Only) The results of image processing is saved using the procedure described below. Once the results of image processing are saved, the previous image state is lost. When the image file is opened again, the image saved is displayed. 1 Select the image to be saved and click [Save] on the operation panel. 2-24 SDR-120F Reference Guide  2.2 Image Processing 2 The Save Change window appears. 2 No. Item Function 2 1 Save all the modified image All changed files are saved. 2 3 Only the focused image Only the selected image The (single) file selected with a focus border is saved. The file selected with a selection border is saved. 2 2 " Focus Border and Selection Border" P.2-10 2 Select a desired menu and click [Save]. 2 The image is saved. 2.2.8 Newly Save (Image Edit Window Only) 2 The image selected is saved as a new image. 1 Select the image to be saved. 2 2.1.7 "Selecting Images" 2 Click [Newly Save]. 2 The Save new image dialog box appears. 2 2 2 2 The image to be saved differs depending on the display mode. • All Frame Display Mode: Only the selected frames are saved as new images. • Representative Frame Display Mode: Each frame included in the selected file is saved in a separate image file. 2.1.6 "Switching Display Mode (Image Edit Window Only)" 2 SDR-120F Reference Guide 2-25  3 Click either [Execute] or [Cancel]. If you click [Execute], the saving operation is executed. If you click [Cancel], the saving operation is aborted and the confirmation dialog box closes. The Image Edit window being opened does not show the newly saved image. To open it, return to the Image List window and select it on the list. • The newly saved image is registered in the Image pane according to the following rule. Image newly saved will be numbered with 4 digit: 1001 1002 1003 .... 2.2.9 Area Setting The area setting determines the true size print area based on the information on a print preset where the true size print has been set. In the true size print without the area setting, the image is printed with its center as the center of a print image. The area setting allows users to set the center of an output image to a desired point. • In order to use the area setting function, the print preset where the true size print has been set needs to be registered. • The measurement calibration is required prior to the area setting. 2.8.3 "Measurement Calibration"  How to Set the Area Setting 1 Click . The process menu display section changes to the area setting menu. Area Setting menu 2-26 SDR-120F Reference Guide  2.2 Image Processing 2 Click [Area Setting] in the menu. 2 Print presets where the true size print has been set are displayed. 2 3 Select a print preset. 2 According to the selected print preset, a frame is displayed to show a printout area with a cross line at its center on the image. 2 In the print preset settings where a true size print has been set, when a print area is set to be larger than the image, the frame is outside of the image and only a cross line may be displayed. In order to display the whole frame, reduce the image. 2 4 Move the frame to the desired print area. The print area can be moved by dragging the mouse within the frame. 2  Canceling the Frame 1 Click . 2 The current frame is deleted. 2  Displaying an Image with the Area Setting When the area setting menu is closed after the setting is completed, or when the image with area setting is displayed, a frame is displayed, but a cross line is not displayed. However this frame cannot be moved or canceled. Enter the area setting menu to move or cancel it. 2 2 2 2 2 SDR-120F Reference Guide 2-27 2.3 DSA Post Processing (Option) The DSA post-processing can be applied to the image that is acquired in DSA radiography. 1 Click . The process menu display section changes to the DSA post-processing menu. 2 1 3 4 No. Item Function [Remask] tab Sets a desired frame as the mask image. The [Landmarking] is 1 used to set the ratio of live images to a mask image. 2.3.1 "Remask and Landmarking" [Rereg.] tab 2 Moves a mask image. 2.3.2 "Re-registration" [RSM] tab 3 Applies the RSM filter to an image. 2.3.3 "RSM Processing" Peak Hold button 4 Creates an image showing a flow of the contrast medium. 2.3.4 "Peak Hold (Stacking) Processing" 2.3.1 Remask and Landmarking The remask processing allows users to use a desired frame as the mask image. It is useful when the first image, the usual mask image, cannot be used because of the motion artifact. The landmarking processing allows users to change the ratio of live images to a mask image in a subtracted image. Although the subtraction processing makes a unchanged part, such as bone, less-visible, the landmarking processing improves visibility of such parts. To perform the these processing, select [Remask] tab of the DSA post-processing menu. 1 2 3 2-28 SDR-120F Reference Guide  2.3 DSA Post Processing (Option) No. Item Function 2 Mask Frame Selection 2 1 Selects a mask frame. "M" indicates the mask frame at the time of radiography. [Reset] 2 Returns a mask frame to the one at the time of a saving image. Image Ratio Selection Adjusts the ratio of Live Images to a mask image. 2 Select it from 0% (Normal DSA Image) to 100% (Only Live image). 3 2 2.3.2 Re-registration 2 The re-registration processing allows users to move a mask image when it needs to be moved because 2 of motion artifact. To perform the re-registration processing, select [Rereg.] tab. 1 2 2 3  Moving a mask image with operation panel 2 No. Item Function [Unit] Specifies the amount of mask image movement per one 2 click. Select it from the list. 1 2 Move Mask button 2 Moves the mask image in the direction indicated by the mark 2 on the button. The center button returns the image to original position. [Cur pos:] 2 3 Displays the current position.  Moving a mask image with mouse operation In re-registration processing, dragging a mouse on an image can also move a mask image. 2 SDR-120F Reference Guide 2-29 2.3.3 RSM Processing RSM processing is subtraction processing using a blurred image as a mask image. Each frame is digitally processed to produce a defocused image, which is then used as a mask image for subtraction processing from the live image. In order to perform the RSM processing, select [RSM] tab of the DSA post-processing menu. Selecting the [RSM] tab changes the image currently displayed to the image to which the RSM processing is applied. Switching from the RSM tab to other tabs cancels RSM processing. 1 No. Item Function RSM filter type Selects the RSM filter type from the type 1 to types 3. The higher the number, the more blurred the mask image for 1 subtraction. When a type is selected, the current displayed image changes to an image to which the selected filter is applied. 2.3.4 Peak Hold (Stacking) Processing The peak hold processing creates one image showing a flow of the contrast medium by stacking up multiple frames of DSA image and then extract the maximum or minimum value of each pixel in the stacked frames. 1 Click to perform the peak hold processing. 2-30 SDR-120F Reference Guide  2.3 DSA Post Processing (Option) 2 The Peak Hold window appears. 1 2 3 2 4 5 6 2 2 2 2 7 8 No. Item Function Peak Hold Processing Type Selects a peak hold processing type. • Black peak: Leaves a smaller pixel value on an image. 2 1 Selects it to leave tracing of the absorption contrast. • White peak: Leaves a larger pixel value on an image. Selects it to leave tracing of the opaque contrast. 2 [Start Frame] 2 Specifies the start frame of the peak hold processing. 3 [End Frame] Specifies the end frame of the peak hold processing. 2 Start and End Frame Selection Slider 4 Selects a start and end frame with check the desired frame. and . Move to 2 [Start] / [Stop] 2 5 / Starts the peak hold processing. It changes to the stop button during the processing. [Re-setting] 6 Cancels a processing result and reset the processing. 7 [Newly Save] Saves a processing result and close the Peak Hold window. 2 [Cancel] 8 Aborts the present result and close the Peak Hold window. 2 SDR-120F Reference Guide 2-31  2 Specify the start frame and end frame of the processing. 3 Click [Start]. The image under processing is displayed in real-time. Click [Stop] to stop processing on the way. 4 After processing completion, click [Newly Save] to save the processed image as the new image. The Peak Hold window closes. If you try the processing again, click [Re-setting]. If you click [Cancel], the processing is aborted and the window closes. A new peak hold image is not displayed in the present Image Edit window. In order to open the new peak hold image, return to the Image List window and select it on the list. 2-32 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing 2.4 Radiography SURE Edit and POST SURE 2 Processing The Radiography SURE refers to image processing for radiography such as DR compression processing and multi-frequency processing. The Radiography SURE creates images suitable for 2 clinical use by applying image processing according to the body part to SPOT and SERIAL images. The Radiography SURE edit adjusts the parameter of the Radiography SURE applied at the time of image acquisition to improve image quality. The POST SURE processing can apply the Radiography 2 SURE to the normal image. 2 The Radiography SURE is automatically applied to the SPOT image and can be applied to the SERIAL image only in post processing. 2.4.1 Image List Display Relating to SURE The image relating the Radiography SURE is identified as follows on the Image List window. 2 Name Radiography Mode Image Type SPOT_R Original image of "SPOT_P" SPOT_P SPOT radiography Radiography SURE processed-SPOT image 2 SERIAL_P SERIAL radiography Radiography SURE processed-SERIAL image The [SPOT_R] image appears when the [ALL] button is selected. 2 2 2  Example for Image List Window 2 2 2 2 SDR-120F Reference Guide 2-33 2.4.2 Radiography SURE Edit For the image with the Radiography SURE applied, the Radiography SURE edit is available. The Radiography SURE edit includes contrast and brightness adjustment on the Image edit operation panel and detailed edit on the Radiography SURE Edit window. • The original image (SPOT, SPOT_R, SERIAL) must be saved in HDD for applying the Radiography SURE. • When the multi frame image is displayed, the Radiography SURE edit will be applied only to the image currently displayed. • The Radiography SURE edit cannot be applied to a newly created SPOT image or SERIAL image with the [Newly Save] button on the Image Edit window, even if the original image remains.  Editing Contrast (CONT) and Brightness (BRIGHT) on Image Edit Operation Panel 1 Click on the Image edit operation panel. The process menu display section changes to the Radiography SURE edit menu. The menu shows the [CONT] (contrast), [BRIGHT] (brightness), SS value and SL value of the image currently displayed, and [Adjust] button for the Radiography SURE edit. 1 2 Radiography SURE edit menu 3 4 No. Item Function [CONT] 1 Adjust the contrast. Specifies with the values from 1 to 100. The contrast will be stronger as the value increases. [BRIGHT] 2 Adjusts brightness. Specifies with the values from -100 to 100. The brightness will be stronger as the value increases. [ROI] 3 Set the ROI (region of interest) on the image and perform density optimization to improve the visibility of the ROI. 2-34 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing No. Item Nega button Function 2 Switches the polarity of the image. 4 Switch to a positive image. Switch to a negative image. 2 2 2 2 2 2 2 2 2 2 2 2 SDR-120F Reference Guide 2-35  2 Edit [CONT] or [BRIGHT] using the Radiography SURE edit menu or mouse. • Adjusting with the menu Increase or decrease with / the [CONT] or [BRIGHT] values or directly enter a numerical value in their fields, and press the [Enter] key. The image contrast or brightness changes. • Adjusting with the mouse Move the mouse pointer over the image. The pointer changes to . Drag horizontally or vertically as appropriate. The image intensity changes in accordance with the direction of movement. Direction of pointer Change in image movement Up The brightness is higher. Down The brightness is lower. Right The contrast is lower. Left The contrast is higher.  Density optimization processing when a region of interest (ROI) is specified on an image 1 Click . 2 Specify the ROI on the image by dragging and dropping with the mouse. 2-36 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing 2  Editing Parameters on Radiography SURE Edit Window The Radiography SURE Edit window provides many types of parameters for image edit. Click [Adjust] on the Radiography SURE edit menu to display the window. 2 2 Radiography SURE edit menu 2 The Radiography SURE Edit window appears. Contrast Enhancement Display SURE Processing Operation panel 2 Display Mode Noise Filter 2 2 Image Display Area 2 2 Process Parameter SS Value/SL Value 2  Display Mode 1 2 2 No. Item Function 2 Original image before the Radiography SURE is applied is displayed in 1 Original the image display area. 2 Processed Processed image after the Radiography SURE is applied is displayed in the image display area. 2 SDR-120F Reference Guide 2-37  Image Display Area The image according to the mode selected in the [Display Mode] is displayed. Image information, such as a patient name, is same as that displayed on the Image List window.  Contrast Enhancement Information The contrast enhancement information of the image currently displayed is displayed. 1 2 No. Item Function 1 Display Gamma Displays the shape of the display gamma applied. Displays histogram information. 2 Histogram Horizontal axis: Pixel value, Vertical-axis: Frequency  SURE Processing Operation Panel 1 2 3 4 5 7 6 8 9 2-38 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing No. Item Function 2 Display and select a parameter ID, and process the displayed image. 1 Parameter ID 2 2 " Parameter ID" P.2-39 Sets the parameter regarding density. 2 Normalize Density 2 " Normalize Density" P.2-40 Multi-Objective Sets the parameter regarding frequency processing. 2 3 Frequency Processing 2 " Multi Objective Frequency Processing" P.2-41 Selects the edge enhancement processing from the list. 4 Edge Enhancement 2 " Edge Enhancement" P.2-42 2 Sets the parameter regarding contrast. The change of the parameter is 5 Contrast Enhancement reflected on the image in the image display area in real-time. 2 " Contrast Enhancement" P.2-42 [Apply] 6 Processes the image with changed parameters and updates the image in the image display area. 2 [Reset Before Edit] 7 Cancels the changes in the Radiography SURE Edit window, and returns to the image before edit. [OK] 2 8 Processes the image with changed parameters and updates the image of the image file. The original image is discarded. 9 [Cancel] 2 Cancels the changes and closes the Radiography SURE Edit window.  Parameter ID 2 The Parameter ID shows the SURE Type and corresponding Parameter ID. To change the SURE Type, click [Edit] to open the [Parameter ID] dialog box. 1 Click [Edit]. 2 The [Parameter ID] dialog box appears. 2 2 Selects the SURE Type from the list. 2 2 2 SDR-120F Reference Guide 2-39  3 Click [OK] or [Cancel] Click [OK] to process the image with new parameters and close the [Parameter ID] dialog box. Click [Cancel] to cancel the changes and close the [Parameter ID] dialog box.  Normalize Density 1 2 3 4 5 6 No. Item Function [Processing] Selects a processing mode from the list. Auto: automatically performs density normalization of the image. Other parameters are invalid. 1 SemiAuto: adjusts density by specifying [SemiROI size] and [SL value]. Fix: adjusts density by directly inputting [SS value] and [SL value]. ROI: Sets the ROI (region of interest) on the image and perform density optimization to improve the visibility of the ROI. ROI It is enabled when the "ROI" is selected as the "Processing". Sets the 2 region of interest (ROI). Drag and drop the mouse over the image to specify the ROI. [MenuCode] 3 Displays the processing type of density normalization. [SemiROISize] It is available only when the "Processing" is [SemiAuto]. 4 Specifies the size of the imaging range from 3 to "Image size"-1, used for calculating the SS value. [SS Value] 5 It is available only when the "Processing" is [Fix]. Specifies the center point of image reading sensibility with the value from 1 to 40000. [SL Value] It is available only when the "Processing" is [SemiAuto] or [Fix]. 6 Specifies the 10 time value of the logarithm value of the range of the incident dose from 1 to 80. 2-40 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing 2  Multi Objective Frequency Processing 1 4 2 5 3 6 2 No.. Item Function 2 [IEB] Specifies the frequency band where the image enhancement is 1 applied. Selects a desired type from the list. Enhancement type: (High frequency) H > M4 > M3 > M2 > M1 > L 2 (Low frequency) [IET] 2 Adjusts the balance of edge enhancement and graininess. Selects a desired type from the list. 2 Sharpness enhancement type: S1 > S2 > S3 > S4 Graininess enhancement type: G1 > G2 > G3 > G4 > G5 > G6 [IEE] Adjusts the intensity of enhancement. The intensity is set within the 2 3 range of 0 to 1600. Zero is no processing and 1600 is the highest intensity. [DCB] Specifies the smoothing mask of the dynamic range compression. 2 4 Selects a desired type from the list. Compression type: (High frequency) H > M2 > M1 > L3 > L2 > L1 > L (Low frequency). 2 [DCT] Specifies the brightness region where the dynamic range compression is applied. Selects a desired type from the list. • Low brightness compression type: (Higher) L4 > L3 > L2 > L1 (Lower) 2 5 • High brightness compression type: (Higher) H4 > H3 > H2 > H1 (Lower) • Low brightness + High brightness compression type: M11, M12, M13, M14, M22, M23, M24, M33, M34, M44 2 (Example) M14: Type with L1 and H4 combined. [DCE] 6 Specifies the intensity of the dynamic range compression. The intensity is set within the range of 0 to 200. Zero is no processing and 2 200 is the highest compression. 2 2 SDR-120F Reference Guide 2-41  Edge Enhancement No. Item Function [E.E.] Selects from the list the type of the spatial filter used for the edge 1 enhancement processing. None: no processing Edge Enhancement (Higher) C4 > C3 > C2 > C1 (Lower)  Contrast Enhancement 1 2 3 5 4 No. Item Function [LUT] 1 Selects the gamma level from the list. [CONT] Adjusts the contrast. Specifies with the values from 1 to 100. The contrast will be stronger as the value increases. 2 It is the same as [CONT] on the Radiography SURE edit menu on the Image edit operation panel and cab be editable using mouse. 2 " Editing Contrast (CONT) and Brightness (BRIGHT) on Image Edit Operation Panel" P.2-34 [BASE] 3 Adjusts the brightness center. Specifies with the values from 0 to 100. The brightness will be stronger as the value increases. [BRIGHT] Adjusts brightness. Specifies with the values from -100 to 100. The brightness will be stronger as the value increases. 4 It is the same as [BRIGHT] on the Radiography SURE edit menu on the Image edit operation panel and cab be editable using mouse. 2 " Editing Contrast (CONT) and Brightness (BRIGHT) on Image Edit Operation Panel" P.2-34 Nega button Switches the polarity of the image. 5 Switch to a positive image. Switch to a negative image. 2-42 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing 2  Noise Filter 1 2 3 2 No. Item Function 1 Selects the checkbox to set the noise filter parameter. [NRB] 2 Selects the intensity of noise removal processing with regard to the 2 frequency component. The target region will be higher frequency component as the number is higher. 2 [NRE] Selects the intensity of subtraction removal of the noise part from 3 an image. The parameter is set within the range of 0 to 200. Zero is no processing, and 200 is the highest intensity. 2  SS Value/SL Value 1 2 2 No. Item Function Indicates SS value (center point of image reading sensibility) of the 1 image currently displayed. The value is not displayed in the original image display mode. 2 Indicates SL value (10 times of the logarithm value of the range of 2 2 the incident dose) of the image currently displayed. The value is not displayed in the original image display mode.  Process Parameter 1 2 2 No. Item Function 2 Registers the changes in the Radiography SURE Edit window as a 1 Update Preset parameter of the preset. The existing preset is discarded. Next image processing will use the new parameter. Registers the changes in the Radiography SURE Edit window as a 2 2 Update User Preset parameter of the user preset. Three user presets can be registered. 2 2 SDR-120F Reference Guide 2-43  When registering a new preset, a current one will be discarded. Make sure to check the contents of a new preset before registration. 1 Edit parameters. 2 Click [Apply] on the SURE processing operation panel. The changed parameters are reflected in the image currently displayed. Check the image. 3 Click [OK] or [Cancel] Click [OK] to process the image with new parameters and update of the image file. The original image is discarded. Click [Cancel] to cancel the changed parameter and close the Radiography SURE Edit window. 2.4.3 POST SURE Processing The POST SURE processing can apply the Radiography SURE to the normal image shown below. Name Image Type SPOT, SERIAL SPOT image, Serial image SPOT_R original image before the Radiography SURE is applied. 1 Display the Image List window. 2 Select one image file to be POST-SURE processed in the image pain. 2.4.1 "Image List Display Relating to SURE" The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the selection border. •The POST SURE processing cannot be applied when multiple images are selected. Be sure to select only one file. •The [SPOT_R] image appears when the [ALL] button is selected. 2-44 SDR-120F Reference Guide  2.4 Radiography SURE Edit and POST SURE Processing 3 Click [Post Sure] on the right click menu. 2 2 The Post Sure window appears. 2 1 2 2 2 3 4 2 5 6 No. Item Function 2 Selects the frame by clicking / or directly input the 1 Frame Range frame number. 2 2 Image Display Area Displays the selected image. Selects the type for the sure processing from the list. 3 SURE Type 4 ID Displays the ID corresponding to the selected type. 2 [OK] 2 5 Processes the image with changed parameters and close the Post Sure window. [Cancel] 6 Cancels the changes and closes the Post Sure window. 4 Select a desired type and then click [OK] or [Cancel]. 2 Click [OK] to process the image with changed parameters and close the Post Sure window. Click [Cancel] to cancel the changes and closes the Post Sure window. The Image List window returns. The original image before the POST SURE processing applied and the processed image are created. 2 2 Original image Processed image SDR-120F Reference Guide 2-45 2.5 Annotations and Measurements Annotation is a note or comment that can be added anywhere in an acquired image. Annotations include text annotations and pointer annotations (arrows and ellipses). Any distance or angle on an acquired image can be measured. The calibration function provide references for distance measurements. The various annotations and measurement objects can be edit, moved and deleted according to your specific requirements. Use measurements only as a reference for assessment since accurate measurement of images is not possible. 1 Click on the Image edit operation panel. The Annotation/Measurement menu is displayed. 1 5 2 6 3 Annotation/ 7 Measurement menu 8 4 9 No. Item Function Annotation input/Selection box Creates and registers a text as annotation. Select the text 1 annotation from the list. 2.6.1 "Creating Text Annotation (Free Text by Direct Input)" [Template] Selects this checkbox to set a text annotation as a template. 2 2.10.1 "Registering/Deleting Annotation Template on Annotation/Measurement Menu" [All frame] 3 Selects the checkbox to reflect the settings on all frames. 2-46 SDR-120F Reference Guide  2.5 Annotations and Measurements No. Item Delete button Function 2 4 Deletes the selected annotation/measurement object. 2.9 "Deleting Annotations/Measurement Objects" Text size 2 5 Sets the text size to small, medium or large. 2.6.3 "Editing Text Annotation" Text button Puts the text annotation onto the image. 2 2.6 "Text Annotation" Arrow button 6 Creates arrows on the image. 2.7 "Pointer Annotations" 2 Ellipse button Creates ellipses on the image. 2.7 "Pointer Annotations" 2 Measure distance button Measures the distance between two or more points. 2.8.1 "Measuring Distance" 7 Measure angle button 2 Measures the angle. 2.8.2 "Measuring Angles" [Cal] Inputs the distance by referring the object of known size. 2 8 After the measurement calibration is set, this button toggles between display/hide of the calibration object. 2.8.3 "Measurement Calibration" Measurement calibration value box 2 Displays or inputs the actual length of the calibration 9 measurement line. "-----" is displayed when the measurement calibration is not set. 2 Annotation/measurement objects added to images are embedded in the image for printing. It is possible to determine whether annotation/measurement objects are embedded or 2 not for each destination when images are sent. Various send settings can be set on one destination. 2 You can set whether to embed the annotation/measurement object or not when sending the image. Contact your Shimadzu representative to change the setting. 2 2 SDR-120F Reference Guide 2-47 2.5.1 All-frame Display Mode/Specific Frame Display Mode Text and pointer annotations are displayed in all frames as default. However, they can be displayed with specific frames. Specific frame display mode All-frame display mode (with checkbox not selected) (with checkbox selected) • Measurement objects are fixed to the specific frame display mode and cannot be changed. • The calibration object is fixed to the all-frame display mode and cannot be changed. • The table below shows the relationship between the annotation and measurement objects and the display mode. Item Annotation Measurement Measurement Calibration Specific frame display Default All-frame display mode All-frame display mode mode Changing of display Possible Not possible Not possible mode All annotation and measurement objects are not displayed during playing image sequences. For a single-frame image, such as a SPOT image, there is no difference in the display modes. For details on actual operation, refer to the following sections: 2 " Switching Text Annotation Display Mode" P.2-52 2 " Switching the Pointer Annotation Display Mode" P.2-55 2-48 SDR-120F Reference Guide  2.6 Text Annotation 2.6 Text Annotation 2 There are two types of text annotations, the "Fixed Text" annotation that you select from registered annotations or the "Free Text" annotation that you can enter directly. The table below summarizes the features of them. 2 Item Fixed Text Free Text Text that is used frequently or 2 Purpose of use Temporary text periodically Registerable as a preset Yes No New input from the Possible Possible 2 Annotation input/Selection * checkbox must be * checkbox must be box selected. cleared. Previous position for that annotation Initial display position when (when creating annotations for the Center of image annotation is created first time, center of image) 2 2.10 "Registering Annotation Template" 2.6.1 Creating Text Annotation (Free Text by Direct Input) 2 Enter text directly in the Annotation input/Selection box to create a text annotation. 2 Up to ten free text annotations you have input can be saved in the free text history, and these can be selected and edited later on. 2.6.2 "Creating Text Annotations (Fixed Text/Free Text in Text History)" Before a free text annotation is inserted, the size of the text can be selected, and text can be registered as fixed text and not part of the free text history. 2.10.1 "Registering/Deleting Annotation Template on Annotation/Measurement 2 Menu" 2 A total of 128 characters can be input to each free text annotation. 2 1 Place the cursor in the Annotation input/Selection box and input the text. 2 2 2 SDR-120F Reference Guide 2-49  2 Click . Text annotation is displayed in the center of images. Text annotation is displayed in the center of the image. 2.6.2 Creating Text Annotations (Fixed Text/Free Text in Text History) Select already registered text strings from the Annotation input/Selection box to create a text annotation. You can also directly input text in the Annotation input/Selection box. 1 Select a desired text string from the list. The selected text string is displayed in the Annotation input/Selection box. Fixed text Free text Text category dividing line Item Function Fixed text The upper half of the dividing line displays fixed text. Free text The lower half of the dividing line displays free text. Directly inputting the same text string as a registered text string results in the same operation as selecting that text string. Free texts are listed in the order of their use while fixed texts list is fixed. 2-50 SDR-120F Reference Guide  2.6 Text Annotation 2 Click . 2 Before the text annotation is inserted, the size of the text can be selected, and the text can be switched between a fixed text and a free text. The text annotation is displayed. 2 Text annotation 2 is displayed. 2 2.6.3 Editing Text Annotation 2 Inserted text annotations can be edited and moved.  Changing Size of Text Annotation The size of a text annotation can be changed. 2 1 Click the inserted text annotation. The text is selected and surrounded with a selection border. 2 2 The selection border is displayed. Text size 2 2 Click a desired text size from the list. The text size changes. 2 2 2 2 SDR-120F Reference Guide 2-51  Moving Text Annotation A text annotation can be moved to anywhere on the acquired image. 1 Click the text annotation. The text is selected and surrounded with a selection border. 2 Drag the text annotation to move it anywhere on the acquired image. The text annotation moves. Drag the border to move. Text annotation moves. 3 Click anywhere on the screen other than the text annotation. The text annotation is deselected and the selection border disappears.  Switching Text Annotation Display Mode 1 Click the text annotation. The state of the selected text annotation is reflected in the Annotation/Measurement menu. 2 Either select or deselect the [All frame] checkbox in the Annotation/Measurement menu. 2-52 SDR-120F Reference Guide  2.7 Pointer Annotations 2.7 Pointer Annotations 2 Create arrows and ellipses on acquired images. 2.7.1 Creating New Pointer Annotations 2 1 Click or . 2 Arrow button 2 Ellipse button 2 Click two points, start point and end point, in the image. 2 • When is clicked 2 Start point 2 End point 2 • When is clicked 2 Start point 2 End point 2 The pointer annotation is created. 2 2 SDR-120F Reference Guide 2-53 2.7.2 Editing Pointer Annotation Inserted pointer annotations can be reshaped and moved. The following describes use of ellipses. However, the same description can be applied to arrows.  Reshaping Pointer Annotation Pointer annotations can be reshaped. 1 Click the inserted pointer annotation. The pointer annotation is selected and displayed as a dotted line enclosed by a grab box. Grab box appears 2 Drag the grab box to enlarge, reduce or reshape it as appropriate. Drag the grab box. Ellipse is reshaped. 2-54 SDR-120F Reference Guide  2.7 Pointer Annotations 2  Moving Pointer Annotations Pointer annotations can be moved. 1 Click the pointer annotation. The grab box is displayed. 2 2 Drag the arrow or ellipse line to the desired position. The pointer annotation moves. 2 2 2 2 Drag the line to move. Pointer annotation moves. 2 3 Click anywhere on screen other than the pointer annotation. The pointer annotation is deselected and the grab box disappears.  Switching the Pointer Annotation Display Mode 2 1 Click the pointer annotation. The state of the selected pointer annotation is reflected in the Annotation/Measurement menu. 2 2 Either select or deselect the [All frame] checkbox in the Annotation/Measurement menu. 2 2 2 2 SDR-120F Reference Guide 2-55 2.8 Measurement Any distance or angle on an acquired image can be measured. • The measurement calibration is required prior to measurement. The dialog box below appears when attempting to start the measurement without measurement calibration. 2.8.3 "Measurement Calibration" • For multi-frame images, the measurement calibration result is applied to all images. • If you change the field size during fluoroscopy with the loop memory mode (for example, Normal to Zoomed), the multi-frame images to be saved will contain images with a different field size. In this case, if you perform measurement calibration in accordance with either size (for example, Normal), the calibration result will be applied to the other (for example, Zoomed), and the measurement result will display an incorrect value. 2.8.1 Measuring Distance You can measure the length along a path formed by joining specified points. (max. 16 points) Distances can be measured between a minimum of two points and a maximum of 16 points. The distance is automatically displayed when the 16th point is specified. 1 Click . Annotation/ Measurement menu 2-56 SDR-120F Reference Guide  2.8 Measurement 2 Click points inside the acquired image to form the path to be measured. (max. 16 points) The measurement line is drawn. 2 3 Double-click a point to specify it as the end point of the measurement line. 2 The total length of the path is displayed in mm (millimeters). 2 Start point Total length is displayed. 2 End point 2  Reshaping Distance Measurement Line You can reshape distance measurement lines that have been inserted. 1 Click the inserted distance measurement line. 2 The grab box is displayed, and the selection border is displayed around the measurement result. 2 Grab box appears. 2 2 2 Drag the grab box to reshape it as appropriate. 2 2 2 Drag grab box. 2 Line is reshaped. The total length of the path changes according to reshaping. SDR-120F Reference Guide 2-57  Moving Distance Measurement Line You can move individual the distance measurement line that has been inserted and the measurement result. Details of moving these objects are the same as in the descriptions for moving pointer annotations and text annotations. 2 " Moving Text Annotation" P.2-52 2 " Moving Pointer Annotations" P.2-55 2.8.2 Measuring Angles Any angle on an acquired image can be measured. 1 Click . 2 Click three points, start point, intermediate point and end point, in the image. The measurement line is drawn, and the angle is displayed. End point The angle is displayed. Intermediate point Start point 2-58 SDR-120F Reference Guide  2.8 Measurement 2  Reshaping Angle Measurement Line You can reshape or change the angle of angle measurement lines that have been inserted. 1 Click the inserted angle measurement line. The measurement line is selected and a grab box is displayed. 2 2 Grab box appears. 2 2 Drag the grab box to reshape it as appropriate. 2 2 2 2 Drag grab box. Angle is changed. 2 The angle value changes according to reshaping.  Moving Angle Measurement Lines You can move individual the angle measurement line that has been inserted and the measurement 2 result. Details of moving these objects are the same as in the descriptions for moving pointer annotations and text annotations. 2 " Moving Text Annotation" P.2-52 2 2 " Moving Pointer Annotations" P.2-55 2 2 SDR-120F Reference Guide 2-59 2.8.3 Measurement Calibration The measurement calibration function provides a reference for distance measurement, which is set by specifying two points of a target object of known size on the acquired image and entering that distance. 1 Click . 2 Specify two points on the target object to be used as the reference. The measurement line is drawn, and the Calibration Value dialog box is displayed for inputting the calibration value. Start point Calibration Value dialog box End point 3 Select the [mm] or [Fr] unit in the Calibration Value dialog box, and input numerical values matching the unit selected. Calibration value input box Unit selection 2-60 SDR-120F Reference Guide  2.8 Measurement 4 Click [Regist] or [Cancel]. 2 Clicking [Regist] displays the numerical value at [Cal] in the Annotation/Measurement menu. Clicking [Cancel] cancels the input of the calibration value, and the window closes. As a result of the measurement calibration, the distance display is updated. 2 2 2 Numerical value is displayed. 2 2 The following restrictions apply to input of the measurement calibration value: • Lower limit: 0.1 mm (When [Fr] is selected, the mm equivalent is 0.1 mm.) 2 • Upper limit: Value that given 0.5 mm of one pixel size after calibration (The upper limit changes according to the length of the measurement line.) 2 When a numerical value outside of the input range is input, an error message appears.  Changing Measurement Calibration Setting The calibration result can be corrected by changing the measurement line and calibration value after setting the measurement calibration. When the calibration result has been corrected, the distance 2 measurement results also is updated interlocked with the new calibration result. • Editing/moving the measurement calibration object Calibration measurement lines can be edited and moved, and measurement calibration text can 2 be moved by the same operations as in measurement of distances. 2 • When a calibration measurement line is selected, the calibration value can be changed by inputting a new value in the calibration value input box in the Annotation/Measurement menu. • Switching between display/hide of the measurement calibration object switches between display/hide of the measurement calibration object. The calibration result is held in memory even if the measurement calibration object is hidden. 2 2 SDR-120F Reference Guide 2-61 2.9 Deleting Annotations/Measurement Objects Inserted annotations and measurement objects can be deleted. 1 Select a desired annotation object on the acquired image. A grab box or selection border is displayed. Grab box appears. 2 Click . The object is deleted. 2.10 Registering Annotation Template The annotation templates can be created, edited and deleted by using the Annotation/Measurement menu or the preset menu. 2.10.1 Registering/Deleting Annotation Template on Annotation/ Measurement Menu A free text annotation can be appended to annotation templates, and a fixed text can be turned into a free text.  New Registration 1 Place the cursor in the Annotation input/Selection box and input the text. 2 Select the [Template] checkbox. Select [Template] checkbox. 2-62 SDR-120F Reference Guide  2.10 Registering Annotation Template 2 The free text annotation is appended to the annotation template. Free text annotation is Fixed text 2 appended to the fixed text annotation. 2 Free text When the free text is input with the [Template] checkbox selected, when the free text is registered as the fixed text by inserting on the image.  Registration From History 2 1 Select a desired free text annotation from the list. The selected text is highlighted. 2 2 Text category Select a free text dividing line annotation. 2 2 Select the [Template] checkbox. Select [Template] 2 checkbox. The free text annotation is appended to the annotation template. 2 Fixed text 2 Free text annotation is appended to the fixed text annotation. Free text 2 2 2 SDR-120F Reference Guide 2-63  Deleting from Annotation Template 1 Select a desired fixed text annotation from the list. The selected text is highlighted. Fixed text Text category dividing line 2 Clear the [Template] checkbox. Clear [Template] checkbox. The fixed text annotation moves to the top of the free text history. Fixed text Fixed text annotation moves to the top of the Free text free text history. 2.10.2 Editing Annotation Template From Preset Menu Annotation template presets can be registered and deleted. Their display order can be sorted. For details, refer to 5.13 "Annotation Template Preset". 2-64 SDR-120F Reference Guide  3 Study Information Input/Output 3.1 MWM The DICOM Modality Worklist Management (MWM) can receive studies from the MWM server and register them with your system. Received studies are manipulated in the MWM tab. 1 2 3 4 5 No. Tab Name Description 1 MWM Tab Displays the list of studies received from the MWM server. [Query Condition] Specifies query conditions for the MWM server. 2 The asterisk (*) indicates that some studies cannot be received though they match conditions. 3.1.2 "Query Condition Setup" [Update] 3 Updates the study list from the MWM server. Displays "*" for studies obtained in the hard disk on the digital image 4 Record processor. [Take Orders] Stores the selected study to the hard disk on the digital image processor. 5 The stored study remains displayed in the MWM tab after the MWM server is disconnected or the system is restarted. 3.1.1 "Take Orders" • In the study list of MWM, study information cannot be updated or registered. • Of the studies that are obtained from the MWM server, performed studies are not displayed in the list on the [MWM] tab. They are displayed on the [Today] or [All] tab. 3-2 SDR-120F Reference Guide  3.1 MWM 3.1.1 Take Orders 3 The study information obtained from the MWM server is stored on the hard disk of the device. The stored study remains displayed on the MWM tab after restarting the device, or disconnecting with the 3 MWM server. 1 Select a desired study to be stored on the hard disk. The selected study is highlighted. 3 Select the study. 3 3 3 2 Click [Take Orders]. The study information is stored on the hard disk of the device. 3 3 The "*" appears in [Record] of the study stored. 3 The study stored on the hard disk will be overwritten when the same study is edited in the MWM server and taken in again. The configuration with not overwrite is available. Contact your Shimadzu representative to change the setting. 3 3 3 3 3 SDR-120F Reference Guide 3-3 3.1.2 Query Condition Setup The MWM query condition is set up. 1 Click [Query Condition]. The MWM Query Condition Setting window appears. Select desired check boxes and enter values. 1 2 3 4 5 6 7 8 9 10 No. Item Function [Server] 1 Selects the target MWM server in the list. [Modality] 2 Filters studies by the image output type. [Location] 3 Filters the reserved study in this device. [Patient’s name] 4 Enters patient’s name. [Patient ID] 5 Specifies a Patient ID. Up to 64 characters can be entered. [Accession No.] 6 Specifies a accession No. [Study Date] 7 Specifies study date range in the list. 8 Check box Select a desired check box to enable a query condition. [Setting] 9 Starts receiving study from the MWM server. [Cancel] 10 Closes the MWM Query Condition Setting window. You can use a wild-card character in the [Patient’s name], [Patient ID] and [Accession No.] fields. It can be added to the head or the end of a character string or both. It cannot be inputted in other place (for example, in the middle of a character string). 3-4 SDR-120F Reference Guide  3.1 MWM 3.1.3 New Study (MWM) 3 1 Select the [MWM] tab to display a list of studies obtained from the MWM server. 2 Select a desired study. The selected study is highlighted. The study information is displayed in the Study information 3 details. Check the information. 3 Select the APR and enter information such as Accession No., APR, Modality, Request Department, Physician, Technologist, and comment (whenever required). 3 The patient information can be edited by clicking [Modify]. M517-V060 OPESCOPE ACTENO FD type Instruction Manual, "3.7 Operating 3 Study List Window" 4 Click [Start Study]. 3 3 [Start Study] Enter 3 information (whenever required). 3 The study starts. 3 3 When performing another operation, not clicking [Start Study] after inputting information in step 3, the Confirm dialog box appears. 3 Click [Yes] to discard information and the dialog box closes. 3 Click [No] to return to the Study List window. 3 SDR-120F Reference Guide 3-5 3.1.4 Auto Study Start When only one study is obtained from the MWM server, its study can be automatically started. Contact your Shimadzu service representative to enable the Auto study start. 3.1.5 Updating Performed Study (MWM) 1 Click [Today] or [All] tab and the desired study, and then [Modify]. Select the desired study. The [Confirm] window appears. 2 Click [Yes] or [No]. Click [Yes] to continue the update. Click [No] to abort the update, and the confirmation window closes. 3-6 SDR-120F Reference Guide  3.1 MWM 3 The [Edit] window appears. Click [MWM Bind]. 3 3 3 3 3 The [MWM Bind] window appears. 3 3 3 4 Select a desired study from the list, and click [Apply]. Refer to the following section for the MWM query method. 3 3.1.2 "Query Condition Setup" 3 3 3 3 SDR-120F Reference Guide 3-7  The [Confirm] window appears. 5 Click [Yes] or [No]. Click [Yes] to update the study information. The following information will be updated. (0010,0010) Patient’s Name (0010,0020) Patient ID (0010,0030) Patient’s Birth Date (0010,0040) Patient’s Sex (0008,0050) Accession Number Click [No] to abort the update, and the confirmation window closes. 3.2 MPPS (Option) When the MPPS (Modality Performed Procedure Step) option is available, the status of the study start and end is notified to the MPPS server. When neither fluoroscopy nor radiography is performed during study, the study is considered to be canceled. When fluoroscopy or radiography is performed during study, and the study is closed, the study is considered to be completed. 3.2.1 Checking MPPS Processing Status When the MPPS option is available, appears in the System/Processing status indicator of the main panel. The status is automatically notified. However the error occurs, flashes. Click flashing to check the error contents. 5.1.5 "MPPS Processing Status (Option)" Check processing status 3-8 SDR-120F Reference Guide  4 Image Input/Output 4.1 Saving Images Image files can be saved in a CD-R or DVD-R for backup copies of image files. Here, "storage media" is used as a general term to refer to a CD-R or DVD-R. • A storage media to which data has been saved with another device is not supported. • Use a Shimadzu-recommended storage media to read and write data. Shimadzu offers no warranty for problems resulting from the use of other types of disk. Recommended CD-R: CD-R P/N: 562-27681-10 <Package of 10 CD-R discs> Recommended DVD-R: DVD-R P/N: 562-27680-10 <Package of 10 DVD-R discs> • This system saves data in recordable format and so additional data can be saved to the same media. However, additional data cannot be saved to a storage media to which data has been saved with another device. • When data is written to a CD-R or DVD-R, in addition to the space required for the image files, approximately 15 MB is used. For this reason, writing multiple image files to a storage media one by one significantly reduces the amount of free space in the storage media. When writing multiple image files to a storage media, group the files to register them beforehand in order to reduce the unnecessary use of free space. 4.1.1 Registering Images For writing images in the CD-R or DVD-R, first, images are registered. Check that a writable storage media is inserted in the CD-R/DVD-R drive. 1 Display the Image List window. 2 Select a desired file. The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the selection border. 4-2 SDR-120F Reference Guide  4.1 Saving Images 3 Click [Media Archive]. 4 4 4 4 4 • If a writable storage media is not inserted in the CD-R/DVD-R drive, the confirmation dialog box appears. Insert a writable storage media. • Writing to multiple storage media in one operation is not possible. Be sure to register data so that its volume is not over the space of one storage media. 4 The Media Archive Confirmation window appears. 4 1 2 4 3 4 4 5 6 No. Item Function 4 Displays the free space of the media inserted in the CD-R/DVD 1 Media Info. 4 drive. Displays the amount of space required to register images. 2 Status The free space of the media is larger than the amount required, "Can be registered to Media" is indicated. 4 4 SDR-120F Reference Guide 4-3  No. Item Function [Image Type to Save] Selects the [Processed Image] checkbox to register processed images to the media. When saving the processed image in the media, you can 3 also save the image display tool. Contact your Shimadzu service representative. to change the setting. When images is registered without processing, clear the checkbox. [Auto Writing] [No]: clicking [Confirm] only registers images and not writes 4 them to a storage media. [Yes]: clicking [Confirm] writes the images to a storage media. [Confirm] 5 Registers images. [Cancel] 6 Aborts the image registering process. 4 Click [Confirm]. As background processing, the images are registered in order. 5.1 "Icons in Main Panel" To abort registration, click [Cancel]. • When the [Auto Writing] is set to [No], at the point when the registration of images to be saved is completed, the images still have not been written to the storage media. The storage media cannot be ejected until writing is complete and so, write them to the storage media or cancel storing. 4.1.3 "Writing to Storage Media" • When an image is written with [Processed Image] checkbox selected, its image display parameter changes to that for processed image. Therefore its original image cannot be restored when retrieving it from a storage media. For an image backup, images should be registered with [Processed Image] checkbox cleared. • If you register images without selecting the [ALL] button, the original image before SURE is applied will not be saved to the storage media. In this case, the Radiography SURE edit cannot be applied even if the image is loaded from the storage media. 4-4 SDR-120F Reference Guide  4.1 Saving Images 4.1.2 Canceling Image Registration 4 The image registration can be canceled. 1 Click in the Image List window. is inverted. 4 A list of the study-related information contained in the storage media is displayed. 2 Click [Cancel Storage]. 4 4 4 The Confirm dialog box appears. 4 4 3 Click either [Yes] or [No]. Click [Yes] to cancel the image registration, and return to the Image List window. 4 Click [No] to abort the cancel, and the dialog box closes. 4.1.3 Writing to Storage Media 4 At the point when the image registration is completed, the images still have not been written to the storage media. Write them to the storage media using the procedure described below. 1 Click in the Image List window. 4 is inverted. A list of the study contained in the storage media is displayed. 4 List of study in storage media 4 4 SDR-120F Reference Guide 4-5  Register additional files from the Image List window. Click [Image List] to return to the Image List window. 2 Click [Save on Media] on the operation panel. The Confirm dialog box appears. • The unprocessed image cannot be saved in media storing a processed image. Since the auto media archive saves unprocessed images after the study ends, the auto media archive cannot be available for media storing a processed image. • The manual of the image display tool is saved in a media storing a processed image. 3 Click either [Yes] or [No]. Click [Yes] to execute the writing. The Image List window returns. Writing is registered as background processing and requires a few minutes to several tens of minutes. 5.1 "Icons in Main Panel" When writing is completed, the storage media is automatically ejected. Click [No] to abort the writing, and the dialog box closes. The storage media cannot be accessed during writing. When an attempt is made to access the storage media, the following Notice dialog box appears. Wait for writing to end. 4-6 SDR-120F Reference Guide  4.2 Reading Images 4.2 Reading Images 4 Images saved on the storage media can be read to the main HDD. 4 Check that a readable storage media is inserted in the CD-R/DVD-R drive. 4 1 Click in the Image List window. is inverted. A list of the study-related information contained in the storage media is displayed. 4 2 Select a desired file. The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the 4 selection border. The [Retrieve] is enabled. Select a study list. 4 4 Item Function 4 [Retrieve] Reads files or images. 3 Click [Retrieve] on the operation panel. 4 The Confirm dialog box appears. 4 4 4 Click either [Yes] or [No]. Click [Yes] to execute retrieval (reading). The dialog box closes, the selected files are registered for background processing, and read processing is executed in order. 4 5.1 "Icons in Main Panel" Click [No] to abort the retrieval (reading) operation, and the dialog box closes. 4 SDR-120F Reference Guide 4-7  • Even if reading is completed, if the same image is already saved in the main HDD, it is not overwritten. • The storage media cannot be accessed while reading is in progress. Wait until reading is completed. 4.3 Special Job The special job provides functions not intended for clinical use, and in the current version the USB Export is registered. 4.3.1 USB Export The USB export is to convert images into the BMP or JPEG format and export them in a USB flash drive for review on standard PCs. • It is necessary to register your USB flash drive in the anti-virus software before use. If not, you may not use it. Contact your Shimadzu service representative for details. • Before using a USB memory storage device, make sure that it is not infected with a virus using virus scanning software that has been updated to the latest definition file 1 Select a desired file. 2 Select [Special Job] - [USB Export] on the right-click menu. 4-8 SDR-120F Reference Guide  4.3 Special Job 4 4 The following dialog box appears when no USB flash drive is connected. Click [OK] to connect it or reconnect it when the USB flash drive has been connected. 4 4 In case that multiple USB flash drives have been connected, images will be exported in the USB flash drive that was connected and recognized at first. 4 3 Select the export option. • When selecting [USB Export] with a study selected, the USB Export window appears. 2 4 1 3 4 4 5 4 6 7 4 No. Item Function [Image File Type] 1 Selects the export format. 4 [Comp. Level] The compression level is available when the export type 2 is JPEG. Click it to open the JPEG Option window for setting compression parameters. The current compression level is indicated on the button. [Overlay] 4 Selects whether image information is embedded in an image to be exported. 3 To remove a patient name from study information, execute the "Anonymous" and then select the Overlay. M517-V060 OPESCOPE ACTENO FD type 4 Instruction Manual, "4.3 Operating Image List Window" 4 SDR-120F Reference Guide 4-9  No. Item Function [Annotation] 4 Selects whether an annotation is embedded in an image to be exported. [Multi frame] 5 Selects frames to be exported when a multi frame image is included in the study selected, [Execute] 6 Executes the export under current settings. [Cancel] The dialog box appears to ask whether the USB flash 7 drive is removed or not. Removes it or cancels the export. • To select and output one image file, the USB Export window for the frame selection appears. This window shows all the frames included in the file. Select the frame to be exported. Other buttons or options on this window are the same as those on the normal USB Export window. 4 Click [Comp. Level] to open the JPEG Option window. Set up the compression parameters. 1 2 3 4-10 SDR-120F Reference Guide  4.3 Special Job No. Item Function 4 [Comp. Level] Sets a compression level by inputting a numeric value of 0 to 80, or by using the slider. As the compression level becomes larger, the 4 1 image quality will be lost so that the file size will be smaller. As the compression level becomes smaller, the image quality will be improved so that the file size 4 will be larger. [OK] 2 Closes the JPEG Option window. The current settings are enabled. 4 [Cancel] 3 Aborts current settings and closes the JPEG Option window. 4 5 Click [Execute] to start exporting images. The dialog below appears to show the processing status. Click [Abort] to stop the processing. 4 4 • When selecting a study or multiple images • The total number of images selected and the number of the exported images are indicated. When selecting one image file 4 The total number of frames selected and the number of the exported frames are indicated. • When clicking [Abort] Images for which the processing is completed until you click [Abort] have been stored in the USB flash drive. The abort process is completed, the following dialog box appears. Click [OK]. 4 4 4 4 4 SDR-120F Reference Guide 4-11  • The following dialog box appears when the export destination folder does not exist in the USB flash drive. If you click [OK], the folder is automatically created in the USB flash drive and the export will be started. If you click [Cancel], the following dialog box appears to ask whether the USB flash drive is removed or not. If you click [OK], the USB flash drive can be removed. In case that multiple USB flash drives are connected, all of them can be removed. If you click [Cancel], the Image List window return. • The following dialog box will appear due to insufficient memory in the USB flash drive during the export processing. Reselect images or replace with the USB flash drive having enough memory. Images for which the processing is completed until the dialog box appears have been stored in the USB flash drive. When the export is completed, the following dialog box appears. 6 Click [OK] to remove the USB flash drive. In case that multiple USB flash drives are connected, all of them can be removed. If you click [Cancel], the Image List window returns. 4-12 SDR-120F Reference Guide  4.4 Sending Images 4.4 Sending Images 4 Image files can be sent via the network. 4 When the [Image Dest] check box is selected of [Auto. Processing] in the APR preset edit, all images are send when the study is ended. 4 5.9.1 "Edit APR Preset Window" 1 Select a desired file. 4 The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the selection border. 4 2 Click [Send to Server] on the operation panel. 4 4 4 The DICOM Send window appears. 4 3 Select a destination from the list and click [Send]. 4 The files are registered for background processing and then will be sent in order. 5.1 "Icons in Main Panel" Click [Cancel] to abort the sending operation, and the window closes. •Settings (reflection of image processing and embedding of annotations) for sending 4 images are different between send destinations. Select a desired preset send destination. •When one server has different send settings, the settings must be registered as 4 individual send destination. •Modality (0008, 0060) of the DICOM tag of the image (SPOT, SERIAL, DSA) is outputted with "RF" or "XA". •The [SPOT_R] image can only be processed if selected alone. 4 SDR-120F Reference Guide 4-13 4.5 DICOM RDSR Output (Option) The DICOM RDSR (Radiation Dose Structured Report) records study-related data including total dose data for the entire study. The RDSR is created and stored separately from the creation and storage of images after study closing. The RDSR is not created for a study in which no fluoroscopy or radiography is performed. 4.5.1 RDSR on Image List Window The RDSR appears on the Image List window in a list or a thumbnail format. • List display • Thumbnail display 4.5.2 Property of RDSR Information of the RDSR can be checked. 1 Right-click the RDSR file and select [Property] on the right-click menu. 4-14 SDR-120F Reference Guide  4.5 DICOM RDSR Output (Option) 2 The image file properties window appears. 4 Check the information. 4 4 4 4.5.3 Sending RDSR The RDSR is sent automatically or manually to the predetermined destination different from the image destination.The sending procedure is the same as that for the image file. 4 4 To change the RDSR destination, contact your Shimadzu service representative. 4 4.5.4 Operations on RDSR 4 The functions below can be applied to the RDSR on the Image List window. The procedure is the same as that for the image file. • Save to media • Retrieve • Protect / Unprotect 4 • Delete • Divide / Combine Study • Anonymous 4 4 4 4 SDR-120F Reference Guide 4-15 4.6 Registering Images for Printing To print the selected image, register it to the print edit using the procedures described below. There are basically two procedures. One involves registering from the Image List window and the other involves registering from the Image Edit window or the Edit tab of the Study window. The registered images are displayed in the print edit list in the print edit operation panel. • Before performing actual printing, make the print settings in the Print Edit window. 4.7 "Printing Images" • When an image is registered to the print destination with the true size print set, the measurement calibration is required on the image prior to the registration. 2.8.3 "Measurement Calibration"  Registering from the Image List 1 Display the Image List window. 2 Select a desired file to register for printing. The selected list is highlighted. When a thumbnail image is selected, it is surrounded by the selection border. The [SPOT_R] image can only be processed if selected alone. 3 Select a print preset and click [Print]. Select a study. Select a print preset and click [Print]. Select a thumbnail image. The image is registered for printing. 4-16 SDR-120F Reference Guide  4.6 Registering Images for Printing 4  Registering from Image Edit window or Edit tab of Study window 1 Select or display the image to be registered for printing. 2 Select a print preset and click [Print] in the operation panel. 4 Select image(s). 4 4 Select a print preset 4 and click [Print]. The image is registered for printing. 4  Note for Area Setting and True Size Print When the area setting has been set to an image or the print mode of "true size" has been set in a selected print preset, the enlargement factor and print area at the time of the print registration are adjusted as follows: 4 Print Mode Normal mode True size mode 4 An enlargement factor will be set so that An enlargement factor is set so that an an image display area fits the style of the image is output in the true size. print preset that has been set. A print area is an image area adjusted with No settings A print area is a whole image adjusted with the enlargement factor that has been the enlargement factor that has been set above, with its center as the center of the 4 set above. print image. Area Setting An enlargement factor is set so that a An enlargement factor is set so that an frame area fits the style of the print preset that has been set. image is output in the true size. A print area is a frame area adjusted with 4 A print area is a frame area adjusted with the enlargement factor that has been set With settings the enlargement factor that has been set above, with its center as the center of the above. When a print film is larger than the print area (frame area), outside of the print image. When a print film is larger than the print area (frame area), outside of 4 frame is printed black. the frame is printed black. 4 4 SDR-120F Reference Guide 4-17 4.7 Printing Images The images can be printed in various formats, providing efficient printing and facilitating diagnosis reading. 4.7.1 Print Edit Window The various parameter for printing is set in the Print Edit window. To edit printing, images must first be registered from the Study, Image List, or Image Edit window. 4.6 "Registering Images for Printing" 1 Click [Print Edit] on the main panel. The window changes to the Print Edit window and the image display area shows the images in the layout of film format selected at print registration. The operation panel switches to the print edit operation panel. Image display Print edit area operation panel (Example: 2x2 layout) 4-18 SDR-120F Reference Guide  4.7 Printing Images 4 When the true size print has been set in the selected print preset, the frame indicates the area to be printed. 4 Print area 4 Example for the case where the true size print has been set.  Operation Panel of Print Edit Window 4 The buttons on the operation panel is used to set parameters for printing. 4 4 4 1 4 4 4 2 4 3 5 6 4 7 4 8 9 10 4 SDR-120F Reference Guide 4-19  No. Item Function A list of the images registered by image registration for printing or 1 Print edit list automatic post processing is displayed. Group Films button 2 Groups the film groups of a patient. [Preset] 3 Selects a registered preset in the list. Delete button 4 Deletes unnecessary image files and films. Print Preset Select button 5 Displays the Print preset select window. The conditions related with the selected preset can be temporally changed. Printer information display section 6 Displays the print settings and film size. 4.7.7 "Editing Print Preset" [Format] 7 Specifies the frame layout on a film in the list. 4.7.7 "Editing Print Preset" [Copies] 8 Specifies the number of print copy. Click / . 4.7.7 "Editing Print Preset" Cut button Cuts the image selected. Paste button Pastes the image copied or cut before the selected image. 9 Blank button Inserts a blank space before the image selected. Separate button Divides a film with the same output type at the position selected. [Print] 10 Prints the images that are specified for printing on film. 4.7.7 "Editing Print Preset" 4-20 SDR-120F Reference Guide  4.7 Printing Images 4  Print Edit List The print edit list shows the print information below: 1 2 3 4 1 3 2 3 4 1 2 3 No. Item Function 1 Patient name Displays patient's name. 4 • Print direction P: Portrait / L: Landscape • Format Ex) 2×3: 2 columns and 3 rows 2 Film group • Number of copies and films Ex) copy 1: 1 copy / [4]: 4 films The film group is classified according to the format and patient name 4 selected at the time of registration for printing. However, even if the patient name and format are the same, once another patient has been registered, the data is registered as a separate film group. 3 Film member Displays films in a film group. Clicking a film displays the film in the image area. 4 4.7.2 Printing Procedure The print procedure is described below. 4 4 If film or format editing is necessary, edit them before printing. 4.7.3 "Editing Print Film" 4 1 Click a film group in the print edit list. is enabled. 4 Film group Print 4 4 4 SDR-120F Reference Guide 4-21  • is not available if a film member is selected. Select a film group. • The true size has been set to the print preset, the preset is fixed. 2 Click . The Print preset select window appears. The selected preset title Preset list is displayed. 1 2 The conditions enclosed by can be changed as part of the selected preset. No. Item Function [OK] 1 Registers the set conditions. [Close] 2 Cancels the print settings. Refer to 4.7.7 "Editing Print Preset" for details on other items. 3 Select a desired preset from the preset list. The title of the selected preset is displayed in the [Preset Title]. 4 Change and check the print conditions as required and click [OK]. If there are no changes, or if you want to cancel the print settings, click [Close]. The Print preset select window is closed. If you re-open the Print preset select window, the information that was entered is cleared and the default setting returns. 4-22 SDR-120F Reference Guide  4.7 Printing Images 5 Check the print settings on the operation panel. 4 Further changes can be made on the panel. Preset list (changeable) Check the registered 4 conditions. Format (changeable) 4 Number of copies (changeable) 4 [Print] 4 6 Click [Print]. The Confirm dialog box appears. 4 4 7 Click either [Yes] or [No]. Click [Yes] to start the printing. 4 The image files selected are registered for background processing and film-print processing is performed in order. 5.1 "Icons in Main Panel" Click [No] to abort the printing, and the dialog box closes. 4 4 After completing the print operation, depending on factors such as the print processing time and the state of the connected printer, it may take some time before film output starts. 4 4 4 SDR-120F Reference Guide 4-23 4.7.3 Editing Print Film The frame layout can be edited by grouping, separating, copy and paste, inserting blank using buttons on the operation panel or right-click menu. 4.7.5 "Performing Processes by Right-Clicking"  Grouping Print Film The film of identical patient that has been registered in the different format is regarded as a different film group in the print edit list. These films can be grouped either by using the buttons on the operation panel or by dragging the mouse. is not available for the film group at the top level. To group a film group together with a film at a lower level, drag the film group. • The example below shows the grouping of 2x2 and 2x3 film groups. 1 Select the film group B (P 2 × 2 copy1 [1]). The selected group is highlighted. is enabled. Film group A [P 2x3] format Film group B [P 2×2] format 2 Either click or drag the group B over the group A. The group B is combined with the group A and the format of the group B changes to that of the group A (P 2×3). Group B is combined with Group A. 4-24 SDR-120F Reference Guide  4.7 Printing Images 4  Deleting Print Film Delete an unnecessary film from the print edit list. 1 Select the film group or film. 4 Film to be deleted 4 4 4 2 Click . 4 The Confirm dialog box appears. 4 4 3 Click either [Yes] or [No]. 4 Click [Yes] to delete the film. Click [No] to abort the deletion, and the dialog box closes. 4 4 4 4 SDR-120F Reference Guide 4-25  Separating Print Film The print film can be separated at a image selected within a film group either by using the buttons on the operation panel or right-click menu. 4.7.5 "Performing Processes by Right-Clicking" • The example below shows the separating of a 2×3-format file group into two parts.(There are 12 registered images.) 1 Click the image at which separation is to be performed. Separation cannot be performed by selecting a film in the print edit list. Select an image in the image display area. The selection border is displayed around the image. on the operation panel is enabled. Single 2×3-format film group (There are 12 images, numbered 01 to 12. Six images are displayed for one film and so there are two films.) Click the image at which Separate separation is to be performed. (In button this case, image 04 is selected.) Film 1 Film 2 2 Click , or select [Separate] on the right-click menu. The film is separated. Film 1 Film 2 The images are separated The one film group is between 03 and 04. The Image 04, the point at which separation separated into two. gray area indicates a blank was performed, is moved to the top-left. space with no images. The gray area after image 12 in film 2 indicates a blank space. 4-26 SDR-120F Reference Guide  4.7 Printing Images 4.7.4 Editing Print Format 4 After selecting a format, further changes can be made to the layout by, for example, copying and pasting images or inserting blank spaces. The desired process is performed either using the buttons in 4 the operation panel or by right-clicking and making the appropriate selection from the menu. 4.7.5 "Performing Processes by Right-Clicking"  Cutting Image An image can be cut and paste. 4 1 Select a desired image either by clicking or dragging. A selection border is displayed around the selected image. is enabled. 4 2 Click , or select [Cut] on the right-click menu. The image selected is cut. 4 4 Select image C and either click or right-click and select [Cut] Image C disappears and 4 from the menu. image D moves up to fill the gap. 4 •If the cut operation is repeated, the image that is clicked or dragged last is temporarily copied and used by the paste function. • Several images can be cut in one operation. 4  Pasting Image 4 The copied or cut image can be pasted. 1 Select a desired image either by clicking or dragging, and either copy (available only after right-clicking) or cut it. 2 Select where to paste the image. 4 A selection border is displayed around the selected image. 3 Click , or select [Paste] on the right-click menu. The copied or cut image is pasted before the selected image. 4 4 SDR-120F Reference Guide 4-27  • The following diagrams show pasting in the 2×3 format. Copy or cut images E and F. Select image A and click or Images E and F are select [Paste] on the right-click pasted before image A. menu.  Inserting Blank Space A blank space can be inserted between two images. 1 Select the image in the front of which the blank space is to be inserted. The selection border is displayed around the image. 2 Click , or select [Blank] on the right-click menu. The blank space is inserted in front of the image selected. Select image C and click , or select A blank space is [Blank] on the right- inserted in front of click menu. image C. Image F is sent to the next film. 4-28 SDR-120F Reference Guide  4.7 Printing Images 4.7.5 Performing Processes by Right-Clicking 4 In addition to using the buttons on the operation panel, some processes can also be performed by clicking the right mouse button. This method also allows the copying and appending and pasting of 4 images, functions not available with the editing buttons. 1 Select an image and right-click it. The process menu is displayed. 1 4 2 4 3 4 5 4 6 No. Menu item Function 1 Cut Cuts the selected image. 4 4 " Cutting Image" P.4-27 Copies images. 2 Copy 4 " Copy" P.4-29 Pastes the copied or cut image before the selected image. 4 3 Paste 4 " Pasting Image" P.4-27 Inserts a blank space before the selected image. 4 Blank 4 " Inserting Blank Space" P.4-28 4 Pastes the copied or cut image behind the selected image. 5 Append 4 " Append" P.4-30 6 Separate Separate a film. 4 " Separating Print Film" P.4-26 4 2 Click a desired menu. The selected process is performed. 4  Copy The image selected is copied, not cut, and can then be pasted. 4 4 4 SDR-120F Reference Guide 4-29  Append "Paste" inserts the copied image before the clicked image. "Append" inserts the copied image behind the clicked image. Image C is copied. Select image A, and click [Append] Image C is pasted after on the right-click menu. image A. 4.7.6 Mouse Wheel Operations The image intensity can be adjusted by dragging the mouse horizontally and vertically with the mouse wheel held down. 2 " Changing Window Width Value and Window Level Value" P.2-16 Mouse wheel 4.7.7 Editing Print Preset The printing conditions can be registered as a preset. The preset can be edit or delete. For details, refer to 5.8 "Editing Print Preset". 4-30 SDR-120F Reference Guide  4.8 Screen Capture 4.8 Screen Capture 4 You can capture the screen of the Live monitor and Reference monitor and output it to a USB flash drive as an image file (PNG format). 4 • It is necessary to register your USB flash drive in the anti-virus software before use. If not, you 4 may not use it. Contact your Shimadzu service representative for details. • Even if the USB flash drive is not connected, the screen capture succeeds because the image is • temporarily output to the internal storage area. However, you cannot take the image out. Before using a USB memory storage device, make sure that it is not infected with a virus using 4 virus scanning software that has been updated to the latest definition file. The default is to capture the entire screen. Contact your Shimadzu service representative to 4 change the area to be captured. 1 Connect the USB flash drive to the USB port on the system. 4 2 Press [Print Screen] key. On some keyboards, the Print Screen key is the same as other keys. In this case, press 4 the [Fn] key and a function key (for example, the [F8] key). The dialog box notifying that screen capture has been acquired appears. If an error or notification dialog box is displayed, this dialog box might not appear until the error or notification dialog box is closed. 4 4 4 4 4 4 SDR-120F Reference Guide 4-31  3 Click [Close] to continue with the screen capture. Click [OK] to complete the screen capture and remove the USB flash drive. If you click [OK], the result of the removal process is displayed. If the removal is successful, remove the USB flash drive. If the removal fails, shut down the system, verify that the power is turned off, and then remove the USB flash drive. If you remove the USB flash drive without the removal procedure above, the files in the USB flash drive may be damaged or the system may be forcibly terminated. 4 If you check the USB flash drive, the following files have been created. [Date_Time_X.png] *X: Live monitor capture files ... "1" Reference monitor capture files ... "2" 4-32 SDR-120F Reference Guide  5 User Utility 5.1 Icons in Main Panel Icons on the main panel indicate system status and background processing status. The background processing is independently executed by the multi-task processor while the processor executes the other processing. 5.1.1 Icons List 1 2 3 4 5 6 7 No. Item Function Network connection icon 1 Displays the network connection status. 5.1.2 "Network Connection Icon" Image send icon Displays the image transmission processing status. 2 5 " Processing Status Window" P.5-4 4.4 "Sending Images" Print icon Displays the print processing status. 3 5 " Processing Status Window" P.5-4 4.7 "Printing Images" Media icon Displays the processing status for the storage media. 4 5 " Processing Status Window" P.5-4 4.1 "Saving Images" 4.2 "Reading Images" MPPS icon (option) Displays the MPPS processing status. 5 5.1.5 "MPPS Processing Status (Option)" 3.2 "MPPS (Option)" Battery-out icon Displays when the battery installed on the PC motherboard should be replaced. 6 If this icon appears, contact your Shimadzu service representative for a new battery. If the system is left for a long time after the icon is displayed, the system will not start. Insufficient image space icon Shows that the saved image capacity is low. If it appears, delete the saved 7 study/image to save free space. Fluoroscopy store or radiography cannot be performed until the capacity is secured. 5-2 SDR-120F Reference Guide  5.1 Icons in Main Panel 5.1.2 Network Connection Icon 5 The icon is displayed as follows, depending on the network connection status:. Icon status Description No network connection 5 5 Connected to the network with a wired LAN cable. If the router option is installed, this icon will be displayed if the connection to the router is successful, even if the LAN cable is not connected. 5 Radio field strength: Strong / Medium / Weak Connected to the network via wireless LAN (Option). Indicates the radio field strength of the access point in three / / levels. 5 5.1.3 Wireless Network Connection Window (Option) 5 The wireless network connection window allows you to operate wireless connection. When the wired communication and the wireless communication are connected at the same 5 time, the wireless communication takes priority. 5 1 Click the Network connection icon on the main panel. The wireless network connection window appears. 1 5 2 5 5 3 4 5 No. Item Function 5 Displays the currently connected wireless network 1 information. 2 Wireless network list Lists the wireless networks to which you can connect. 5 SDR-120F Reference Guide 5-3  No. Item Function [Reset] Resets the wireless adapter and performs connection 3 processing again. If connection fails, pressing this button may improve the problem. / [Connect] / [Disconnect] 4 Connects/disconnects to the selected wireless network. [Close] 5 Closes the wireless network connection window. 2 Select a wireless network you want to operate and connect/disconnect it. If you want to change the access point registration, contact your Shimadzu service representative. 5.1.4 Image Send, Print, and Media Icons The processing status can be checked in more detail and related operations can be performed. The appearance of the icons changes with the processing status as described below Button State Processing Status Out No processing is taking place. Lit Processing is taking place. Blinking Processing was interrupted or an error occurred.  Processing Status Window The processing status can be checked in more detail and related operations can be performed. 1 Click on the main panel. The Status window appears. 4 *1 2 3 * indicates that a button changes when pressed. 5-4 SDR-120F Reference Guide  5.1 Icons in Main Panel No. Item Function 5 [Pause] Pauses processing. If clicked, it changes to [Restart]. *1 [Restart] 5 Restarts processing. If clicked, it changes to [Pause]. [Abort] 2 Aborts processing. Select a desired process in the processing status list and click [Abort]. The confirmation dialog box appears. Select either [Yes] or [No]. 5 [Close] 3 Closes the Status window. 4 Processing status list The processing status is displayed for each process. 5 5 If [Pause] or [Abort] is clicked for image send, depending on the destination, operation may not 5 be possible for approximately 1 minute.  Displayed Information Item names 5 Item name Description 5 Patient name The patient's name is displayed. Patient ID The patient ID is displayed. Status The status (e.g., "Running" or "error") is displayed. 5 Progress The progress of the process is displayed. The information below is displayed. Details Send tab: Image sending destination Print tab: Print preset name 5 Media tab: Current processing Error information The error code is displayed. Time The time of error occurrence is displayed. 5 If some item are hidden, scroll the scroll bar to right side.  Switching Processes 5 To check the status of another type of process, click the tab. 5 Switch tabs. SDR-120F Reference Guide 5-5  Processing Errors If an error occurs during processing, "Error" is displayed in the [Status] column in the Status window, and subsequent process automatically enter pause status. • Continuing Processing 1 Check the error code displayed under [Error Info.] and perform appropriate action according to M517-V060 OPESCOPE ACTENO FD type Instruction Manual, "5. Troubleshooting". If [Error Info.] is hidden, scroll the scroll bar to right side. Check the error 2 After the action is completed, select the process and click [Restart] to resume processing. Select the process. • Aborting Processing Before Completion 1 Select a desired process. The selection is highlighted. 2 Click [Abort]. Select the process to be aborted. The Confirm dialog box appears. 5-6 SDR-120F Reference Guide  5.1 Icons in Main Panel 3 Click either [Yes] or [No]. 5 Click [Yes] to abort and delete the process from the process list. Click [No] to cancel the process abortion, and the dialog box is closed. 5 5 • If it is not possible to continue the process, click [Abort] to abort the process. • If nothing is displayed in the list, all processes have done or no process takes place. 5.1.5 MPPS Processing Status (Option) When the MPPS option is available, the MPPS icon appears on the main panel. When the 5 communication error occurs, blinks. Check the error contents. 1 Click on the main panel. 5 The MPPS Error List window appears. 2 5 3 1 5 4 No. Item Function 5 1 Error List Displays the patient's name, patient ID, and date where the error occurs. [Remove] 2 Stops the notification of the patient selected in the error list. The notification is deleted. 5 [Resend] 3 Notifies again the patient selected in the error list. 4 [Close] 5 Closes the MPPS Error List window. 2 Select the target patient and perform necessary processing. 5 5 5 SDR-120F Reference Guide 5-7 5.2 System Information The system information shows the system version. 1 Click [System] on the main panel. The system menu is displayed. System menu 2 Click [System Info.]. The system version is displayed. 3 Click [Close] to close the System Information window. 5.3 Save Screen It is used to hide a screen temporarily for switching a patient. The Save screen is available only out of study. 1 Click [System] at the top right of the window. The system menu is displayed. 2 Select the [Utility] and [Save Screen]. The screen is hidden. 3 In order to display the screen, move the mouse. 5-8 SDR-120F Reference Guide  5.4 SMPTE Pattern Display 5.4 SMPTE Pattern Display 5 The SMPTE pattern is used for monitor quality control. The SMPTE pattern display is available only out of study. 5 1 Click [System] at the top right of the window. The system menu is displayed. 2 Select the [Utility] and [Display SMPTE pattern]. 5 5 The SMPTE pattern is displayed. 5 3 In order to restore the screen, move the mouse. 5.5 OSS License Display 5 The list screen of the OSS (Open Source Software) license used by the SDR-120F is displayed. 1 Click [System] at the top right of the window. The system menu is displayed. 5 2 Select the [Utility] and [Display OSS License]. 5 5 The license list screen appears. 5 5 5 3 Click [Close]. The license list screen closes. 5 SDR-120F Reference Guide 5-9 5.6 FPD Calibration The FPD calibration automatically adjusts the FPD to reduce the influence of temperature and time on image quality. The FPD calibration communicates with the FPD. Before the calibration, confirm that the C-arm cart is connected and the power is turned on. 1 Click [System] at the top right of the window. The system menu is displayed. 2 Select the [Calibration]. The calibration menu is displayed. Calibration menu 3 Select a desired menu. 5.6.1 FPD Calibration The periodic FPD calibration should be performed every 6 months for proper image acquisition. If the FPD calibration has expired, a message appears at startup and a study start. If the message appears, perform the FPD calibration as follows. The equipment can be used as usual even if the FPD calibration period has expired. You can perform the FPD calibration before and after the expiration date. Exposures are made intermittently during the FPD calibration. 5-10 SDR-120F Reference Guide  5.6 FPD Calibration 5 • The FPD calibration cannot be performed for 10 minutes after the FPD is activated or for 2 minutes after fluoroscopy/radiography. 5 • After the FPD calibration, perform fluoroscopy and fluoroscopy (boost pulse), and radiography to make sure there are no unusual artifacts or unevenness in the acquired image. If any • abnormalities are observed, perform the FPD calibration again. If, after the FPD calibration, the image still contains an artifact or a defective pixel such as a 5 bright or dark pixel, contact your Shimadzu service representative. • Depending on the storage and operation environment, or if the FPD is subjected to an impact, 5 there may be adverse effects on the image that cannot be corrected by the software. In the worst case, the FPD needs to be replaced. The FPD calibration is available only out of study. 1 Check that the C-arm is at its home position. 5 The zero on each scale is the C-arm’s home position. M517-V060 OPESCOPE ACTENO FD type Instruction Manual, "3.6.6 About the Scales" 5 5 5 5 5 5 5 5 SDR-120F Reference Guide 5-11  2 Click [FPD Calibration]. The FPD Calibration window appears. 3 Click [Yes] or [No]. Click [No] to cancel the FPD calibration and close the window. Click [Yes] to display the instructions to start the FPD calibration. 4 Follow the instructions on the screen, and then click [OK], or click [Cancel]. If you click [OK] with the grid inserted, an error occurs and you cannot proceed. Click [OK] to start preparations for the FPD calibration and to display the progress. Please wait until it becomes 100%. Click [Cancel] to display the confirmation dialog box. If you follow the on-screen instructions to stop the calibration, it is canceled and the dialog box closes. 5-12 SDR-120F Reference Guide  5.6 FPD Calibration 5 When the preparation is completed, a message appears asking you to operate the fluoroscopy foot switch. 5 Follow the instructions. 5 5 Click [Cancel] to display the confirmation dialog box. If you follow the on-screen instructions to stop the calibration, it is canceled and the dialog box closes. 6 Press the foot switch to display the progress bar. 5 5 5 Click [Cancel] to cancel the calibration and to display the confirmation dialog box. Click [OK] to close it. 5 If the foot switch is released or there is an error in processing, a dialog log box appears to inform you of the cancellation. 5 5 5 Click [OK] to retry the FPD calibration. 7 When the FPD calibration is completed, the completion dialog box appears. Click [OK] to 5 complete the FPD calibration. 5 5 SDR-120F Reference Guide 5-13 5.6.2 Offset Calibration With the offset calibration, you can manually perform temperature correction of the FPD, which is automatically processed on a regular basis. If you see a border near the center of the image or if the entire image is collapsed, the offset calibration may improve these problems. Do not perform the offset calibration within 30 seconds after X-ray exposure. The acquired image may be inappropriate. 1 Click [System] - [Calibration] - [Offset Calibration]. The offset calibration window appears. 2 Click [Yes] or [No]. Click [No] to cancel the offset calibration and close the window. Click [Yes] to start the offset calibration. Click [Cancel] to display the confirmation dialog box. Follow the instruction on the dialog box to cancel the calibration. 3 When the offset calibration is completed, the completion dialog box appears. Click [OK] to close the dialog box. 5-14 SDR-120F Reference Guide  5.6 FPD Calibration 5.6.3 History of FPD Calibration 5 The history of the FPD calibration can be checked. 1 Click [System] - [Calibration] - [Record]. 5 5 The Record of calibration window appears. 5 2 Check the history and click [Close] to close the window. 5 5 5 5 5 5 5 5 5 SDR-120F Reference Guide 5-15 5.7 Editing Presets Frequently used fluoroscopy and radiography conditions can be registered as "presets". The preset edit is available only out of study. 1 Click [System] on the main panel. The system menu is displayed. 2 Select [Edit Preset]. The preset selection menu is displayed. Preset selection menu 3 Select a desired preset. The edit window for the selected preset appears. For details on procedures from here on, refer to the following: 5.8 "Editing Print Preset" 5.9 "Editing APR Presets" 5.10 "Requesting Department Preset" 5.11 "Physician's Name Presets" 5.12 "Technologist's Name Presets" 5.13 "Annotation Template Preset" 5-16 SDR-120F Reference Guide  5.8 Editing Print Preset 5.8 Editing Print Preset 5 The printing conditions can be registered as a preset. The preset can be edit or delete. 5.8.1 Print Preset Window 5 1 Select [Print preset]. 5 5 The Print preset window appears. 1 2 3 9 10 5 4 5 11 6 7 5 13 8 12 5 Item Function 1 [Preset Title] Enters a new preset title or display a registered preset 5 title. 5 [Printer] 2 Selects the printer from the printer list registered in the system. [Film Dir.] 5 3 Specifies the orientation of the printing film, either portrait or landscape, in the list. [Film Size] Specifies the size of the printing film in the list. 4 5 [Print Mode] Specifies the print mode in the list. 5 5 5 SDR-120F Reference Guide 5-17  Item Function [Format] Specifies the frame layout on the film in the list. 6 [Style] Selects the film style. • NORMAL: Image information is printed over the image. • FIT (INNER): Image is enlarged so that it fills the space horizontally, but 7 the whole image is printed on a film. Image information is printed in the margins of the image. • FIT (OUTER): Image is enlarged so that it fills the space vertically, and parts that protrude on the left and right are not printed. Image information is printed within the image. [Copy] 8 Specifies the number of print copies (i.e., the number of copies per film). Click ./ . [New Regist] 9 Save the set preset condition with a new preset title. [Save] 10 Saves changes under the same preset title. Previously registered information is discarded. [Delete] 11 Deletes the selected preset. [Close] 12 Closes the Print preset window. Changes the display order of presets when there are 13 / multiple presets. * Items 1 to 7 are the same parameters of those in the Print preset select window. 5-18 SDR-120F Reference Guide  5.8 Editing Print Preset 5 Registered sizes and formats are only displayed. To change the registered contents, contact 5 your Shimadzu service representative. 5.8.2 Registering Preset Title 5 1 Enter a new preset title in items in the list. and Select a desired 5 To overwrite an existing preset, select the preset title from the preset list, and make desired changes by making selections. Enter a new preset title (to create a new preset). 5 Select a preset (to overwrite it). Either register a new preset or save (i.e., overwrite) an 5 Make desired existing one. selections. 5 5 2 Click either [New Regist] or [Save]. The settings are saved. 5 If you select [New Regist] with a existing preset title, the confirmation dialog box appears. 5 Assign a new preset title and save the new preset. 3 Click [Close]. 5 The Print preset window closes. 5 5 SDR-120F Reference Guide 5-19  If a preset title is not entered in preset registration, the following Notice dialog box appears. Enter the preset title for registration. 5.8.3 Deleting Preset Title 1 Select the preset title to be deleted from the preset list and click [Delete]. The Confirm dialog box appears. 2 Click either [Yes] or [No]. Click [Yes] to delete the selected preset from the list. Click [No] to abort the deletion, and the dialog box closes. 5-20 SDR-120F Reference Guide  5.8 Editing Print Preset 5.8.4 Preset Registration for True Size Print 5 A print preset for true size print can be registered. In the true size print, the enlargement factor used for a printout is calculated based on the pixel size calculated from a print area of a film and the system 5 geometry (FOV size), and full sized image is printed. 5 An error is included in the output. 1 Select [True Size] from the drop-down menu of the Print Mode box. 5 Setting fields for true size calibration are displayed. 5 5 5 2 Select or input a desired value in each field. 5 Item Function [Vertical size (mm)] Used to specify the height size of the print area. When the 1 layout of 1 x 2 or 2 x 2 is selected, the size of one frame will 5 be set. [Horizontal size (mm)] Used to specify the width size of the print area. When the 2 layout of 1 x 2 or 2 x 2 is selected, the size of one frame will be set. [SID Calib. (mm)] 5 The standard value is 0. In the standard, an enlargement factor is adjusted so that an object above 10cm from the tabletop is printed in full size. In order to use an enlargement factor equivalent to 5 3 radiography with a cassette on the tabletop such as conventional CR radiography or film exposure, input the 5 distance from the X-ray tube to tabletop. In order to use an enlargement factor equivalent to other CR radiography systems and film exposure systems, input the same SID value as that of these systems. 5 SDR-120F Reference Guide 5-21 5.9 Editing APR Presets The Edit APR Preset allows you to change the preset fluoroscopy sand radiography conditions. 5.9.1 Edit APR Preset Window 1 Select [APR Preset]. The Edit APR Preset window appears. 2 1 5 3 *4 6 7 * indicates that the appearance changes according to the button selected. No. Item Function 1 APR preset list Lists the registered APR presets. [Field of View] Selects the field of view: Normal or Zoomed. [Def. Acq. Mode] Selects the default acquisition mode from the Spot, Serial 2 or DSA. [V Reverse] Selects the vertical reverse ON or OFF. [H Reverse] Selects the horizontal reverse ON or OFF. 5-22 SDR-120F Reference Guide  5.9 Editing APR Presets No. Item Function Displays the agent responsible for the APR change and 5 the date of the last change. 3 If you want to change the agent, contact your Shimadzu service representative. Selects a tab to set conditions. 5 4 Mode setting area 5.9.2 "Fluoroscopy Condition Setting" 5.9.3 "Radiography Condition Setting" 5 [Image Dest 1/2] Selects the destination to send the image automatically 5 when the study ends. You can set up to two destinations. [Print Preset] Select the printer to print the image automatically at the 5 5 end of study. [Send RDSR] (option) Sets OFF/ON for automatic transmission of dose report 5 at the end of study. [Media Archive] Sets OFF/ON for the media archive registration of the image at the end of study. 6 [Save] Saves the changes in the Edit APR Preset window. 5 [Close] 7 Closes the Edit APR Preset window. 5 The following Confirm dialog box appears if you click the [Close] without saving the new 5 settings. 5 5 Click [Yes] to discard the changes and closes the Edit APR Preset window. Click [No] to return the Edit APR Preset window. 5 5 SDR-120F Reference Guide 5-23 5.9.2 Fluoroscopy Condition Setting The Fluoro. tab provides the fluoroscopy condition settings. 1 2 3 4 5 6 8 7 9 10 11 12 No. Item Function [Dose Mode] 1 Selects the dose mode: High Quality, Normal, Low Dose 1, Low Dose 2, or Boost Pulse. [Fluoro. Rate] 2 Selects the fluoroscopy rate: DC, 15 fps, 10 fps, 7.5 fps, or 3.75 fps. [Store Mode] Selects either the frame memory mode to store only one frame or 3 the loop memory mode to store a loop memory image (continuous fluoroscopy images). [Loop Frames] 4 Enters a value of 100 to 300 for the number of images to be stored in the loop memory mode. [Recursive] [Edit Recursive-Rate] Selects the strength of recursive processing that improves the 5 graininess of the image. Recursive processing can be set per fluoroscopy rate. 5 " Edit Recursive-Rate Table" P.5-25 [Noise Reduct] 6 Selects the strength of the noise reduction processing from 1 to 5. [D.R.C] 7 Selects the strength of the dynamic range compression from 1 to 5. [Contour Enh.] 8 Selects the strength of the enhancement processing from 1 to 5. [Gamma Type] [Gamma Level] 9 Selects the display gamma table. The parameters you can select depend on the type. 5-24 SDR-120F Reference Guide  5.9 Editing APR Presets No. Item Function [Edge Type] [Edge Level] 5 10 Selects the parameter to sharpen the edge (outline) of the image. The parameters you can select depend on the type. [Brightness] 5 11 Selects the brightness of the fluoroscopy image from +4, +3, +2, +1, 0, -1, and -2. 12 [Edit Brightness] Sets the image gradation processing. 5 5 " Edit Width/Level-Brightness Table" P.5-26 5  Edit Recursive-Rate Table Clicking [Edit Recursive-Rate] shows a table to select the recursive processing strength. 5 1 5 5 2 3 5 No. Item Function Selects the processing strength of the recursive processing from 1 to 5 per 1 Strength setting fluoroscopy rate. [Save Temp.] 2 Temporarily saves the changes made in the Edit Recursive-Rate Table. To save the changes, you need to save them in the Edit APR Preset 5 window. [Close] 3 Closes the Edit Recursive-Rate Table. 5 5 5 5 SDR-120F Reference Guide 5-25  Edit Width/Level-Brightness Table Clicking [Edit Brightness] shows a table to set the Width and Level. 1 2 3 No. Item Function Sets the Width from 1 to 32768, and the Level from 0 to 16383. 1 Width/Level setting If an out-of-range value is entered, it is corrected to the in-range value automatically. [Save Temp.] Temporarily saves the changes made in the Edit Width/Level- 2 Brightness Table. To save the changes, you need to save them in the Edit APR Preset window. [Close] 3 Closes the Edit Width/Level-Brightness Table. 5-26 SDR-120F Reference Guide  5.9 Editing APR Presets 5.9.3 Radiography Condition Setting 5 The radiography conditions of the SPOT, SERIAL, and DSA are set up in the each tab. 1 5 5 *5 2 3 5 4 Spot radiography condition setting 5 5 1 **6 **8 **7 **9 5 2 3 5 4 5 SERIAL/DSA radiography condition The item with "*" appears only for the SPOT tab. The items with "**" appear only for the SERIAL or the DSA tab. No. Item Function 5 [Nega/Posi] 1 Sets the negative/positive of the radiography image. 2 [AWC] Selects the type of AWC for automatic density adjustment. 5 [Gamma Type] [Gamma Level] 3 Selects the display gamma table. The parameters you can select depend on the type. 5 5 SDR-120F Reference Guide 5-27  No. Item Function [Edge Type] [Edge Level] 4 Selects a parameter to sharpen the edge (outline) of the image. The parameters you can select depend on the type. [SURE Type] *5 Selects the part to be examined from the list. [Acq.Rate] Selects the number of frames to acquire per second from 0.5, 1, 2, **6 3, 3.75, 5, or 7.5 fps. If the acquisition frame with a selected rate exceeds the maximum number of frames, the acquisition time is automatically adjusted. [Acq. Frames] Displays the number of frames to be acquired with set-up rate and time. The maximum number of frames with current settings is **7 displayed in [ ]. If the number of frames exceeds the maximum, the number blinks. Reduces the rate or time. [Acq.Time] Sets the time between the start and end of radiography. **8 The maximum time according to the rate is displayed in [] below the input field. If an input value exceeds the maximum time, it is automatically adjusted to the in-range value. [Auto Play] **9 Sets the auto play after the acquisition between ON and OFF. When the Acq mode is changed, the Acq rate hold in the X-ray generator is set. 5-28 SDR-120F Reference Guide  5.10 Requesting Department Preset 5.10 Requesting Department Preset 5 In the requesting department preset, you register or delete the requesting department. 5.10.1 Registering Requesting Department Presets 5 1 Select [Requesting department preset]. 5 5 The Requesting department preset window appears. *2 5 3 *1 5 4 5 6 7 * indicates that the appearance changes 5 according to the preset. No. *1 Item Preset list Function Displays preset names currently registered. 5 *2 Department Adds a preset name or displays registered one. 3 [Add] Registers the preset name to the preset list. 5 Change order buttons Changes the order of the currently selected preset. 4 / Selecting moves the preset one up. 5 Selecting moves the preset one down. [Delete] 5 5 Deletes the currently selected preset. [Save] 6 Saves the new settings. 7 [Close] Closes the Requesting department preset window. 5 5 SDR-120F Reference Guide 5-29  2 Enter the requesting department's name at [Department]. The confirmation dialog box appears if the [Add] is clicked without entering the requesting department name. Enter the name. 3 Click [Add]. The requesting department name is registered to the preset list. 4 Click or button (if necessary). The order of the presets is changed. 5 Click [Save]. The new settings are saved. If the [Save] is not clicked, the new settings are discarded. 6 Click [Close]. The Requesting department preset window closes. The following Confirm dialog box appears if the [Close] is clicked without saving the new settings. Click [Yes] to discard the changes and closes the Requesting department preset window. Click [No] to return the Requesting department preset window. 5-30 SDR-120F Reference Guide  5.10 Requesting Department Preset 5.10.2 Deleting Requesting Department Presets 5 1 Select the name of the preset to be deleted from the list. The selected preset is highlighted. The selected 5 preset is highlighted. 5 5 2 Click [Delete]. The Confirm dialog box appears. 5 5 3 Click either [Yes] or [No]. 5 Click [Yes] to delete the selected preset. Click [No] to cancel the deletion, and the Confirm dialog box closes. 4 Click [Close]. 5 The Requesting department preset window closes. 5 5 5 5 5 SDR-120F Reference Guide 5-31 5.11 Physician's Name Presets In the physician's name preset, you register or delete the physician's name. 1 Select [Physician's name preset]. The Physician's name preset window appears. 1 No. Item Function 1 Name Adds a physician's names or displays registered one. For details on other items and operations, refer to 5.10 "Requesting Department Preset". 5.12 Technologist's Name Presets In the technologist's name preset, you register or delete the technologist's name. 1 Select [Technologist's name preset]. The Technologist's name preset window appears. 1 No. Item Function 1 Name Adds a technologist's names or displays registered one. For details on other items and operations, refer to 5.10 "Requesting Department Preset". 5-32 SDR-120F Reference Guide  5.13 Annotation Template Preset 5.13 Annotation Template Preset 5 1 Select [Annotation template preset]. 5 5 The Annotation template preset window appears. 5 1 5 No. Item Function 5 1 Template Adds a template or displays a existing template. For details on other button and operation in the window, refer to Department Preset". 5.10 "Requesting 5 5 5 5 5 5 5 SDR-120F Reference Guide 5-33  This page is intentionally left blank. 5-34 SDR-120F Refereence Guide  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:04:09 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:03:51 EET PD506-032A Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO FD type GENERAL The OPESCOPE ACTENO FD type is an imaging system whose main applications are X-ray fluoroscopy and radiography during surgery. 1  OPESCOPE ACTENO FD type FEATURES (4) The absence of levers and cables on the C-arm 1. C-arm operability makes it easy to wipe and keep clean. (1) Electromagnetic lock mechanism The fully balanced C-arm is manually operated very easily and needs no levers. The independent electromagnetic lock mechanisms allow individual locking of all movements, which ensures quick and accurate C-arm positioning. (5) The width at the C-arm cart is just 800 mm. Moving the system through narrow doors into the operation room and positioning the unit in the busy room with many surgical devices become easier. 2. Technology for high quality imaging (1) High resolution FPD The system incorporates a 8 inch FPD (Flat Panel Detector) and a 100 kHU X-ray tube for high- resolution imaging. (2) Doctor handle The C-arm lock-free switch on the FPD grabber handle allows for rapid single-handed C-arm positioning by the doctor. (2) SCORE PRO Advance SCORE PRO Advance (SPA) is the name of Shimadzu image processing technology, which achieves both high image quality and dose reduction. without SPA with SPA (3) C-arm cart weighs only 260 kg but has 780 mm wide opening space between FPD & generator which minimizes interference with the operation table. It simplifies approaches to the surgical site and maintains adequate working space for the surgeon. (3) Boost pulse fluoroscopy This high-output, pulsed X-ray exposure results in high-contrast, high-quality images while limiting the X-ray dose. 2  OPESCOPE ACTENO FD type (4) Auto(standard) and Pinpoint(option) brightness control CONFIGURATION Auto ① STANDARD CONFIGURATION The system has automatic brightness control C-arm cart 1set function which analyzes the fluoroscopy image High frequency X-ray generator 1set brightness at real time and maintains optimal (including X-ray tube and collimator) brightness by controlling x-ray conditions. FPD 1set Pinpoint Monitor cart 1set This option provides the best brightness to pointed ROI at any place in FOV in real time. ② OPTIONAL ITEMS • Laser pointer Selectable projection direction: from FPD side or tube side • C-arm cover Disposable type cover. • Image display on C-arm main panel This displays live monitor image on C-arm’s main panel. • Monitor moving function The monitor height can be adjusted to up or down and 3. New dose management the monitors can be folded. (1) The system offers genuine pulsed fluoroscopy at • Heat pipe unit 15 fps as standard. This is the cooling pipe in X-ray tube. (2) The system allows the insertion of a Beam • Hand switch Hardening (BH) filter to cut soft X-rays up to 50%. Secondary (fluoroscopy/radiography) exposure control. (3) The virtual collimation can be set from the • Wireless hand switch Last-Image-Hold (LIH) image. Wireless type hand switch. (4) Grid removable function • Clone display & Image export The grid can be removed to minimize dose level. Clone display (5) DAP value display This enables you to have the same live fluoroscopic The DAP value calculated by the system (or image. measured by a dosimeter (option) ) will be on both left & right monitors. displayed at real-time on the touchscreen and Image export monitor. DVI port on monitor cart can export fluoroscopic image. (6) Long cable foot switch (option) allows the operator • Dosimeter to retreat outside the operating room avoiding • DSA acquisition X-ray exposure. • DICOM MPPS / DICOM RDSR • Wireless DICOM communication 4. Various options The various options allow you to accommodate the most suitable system configuration flexibly for each facility and upgrade to have wireless DICOM connection unit or DSA capability etc., whenever needed. 3  OPESCOPE ACTENO FD type SPECIFICATIONS ① C-arm cart SID (Source Image receptor Distance) 1005mm Minimum horizontal X-ray level from floor 774mm (Under X-ray tube position) 1104mm (Over X-ray tube position) C-arm rotation 120° C-arm axial rotation 300/-120° C-arm up/down travel 450mm C-arm FWD/REV travel 200mm C-arm swiveling ±12.5° C-arm free space 780mm Touch Panel Display 8.4 inches, 800 x 600 pixels ② X-ray control unit Nominal maximum output 2kW Setting range of tube voltage 40 to 110kV Digital radiography Short-time rating (Manual SPOT) 100kV, 3.20mAs (20mA) 110kV, 2.50mAs (16mA) Short-time rating (Memory shot) 110kV, 2.65mAs (16mA) Setting range of mAs (Manual SPOT) 0.50 to 3.20mAs Setting range of mAs (Memory shot) 0.30 to 2.65mAs Tube current (Manual SPOT) 20mA Tube current (Memory shot) 16mA Pulse fluoroscopy Rate of pulse fluoroscopy 3.75, 7.5, 10, 15fps Nominal max. tube voltage and max. tube current 110kV, 4.9mA that can flow at nominal max. tube voltage Max. tube current and max. tube voltage to 6.8mA, 80kV achieve max. tube current Tube current 0.5 to 6.8 mA (100V/200V mode) Boost pulse fluoroscopy Rate of boost pulse fluoroscopy 3.75, 7.5 fps Nominal max. tube voltage and max. tube current 110kV, 9.8mA that can flow at nominal max. tube voltage Max. tube current and max. tube voltage to 13.5mA, 80kV achieve max. tube current Continuous fluoroscopy DC (Acquisition rate:30fps) Nominal max. tube voltage and max. tube current 110kV, 4.9mA (200V mode) that can flow at nominal max. tube voltage 110kV, 3.6mA (100V mode) Max. tube current and max. tube voltage to 6.8mA, 80kV (200V mode) achieve max. tube current 5mA, 80kV (100V mode) Tube current 0.5 to 6.8 mA (200V mode) 0.5 to 5.0 mA (100V mode) ③ X-ray tube X-ray tube type Stationary anode type Focal spot size 0.6mm Anode heat storage capacity 100kHU Tube assembly heat storage capacity 680kHU (480kJ) Maximum tube cooling rate 226HU/s (160W) Target (angle and material) 8°, Tungsten ④ Collimator Octagonal collimator Electrical drive (opening/closing), made of Tungsten Parallel collimator Electrical drive (opening/closing and rotation), made of Cu Compensating filter Electrical drive (filter selection), made of Cu, 0.1mm thick 0.2mm thick 0.3mm thick 3.0mmAl 3.7mmAl 3.8mmAl ⑤ FPD X-ray Conversion material CsI Pixel area 210mm (V) × 210mm (H) Pixels array 1024 (V) × 1024 (H) Effective pixel area 205mm (V) × 205mm (H) Effective pixels array 1000 (V) × 1000 (H) Pixel pitch 205μm MTF 48% or more (@1.0lp/mm) DQE 62% or more (@0.0lp/mm) 4  OPESCOPE ACTENO FD type Energy width 40-110kVp A/D range 16bit Ambient temperature 10℃～40℃ Relative Humidity 10 to 90% (Free of dew condensation) ⑥ Imaging system X-ray detector Flat panel detector X-ray conversion material CsI Pixel pitch 205um MTF 48% or more (@1.0lp/mm) DQE 62% or more (@0.0lp/mm) Dynamic range 16bits (65,536 graduations) Pixel area 210mm (V) × 210mm (H) Effective pixel area 205mm (V) × 205mm (H) ⑦ Monitor Monitor type 19 inch LCD , Color ⑧ Grid Grid ratio 13:1 Strips per centimeter 70 lines/cm Inter space material Fiber ⑨ Digital Radiography unit OS Windows10 or later Imaging mode ・Continuous/ Pulse/ Boost pulse fluoroscopy ・Digital spot / Serial radiography ・Real time DSA(option) Fluoroscopy acquisition LIH or Loop images 1000×1000matrix,16bits SPOT acquisition 1000×1000matrix,16bits Serial acquisition 0.5, 1.0, 2.0, 3.0, 3.75, 5.0, 7.5 fps 1000×1000matrix,16bits Real time DSA acquisition (option) 0.5, 1.0, 2.0, 3.0, 3.75, 5.0, 7.5 fps 1000×1000matrix,16bits HDD image storage 30,000 images or more(1,000×1,000, 16bit) Output media DVD-R/CD-R (DICOM), USB flash drive (JPEG or BMP) Image processing ・SCORE PRO Advance (Fluoroscopy) ・SURE (SPOT) ・Edge enhancement, Window/Level adjustment ・Flip (vertical/ horizontal), Black/ White inversion image rotation ・×4 zoom, Panning ・Multiple image display for 2×2/4×4 ・Distance / angle measurement ・Annotation display ・Re-masking (Requires DSA option.) ・Re-registration (Requires DSA option.) ・Stacking (Requires DSA option.) ・RSM filter processing (Requires DSA option.) DICOM DICOM Media Storage CD-R, DVD-R communication DICOM Storage Sends images to server/ viewer. DICOM Print Sends images to laser imager. DIOCM MWM Receives examination information from the HIS/RIS (Modality Worklist Management) server. DICOM MPPS (option) Sends study results to HIS/RIS server. (Modality Performed Procedure Step) DICOM RDSR (option) Makes the dose reports. (Radiation Dose Structured Report) 5  OPESCOPE ACTENO FD type Environmental Conditions and Power Supply ① Operation Conditions Temperature ： 10 to 35℃ Relative Humidity ： 30 to 80% (Free of dew condensation) Atmospheric pressure ： 800 to 1060 hPa Atmosphere ： Atmosphere without explosive gases or corrosive gases ② Power supply System ： Single phase AC Frequency ： 50 or 60Hz Capacity ： 2.0kVA or more Voltage and power impedance ： 100, 110, 120 V ±10% less than 0.2Ω (100V mode) 200, 220, 230, 240 V±10% less than 0.8Ω (200V mode) Main breaker ： Inverter-applicable ③ Power Consumption 100/110/120V 200/220/230/240V Long time 15A 10A Short time 45A 20A 6  OPESCOPE ACTENO FD type DIMENSIONS unit : mm Weight : C-arm cart 250kg (with options：260kg) Monitor cart 140kg (with maximum load：155kg) Label Description: SURGICAL MOBILE C-ARM IMAGING SYSTEM OPESCOPE ACTENO Founded in 1875, Shimadzu corporation, a leader in the development of advanced technologies, has a distinguished history of innovation built on the foundation of contributing to society through science and technology. We maintain a global network of sales, service, technical support and applications centers on six continents, and have established long-term relationships with a host of highly trained distributors located in over 100 countries. For information about Shimadzu. and to contact your local office. please visit our Web site at Shimadzu Corporation Medical Systems Division has been certified by www.shimadzu.com TÜV Rheinland as a manufacturer of medical systems in compliance with ISO9001:2015 Quality Management Systems and ISO13485:2016 Medical Devices Quality Management Systems. Remarks: ⚫ Every value in this document is a standard value, and it may vary a little from the actual at each site. ⚫ The appearances and specifications are subject to change for reasons of improvement without notice ⚫ Items and components in the photos may include optional items. Please confirm with your sales representative for details. Headquarters ⚫ Certain configurations may not be available pending regulatory clearance. 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto 604-8511, Japan ⚫ Contact your sales representative for information on specific configurations. https://www.shimadzu.com/med/ ⚫ Before operating this system, you should first thoroughly review the Instruction Manual. 7  Digitally signed by Botnaru Andrei Date: 2025.01.14 09:05:38 EET Reason: MoldSign Signature Location: Moldova MOLDOVA EUROPEANĂ sl (^t.r $s s\ F\1 sii &\ R. NS. \s. Sq$l G- s A\ s. :i\ \ s. .X {ir} v N I\lP, st X m I\ tFi tF{ El> s:SP E LR] IN. IN\ LN IS IS tr kI ti\ t:\ ry) t\-\) fT t*ql N X { t3 .*C Fi H ft t*i G 'b l-{ s$ ER \IN €tu {- tr tr tr tr Hz a s tF fr 7 rfi) =3 Orfl F 1>t. fill ts o- ra^ $ -rEil -J I H oH ="a TJ?E F> mt E- s x # AE #{ JI vl 6l cl  1 / 19 HANKEPASS Hankepass ehk Euroopa ühtne hankedokument (ESPD) on ettevõtja enda kinnitus, mis on esialgne tõend ametiasutuste või kolmandate isikute poolt väljastatavate tõendite asemel. Pakkumus:530334 Ettevõtja: Neotec SRL Roll: peapakkuja I OSA: HANKE JA HANKIJAGA SEOTUD TEAVE Teave avaldamise kohta Teate number ELTs: - ELT URL: Riigi ametlik teataja: 279740 Kui Euroopa Liidu Teatajas hankekuulutust avaldatud ei ole või kui selle avaldamist ei nõuta, peab avaliku sektori hankija või võrgustiku sektori hankija ise teabe esitama, et hankemenetlust saaks üheselt identifitseerida (nt viide siseriikliku avaldamise kohta). Hankija andmed Ametlik nimi: Riigi Kaitseinvesteeringute Keskus (70009764) Riik: Eesti Hankija aadress: Järve tn 34a Hankija veebiaadress: https://www.kaitseinvesteeringud.ee/ E-posti aadress: [email protected] Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  2 / 19 Teave hankemenetluse kohta Hanke menetlusliik: Avatud hankemenetlus Pealkiri: Mobiilne röntgenseade Lühikirjeldus: Hanke esemeks on mobiilne röntgenseade (arkoskoop), mis soetatakse Moldova Kaitseministeeriumile vastavalt lõppkasutaja vajadustele ning EPF MOLDOVA projektile. Hanke eesmärk on ühekordse hankelepingu sõlmimine ühe pakkujaga ühekordseks ostuks mobiilse röntgenseadme soetamiseks koos tarne ja paigaldusega Moldova Vabariiki ning esmase kasutajakoolitusega. Avaliku sektori hankija või võrgustiku sektori hankija poolt toimikule antud viitenumber (kui on asjakohane): 279740 Hanke liik: Asjad Hanke CPV-d: 33111000-1 Röntgenoloogiaseadmed Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  3 / 19 II OSA: ETTEVÕTJAGA SEOTUD TEAVE A: Teave ettevõtja kohta Nimi: Neotec SRL Registrikood: 1002600048135 Riik: MDA Aadress: strada Zaikin, 37 Chisinau MD-2005 Üldine veebileht: www.neotec.md Kontaktisikud: Andrei Botnaru Kontaktide e-posti aadressid: [email protected] Kontaktide telefoninumbrid: +373 69111661 Ettevõtte suurus: Keskmise suurusega ettevõte Töötajate arv: 18 Käive: 1672000 Valuuta: EUR Finantsalase võimekuse kirjeldus: Tehnilise võimekuse kirjeldus: Teostatud tööde kirjeldus: Ettevõtja tegevusvaldkond: Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  4 / 19 ETTEVÕTJA ON KAITSTUD TÖÖKOHT Ainult reserveeritud hangete puhul: kas ettevõtja puhul on tegemist kaitstud töökohaga, sotsiaalse ettevõttega või ta täidab lepingut kaitstud tööhõive programmide raames? Küsimused ettevõtjale: 1. Mis on Teie vastus? Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? Vastus: Ei ETTEVÕTJA ON KANTUD TUNNUSTATUD ETTEVÕTJATE AMETLIKKU NIMEKIRJA Kui see on asjakohane, siis kas ettevõtja on kantud tunnustatud ettevõtjate ametlikku nimekirja või kas tal on olemas samaväärne tõend (nt riikliku (eel)kvalifitseerimissüsteemi alusel)? Küsimused ettevõtjale: 1. Mis on Teie vastus? Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? Vastus: Ei HANKEMENETLUSES KOOS OSALEVAD ETTEVÕTJAD Kas ettevõtja osaleb hankemenetluses koos teistega? Küsimused ettevõtjale: Ettevõtja nimi:Neotec SRL Ettevõtja ID:1002600048135 Ettevõtja roll: peapakkuja 4. Kas see teave on elektrooniliselt kättesaadav? Vastus: Ei 5. URL Vastus: https://riigihanked.riik.ee TEAVE TEISTE ÜKSUSTE SUUTLIKKUSELE TOETUMISE KOHTA Kas ettevõtja toetub teiste üksuste suutlikkusele, et täita esitatud valikukriteeriumid ning eeskirjad (kui neid on)? Küsimused ettevõtjale: 1. Mis on Teie vastus? Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? Vastus: Ei 6. URL Vastus: https://riigihanked.riik.ee Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  5 / 19 TEAVE NENDE ALLHANKIJATE KOHTA, KELLE NÄITAJATELE ETTEVÕTJA EI TUGINE Kas ettevõtja kavatseb sõlmida lepingu mis tahes osa kohta allhanke kolmanda isikuga? Küsimused ettevõtjale: 1. Mis on Teie vastus? Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? Vastus: Ei 6. URL Vastus: https://riigihanked.riik.ee HANKE OSAD Hanke osad, mille kohta ettevõtja soovib pakkumuse esitada Küsimused ettevõtjale: 1. Hanke osa number Vastus: 2. Kas see teave on elektrooniliselt kättesaadav? Vastus: Jah 3. URL Vastus: https://riigihanked.riik.ee ETTEVÕTJA KINNITUSED MAKSUDE TASUMISE KOHTA Kas ettevõtja saab esitada tõendi sotsiaalkindlustusmaksete ja maksude tasumise kohta või esitada teabe, mis võimaldaks avaliku sektori hankijal või võrgustiku sektori hankijal saada sellise teabe otse ükskõik millise liikmesriigi tasuta andmebaasist? Küsimused ettevõtjale: 1. Mis on Teie vastus? Vastus: Jah 2. Kas see teave on elektrooniliselt kättesaadav? Vastus: Jah 3. URL Vastus: https://date.gov.md/open/company-details 4. Kood Vastus: IDNO 1002600048135 Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  6 / 19 B: Teave ettevõtja esindajate kohta Eesnimi: Perekonnanimi: Sünniaeg: Sünnikoht: Aadress: Linn/vald: Postiindeks: Riik: E-post: Telefon: Vajaduse korral esitage üksikasjalik teave esindamise kohta (selle vormid, ulatus, eesmärk, ...): III OSA: KÕRVALDAMISE ALUSED A: Kõrvalejätmise alused seoses kriminaalasjas tehtud süüdimõistva otsusega OSALEMINE KURITEGELIKUS ORGANISATSIOONIS Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud kuritegelikus organisatsioonis osalemise eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? Viide seadusele: RHS § 95 lg 1 p 1 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kuritegelikus ühenduses osalemise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei KORRUPTSIOON Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud korruptsiooni eest kõige rohkem viimase viie aasta jooksul või Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  7 / 19 kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? See kõrvalejätmise alus hõlmab ka korruptsiooni avaliku sektori hankija (võrgustiku sektori hankija) või ettevõtja riigi õiguses sätestatud määratluses. Viide seadusele: RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud aususe kohustuse rikkumise või korruptiivse teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei PETTUS Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud kelmuse eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? Viide seadusele: RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kelmuse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei TERRORIAKTI TOIMEPANEK VÕI TERRORISTLIKU TEGEVUSEGA SEOTUD ÕIGUSRIKKUMISED Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud terroriakti toimepaneku või terroristliku tegevusega seotud õigusrikkumiste eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  8 / 19 kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? Viide seadusele: RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud terroriakti toimepaneku või muu terroristliku tegevusega seotud kuriteo või sellele kihutamise, kaasaaitamise või selle katse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei RAHAPESU VÕI TERRORISMI RAHASTAMINE Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud rahapesu või terrorismi rahastamise eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? Viide seadusele: RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud rahapesualase süüteo või terrorismi rahastamise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei LASTE TÖÖJÕU KASUTAMINE JA MUUD INIMKAUBANDUSE VORMID Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud laste tööjõu kasutamise või muude inimkaubanduse vormide eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? Viide seadusele: Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  9 / 19 RHS § 95 lg 1 p 3 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud laste tööjõu ebaseadusliku kasutamise või inimkaubandusega seotud teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 8. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei B: Kõrvalejätmise alused seoses maksude või sotsiaalkindlustusmaksete tasumisega MAKSUDE TASUMINE Kas ettevõtja on rikkunud oma maksude tasumise kohustusi nii asukohariigis kui ka avaliku sektori hankija või võrgustiku sektori hankija liikmesriigis, kui see erineb asukohariigist? Viide seadusele: RHS § 95 lg 1 p 4 „kellel on riikliku maksu, makse või keskkonnatasu maksuvõlg maksukorralduse seaduse tähenduses või maksuvõlg /…/ tema asukohariigi õigusaktide kohaselt“ Tingimuse kirjeldus: Piirmäär: 0 Valuuta: EUR Lisainfo: Maksukorralduse seaduse kohaselt ei väljasta maksuhaldur maksuvõlgade tõendit juhul, kui maksukohustuslasel olev kõikide sama maksuhalduri hallatavate maksude võlg, arvestamata haldusaktiga kindlaksmääramata intressi, on väiksem kui 100 eurot või kui maksuvõla tasumine on ajatatud. Välismaise ettevõtja puhul väljastatakse maksuvõlgade tõend tema asukohariigi õigusaktide kohaselt. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 12. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei SOTSIAALKINDLUSTUSMAKSETE TASUMINE Kas ettevõtja on rikkunud oma sotsiaalkindlustusmaksete tasumise kohustusi nii asukohariigis kui ka avaliku sektori hankija või võrgustiku sektori hankija liikmesriigis, kui see erineb asukohariigist? Viide seadusele: RHS § 95 lg 1 p 4 „kellel on riikliku /…/ makse /…/ maksuvõlg maksukorralduse seaduse tähenduses või sotsiaalkindlustusemaksete võlg tema asukohariigi õigusaktide kohaselt Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  10 / 19 Tingimuse kirjeldus: Piirmäär: 0 Valuuta: EUR Lisainfo: Maksukorralduse seaduse kohaselt ei väljasta maksuhaldur maksuvõlgade tõendit juhul,kui maksukohustuslasel olev kõikide sama maksuhalduri hallatavate maksude võlg, arvestamata haldusaktiga kindlaksmääramata intressi, on väiksem kui 100 eurot või kui maksuvõla tasumine on ajatatud. Välismaise ettevõtja puhul väljastatakse maksuvõlgade tõend tema asukohariigi õigusaktide kohaselt. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 12. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei C: Kõrvalejätmise alused seoses maksejõuetusega, huvide konfliktiga või ametialaste käitumisreeglite rikkumisega KOKKULEPE VÕLAUSALDAJATEGA Kas ettevõtja on sõlminud kokkuleppe võlausaldajatega? Viide seadusele: RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei SISERIIKLIKU ÕIGUSE KOHANE SAMALAADNE OLUKORD, NÄITEKS PANKROT Kas ettevõtja on siseriiklike õigusnormide alusel toimuva samalaadse menetluse tõttu samalaadses olukorras? Viide seadusele: RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt“, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  11 / 19 Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei VARA HALDAB LIKVIDEERIJA Kas ettevõtja vara haldab likvideerija või kohus? Viide seadusele: RHS § 95 lg 4 p 3 „kes on pankrotis, likvideerimisel või kelle suhtes on algatatud pankrotimenetlus või kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei ÄRITEGEVUS ON PEATATUD Kas ettevõtja äritegevus on peatatud? Viide seadusele: RHS § 95 lg 4 p 3 „kelle äritegevus on peatatud, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei SÜÜDI AMETIALASTE KÄITUMISREEGLITE OLULISES RIKKUMISES Kas ettevõtja on süüdi ametialaste käitumisreeglite olulises rikkumises? Vt siseriiklikud Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  12 / 19 õigusaktid, asjaomane teade või hankedokumendid, kui see on asjakohane. Viide seadusele: RHS § 95 lg 4 p 4 „kes on raskelt eksinud ametialaste käitumisreeglite vastu ja see muudab tema aususe küsitavaks“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei KONKURENTSI MOONUTAMISE EESMÄRGIL TEISTE ETTEVÕTJATEGA SÕLMITUD KOKKULEPPED Kas ettevõtja on teiste ettevõtjatega sõlminud kokkuleppeid, mille eesmärk on moonutada konkurentsi? Viide seadusele: RHS § 95 lg 4 p 5 „konkurentsi kahjustava kokkuleppe, ettevõtjate ühenduse otsuse või kooskõlastatud tegevuse tõttu“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei HANKEMENETLUSES OSALEMISEGA KAASNEV HUVIDE KONFLIKT Kas ettevõtja on teadlik hankemenetluses osalemisega kaasnevast mis tahes huvide konfliktist siseriikliku õiguse, asjakohase teatise või hankedokumentide kohaselt? Viide seadusele: RHS § 95 lg 4 p 6 „kui huvide konflikti ei ole muude vahenditega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  13 / 19 Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 3. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei OTSENE VÕI KAUDNE OSALEMINE KÄESOLEVA HANKEMENETLUSE ETTEVALMISTAMISEL Kas ettevõtja või temaga seotud ettevõtja on nõustanud avaliku sektori hankijat või võrgustiku sektori hankijat hankemenetluse ettevalmistamisel või olnud muul viisil seotud hankemenetluse ettevalmistamisega? Viide seadusele: RHS § 95 lg 4 p 7 „kelle pakkumuse või taotluse koostamisel on osalenud isik, kes on osalenud sama riigihanke ettevalmistamisel või on muul viisil hankijaga seotud, ja sellele isikule seetõttu teadaolev info annab talle eelise teiste riigihankes osalejate eest ning sellest tingitud konkurentsi moonutamist ei ole muude vahendistega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 3. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei ENNETÄHTAEGNE LÕPETAMINE, KAHJUTASU VÕI VÕRRELDAVAD SANKTSIOONID Kas ettevõtja on kogenud, et varasem riigihankeleping või võrgustiku sektori hankijaga sõlmitud varasem hankeleping või varasem kontsessioonileping on lõpetatud enneaegselt, või on määratud kahjutasu või sellega võrreldavad sanktsioonid seoses kõnealuse varasema lepinguga? Viide seadusele: RHS § 95 lg 4 p 8 „kes on oluliselt või pidevalt rikkunud eelnevalt sõlmitud hankelepingu olulist tingimust või hankelepingute olulisi tingimusi nii, et rikkumise tulemusena on lepingust taganetud või leping üles öeldud, hinda alandatud, hüvitatud kahju või makstud leppetrahvi". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Alates 1.09.2017 alustatud hangete tulemusena sõlmitud riigihankelepingute kohta leiab infot riigihangete registrist. Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  14 / 19 Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei SÜÜDI VALEANDMETE ESITAMISES, ON JÄTNUD TEAVET ESITAMATA, EI SUUDA NÕUTUD DOKUMENTE ESITADA, HANKINUD KÄESOLEVA MENETLUSE KOHTA KONFIDENTSIAALSET TEAVET Kas ettevõtja on olnud ühes järgmistest olukordadest: a) ta on kõrvalejätmise aluste puudumise või valikukriteeriumide täitmise kontrollimiseks nõutava teabe esitamisel esitanud valeandmeid; b) ta on jätnud sellist teavet esitamata; c) ta ei ole esitanud viivitamata avaliku sektori hankija või võrgustiku sektori hankija nõutud täiendavad dokumendid, ja d) ta on tegutsenud eesmärgiga mõjutada lubamatul viisil avaliku sektori hankija või võrgustiku sektori hankija otsustusprotsessi, et saada konfidentsiaalseid andmeid, mis võivad anda talle põhjendamatu eelise hankemenetluses, või hooletusest esitanud eksitavat teavet, mis võib oluliselt mõjutada kõrvalejätmise, valiku või lepingu hindamise kohta tehtavaid otsuseid? Viide seadusele: RHS § 95 lg 4 p 9 „kes on esitanud valeandmeid käesolevas paragrahvis sätestatud või RHS §- des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta“; RHS § 95 lg 4 p 9 „kes on jätnud andmed käesolevas paragrahvis sätestatud või käesoleva seaduse §-des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta esitamata“; RHS § 95 lg 4 p 9 „kes on jätnud käesoleva seaduse § 104 lõigete 7 ja 8 alusel hankija nõutud täiendavad dokumendid esitamata“; RHS § 95 lg 4 p 10 „kes on tegutsenud eesmärgiga mõjutada hankijat või esitanud hooletusest eksitavat teavet, mis on võinud mõjutada hankija otsuseid riigihankes, või on tegutsenud eesmärgiga saada konfidentsiaalset teavet, mis on võinud anda talle põhjendamatu eelise teiste riigihankes osalejate ees“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 2. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei KESKKONNAÕIGUSE VALDKONNAS KOHALDATAVATE KOHUSTUSTE TÄITMATA JÄTMINE Kas ettevõtja on enda teada rikkunud keskkonnaõiguse valdkonnas kohaldatavaid kohustusi? Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  15 / 19 Viide seadusele: RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid keskkonnaõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei SOTSIAALÕIGUSE VALDKONNAS KOHALDATAVATE KOHUSTUSTE TÄITMATA JÄTMINE Kas ettevõtja on enda teada rikkunud sotsiaalõiguse valdkonnas kohaldatavaid kohustusi? Viide seadusele: RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid sotsiaalõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei TÖÖÕIGUSE VALDKONNAS KOHALDATAVATE KOHUSTUSTE TÄITMATA JÄTMINE Kas ettevõtja on enda teada rikkunud tööõiguse valdkonnas kohaldatavaid kohustusi? Viide seadusele: RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid tööõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  16 / 19 Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 5. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei PANKROT Kas ettevõtja on pankrotis? Viide seadusele: RHS § 95 lg 4 p 3 „kes on pankrotis, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei MAKSEJÕUETUS Kas ettevõtja suhtes on algatatud maksejõuetus- või likvideerimismenetlus? Viide seadusele: RHS § 95 lg 4 p 3 „kes on likvideerimisel või kelle suhtes on algatatud pankrotimenetlus, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 4. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  17 / 19 D: Ainult siseriiklikest õigusaktidest tulenevad kõrvalejätmise alused AINULT SISERIIKLIKEST ÕIGUSAKTIDEST TULENEVAD KÕRVALEJÄTMISE ALUSED: SEADUSLIKU ALUSETA VIIBIVALE VÄLISMAALASELE TÖÖTAMISE VÕIMALDAMISE EEST Kas ettevõtja on rikkunud RHS § 95 lg 1 p-st 2 tuleneva kõrvalejätmise alusega seotud kohustusi? Viide seadusele: RHS § 95 lg 1 p 2 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud riigis ilma seadusliku aluseta viibivale välismaalasele töötamise võimaldamise või välismaalase Eestis töötamise tingimuste rikkumise võimaldamise, sealhulgas seaduses sätestatud töötasu määrast väiksema töötasu maksmise eest“. Kohustuslik kõrvaldamise alus. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 2. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei AINULT SISERIIKLIKEST ÕIGUSAKTIDEST TULENEVAD KÕRVALEJÄTMISE ALUSED: RAHVUSVAHELISE SANKTSIOONI SUBJEKT Kas ettevõtja on rikkunud RHS § 95 lg 1 p-st 5 tuleneva kõrvalejätmise alusega seotud kohustusi? Viide seadusele: RHS § 95 lg 1 p 5. Kellega hankelepingu sõlmimine rikuks rahvusvahelist või Vabariigi Valitsuse sanktsiooni rahvusvahelise sanktsiooni seaduse tähenduses. Hankija kontrollib käesoleva seaduse § 95 lõike 1 punktis 5 sätestatud kõrvaldamise alust pakkuja või taotleja kinnituse alusel. Hankija võib põhjendatud kahtluse korral nõuda pakkujalt või taotlejalt täiendavate andmete või tõendite esitamist, mis võimaldavad kõrvaldamise alust kontrollida. (RHS § 96 lg 2.1). Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 2. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  18 / 19 AINULT SISERIIKLIKEST ÕIGUSAKTIDEST TULENEVAD KÕRVALEJÄTMISE ALUSED: KARISTATUD MAKSUALASTE SÜÜTEGUDE EEST Kas ettevõtja on rikkunud RHS § 95 lg 4 p-st 11 tuleneva kõrvalejätmise alusega seotud kohustusi? Viide seadusele: RHS § 95 lg 4 p 11 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget või muud seaduslikku esindajat on karistatud maksualaste süütegude eest“. Vabatahtlik kõrvaldamise alus. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Ettevõtjalt oodatavad vastused: 1. Mis on Teie vastus? (Raadionupp valikutega "Jah/Ei") Vastus: Ei 2. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei IV OSA: KVALIFITSEERIMISTINGIMUSED C: Tehniline ja kutsealane suutlikkus ASJADE HANKELEPINGUTE PUHUL: TÄPSUSTATUD LIIKI TARNETE TEOSTAMINE Ainult asjade riigihankelepingute puhul: Ettevõtja on arvestusperioodi jooksul kohale toimetanud täpsustatud liiki asjade puhul järgmised peamised tarned. Avaliku sektori hankijad võivad nõuda kuni kolme aasta kogemuse tõendamist ja võtta arvesse rohkem kui kolme aasta vanuseid kogemusi. Viide seadusele: RHS § 101 lg 1 p 2 „nimekiri hankija kindlaks määratud tunnustele vastavate asjade müügi lepingutest, mis on täidetud riigihanke algamisele eelneva 36 kuu jooksul, koos teabega nende maksumuse, kuupäevade ja teiste lepingupoolte kohta“ RHS § 101 lg 2 „hankija võib piisava konkurentsi tagamiseks arvesse võtta andmeid rohkem kui 36 kuu eest täidetud asjade müügi lepingute kohta“ Tingimuse selgitus: Pakkuja peab omama eelnevat kogemust hankeobjektiga sarnaste toodete tootmisel ja/või müümisel ning paigaldamisel. Hankeesemega sarnaseks tooteks peab hankija tehniliste tingimuste dokumendis nimetatud miinimumnõuetele vastavaid tooteid. Eelnev kogemus hankeobjektiga sarnaste toodete tootmisel ja/või müümisel ning paigaldamisel - täidetud vähemalt üks tellimus eelneva 36 kuu jooksul vähemalt 100 000 euro eest. Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  19 / 19 Tingimuse kirjeldus: Minimaalne teostatud tööde arv: 1 Kirjeldus: Eelnev kogemus hankeobjektiga sarnaste toodete tootmisel ja/või müümisel ning paigaldamisel - täidetud vähemalt üks tellimus eelneva 36 kuu jooksul vähemalt 100 000 euro eest. Ettevõtjalt oodatavad vastused: 1. Kirjeldus (Suur sisestusala (max pikkus 4000 tähemärki)) Vastus: Contract nr. 203225849 from 29 September 2023 whith World Health Organization. 2. Kogusumma (Summa) Vastus: 127216 3. Valuuta (Vääring) Vastus: USD 4. Ettevõtja vastutusala (Suur sisestusala (max pikkus 4000 tähemärki)) Vastus: Delivery, Instalation and further maintenance 5. Summa (Summa) Vastus: 2 6. Valuuta (Vääring) Vastus: EUR 7. Ajavahemik (Periood) Vastus: 29.09.2023 - 30.10.2023 8. Kas info on konfidentsiaalne? (Raadionupp valikutega "Jah/Ei") Vastus: Jah 9. Tellija nimi (Sisestusväli (max pikkus 250 tähemärki)) Vastus: IMSP Spitalul Clinic Balti Spitalul Clinic de Traumatologie i Ortopedie 10. Kontaktisiku nimi (Sisestusväli (max pikkus 250 tähemärki)) Vastus: Gheorge Brinza -Director IMSP Spitalul Clinic Balti Serghei TEPA - Director Spitalul Clinic de Traumatologie i Ortopedie 11. E-mail (Sisestusväli (max pikkus 250 tähemärki)) Vastus: [email protected] IMSP Spitalul Clinic Balti [email protected] Spitalul Clinic de Traumatologie i Ortopedie 13. Kas see teave on elektrooniliselt kättesaadav? (Raadionupp valikutega "Jah/Ei") Vastus: Ei Kokkuvõtlikud kinnitused Ettevõtja kinnitab, et esitatud teave on täpne ja õige ning et ta on teadlik valeandmete esitamise tagajärgedest. Ettevõtja kinnitab, et tal on võimalik vajaduse korral viivitamata tema kinnitustele vastavad dokumendid hankijale esitada. Ettevõtja kinnitab, et ta on nõus oma kinnitustele vastavate andmete väljastamisega hankijale, kui need andmed on avalike andmete põhjal hankijale oluliste kulutusteta elektroonilisest andmekogust kättesaadavad. Kinnituse andja nimi: Andrei Botnaru, Managing director Neotec SRL Koostatud 14.01.2025 09:58:58 https://riigihanked.riik.ee/rhr-web/#/procurement/7352184/general-info  GLOBAL PROCUREMENT AND LOGISTICS Global Service Centre BLOCK 3510, JALAN TEKNOKRAT 6, 63000 CYBERJAYA, MALAYSIA, Date : 28 August 2023 SC NEOTEC SRL 37 IVAN ZAIKIN STR. CHISINAU MOLDOVA, REPUBLIC OF Telephone: +37322852250 e-mail: [email protected] PURCHASE ORDER 203225849 Delivery Urgency: Emergency Goods required to be ready for shipment by: 29 September 2023 Delivery terms (INCOTERMS2020): DAP Balti, Moldova Payment Terms: As per attached WHO General Conditions Supplier Reference: The Supplier is required to sign and return the Acknowledgement attached. Total Order Value USD 127,216.00 Please comply with General Terms and Conditions enclosed. Authorized Signatory: Enquiry Contact: MissAnastasia ANDRONACHI Tel: Mr Santiago Millan Unit Head e-mail: [email protected] Global Procurement and Logistics (HQ/BOS/SUP/GPL) Page 1 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 Currency: USD Item no Item Description Quantity Unit Unit Price Net Amount 1.0 2 Each C-Arm system: Opescope Acteno 63,608.0000 127,216.00 (Shimadzu/Japan) C-arm radiodiagnostic system Opescope Acteno, Please reffrer to the Annex 1 Warranty: minimum 24 months. Available authorized service center in Republic of Moldova. Product Code: Keep Cool: DGR UN: WHO Internal Reference :Reg.No/Line No. 2023/1391740/ 1 :Req.No/Line No. 1252569/ 1 Total Order Value USD 127,216.00 Notes to Supplier : Special Instructions for Medical Products (Products including, but not limited to, finished pharmaceutical products, medical devices, vaccines and IVD products.) Invoice or Packing (or forwarding) list must indicate manufacture and expiry dates together with batch number (if there is no expiry date or batch number clearly indicate with "n/a"). The remaining shelf life (RSL) of Products should be aligned with WHO guidance "Technical Report Series 1025, 2020, Specifications for Pharmaceutical Preparations- annex 8: Points to consider for setting the remaining shelf-life of medical products upon delivery" "https://www.who.int/publications/m/item/trs-1025-annex-8-shelf-life-medical-products-delivery" Required Certificates • Certificate of analysis for each batch (medicines and IVDs) • Batch Release certificate (vaccines) Payment of invoices cannot be made in the absence of the certificate of analysis or of the release certificate. ORIGINAL 203225849 Sensitivity: Internal & Restricted Page 2 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 For cold chain shipments, in addition to proper handling, packaging and labelling (in accordance with relevant national/regional/international regulations), the supplier needs to comply with the following "quality" requirement and include datalogger(s) as follows: -20ºC 2-8ºC 15-25ºC By Air 1 datalogger + 1 freeze Commercial 1 datalogger per carton tag per carton box/pallet 1 datalogger per shipment flight box/pallet shipper shipper Chartered 1 datalogger per carton 1 datalogger per carton 1 datalogger per 30 pallets flight box/pallet shipper box/ pallet shipper By Sea Full container n/a** n/a 1 datalogger per shipment load Shared n/a** n/a 1 datalogger per 30 pallets container By Road 1 datalogger + 1 freeze Full container 1 datalogger per carton tag per carton box/pallet 1 datalogger per container load box/pallet shipper shipper 1 datalogger + 1 freeze Shared space 1 datalogger per carton tag per carton box/pallet 1 datalogger per shipment load box/pallet shipper shipper **n/a in the above table means that mode of shipment is not foreseen for this kind of products Please refer to DELIVERY INSTRUCTIONS attached. ORIGINAL 203225849 Sensitivity: Internal & Restricted Page 3 of 3  GLOBAL PROCUREMENT AND LOGISTICS Global Service Centre BLOCK 3510, JALAN TEKNOKRAT 6, 63000 CYBERJAYA, MALAYSIA, PURCHASE ORDER 203225849 DELIVERY INSTRUCTIONS Date: 28 August 2023 Mode of Shipment: SURFACE FREIGHT Supplier: SC NEOTEC SRL 37 IVAN ZAIKIN STR. CHISINAU MOLDOVA, REPUBLIC OF Telephone: +37322852250 e-mail: [email protected] Insurance: Insurance coverage is provided by WHO (unless otherwise specified in INCOTERMS 2020). In case of INCOTERMS CIF, CIP, DDP or DAP, the supplier is requested to insure the goods "DOOR TO DOOR" under "ALL RISK", including war and strike, up to the final destination. Forwarding Agent: NO FORWARDER "No Forwarding Agent. Please proceed with expediting the shipment on behalf of the World Health Organization". Documents required for shipment: As soon as the goods for this Purchase Order are ready for dispatch, the Supplier is requested to provide WHO, the following documents, in addition to the standard documents required for the shipment: Delivery: NO PARTIAL DELIVERY WILL BE ACCEPTED WITHOUT WRITTEN AGREEMENT BY WHO. The delivery of the goods must comply with the delivery date mentioned in the purchase order. If the delivery date cannot be met, the supplier must inform GSC Shipping unit ([email protected]) of the new delivery date. No delivery shall take place before agreement is received from WHO's appointed forwarder, if any. Any impediment to deliver must be advised in writing to WHO and to the appointed forwarder, if any, as soon as possible. Packing Details: Page 1 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 The Packing list must include weight and dimensions per package with gross weight in kilograms and volume in cubic meters, i.e.: a) Item description and quantity, weight and dimensions in cm per parcel b) Total gross weight in kilograms and volume in cubic meters c) In case of perishable or dangerous items: full details with temperature degree, UN No, Class no. Flashpoint are to be clearly indicated on the packing list and in the invoice. For shipments of pharmaceuticals, the outer carton must clearly indicate: a) Batch number b) Expiry date Packaging and Palletization: Packaging must be suitable for the mode of transport indicated, shall conform with national/regional/international rules and regulations and best practices, shall account for special requirements related to the transportation and storage of dangerous goods and/or perishables. The supplier shall ensure that: Packaging materials shall be of good quality, capable of providing adequate protection to the goods for carriage by air, sea, rail and/or road to final destinations worldwide, including remote locations. Packaging materials are strong, able to be stacked to a height of 2 meters, and resistant to puncturing, suitable for shipment, storage and use inworld-wide, including destinations with elevated temperatures and humidity, adverse climatic and storage conditions, unless otherwise stated. All wooden packaging, including pallets and boxes, shall undergo heat treatment, impregnation or fumigation, and shall be appropriately marked as having undergone such process. A certificate of conformity has to be provided to the Forwarder, if any, together with shipping documents. Deliveries should be packed/palletized (pallet 120 x 80 cm with 15 cm ground clearance), with a maximum height of 160 cm (ALL IN) for AIRFREIGHT and 210 cm (ALL IN) for SEA FREIGHT, in the most cost- effective way for the indicated mode of shipment to minimize freight costs. If cargo is not palletized, please contact GSC Shipping unit ([email protected]) for further instructions. Marking and Labelling: Parcels should be numbered consecutively (e.g. 1of 2, 2of 2), unless otherwise specified. The gross weight of the parcel must also be indicated on each package. All packages and documents should be marked as follows: DELIVERY INSTRUCTIONS TO SUPPLIER 203225849 Sensitivity: Internal & Restricted Page 2 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 For: WHO COUNTRY OFFICE, MOLDOVA WHO COUNTRY OFFICE, MOLDOVA 29, SFATUL TARII STR. 29, SFATUL TARII STR. CHISINAU CHISINAU MD-2012MOLDOVA, REPUBLIC OF MD-2012 +373 22 83 99 60 +373 22 83 99 60 +373 22 83 99 63 +373 22 83 99 63 MS SVETLANA GOLAN MS SVETLANA GOLAN [email protected] [email protected] Reference No : 2023/1391740 Order No. : 203225849 Invoicing Instructions: Invoices must be sent via email to [email protected] Please do not send enquiries to this email. You may contact your focal person in WHO (the person who provided this Purchase Order to you) for enquiries. In order to ensure timely and accurate payment, invoices must include: • Invoice number • Purchase Order number, Quantity and Unit price against each invoice line; • Invoice descriptions matching with PO descriptions • Invoice currency same as the Purchase Order Currency also corresponding with the currency of the bank account provided to WHO; • Supplier name as in the PO Invoices shall be clearly readable and stamps or any other additional markings should not obscure the original invoice content. Invoices shall not be handwritten. DELIVERY INSTRUCTIONS TO SUPPLIER 203225849 Sensitivity: Internal & Restricted Page 3 of 3  GLOBAL PROCUREMENT AND LOGISTICS Global Service Centre BLOCK 3510, JALAN TEKNOKRAT 6, 63000 CYBERJAYA, MALAYSIA, Date: 28 August 2023 Forwarding Agent: NO FORWARDER PURCHASE ORDER 203225849 SHIPPING INSTRUCTIONS Mode of Shipment: SURFACE FREIGHT Supplier: SC NEOTEC SRL 37 IVAN ZAIKIN STR. CHISINAU MOLDOVA, REPUBLIC OF Telephone: +37322852250 e-mail: [email protected] Follow-up on delivery: Please note that the Forwarder, if any, mentioned above is in charge of following up timely delivery of the goods and of sending a reminder to the supplier as follows: EMERGENCY Delivery: The forwarder must immediately contact the supplier and obtain confirmation of the delivery date. In case of difficulties please contact GSC Shipping unit ([email protected]) immediately. URGENT Delivery: The first reminder must be sent to the Supplier, 7 days before the delivery date. If required, the second reminder will have to be sent 3 days before the delivery date. Without a supplier confirmation of delivery date within 24hours, the GSC Shipping unit ([email protected]) must be advised in order to follow up the matter. NORMAL Delivery: The first reminder must be sent to the supplier 7 days prior to the delivery date. If needed, the second reminder will have to be sent at the end of the delivery date day. Without supplier's confirmation of delivery date within 24hours, the GSC Shipping unit ([email protected]) must be advised in order to follow up the matter. REVISED Delivery Date: In case of a revised delivery date provided by the supplier, the forwarder must advise GSC Shipping unit ([email protected]) accordingly. INCOTERMS 2020 agreed: DAP Balti, Moldova Documents required for shipment: Page 1 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 As soon as the goods for this Purchase Order are ready for dispatch, the Supplier is requested to provide WHO, the following documents, in addition to the standard documents required for the shipment: Freight charges payable: By: SUPPLIER From: DAP Balti, Moldova Up to: DAP Balti, Moldova Special instructions: The following note, if any, must appear on all Shipping Documents: Pre-advice: A Pre-advice with copies of all requested documents must be sent by e-mail, if it is not possible then by fax, to the following recipients at least 48 hours before the arrival of the goods. For Emergency orders and Special Courier shipment at least 24 hours before the arrival of the goods. E-mail Fax WHO COUNTRY OFFICE, [email protected] +373 22 83 99 70 MOLDOVA CHISINAU WORLD HEALTH ORGANIZATION GSC Shipping unit +60 3 8871 7142 WHO/GSC/GPL ([email protected]). ANDRONACHI, Miss Anastasia [email protected] In case of transmission difficulties please immediately advise GSC Shipping unit ([email protected]). Shipper: The WORLD HEALTH ORGANIZATION or ORGANISATION MONDIALE DE LA SANTE are to be stated as SHIPPER on all shipping documents. Shipping Address: (Bill of Lading or consignment note to be made out to): For: WHO COUNTRY OFFICE, MOLDOVA WHO COUNTRY OFFICE, MOLDOVA 29, SFATUL TARII STR. 29, SFATUL TARII STR. CHISINAU CHISINAU MD-2012MOLDOVA, REPUBLIC OF MD-2012 +373 22 83 99 60 +373 22 83 99 60 +373 22 83 99 63 +373 22 83 99 63 MS SVETLANA GOLAN MS SVETLANA GOLAN [email protected] [email protected] SHIPPING INSTRUCTIONS 203225849 Sensitivity: Internal & Restricted Page 2 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 Reference No : 2023/1391740 Order No. : 203225849 Distribution of Transport Documents: IMPORTANT: For all modes of transport, except for Sea freight, the Shipping documents should be sent together with the shipment. For Sea freight shipments, please mail the documents by special courier such as TNT, DHL or similar. Please also send the indicated Transport Documents to the following addresses: WHO COUNTRY OFFICE, MOLDOVA 1 COPY of Rail Way Bill 29, SFATUL TARII STR. 2 COPIES of Commercial Invoice CHISINAU 2 COPIES of Packing List MD-2012 MOLDOVA, REPUBLIC OF 1 SET of original Documents specified in 'Documents required for shipment' For: MS SVETLANA GOLAN Insurance: The insurance is covered by WHO (unless otherwise specified in INCOTERMS 2020). In case of INCOTERMS CIF, CIP, DDP or DAP, the supplier is requested to insure the goods "Door to Door" under "ALL RISKS" including war and strike up to the final destination. Remarks: For further shipping information, please Authorized Signatory: contact GSC Shipping unit ([email protected]): Mr Santiago Millan Unit Head Global Procurement and Logistics (HQ/BOS/SUP/GPL) SHIPPING INSTRUCTIONS 203225849 Sensitivity: Internal & Restricted Page 3 of 3  GLOBAL PROCUREMENT AND LOGISTICS Global Service Centre BLOCK 3510, JALAN TEKNOKRAT 6, 63000 CYBERJAYA, MALAYSIA, Date : 28 August 2023 SC NEOTEC SRL 37 IVAN ZAIKIN STR. CHISINAU MOLDOVA, REPUBLIC OF PURCHASE ORDER 203225849 ACKNOWLEDGEMENT DOCUMENT IMPORTANT The supplier is requested to sign and return the scanned copy of Acknowledgement Document to WHO via the same email of the person whom provided this Purchase Order to you. Failure to do so may cause cancellation of the order without any notice. Goods required to be ready for shipment by: 29 September 2023 Delivery Terms (INCOTERMS2020): DAP Balti, Moldova Payment Terms: As per attached WHO Standard Terms and Conditions WORLD HEALTH ORGANIZATION ORDER TERMS AND CONDITIONS ACCEPTED. Supplier Order No: Digitally signed by Botnaru Andrei Date: 2023.08.29 13:59:22 EEST Supplier's Signature: Reason: MoldSign Signature Date: Location: Moldova Name and Title: The Supplier is required to sign and return the Acknowledgement attached. Total Order Value USD 127,216.00 Please comply with General Terms and Conditions enclosed. Authorized Signatory: Enquiry Contact: MissAnastasia ANDRONACHI Tel: Mr Santiago Millan Unit Head e-mail: [email protected] Global Procurement and Logistics (HQ/BOS/SUP/GPL) Page 1 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 General Terms and Conditions 1. CONTRACT TERMS AND CONDITIONS 14. COMPLIANCE WITH WHO CODES AND POLICIES This Purchase Order, once accepted by the Vendor by signing and returning By entering into this Purchase Order, the Vendor acknowledges that it has the Acknowledgement Document or delivering the goods specified herein, read, and hereby accepts and agrees to comply with, the WHO Policies (as shall form a binding contract between the World Health Organization (WHO) defined below). In connection with the foregoing, the Vendor shall take and the Vendor. The contract between the parties is subject exclusively to the appropriate measures to prevent and respond to any violations of the terms and conditions detailed below. Any contractual terms and conditions of standards of conduct, as described in the WHO Policies, by its employees and the Vendor, whether included in the offer, invoices or any other document, are any other natural or legal persons engaged or otherwise utilized in connection hereby excluded. In the event this Purchase Order contains any provisions, with the supply and delivery of the goods under the Purchase Order. which are contrary to the provisions contained in the Vendor's offer, the provisions of this Purchase Order shall take precedence. Without limiting the foregoing, the Vendor shall promptly report to WHO, in accordance with the terms of the applicable WHO Policies, any actual or 2. DELIVERY DATE suspected violations of any WHO Policies of which the Vendor becomes The Delivery Date shall mean the date on which the goods are required to be aware. available at the location indicated in the Purchase Order under "Delivery For purposes of the Purchase Order, the term "WHO Policies" means Terms". collectively: (a) the WHO Code of Ethics and Professional Conduct; 3. PAYMENT TERMS (b) the WHO Policy Directive on Protection from sexual exploitation and (a) WHO shall, on fulfilment of the Delivery Terms, unless otherwise specified sexual abuse (SEA); in the Purchase Order, make payment within 30 days of receipt of the (c) the WHO Policy on Preventing and Addressing Abusive Conduct; Vendor's invoice for the goods and copies of the customary shipping (d) the WHO Code of Conduct for responsible Research; documents specified in the Purchase Order. (e) the WHO Policy on Whistleblowing and Protection Against Retaliation; (b) Payment against the invoice referred to above will reflect any discount (f) the WHO Policy on Prevention, Detection and Response to Fraud and shown under the payment terms provided payment is made within the period Corruption, and shown in the payment terms of the Purchase Order. (g) the UN Supplier Code of Conduct, in each case, as amended from time to (c) Unless authorized by WHO, a separate invoice must be submitted in time and which are publicly available on the WHO website at the following respect of each Purchase Order. Each invoice shall indicate the identification links: http://www.who.int/about/finances-accountability/procurement/en/ for the number of the corresponding Purchase Order. UN Supplier Code of Conduct and at http://www.who.int/about/ethics/en/ for (d) The prices shown in the Purchase Order may not be increased, except the other WHO Policies. with the express written agreement of WHO. (e Inspection prior to shipment does not relieve the Vendor from its contractual obligations. 15. ZERO TOLERANCE FOR SEXUAL EXPLOITATION AND ABUSE, (f) WHO shall have a reasonable time after delivery of the goods to inspect SEXUAL HARASSMENT AND OTHER TYPES OF ABUSIVE CONDUCT them and to reject and refuse acceptance of goods not conforming to the WHO has zero tolerance towards sexual exploitation and abuse, sexual Purchase order; payment for goods pursuant to the Purchase Order shall not harassment and other types of abusive conduct. In this regard, and without be deemed to constitute acceptance by WHO of the goods. limiting any other provisions contained herein, the Vendor warrants that it shall: 4. TAX EXEMPTION (a) take all reasonable and appropriate measures to prevent sexual The price shall reflect any tax exemption to which WHO may be entitled by exploitation or abuse as described in the WHO Policy Directive on Protection reason of the immunity it enjoys. WHO is, as a general rule, exempt from all from sexual exploitation and sexual abuse (SEA), and/or sexual harassment direct taxes, custom duties and the like, and the Vendor will consult with WHO and other types of abusive conduct as described in the WHO Policy on so as to avoid the imposition of such charges with respect to this contract and Preventing and Addressing Abusive Conduct by any of its employees and any the goods supplied hereunder. As regards excise duties and other taxes other natural or legal persons engaged or otherwise utilized in connection with imposed on the sale of goods (e.g. VAT), the Vendor agrees to verify in the supply and delivery of the goods under the Purchase Order; and consultation with WHO whether in the country where the VAT would be (b) promptly report to WHO and respond to, in accordance with the terms of payable, WHO is exempt from such VAT at the source, or entitled to claim the respective Policies, any actual or suspected violations of either Policy of reimbursement thereof. If WHO is exempt from VAT, this shall be indicated on which the Vendor becomes aware. the invoice, whereas if WHO can claim reimbursement thereof, the Vendor agrees to list such charges on its invoices as a separate item and, to the 16. TOBACCO/ARMS RELATED DISCLOSURE STATEMENT extent required, cooperate with WHO to enable reimbursement thereof. Vendors may be required to disclose relationships they may have with the tobacco and/or arms industry through completion of the WHO Tobacco/Arms 5. EXPORT LICENCE Disclosure Statement. In the event WHO requires completion of this The Purchase Order is subject to the Vendor obtaining any export licence or Statement, the Vendor undertakes not to permit the goods to be supplied, until other governmental authorization which may be necessary. It will be the WHO has assessed the disclosed information and confirmed to the Vendor in responsibility of the Vendor to obtain such licence or authorization, however, writing that the goods can be supplied. WHO will provide such assistance within its power as the Vendor may reasonably request. In the event of refusal of any necessary export licence or 17. ANTI-TERRORISM AND UN SANCTIONS; FRAUD AND CORRUPTION other governmental authorization, the Purchase Order will be cancelled and all The Vendor warrants for the entire duration of the Purchase Order that: claims between the parties automatically waived. For export licence (a) it is not and shall not be involved in, or associated with, any person or application and Exchange Control purposes, the source of funds or type of entity associated with terrorism, as designated by any UN Security Council account from which payment for this order will be made is named overleaf. sanctions regime, that it shall not make any payment or provide any other support to any such person or entity and that it shall not enter into any 6. RISK OF LOSS, DAMAGE OR DESTRUCTION employment or other contractual relationship with any such person or entity; Risk of loss or damage to, or destruction of the goods shall be borne by the (b) it shall not engage in any fraudulent or corrupt practices, as defined in the Vendor until physical delivery of the goods has been completed in accordance WHO Policy on Prevention, Detection and Response to Fraud and Corruption, with the Purchase Order. in connection with the execution of the Purchase Order; (c) it shall take all the necessary measures to prevent the financing of 7. FITNESS OF GOODS/PACKING terrorism and/or any fraudulent or corrupt practices as referred to above in The Vendor warrants that the goods, including adequate packaging, conform connection with the execution of the Purchase Order; and to the specifications and are fit for the purposes for which such goods are d) it shall promptly report to WHO, through the WHO Integrity Hotline or ordinarily used and for purposes expressly made known to the Vendor by directly to the WHO Office of Internal Oversight Services (IOS), any credible WHO, and are free from defects in workmanship and materials. The Vendor allegations of actual or suspected fraudulent or corrupt practices, as defined in also warrants that the goods are contained or packaged adequately to protect the WHO Policy on Prevention, Detection and Response to Fraud and them. Corruption of which the Vendor becomes aware and respond to such allegations in an appropriate and timely manner in accordance with its 8. WARRANTY respective rules, regulations, policies and procedures. Furthermore, the The Vendor warrants that the use or supply by WHO of the goods delivered Vendor agrees to cooperate with WHO and/or parties authorized by WHO in under the Purchase Order do not infringe any patent, trade name, trademark relation to the response. Relevant information on the nature of any credible or other third party right. In addition, the Vendor shall pursuant to this warranty allegations of such actual or suspected violations, as well as the details of the indemnify, defend and hold harmless WHO from any actions or claims brought intended response and the outcome of any such response, should be against WHO pertaining to the alleged infringement of a patent, design, trade communicated and coordinated with WHO, with the understanding that, name, trademark or other third party right. subject to the terms of the WHO Policy on Prevention, Detection and Response to Fraud and Corruption, confidentiality and the due process rights 9. FORCE MAJEURE of those involved will be respected. Neither party to the Purchase Order shall be held responsible for delay in the ORIGINAL(Acknowledgement) 203225849 Sensitivity: Internal & Restricted Page 2 of 3  WORLD HEALTH ORGANIZATION PURCHASE ORDER - 203225849 fulfilment thereof due to force majeure, strikes, lock out, war, civil unrest, or In the event that any resources, assets and/or funds provided to or acquired other factors outside its control by the Vendor under the Purchase Order are found to have been used by the Vendor, its employees or any other natural or legal persons engaged or 10. RIGHTS OF WHO otherwise utilized for the supply and/or deliver of the goods under the In case of failure by the Vendor to comply with the terms and conditions of the Purchase Order, to finance, support or conduct any terrorist activity or any Purchase Order, including but not limited to failure to obtain necessary export fraudulent or corrupt practices, the Vendor shall promptly reimburse and licences, or to make delivery of all or part of the goods by the agreed Delivery indemnify WHO for such resources, assets and/or funds (including any liability Date(s), WHO may, after giving the Vendor reasonable notice to perform and arising from such use). without prejudice to any other rights or remedies, exercise one or more of the following rights: 18. BREACH OF ESSENTIAL TERMS (a) Procure all or part of the goods from other sources, in which event WHO The Vendor acknowledges and agrees that each of the provisions of may hold the Vendor responsible for any additional cost occasioned thereby. Paragraphs 14, 15, 16 and 17 hereof constitutes an essential term of the (b) Refuse to accept delivery of all or part of the goods; and/or Purchase Order, and that in case of breach of any of these provisions, WHO (c) Terminate the Purchase Order. may, in its sole discretion, decide to: (a) terminate this Purchase Order, and/or any other contract concluded by 11. INDEMNIFICATION WHO with the Vendor, immediately upon written notice to the Vendor, without The Vendor shaft indemnify and save harmless WHO, the Government and any liability for termination charges or any other liability of any kind; and/or any other party who receives the goods delivered hereunder from and against (b) exclude the Vendor from participating in any ongoing or future tenders all claims, damages, losses, costs and expenses arising out of any injury, and/or entering into any future contractual or collaborative relationships with sickness or death to persons or any loss of or damage to property, caused by WHO. the fault or negligence of the Vendor. WHO shall promptly give notice to the WHO shall be entitled to report any violation of such provisions to WHO's Vendor of any claims, damages, losses, costs and expenses and shall governing bodies, other UN agencies, and/or donors. cooperate in a reasonable manner with the Vendor. 19. PUBLICATION OF AGREEMENTS 12. ASSIGNMENT AND INSOLVENCY Subject to considerations of confidentiality, WHO may acknowledge the (a) The Vendor shall not assign, transfer, pledge or make other disposition of existence of this Purchase Order to the public and publish and/or otherwise this Purchase Order or any part thereof, or any of the Vendor's rights, claims publicly disclose the Vendor's name and country of incorporation, general or obligations under this Purchase Order except with the prior written consent information with respect to the goods supplied hereunder and the Purchase of WHO. Order value. Such disclosure will be made in accordance with WHO's (b) Should the Vendor be adjudicated bankrupt, or be liquidated or become Information Disclosure Policy and shall be consistent with the terms of this insolvent, or should the Vendor make an assignment for the benefit of its Purchase Order. creditors, or should a Receiver be appointed on account of the insolvency of the Vendor, WHO may, without prejudice to any other right or remedy it may 20. AUDIT AND INVESTIGATIONS have under these General Terms and Conditions, terminate this Purchase WHO may request a financial and operational review or audit of the goods Order forthwith. The Vendor shall immediately inform WHO of the occurrence supplied by the Vendor under this Purchase Order, to be conducted by WHO of any of the above events. and/or parties authorized by WHO, and the Vendor undertakes to facilitate such review or audit. This review or audit may be carried out at any time 13. USE OF WHO NAME AND EMBLEM during the period of the supply of the goods under this Purchase Order, or Without WHO's prior written approval, the Vendor shall not, in any statement within five years of the supply of the goods. In order to facilitate such financial or material of an advertising or promotional nature, refer to this Purchase and operational review or audit, the Vendor shall keep accurate and Order or the Vendor's relationship with WHO, or otherwise use the name (or systematic accounts and records in respect of the goods supplied under this any abbreviation thereof) and/or emblem of WHO. Purchase Order. Similarly, WHO may initiate an investigation into credible allegations of fraud and corruption and other forms of misconduct based on information received in accordance with its respective policies, procedures and rules. In this context, the Vendor shall make available, without restriction, to WHO and/or parties authorized by WHO: (a) the Vendor's books, records and systems (including all relevant financial and operational information) relating to this Purchase Order; and (b) reasonable access to the Vendor's premises and personnel. The Vendor shall provide satisfactory explanations to all queries arising in connection with the aforementioned audit and access rights. WHO may request the Vendor to provide complementary information about the goods supplied under this Purchase Order that is reasonably available, including the findings and results of an audit (internal or external) conducted by the Vendor and related to the goods supplied hereunder. 21. SURVIVING PROVISIONS Those provisions of this Purchase Order that are intended by their nature to survive its expiration or earlier termination shall continue to apply. 22. SETTLEMENT OF DISPUTES Any matter relating to the interpretation or application of this Purchase Order which is not covered by its terms shall be resolved by reference to Swiss law. Any dispute relating to the interpretation or application of this Purchase Order shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by the parties or, in the absence of agreement, with the Rules of Arbitration of the International Chamber of Commerce. The parties shall accept the arbitral award as final. 23. PRIVILEGES AND IMMUNITIES Nothing contained in or relating to this Purchase Order shall be deemed to constitute a waiver of any of the privileges and immunities enjoyed by WHO and/or as submitting WHO to any national court jurisdiction. ORIGINAL(Acknowledgement) 203225849 Sensitivity: Internal & Restricted Page 3 of 3  <?xml version="1.0" encoding="UTF-8"?> <QualificationApplicationResponse xmlns="urn:X-test:UBL:Pre-award:QualificationApplicationResponse" xmlns:ns6="urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2" xmlns:ns5="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" xmlns:ns8="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" xmlns:ns7="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" xmlns:cac="urn:X-test:UBL:Pre-award:CommonAggregate" xmlns:cbc="urn:X-test:UBL:Pre-award:CommonBasic" xmlns:ns9="http://data.europa.eu/p27/eforms-ubl-extensions/1" xmlns:ns4="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1"> <cbc:UBLVersionID schemeAgencyID="OASIS-UBL-TC">2.2</cbc:UBLVersionID> <cbc:CustomizationID schemeAgencyID="CEN-BII" schemeVersionID="3.0">urn:www.cenbii.eu:transaction:biitrdm092:ver3.0</cbc:CustomizationID> <cbc:ProfileID schemeAgencyID="CEN-BII" schemeVersionID="2.0">4.1</cbc:ProfileID> <cbc:ID schemeAgencyID="RHR">f9870f61-0b42-453d-b51c-650a57669bcc</cbc:ID> <cbc:CopyIndicator>false</cbc:CopyIndicator> <cbc:UUID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="4">0fddbf2d-1e33-4267-b04f-52b59b72ccb6</cbc:UUID> <cbc:ContractFolderID schemeAgencyID="RHR">279740</cbc:ContractFolderID> <cbc:IssueDate>2025-01-14</cbc:IssueDate> <cbc:IssueTime>09:59:00</cbc:IssueTime> <cbc:VersionID schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1.0</cbc:VersionID> <cbc:ProcedureCode listID="ProcedureType" listAgencyID="EU-COM-OP" listVersionID="1.0">OPEN</cbc:ProcedureCode> <cbc:QualificationApplicationTypeCode listID="QualificationApplicationType" listAgencyID="EU-COM-GROW" listAgencyName="DG GROW (European Commission)" listVersionID="2.0.2">SELFCONTAINED</cbc:QualificationApplicationTypeCode> <cac:ContractingParty> <cac:Party> <cbc:WebsiteURI>https://www.kaitseinvesteeringud.ee/</cbc:WebsiteURI> <cac:PartyIdentification> <cbc:ID schemeAgencyID="RHR">70009764</cbc:ID> </cac:PartyIdentification> <cac:PartyName> <cbc:Name>Riigi Kaitseinvesteeringute Keskus</cbc:Name> </cac:PartyName> <cac:PostalAddress> <cbc:StreetName>Järve tn 34a</cbc:StreetName> <cbc:CityName> Tallinn</cbc:CityName> <cbc:PostalZone>11314</cbc:PostalZone> <cac:Country> <cbc:IdentificationCode listID="CountryCodeIdentifier" listAgencyID="ISO" listVersionID="1.0">EE</cbc:IdentificationCode> <cbc:Name>Eesti</cbc:Name> </cac:Country> </cac:PostalAddress> <cac:Contact> <cbc:Name>MARTIN KÄREMAA</cbc:Name> <cbc:Telephone>+372 58668702</cbc:Telephone> <cbc:ElectronicMail>[email protected]</cbc:ElectronicMail> </cac:Contact> </cac:Party> </cac:ContractingParty> <cac:EconomicOperatorParty> <cac:QualifyingParty> <cbc:EmployeeQuantity>18</cbc:EmployeeQuantity> <cac:FinancialCapability> <cbc:ValueAmount currencyID="EUR">1672000</cbc:ValueAmount> </cac:FinancialCapability> </cac:QualifyingParty> <cac:EconomicOperatorRole> <cbc:RoleCode listID="EORoleType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">SCLE</cbc:RoleCode> <cbc:RoleDescription languageID="ET">peapakkuja</cbc:RoleDescription> </cac:EconomicOperatorRole> <cac:Party> <cbc:WebsiteURI>www.neotec.md</cbc:WebsiteURI> <cbc:IndustryClassificationCode listID="EOIndustryClassificationCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">MEDIUM</cbc:IndustryClassificationCode> <cac:PartyIdentification> <cbc:ID schemeAgencyID="RHR">1002600048135</cbc:ID> </cac:PartyIdentification> <cac:PartyName> <cbc:Name>Neotec SRL</cbc:Name> </cac:PartyName> <cac:PostalAddress> <cbc:CityName>Chisinau</cbc:CityName> <cbc:PostalZone>MD-2005</cbc:PostalZone> <cac:AddressLine> <cbc:Line>strada Zaikin, 37</cbc:Line> </cac:AddressLine> <cac:Country> <cbc:IdentificationCode listID="CountryCodeIdentifier" listAgencyID="ISO" listVersionID="1.0">MD</cbc:IdentificationCode> <cbc:Name>Moldova</cbc:Name> </cac:Country> </cac:PostalAddress> <cac:Contact> <cbc:Name>Andrei Botnaru</cbc:Name> <cbc:Telephone>+373 69111661</cbc:Telephone> <cbc:ElectronicMail>[email protected]</cbc:ElectronicMail> </cac:Contact> </cac:Party> </cac:EconomicOperatorParty> <cac:ProcurementProject> <cbc:Name>Mobiilne röntgenseade</cbc:Name> <cbc:Description languageID="ET">Hanke esemeks on mobiilne röntgenseade (arkoskoop), mis soetatakse Moldova Kaitseministeeriumile vastavalt lõppkasutaja vajadustele ning EPF MOLDOVA projektile. Hanke eesmärk on ühekordse hankelepingu sõlmimine ühe pakkujaga ühekordseks ostuks mobiilse röntgenseadme soetamiseks koos tarne ja paigaldusega Moldova Vabariiki ning esmase kasutajakoolitusega.</cbc:Description> <cbc:ProcurementTypeCode listID="ProjectType" listAgencyID="EU-COM-OP" listVersionID="1.0">SUPPLIES</cbc:ProcurementTypeCode> <cac:MainCommodityClassification> <cbc:ItemClassificationCode>33111000-1</cbc:ItemClassificationCode> </cac:MainCommodityClassification> </cac:ProcurementProject> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">005eb9ed-1347-4ca3-bb29-9bc0db64e1ab</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.PARTICIPATION_IN_CRIMINAL_ORGANISATION</cbc:CriterionTypeCode> <cbc:Name>Osalemine kuritegelikus organisatsioonis</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud kuritegelikus organisatsioonis osalemise eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 1 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kuritegelikus ühenduses osalemise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 1 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kuritegelikus ühenduses osalemise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8a42266c5fb24e32ff421942459d66ac-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0f37dbede2411eb4a8fe4e65f2b4e0bc-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0f37dbede2411eb4a8fe4e65f2b4e0bc-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0f37dbede2411eb4a8fe4e65f2b4e0bc-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0f37dbede2411eb4a8fe4e65f2b4e0bc-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c0750b31f837dc0a061f4b08cfbff932-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fcf54563bb12424d74c6eab13b3bff3e-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7498d35783aaf5b55a3d4b5b1f7995d2-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">03a11607d1053d3bf94f29fdae2d8519-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c27b7c4e-c837-4529-b867-ed55ce639db5</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.CORRUPTION</cbc:CriterionTypeCode> <cbc:Name>Korruptsioon</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud korruptsiooni eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt? See kõrvalejätmise alus hõlmab ka korruptsiooni avaliku sektori hankija (võrgustiku sektori hankija) või ettevõtja riigi õiguses sätestatud määratluses.</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud aususe kohustuse rikkumise või korruptiivse teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud aususe kohustuse rikkumise või korruptiivse teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">94bafa958a57a2f5fa7af1f5c03b1e54-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e02a375844ffeed61bf8e900d79fdac-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e02a375844ffeed61bf8e900d79fdac-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e02a375844ffeed61bf8e900d79fdac-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e02a375844ffeed61bf8e900d79fdac-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">349df04fcc0fc67f069277acb8c9dbc6-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f40dcf93e5a4c45cbe614d6e548ef291-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">07df47ce65627207b1b045f7a91524fe-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2f83fb0e402357838fb6473a22095ad0-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">297d2323-3ede-424e-94bc-a91561e6f320</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.FRAUD</cbc:CriterionTypeCode> <cbc:Name>Pettus</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud kelmuse eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kelmuse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud kelmuse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">664e928718e7857cd0a1f6f4ce5d5e78-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9aecbda897b5af788719bf9785379d9a-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9aecbda897b5af788719bf9785379d9a-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9aecbda897b5af788719bf9785379d9a-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9aecbda897b5af788719bf9785379d9a-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">339e6fdf2845953de42156e24c396a3c-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0ddc4872e3fcfe77a5981c65b9277fb6-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e63f6d15c35d9de0ca7ce2f47548ba6-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">465acd61bc65f51b8be110b516ebe3c0-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d486fb70-86b3-4e75-97f2-0d71b5697c7d</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.TERRORIST_OFFENCES</cbc:CriterionTypeCode> <cbc:Name>Terroriakti toimepanek või terroristliku tegevusega seotud õigusrikkumised</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud terroriakti toimepaneku või terroristliku tegevusega seotud õigusrikkumiste eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud terroriakti toimepaneku või muu terroristliku tegevusega seotud kuriteo või sellele kihutamise, kaasaaitamise või selle katse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud terroriakti toimepaneku või muu terroristliku tegevusega seotud kuriteo või sellele kihutamise, kaasaaitamise või selle katse eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">85d57d4b7fa89f637f91d9d8b027405c-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d0a0120138d89be004580e67f236998a-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d0a0120138d89be004580e67f236998a-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d0a0120138d89be004580e67f236998a-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d0a0120138d89be004580e67f236998a-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0370883c347256e5a0135b8a84fd760b-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">17aedd2261f7feab717cb32c3b5aeb29-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2d902c8235ebefb9296053f5363306ef-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fa2df2255415653c837e2025a50cfb0a-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">47112079-6fec-47a3-988f-e561668c3aef</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.MONEY_LAUNDERING</cbc:CriterionTypeCode> <cbc:Name>Rahapesu või terrorismi rahastamine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud rahapesu või terrorismi rahastamise eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud rahapesualase süüteo või terrorismi rahastamise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 1 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud rahapesualase süüteo või terrorismi rahastamise eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2d056d00bb0a19f4805cac08dcf7a67d-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">52cacf5f0daca4e3430d7251c0c7da1d-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">52cacf5f0daca4e3430d7251c0c7da1d-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">52cacf5f0daca4e3430d7251c0c7da1d-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">52cacf5f0daca4e3430d7251c0c7da1d-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1c90295ec86cb799a8c1232d8e420c01-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c8178fa1450e3748f0725690078c2c62-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">db96b332d0df0d7ce653977d80137c3e-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e9226efb7961e6beeb7ab8e273e95028-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d789d01a-fe03-4ccd-9898-73f9cfa080d1</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONVICTIONS.CHILD_LABOUR-HUMAN_TRAFFICKING</cbc:CriterionTypeCode> <cbc:Name>Laste tööjõu kasutamine ja muud inimkaubanduse vormid</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja ise või tema haldus-, juht- või järelevalveorgani liige või isik, kellel on volitused seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on lõpliku süüdimõistva kohtuotsusega süüdi mõistetud laste tööjõu kasutamise või muude inimkaubanduse vormide eest kõige rohkem viimase viie aasta jooksul või kehtib süüdimõistvas kohtuotsuses sätestatud kõrvalejäämise kohustus endiselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 3 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud laste tööjõu ebaseadusliku kasutamise või inimkaubandusega seotud teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 3 ja lg 2 "keda või kelle haldus-, juhtimis- või järelevalveorgani liiget, prokuristi või muud isikut, kellel on volitus seda ettevõtjat esindada, tema nimel otsuseid teha või teda kontrollida, on karistatud laste tööjõu ebaseadusliku kasutamise või inimkaubandusega seotud teo eest". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c637c0c-7703-4389-ba52-02997a055bd7</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c97dab162756613157478a51204f9c86-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">83022e29557557a368016539d73d38bb-1.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">83022e29557557a368016539d73d38bb-1.1.2</cbc:ID> <cbc:Description languageID="ET">Põhjus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">83022e29557557a368016539d73d38bb-1.1.3</cbc:ID> <cbc:Description languageID="ET">Kes süüdi mõisteti?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">83022e29557557a368016539d73d38bb-1.1.4</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f4978772-3126-4ded-bc30-f50da8c3a038</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ed85f82954382b639f1eaf50017a064e-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c19c11d54efe2c12b6e51dba2a083519-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">036d42bf0ba523328b09842e95e5a483-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">49fbdd637d5d0872abb6062ade6f09e8-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b61bbeb7-690e-4a40-bc68-d6d4ecfaa3d4</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONTRIBUTIONS.PAYMENT_OF_TAXES</cbc:CriterionTypeCode> <cbc:Name>Maksude tasumine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on rikkunud oma maksude tasumise kohustusi nii asukohariigis kui ka avaliku sektori hankija või võrgustiku sektori hankija liikmesriigis, kui see erineb asukohariigist?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 4 „kellel on riikliku maksu, makse või keskkonnatasu maksuvõlg maksukorralduse seaduse tähenduses või maksuvõlg /…/ tema asukohariigi õigusaktide kohaselt“</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 4 „kellel on riikliku maksu, makse või keskkonnatasu maksuvõlg maksukorralduse seaduse tähenduses või maksuvõlg /…/ tema asukohariigi õigusaktide kohaselt“</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">53c9aad8-dc80-48f8-85d9-755c2aab8e95</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">591b6f30ce0753042d115e2cc81bf72f-1.1</cbc:ID> <cbc:Description languageID="ET">Piirmäär</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> <cbc:ExpectedAmount currencyID="EUR">0</cbc:ExpectedAmount> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">591b6f30ce0753042d115e2cc81bf72f-1.2</cbc:ID> <cbc:Description languageID="ET">Lisainfo</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> <cbc:ExpectedDescription>Maksukorralduse seaduse kohaselt ei väljasta maksuhaldur maksuvõlgade tõendit juhul, kui maksukohustuslasel olev kõikide sama maksuhalduri hallatavate maksude võlg, arvestamata haldusaktiga kindlaksmääramata intressi, on väiksem kui 100 eurot või kui maksuvõla tasumine on ajatatud. Välismaise ettevõtja puhul väljastatakse maksuvõlgade tõend tema asukohariigi õigusaktide kohaselt.</cbc:ExpectedDescription> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">098fd3cc-466e-4233-af1a-affe09471bce</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d2b922c3afdd52c13d295e3333eafa67-1.1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f8499787-f9f8-4355-95e2-9784426f4d7b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6e0837518cbfb4371e9e83fccd266ab3-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Asjaomane riik või liikmesriik</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CODE_COUNTRY</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6e0837518cbfb4371e9e83fccd266ab3-1.1.1.2</cbc:ID> <cbc:Description languageID="ET">Asjaomane summa</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c2aec9f-4876-4c33-89e6-2ab6d6cf5d02</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3850a15a4a07b298d461d08e23b39837-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas see kohustuste rikkumine on tuvastatud muude vahenditega kui kohtu- või haldusotsusega?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">80633323-a7b6-4206-9728-e4534eaad8b2</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">99537009354605a4395aa686ead557a2-1.1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage kasutatud vahendeid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">536417dc-8130-4981-85c5-fceba5541c58</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONFALSE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">113999e18124b44c72e77ada9dd4b8a8-1.1.1.1.2.1</cbc:ID> <cbc:Description languageID="ET">Kui kohustuste rikkumine tuvastati kohtu- või haldusotsusega, märkige, kas see otsus on lõplik ja siduv.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8aaac22d-1b59-442e-9210-a6e70ec05962</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fa9ea46b75af4d23c4e5dc8d8fc11224-1.1.1.1.2.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fa9ea46b75af4d23c4e5dc8d8fc11224-1.1.1.1.2.1.2</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a49e6e25-0059-47da-9397-72c2db5fd5b1</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">599ae929bd55fd657520932db9f31bc6-1.1.1.1.3.1</cbc:ID> <cbc:Description languageID="ET">Kas ettevõtja on täitnud oma kohustused tasumisele kuuluvate maksude või sotsiaalkindlustusmaksete tasumisega või siduva kokkuleppe sõlmimisega tasumisele kuuluvate maksude või sotsiaalkindlustusmaksete, sealhulgas vajaduse korral kogunenud intresside ja viiviste tasumise kohta?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">42a44eb9-b8c9-4a67-8776-e77fc5356efe</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7bc8a3613be0efa08f1a1e6aeb2de593-1.1.1.1.3.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e5f319d2c9fe7a95fde7de1281fac693-1.2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">671f28fb772390c67435047894df84da-1.2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7d85e333-bbab-49c0-be8d-c36d71a72f5e</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONTRIBUTIONS.PAYMENT_OF_SOCIAL_SECURITY</cbc:CriterionTypeCode> <cbc:Name>Sotsiaalkindlustusmaksete tasumine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on rikkunud oma sotsiaalkindlustusmaksete tasumise kohustusi nii asukohariigis kui ka avaliku sektori hankija või võrgustiku sektori hankija liikmesriigis, kui see erineb asukohariigist?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 1 p 4 „kellel on riikliku /…/ makse /…/ maksuvõlg maksukorralduse seaduse tähenduses või sotsiaalkindlustusemaksete võlg tema asukohariigi õigusaktide kohaselt</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 1 p 4 „kellel on riikliku /…/ makse /…/ maksuvõlg maksukorralduse seaduse tähenduses või sotsiaalkindlustusemaksete võlg tema asukohariigi õigusaktide kohaselt</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">53c9aad8-dc80-48f8-85d9-755c2aab8e95</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">44ba5e05d88564516899a6caa5014f45-1.1</cbc:ID> <cbc:Description languageID="ET">Piirmäär</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> <cbc:ExpectedAmount currencyID="EUR">0</cbc:ExpectedAmount> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">44ba5e05d88564516899a6caa5014f45-1.2</cbc:ID> <cbc:Description languageID="ET">Lisainfo</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> <cbc:ExpectedDescription>Maksukorralduse seaduse kohaselt ei väljasta maksuhaldur maksuvõlgade tõendit juhul,kui maksukohustuslasel olev kõikide sama maksuhalduri hallatavate maksude võlg, arvestamata haldusaktiga kindlaksmääramata intressi, on väiksem kui 100 eurot või kui maksuvõla tasumine on ajatatud. Välismaise ettevõtja puhul väljastatakse maksuvõlgade tõend tema asukohariigi õigusaktide kohaselt.</cbc:ExpectedDescription> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">098fd3cc-466e-4233-af1a-affe09471bce</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a798f5c4df3b296808ec367318de88e5-1.1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f8499787-f9f8-4355-95e2-9784426f4d7b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5dbfb3a91a6e078f0443d416b526bd2b-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Asjaomane riik või liikmesriik</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CODE_COUNTRY</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5dbfb3a91a6e078f0443d416b526bd2b-1.1.1.2</cbc:ID> <cbc:Description languageID="ET">Asjaomane summa</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c2aec9f-4876-4c33-89e6-2ab6d6cf5d02</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8546e692e09bc12544954a34bac569e8-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas see kohustuste rikkumine on tuvastatud muude vahenditega kui kohtu- või haldusotsusega?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">80633323-a7b6-4206-9728-e4534eaad8b2</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8464a199433494573513c685259522d6-1.1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage kasutatud vahendeid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">536417dc-8130-4981-85c5-fceba5541c58</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONFALSE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f31a7e715511387237a9a0e9d9367cab-1.1.1.1.2.1</cbc:ID> <cbc:Description languageID="ET">Kui kohustuste rikkumine tuvastati kohtu- või haldusotsusega, märkige, kas see otsus on lõplik ja siduv.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8aaac22d-1b59-442e-9210-a6e70ec05962</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">16479b3ac96f8f8b5399c4ad36a10881-1.1.1.1.2.1.1</cbc:ID> <cbc:Description languageID="ET">Süüdimõistmise kuupäev</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DATE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">16479b3ac96f8f8b5399c4ad36a10881-1.1.1.1.2.1.2</cbc:ID> <cbc:Description languageID="ET">Süüdimõistvas otsuses sõnaselgelt esitatud kõrvalejätmise kestus.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a49e6e25-0059-47da-9397-72c2db5fd5b1</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">92ff80c7de4626861254e250bbe19ea8-1.1.1.1.3.1</cbc:ID> <cbc:Description languageID="ET">Kas ettevõtja on täitnud oma kohustused tasumisele kuuluvate maksude või sotsiaalkindlustusmaksete tasumisega või siduva kokkuleppe sõlmimisega tasumisele kuuluvate maksude või sotsiaalkindlustusmaksete, sealhulgas vajaduse korral kogunenud intresside ja viiviste tasumise kohta?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">42a44eb9-b8c9-4a67-8776-e77fc5356efe</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">81d96d9e2996738bfa585ef23cd27356-1.1.1.1.3.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">06238c8b82047ad5f649f64687cfed04-1.2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">29eb41abb32b80f2eaee7c1119ad2de7-1.2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a80ddb62-d25b-4e4e-ae22-3968460dc0a9</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.SOCIAL.ENVIRONMENTAL_LAW</cbc:CriterionTypeCode> <cbc:Name>Keskkonnaõiguse valdkonnas kohaldatavate kohustuste täitmata jätmine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on enda teada rikkunud keskkonnaõiguse valdkonnas kohaldatavaid kohustusi?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid keskkonnaõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid keskkonnaõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">976b5acb-c00f-46ca-8f83-5ce6abfdfe43</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d71f2afecb0aec233e2f178327ac18d1-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">64a2102c-4af1-4ecb-97b3-0c41907ec0f6</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1ff6a9b11f304e371d19a71696b40692-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5f9f09f7-f701-432c-9fdc-c22c124a74c9</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3b7d89cfcf10f74aa676e483995c16fd-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0bdd2a3f426dd4905973701b1a1f6d92-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">795818013abcd8fa0b614f8ab21ae90b-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4013da9224d17002f76e00d9412b180c-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a261a395-ed17-4939-9c75-b9ff1109ca6e</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.SOCIAL.SOCIAL_LAW</cbc:CriterionTypeCode> <cbc:Name>Sotsiaalõiguse valdkonnas kohaldatavate kohustuste täitmata jätmine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on enda teada rikkunud sotsiaalõiguse valdkonnas kohaldatavaid kohustusi?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid sotsiaalõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid sotsiaalõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">976b5acb-c00f-46ca-8f83-5ce6abfdfe43</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dced61ca05d4b6509ba11c848f7efc58-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">64a2102c-4af1-4ecb-97b3-0c41907ec0f6</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">17fe0dcaaf85a079d239d6fafa8dc1d3-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5f9f09f7-f701-432c-9fdc-c22c124a74c9</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">686813b025a645cc4d0b1d7fcb0ba9f6-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">39332400589476c7707f21c8e0c2b54e-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0cc2de07ff96b1169913b554d5735478-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a682002a8a80a80d183259605439ec4d-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a34b70d6-c43d-4726-9a88-8e2b438424bf</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.SOCIAL.LABOUR_LAW</cbc:CriterionTypeCode> <cbc:Name>Tööõiguse valdkonnas kohaldatavate kohustuste täitmata jätmine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on enda teada rikkunud tööõiguse valdkonnas kohaldatavaid kohustusi?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid tööõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 2 „kes on rikkunud õigusaktidest või kollektiivlepingust tulenevaid tööõiguse valdkonnas kohaldatavaid kohustusi“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">976b5acb-c00f-46ca-8f83-5ce6abfdfe43</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">db41347baa09a8c0a5cae4ca70927e9d-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">64a2102c-4af1-4ecb-97b3-0c41907ec0f6</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bdc15f1fd5cb7d2fdf337938f94532a0-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5f9f09f7-f701-432c-9fdc-c22c124a74c9</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ffdc8a5b7494a18912169cfd794a75e9-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">474e8f18919316713aabbf2229006484-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ece600a9097944288e11a1b6699fb6bb-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5cd1931d64fae933e71cf960ece3e7f5-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d3732c09-7d62-4edc-a172-241da6636e7c</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.BANKRUPTCY</cbc:CriterionTypeCode> <cbc:Name>Pankrot</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on pankrotis?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kes on pankrotis, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kes on pankrotis, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">056f8a7d83e7385f1028c51aa00aa34b-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">84295052d2d27a0dcbd585edbb05be50-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">84295052d2d27a0dcbd585edbb05be50-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">de8e758fa6893cfd64668285fa226847-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">224dd6120f91e22d17b778928fea1886-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">396f288a-e267-4c20-851a-ed4f7498f137</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.INSOLVENCY</cbc:CriterionTypeCode> <cbc:Name>Maksejõuetus</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja suhtes on algatatud maksejõuetus- või likvideerimismenetlus?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kes on likvideerimisel või kelle suhtes on algatatud pankrotimenetlus, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kes on likvideerimisel või kelle suhtes on algatatud pankrotimenetlus, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8d66094d6187fbeb250bc18bf2899a37-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4358a8a9070a246e426e3427d85d0711-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4358a8a9070a246e426e3427d85d0711-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8bc3c952560f6ad78eb65c5373517e78-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4e2ff0e2165c44a6eebfb787e2860295-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">68918c7a-f5bc-4a1a-a62f-ad8983600d48</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.CREDITORS_ARRANGEMENT</cbc:CriterionTypeCode> <cbc:Name>Kokkulepe võlausaldajatega</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on sõlminud kokkuleppe võlausaldajatega?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5a10919abd31fa6f8738ed8e2bfc2c30-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2c7ffedaa22412614e54b2c73f32ba1f-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2c7ffedaa22412614e54b2c73f32ba1f-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0da3567bd1587969627a71cc637bf3ff-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">24bfa7ce46068d5a8d31e88dde804e66-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">daffa2a9-9f8f-4568-8be8-7b8bf306d096</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.BANKRUPTCY_ANALOGOUS</cbc:CriterionTypeCode> <cbc:Name>Siseriikliku õiguse kohane samalaadne olukord, näiteks pankrot</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on siseriiklike õigusnormide alusel toimuva samalaadse menetluse tõttu samalaadses olukorras?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt“, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt“, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">476a15b9d9f85459a63cadc3e3b73460-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fd166074bd97f8be871238ee0a3472df-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fd166074bd97f8be871238ee0a3472df-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">699c2f5f4ae65e623002d40bb3ee7ee9-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bd91129f6a3774fbe6d0215a59cf966c-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8fda202a-0c37-41bb-9d7d-de3f49edbfcb</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.LIQUIDATOR_ADMINISTERED</cbc:CriterionTypeCode> <cbc:Name>Vara haldab likvideerija</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja vara haldab likvideerija või kohus?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kes on pankrotis, likvideerimisel või kelle suhtes on algatatud pankrotimenetlus või kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kes on pankrotis, likvideerimisel või kelle suhtes on algatatud pankrotimenetlus või kes on muus sellesarnases olukorras tema asukohamaa õigusaktide kohaselt, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67b088a852a32478afb7cc8fd19d3fb5-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">896385ffd24ec34f1c414abfc97e0541-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">896385ffd24ec34f1c414abfc97e0541-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3c0b4f12a3e8a3f4f4023932e10ed8a9-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">116e9a32beda1ed6e51a9f70a9b5350b-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">166536e2-77f7-455c-b018-70582474e4f6</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.BUSINESS.ACTIVITIES_SUSPENDED</cbc:CriterionTypeCode> <cbc:Name>Äritegevus on peatatud</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja äritegevus on peatatud?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 3 „kelle äritegevus on peatatud, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 3 „kelle äritegevus on peatatud, välja arvatud asjade ostmisel RHS § 49 lõikes 4 sätestatud juhul ja tingimustel“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d91c11a1-f19e-4b83-8ade-c4be2bf00555</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b1f1dc7c01597a65463e2c18253f83c0-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">aeef523b-c8fc-4dba-9c34-03e34812567b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e467bed89b7031d88fb3001fdc28ad5a-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e467bed89b7031d88fb3001fdc28ad5a-1.1.2</cbc:ID> <cbc:Description languageID="ET">Märkige põhjused, miks lepingu täitmine on sellest hoolimata võimalik. Seda teavet ei ole tarvis esitada, kui ettevõtja kõrvalejätmine on kohaldatava siseriikliku õiguse alusel muudetud konkreetsel juhul kohustuslikuks ja puudub võimalus teha erandit, isegi kui ettevõtja suudab lepingut täita.</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">962c3b6715f062c66fb25afbefe1360a-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ea6187efebc1a1857977d16abc945fc2-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">514d3fde-1e3e-4dcd-b02a-9f984d5bbda3</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.MISCONDUCT.MC_PROFESSIONAL</cbc:CriterionTypeCode> <cbc:Name>Süüdi ametialaste käitumisreeglite olulises rikkumises</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on süüdi ametialaste käitumisreeglite olulises rikkumises? Vt siseriiklikud õigusaktid, asjaomane teade või hankedokumendid, kui see on asjakohane.</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 4 „kes on raskelt eksinud ametialaste käitumisreeglite vastu ja see muudab tema aususe küsitavaks“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 4 „kes on raskelt eksinud ametialaste käitumisreeglite vastu ja see muudab tema aususe küsitavaks“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67362ec7-cec3-4cb8-a38e-5d7a2a31e6d8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e84b04d9cced34ecb51466b1045b0324-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2cbcf978-765c-40aa-996b-b1d082485cef</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7ab1f28d8861d49aa1c1dbfc1997d3b0-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5f9f09f7-f701-432c-9fdc-c22c124a74c9</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8bfe32ac76744c6049299eb020f85ef6-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6744a0ed579ff20ba20322faee3ee894-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1ee9e1dfca8300341b206644744d8fe0-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5003c2b1f82b8e2b422f49b35ce79fff-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">56d13e3d-76e8-4f23-8af6-13e60a2ee356</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.MISCONDUCT.MARKET_DISTORTION</cbc:CriterionTypeCode> <cbc:Name>Konkurentsi moonutamise eesmärgil teiste ettevõtjatega sõlmitud kokkulepped</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on teiste ettevõtjatega sõlminud kokkuleppeid, mille eesmärk on moonutada konkurentsi?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 5 „konkurentsi kahjustava kokkuleppe, ettevõtjate ühenduse otsuse või kooskõlastatud tegevuse tõttu“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 5 „konkurentsi kahjustava kokkuleppe, ettevõtjate ühenduse otsuse või kooskõlastatud tegevuse tõttu“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67362ec7-cec3-4cb8-a38e-5d7a2a31e6d8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8486f521e63eee007f5f05abbddcaae9-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2cbcf978-765c-40aa-996b-b1d082485cef</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c96332968ed78a89a12a5c216709a0-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5f9f09f7-f701-432c-9fdc-c22c124a74c9</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a52c3fb0a59b96a1caff33f76f2f8810-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">78c7691916ecc30f63e0ac9736967fb5-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">03299642dcd03d0b74e6fcec1d941d60-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6d4c134c796c2ea86c7c641ce0c2b5bd-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b1b5ac18-f393-4280-9659-1367943c1a2e</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONFLICT_OF_INTEREST.PROCEDURE_PARTICIPATION</cbc:CriterionTypeCode> <cbc:Name>Hankemenetluses osalemisega kaasnev huvide konflikt</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on teadlik hankemenetluses osalemisega kaasnevast mis tahes huvide konfliktist siseriikliku õiguse, asjakohase teatise või hankedokumentide kohaselt?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 6 „kui huvide konflikti ei ole muude vahenditega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 6 „kui huvide konflikti ei ole muude vahenditega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67362ec7-cec3-4cb8-a38e-5d7a2a31e6d8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">762dc3a323dc6704cf8944168406e22a-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">73f0fe4c-4ed9-4343-8096-d898cf200146</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">780c0fd2e78afa0975228976830a65a3-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">354daa93c73508e8eceb357ca3a9475a-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d67d6ca6bf8276440a77447c332e1972-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">61874050-5130-4f1c-a174-720939c7b483</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONFLICT_OF_INTEREST.PROCEDURE_PREPARATION</cbc:CriterionTypeCode> <cbc:Name>Otsene või kaudne osalemine käesoleva hankemenetluse ettevalmistamisel</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja või temaga seotud ettevõtja on nõustanud avaliku sektori hankijat või võrgustiku sektori hankijat hankemenetluse ettevalmistamisel või olnud muul viisil seotud hankemenetluse ettevalmistamisega?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 7 „kelle pakkumuse või taotluse koostamisel on osalenud isik, kes on osalenud sama riigihanke ettevalmistamisel või on muul viisil hankijaga seotud, ja sellele isikule seetõttu teadaolev info annab talle eelise teiste riigihankes osalejate eest ning sellest tingitud konkurentsi moonutamist ei ole muude vahendistega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 7 „kelle pakkumuse või taotluse koostamisel on osalenud isik, kes on osalenud sama riigihanke ettevalmistamisel või on muul viisil hankijaga seotud, ja sellele isikule seetõttu teadaolev info annab talle eelise teiste riigihankes osalejate eest ning sellest tingitud konkurentsi moonutamist ei ole muude vahendistega võimalik vältida“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67362ec7-cec3-4cb8-a38e-5d7a2a31e6d8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a3e8a6e67e44334c5f2afdd4e7562fa7-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">73f0fe4c-4ed9-4343-8096-d898cf200146</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0061708149ea470bdbbabfe4419df655-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a8999a4d1b62c66814d34ecfebb4c1ae-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f841acfbfb1d4890cf6a40e5f4ac215e-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3293e92b-7f3e-42f1-bee6-a7641bb04251</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONFLICT_OF_INTEREST.EARLY_TERMINATION</cbc:CriterionTypeCode> <cbc:Name>Ennetähtaegne lõpetamine, kahjutasu või võrreldavad sanktsioonid</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on kogenud, et varasem riigihankeleping või võrgustiku sektori hankijaga sõlmitud varasem hankeleping või varasem kontsessioonileping on lõpetatud enneaegselt, või on määratud kahjutasu või sellega võrreldavad sanktsioonid seoses kõnealuse varasema lepinguga?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 8 „kes on oluliselt või pidevalt rikkunud eelnevalt sõlmitud hankelepingu olulist tingimust või hankelepingute olulisi tingimusi nii, et rikkumise tulemusena on lepingust taganetud või leping üles öeldud, hinda alandatud, hüvitatud kahju või makstud leppetrahvi". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Alates 1.09.2017 alustatud hangete tulemusena sõlmitud riigihankelepingute kohta leiab infot riigihangete registrist.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 8 „kes on oluliselt või pidevalt rikkunud eelnevalt sõlmitud hankelepingu olulist tingimust või hankelepingute olulisi tingimusi nii, et rikkumise tulemusena on lepingust taganetud või leping üles öeldud, hinda alandatud, hüvitatud kahju või makstud leppetrahvi". Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud. Alates 1.09.2017 alustatud hangete tulemusena sõlmitud riigihankelepingute kohta leiab infot riigihangete registrist.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67362ec7-cec3-4cb8-a38e-5d7a2a31e6d8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">88f454ed56cf088fa5cd0eb926751769-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">73f0fe4c-4ed9-4343-8096-d898cf200146</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3a97fb9147ccaa40e15fdea13f565e3f-1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">20c5361b-7599-4ee6-b030-7f8323174d1e</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9e99ebf957680af144d88b6c9fa3f90c-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kas olete võtnud meetmeid, et tõendada oma usaldusväärsust („Self-Cleaning”)?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">74e6c7b4-757b-4b40-ada6-fad6a997c310</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fe85fa176b7dbacd117f0d19f7611fb5-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldage neid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">24f26f42d53a913959ce42027dc14bb1-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">398000286b23baf64b55b4bc0665b84d-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">696a75b2-6107-428f-8b74-82affb67e184</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.CONFLICT_OF_INTEREST.MISINTERPRETATION</cbc:CriterionTypeCode> <cbc:Name>Süüdi valeandmete esitamises, on jätnud teavet esitamata, ei suuda nõutud dokumente esitada, hankinud käesoleva menetluse kohta konfidentsiaalset teavet</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on olnud ühes järgmistest olukordadest: a) ta on kõrvalejätmise aluste puudumise või valikukriteeriumide täitmise kontrollimiseks nõutava teabe esitamisel esitanud valeandmeid; b) ta on jätnud sellist teavet esitamata; c) ta ei ole esitanud viivitamata avaliku sektori hankija või võrgustiku sektori hankija nõutud täiendavad dokumendid, ja d) ta on tegutsenud eesmärgiga mõjutada lubamatul viisil avaliku sektori hankija või võrgustiku sektori hankija otsustusprotsessi, et saada konfidentsiaalseid andmeid, mis võivad anda talle põhjendamatu eelise hankemenetluses, või hooletusest esitanud eksitavat teavet, mis võib oluliselt mõjutada kõrvalejätmise, valiku või lepingu hindamise kohta tehtavaid otsuseid?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 95 lg 4 p 9 „kes on esitanud valeandmeid käesolevas paragrahvis sätestatud või RHS §-des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta“; RHS § 95 lg 4 p 9 „kes on jätnud andmed käesolevas paragrahvis sätestatud või käesoleva seaduse §-des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta esitamata“; RHS § 95 lg 4 p 9 „kes on jätnud käesoleva seaduse § 104 lõigete 7 ja 8 alusel hankija nõutud täiendavad dokumendid esitamata“; RHS § 95 lg 4 p 10 „kes on tegutsenud eesmärgiga mõjutada hankijat või esitanud hooletusest eksitavat teavet, mis on võinud mõjutada hankija otsuseid riigihankes, või on tegutsenud eesmärgiga saada konfidentsiaalset teavet, mis on võinud anda talle põhjendamatu eelise teiste riigihankes osalejate ees“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Title> <cbc:Description languageID="ET">RHS § 95 lg 4 p 9 „kes on esitanud valeandmeid käesolevas paragrahvis sätestatud või RHS §-des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta“; RHS § 95 lg 4 p 9 „kes on jätnud andmed käesolevas paragrahvis sätestatud või käesoleva seaduse §-des 98-101 sätestatu alusel hankija kehtestatud kvalifitseerimise tingimustele vastavuse kohta esitamata“; RHS § 95 lg 4 p 9 „kes on jätnud käesoleva seaduse § 104 lõigete 7 ja 8 alusel hankija nõutud täiendavad dokumendid esitamata“; RHS § 95 lg 4 p 10 „kes on tegutsenud eesmärgiga mõjutada hankijat või esitanud hooletusest eksitavat teavet, mis on võinud mõjutada hankija otsuseid riigihankes, või on tegutsenud eesmärgiga saada konfidentsiaalset teavet, mis on võinud anda talle põhjendamatu eelise teiste riigihankes osalejate ees“. Kui hankemenetlusest kõrvaldamise alus esineb, võib ettevõtja soovi korral esitada tõendeid selle kohta, et ta on võtnud meetmeid oma usaldusväärsuse taastamiseks. Heastamise võimalus on ettevõtjal juhul, kui tegemist on rahvusvahelist piirmäära ületava hankega või hankija on selle hanke alusdokumentides ette näinud.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f3a6836d-2de2-4cd1-81ca-fb06178d05c5</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e5651c9fcebc0f9e0b6c2adea0f6ae0a-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">797467a9cd053779f8189cc09b53cd15-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8906d536a55e83e14c0fa8af7e18529a-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3a18a175-1863-4b1d-baef-588ce61960ca</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.SELECTION.TECHNICAL_PROFESSIONAL_ABILITY.REFERENCES.SUPPLIES_DELIVERY_PERFORMANCE</cbc:CriterionTypeCode> <cbc:Name>Asjade hankelepingute puhul: täpsustatud liiki tarnete teostamine</cbc:Name> <cbc:Description languageID="ET">Ainult asjade riigihankelepingute puhul: nimekiri hankija kindlaksmääratud tunnustele vastavate asjade müügi või teenuste osutamise lepingutest, mis on täidetud riigihanke algamisele eelneva 36 kuu jooksul, koos teabega nende maksumuse, kuupäevade ja teiste lepingupoolte kohta. Avaliku sektori hankijad võivad võtta arvesse rohkem kui kolme aasta vanuseid lepinguid.</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">RHS § 101 lg 1 p 2 „nimekiri hankija kindlaks määratud tunnustele vastavate asjade müügi lepingutest, mis on täidetud riigihanke algamisele eelneva 36 kuu jooksul, koos teabega nende maksumuse, kuupäevade ja teiste lepingupoolte kohta“ RHS § 101 lg 2 „hankija võib piisava konkurentsi tagamiseks arvesse võtta andmeid rohkem kui 36 kuu eest täidetud asjade müügi lepingute kohta“</cbc:Title> <cbc:Description languageID="ET">RHS § 101 lg 1 p 2 „nimekiri hankija kindlaks määratud tunnustele vastavate asjade müügi lepingutest, mis on täidetud riigihanke algamisele eelneva 36 kuu jooksul, koos teabega nende maksumuse, kuupäevade ja teiste lepingupoolte kohta“ RHS § 101 lg 2 „hankija võib piisava konkurentsi tagamiseks arvesse võtta andmeid rohkem kui 36 kuu eest täidetud asjade müügi lepingute kohta“</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">381bea15-9460-49f7-a6d0-15d13059de29</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4029b647bae0d29afad66552a4c54583-1.1</cbc:ID> <cbc:Description languageID="ET">Minimaalne teostatud tööde arv</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUANTITY_INTEGER</cbc:ValueDataTypeCode> <cbc:ExpectedValueNumeric>1</cbc:ExpectedValueNumeric> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">53c9aad8-dc80-48f8-85d9-755c2aab8e95</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6431fac8-f742-4512-b215-d0a2ab89c10d</cbc:ID> <cbc:Description languageID="ET"/> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CAPTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">NONE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">167ab253-4fb7-4e45-81be-b049fba44b3a</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2"></cbc:ID> <cbc:Description languageID="ET"/> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d663aca5-5f3c-4980-b825-81e1bd7db381</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e8056dbf0b7aeac2125a1766f1dc6f2b-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">REQUIREMENT</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> <cbc:ExpectedDescription>Eelnev kogemus hankeobjektiga sarnaste toodete tootmisel ja/või müümisel ning paigaldamisel - täidetud vähemalt üks tellimus eelneva 36 kuu jooksul vähemalt 100 000 euro eest.</cbc:ExpectedDescription> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a44e24e9-f878-4651-9ead-e0b1387dae09</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7c54832b-7d86-4036-8223-df1a59baeeab</cbc:ID> <cbc:Description languageID="ET"/> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CAPTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">NONE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c8ec5c30-2c17-4936-abbb-392523d873e5</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Kirjeldus</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.2</cbc:ID> <cbc:Description languageID="ET">Kogusumma</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.3</cbc:ID> <cbc:Description languageID="ET">Ettevõtja vastutusala</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.4</cbc:ID> <cbc:Description languageID="ET">Summa</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">AMOUNT</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.5</cbc:ID> <cbc:Description languageID="ET">Ajavahemik</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERIOD</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.6</cbc:ID> <cbc:Description languageID="ET">Kas info on konfidentsiaalne?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6afa7569-e4c4-4538-be89-84a82b2a301b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.1</cbc:ID> <cbc:Description languageID="ET">Tellija nimi</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.2</cbc:ID> <cbc:Description languageID="ET">Kontaktisiku nimi</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.3</cbc:ID> <cbc:Description languageID="ET">E-mail</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.4</cbc:ID> <cbc:Description languageID="ET">Telefon</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8f6f05690d25c2afdf53a2738aa200c9-1.1.1.2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1dff584eea1b41456082967ba378d4f5-1.1.1.2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2043338f-a38a-490b-b3ec-2607cb25a017</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.SHELTERED_WORKSHOP</cbc:CriterionTypeCode> <cbc:Name>Ettevõtja on kaitstud töökoht</cbc:Name> <cbc:Description languageID="ET">Ainult reserveeritud hangete puhul: kas ettevõtja puhul on tegemist kaitstud töökohaga, sotsiaalse ettevõttega või ta täidab lepingut kaitstud tööhõive programmide raames?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6febbe4a-e715-427c-a2b1-19cfabadaef0</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">916ab5ce762c49fbffd04765384d9195-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a5e33369-e2b5-45f7-9969-ddb1c3ae17c8</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4ce62b05d3766bb39de778d0137f6854-1.1.1</cbc:ID> <cbc:Description languageID="ET">Milline on puudega või ebasoodsas olukorras olevate töötajate osakaal?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">PERCENTAGE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4ce62b05d3766bb39de778d0137f6854-1.1.2</cbc:ID> <cbc:Description languageID="ET">Kui seda on nõutud, täpsustage, millisesse puudega või ebasoodsas olukorras olevate töötajate kategooriasse või kategooriatesse asjaomased töötajad kuuluvad?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8511a8ee6a5fe826b0c1c6759cc36403-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">223fa7313710bdb119eb9d1350d79d32-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9b19e869-6c89-4cc4-bd6c-ac9ca8602165</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.REGISTERED_IN_OFFICIAL_LIST</cbc:CriterionTypeCode> <cbc:Name>Ettevõtja on kantud tunnustatud ettevõtjate ametlikku nimekirja</cbc:Name> <cbc:Description languageID="ET">Kui see on asjakohane, siis kas ettevõtja on kantud tunnustatud ettevõtjate ametlikku nimekirja või kas tal on olemas samaväärne tõend (nt riikliku (eel)kvalifitseerimissüsteemi alusel)?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">64162276-7014-408f-a9af-080426bfe1fd</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9ec5f8c89b9cfb663ec773102d3d63ea-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9026e403-3eb6-4705-a9e9-e21a1efc867d</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f2d7fc19dc0a371b177d7d52cc641649-1.1.1</cbc:ID> <cbc:Description languageID="ET">a) Vajaduse korral märkige asjakohane registreerimis- või sertifitseerimisnumber:</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f2d7fc19dc0a371b177d7d52cc641649-1.1.2</cbc:ID> <cbc:Description languageID="ET">c) Viited, millele registreerimine või sertifitseerimine tugineb ja vajaduse korral ametlikus nimekirjas omistatud klassifikatsioon:</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f2d7fc19dc0a371b177d7d52cc641649-1.1.3</cbc:ID> <cbc:Description languageID="ET">d) Kas registreerimine või sertifitseerimine hõlmab kõiki nõutud valikukriteeriume?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8474ff05cd1affe49977b11837ffc832-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7f182a877442795f199f19e30c2f4cb1-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ee51100f-8e3e-40c9-8f8b-57d5a15be1f2</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.TOGETHER_WITH_OTHERS</cbc:CriterionTypeCode> <cbc:Name>Hankemenetluses koos osalevad ettevõtjad</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja osaleb hankemenetluses koos teistega?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d939f2c6-ba25-4dc4-889c-11d1853add19</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b084ef65294946d13ab11527833322a8-1.1</cbc:ID> <cbc:Description languageID="ET">Ettevõtja nimi</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b084ef65294946d13ab11527833322a8-1.2</cbc:ID> <cbc:Description languageID="ET">Ettevõtja ID</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b084ef65294946d13ab11527833322a8-1.3</cbc:ID> <cbc:Description languageID="ET">Ettevõtja roll</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67abefe9c6becc08ff7027f880cf8e58-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">431420fc0327c7dfc0c8e338db661a4f-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0d62c6ed-f074-4fcf-8e9f-f691351d52ad</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.RELIES_ON_OTHER_CAPACITIES</cbc:CriterionTypeCode> <cbc:Name>Teave teiste üksuste suutlikkusele toetumise kohta</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja toetub teiste üksuste suutlikkusele, et täita esitatud valikukriteeriumid ning eeskirjad (kui neid on)?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">289f39b3-2a15-421a-8050-a29858031f35</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f6b858925af7cad9dee2869edd4ff60c-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">50e9a74e-969e-4d79-8e19-8af71cb7c54a</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fe96fce0e7baaa249d8559a7af0f3212-1.1.1</cbc:ID> <cbc:Description languageID="ET">Ettevõtja nimi</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fe96fce0e7baaa249d8559a7af0f3212-1.1.2</cbc:ID> <cbc:Description languageID="ET">Ettevõtja ID</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fe96fce0e7baaa249d8559a7af0f3212-1.1.3</cbc:ID> <cbc:Description languageID="ET">Ettevõtja roll</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9715cfa07bc54f829aa383179c605554-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6833f9ee60ab7d82b44c62c2da533ff0-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c0c4b1-ca50-4667-9487-461f3eed4ed7</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.SUBCONTRACTS_WITH_THIRD_PARTIES</cbc:CriterionTypeCode> <cbc:Name>Teave nende allhankijate kohta, kelle näitajatele ettevõtja ei tugine</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja kavatseb sõlmida lepingu mis tahes osa kohta allhanke kolmanda isikuga?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">289f39b3-2a15-421a-8050-a29858031f35</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bf6b522598fc8784858a6712851f7fa2-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">50e9a74e-969e-4d79-8e19-8af71cb7c54a</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f7918353a4a25b03e4d1ad59de641e39-1.1.1</cbc:ID> <cbc:Description languageID="ET">Ettevõtja nimi</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f7918353a4a25b03e4d1ad59de641e39-1.1.2</cbc:ID> <cbc:Description languageID="ET">Ettevõtja ID</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f7918353a4a25b03e4d1ad59de641e39-1.1.3</cbc:ID> <cbc:Description languageID="ET">Ettevõtja roll</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">DESCRIPTION</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6c3dc3029e6128b5025c2727085b8a67-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9895d63fec57f19d41d599f8db9cdf91-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8b9700b7-b13c-41e6-a220-6bbf8d5fab31</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.LOTS_TENDERED</cbc:CriterionTypeCode> <cbc:Name>Hanke osad</cbc:Name> <cbc:Description languageID="ET">Hanke osad, mille kohta ettevõtja soovib pakkumuse esitada</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">289f39b3-2a15-421a-8050-a29858031f35</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a8f39f21f1a4f61006839d17c48d58c3-1.1</cbc:ID> <cbc:Description languageID="ET">Hanke osa number</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">130b632716c48f4b7f69f61016f3ef5c-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">557c987e3ce67681b7c884af3c38f3f4-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5a8dea31-5db9-4e03-862b-07810aa6a7fd</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.OTHER.EO_DATA.CONTRIBUTIONS_CERTIFICATES</cbc:CriterionTypeCode> <cbc:Name>Ettevõtja kinnitused maksude tasumise kohta</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja saab esitada tõendi sotsiaalkindlustusmaksete ja maksude tasumise kohta või esitada teabe, mis võimaldaks avaliku sektori hankijal või võrgustiku sektori hankijal saada sellise teabe otse ükskõik millise liikmesriigi tasuta andmebaasist?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET"/> <cbc:Description languageID="ET"/> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">289f39b3-2a15-421a-8050-a29858031f35</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">642c63e9ae63a12207197f19f3d6a53e-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e2eb7a88e019a3caf911d6a20865d056-2.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">560e5e7ef0d3d163430768039c402848-2.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterion> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">63adb07d-db1b-4ef0-a14e-a99785cf8cf6</cbc:ID> <cbc:CriterionTypeCode listID="CriteriaTypeCode" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CRITERION.EXCLUSION.NATIONAL.OTHER</cbc:CriterionTypeCode> <cbc:Name>Ainult siseriiklikest õigusaktidest tulenevad kõrvaldamise alused</cbc:Name> <cbc:Description languageID="ET">Kas ettevõtja on rikkunud asjaomases teates või hankedokumentides sätestatud ainult siseriiklikest õigusaktidest tulenevate kõrvalejätmise alustega seotud kohustusi?</cbc:Description> <cac:Legislation> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c753a2c5-59e6-4970-b6eb-27224e96bf76</cbc:ID> <cbc:Title languageID="ET">Avaliku sektori hankemenetlustes kohalduvad RHS § 95 lg 1 p-d 2 ja 5 ning § 95 lg 4 p-d 1 ja 11. Avaliku sektori erihangetes kohalduvad RHS § 95 lg 1 p-d 2 ja 5 ning vabatahtlike kõrvaldamise aluste kohaldamist täpsustab hankija hanke alusdokumentides. Võrgustiku sektori hangetes täpsustab hankija hanke alusdokumentides, milliseid siseriiklikke kõrvaldamise aluseid ta kohaldab. Siseriiklikud kõrvaldamise alused RHS-is on järgnevad: § 95 lg 1 p 2 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget või muud seaduslikku või asjaomase riigihankega seotud lepingulist esindajat on karistatud riigis ilma seadusliku aluseta viibivale välismaalasele töötamise võimaldamise või välismaalase Eestis töötamise tingimuste rikkumise võimaldamise, sealhulgas seaduses sätestatud töötasu määrast väiksema töötasu maksmise eest“ (kohustuslik kõrvaldamise alus); RHS § 95 lg 1 p 5 „kes või kelle haldus-, juhtimis- või järelevalveorgani liige on rahvusvahelise sanktsiooni subjekt rahvusvahelise sanktsiooni seaduse tähenduses“ (kohustuslik kõrvaldamise alus); RHS § 95 lg 4 p 1 „kellel on hankija asukohajärgse kohaliku maksu maksuvõlg maksukorralduse seaduse tähenduses“ (vabatahtlik kõrvaldamise alus); RHS § 95 lg 4 p 11 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget või muud seaduslikku esindajat on karistatud maksualaste süütegude eest (vabatahtlik kõrvaldamise alus)“.</cbc:Title> <cbc:Description languageID="ET">Avaliku sektori hankemenetlustes kohalduvad RHS § 95 lg 1 p-d 2 ja 5 ning § 95 lg 4 p-d 1 ja 11. Avaliku sektori erihangetes kohalduvad RHS § 95 lg 1 p-d 2 ja 5 ning vabatahtlike kõrvaldamise aluste kohaldamist täpsustab hankija hanke alusdokumentides. Võrgustiku sektori hangetes täpsustab hankija hanke alusdokumentides, milliseid siseriiklikke kõrvaldamise aluseid ta kohaldab. Siseriiklikud kõrvaldamise alused RHS-is on järgnevad: § 95 lg 1 p 2 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget või muud seaduslikku või asjaomase riigihankega seotud lepingulist esindajat on karistatud riigis ilma seadusliku aluseta viibivale välismaalasele töötamise võimaldamise või välismaalase Eestis töötamise tingimuste rikkumise võimaldamise, sealhulgas seaduses sätestatud töötasu määrast väiksema töötasu maksmise eest“ (kohustuslik kõrvaldamise alus); RHS § 95 lg 1 p 5 „kes või kelle haldus-, juhtimis- või järelevalveorgani liige on rahvusvahelise sanktsiooni subjekt rahvusvahelise sanktsiooni seaduse tähenduses“ (kohustuslik kõrvaldamise alus); RHS § 95 lg 4 p 1 „kellel on hankija asukohajärgse kohaliku maksu maksuvõlg maksukorralduse seaduse tähenduses“ (vabatahtlik kõrvaldamise alus); RHS § 95 lg 4 p 11 „keda või kelle haldus-, juhtimis- või järelevalveorgani liiget või muud seaduslikku esindajat on karistatud maksualaste süütegude eest (vabatahtlik kõrvaldamise alus)“.</cbc:Description> <cac:Language> <cbc:LocaleCode listID="LanguageCodeEU" listAgencyName="EU-COM-GROW" listVersionID="2.0.2">ET</cbc:LocaleCode> </cac:Language> </cac:Legislation> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2"></cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">30048e48-16c4-4150-aa2c-939965f6f91c</cbc:ID> <cbc:Description languageID="ET"/> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CAPTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">NONE</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2"></cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ee6d410c25e2dc277d8cc35caa8089e8-1.1</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2"/> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2"></cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ee6d410c25e2dc277d8cc35caa8089e8-1.2</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2"/> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2"></cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ee6d410c25e2dc277d8cc35caa8089e8-1.3</cbc:ID> <cbc:Description languageID="ET">Mis on Teie vastus?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2"/> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> <cac:TenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7458d42a-e581-4640-9283-34ceb3ad4345</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ON*</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a531f251e54c354ff4934abc376d6301-1.1</cbc:ID> <cbc:Description languageID="ET">Kas see teave on elektrooniliselt kättesaadav?</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">INDICATOR</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> <cac:SubsidiaryTenderingCriterionPropertyGroup> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41dd2e9b-1bfd-44c7-93ee-56bd74a4334b</cbc:ID> <cbc:PropertyGroupTypeCode listID="PropertyGroupType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">ONTRUE</cbc:PropertyGroupTypeCode> <cac:TenderingCriterionProperty> <cbc:ID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1fe6f352b8fce36ae55b86fb37f488d4-1.1.1</cbc:ID> <cbc:Description languageID="ET">Tõendid</cbc:Description> <cbc:TypeCode listID="CriterionElementType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">QUESTION</cbc:TypeCode> <cbc:ValueDataTypeCode listID="ResponseDataType" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">EVIDENCE_IDENTIFIER</cbc:ValueDataTypeCode> </cac:TenderingCriterionProperty> </cac:SubsidiaryTenderingCriterionPropertyGroup> </cac:TenderingCriterionPropertyGroup> </cac:TenderingCriterion> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">40eff29f-5d55-45d5-95ed-427feb15ffa4</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2d056d00bb0a19f4805cac08dcf7a67d-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">00deec3a-a6b4-4155-8a99-3887a5cec97d</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d8c66b3b-0004-43fb-a909-5433a0e9a61f</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">db96b332d0df0d7ce653977d80137c3e-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">adc6d99e-c119-44e8-8385-8b5f772a797e</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f9ac9a10-439e-4302-aebb-431108068438</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a531f251e54c354ff4934abc376d6301-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3afb1001-785f-4ef2-a00c-fb17aec4e844</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0ea01d66-ca95-4264-982d-036a9acf2854</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e75649a8-ea57-4a62-be7f-e6bb12e22753</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0d7f41b9-4ca2-4f0d-a4f9-e22d904b336f</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e5651c9fcebc0f9e0b6c2adea0f6ae0a-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">76d51674-12d2-4cd1-89d4-072690d9d577</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9f8307f8-c04f-4667-b9f6-bf937b41dcc7</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">797467a9cd053779f8189cc09b53cd15-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ecd7c085-027f-4d33-aeec-23f095b4dbe3</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">116895b2-555b-4e07-b46c-0fea8b9bb4f3</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">762dc3a323dc6704cf8944168406e22a-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41d0574f-435a-4fa4-bca1-85f3abed6fe8</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">cac97330-3203-4ebf-8220-4051781e7aba</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">354daa93c73508e8eceb357ca3a9475a-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">da6d117e-102c-4cd6-8391-d5a376f2f986</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f904d699-547f-4cd5-b2ad-2b037c70605e</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a3e8a6e67e44334c5f2afdd4e7562fa7-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e626a6cf-c185-49e2-90c2-85e1dba7d4de</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">288a7a69-e8a2-4b4f-ac5e-4f7972581ce4</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a8999a4d1b62c66814d34ecfebb4c1ae-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fbb09f33-cef8-4ef8-addb-17473229a52a</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">43292b81-3876-4843-81bf-8c9fdb8c5981</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8d66094d6187fbeb250bc18bf2899a37-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">712113ea-dd8a-4417-9a76-d930517e7f1d</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">663783f6-28b5-40f6-9375-8f004af0a258</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8bc3c952560f6ad78eb65c5373517e78-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">03f7caf0-63c1-4903-8c79-81480fcb4986</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c0183b5f-1058-4f83-983e-f51cc8915548</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f6b858925af7cad9dee2869edd4ff60c-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">69fecbe0-1b86-45b0-82ed-14b2b72b5ec9</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">91bfb2b1-93c2-4e44-9a61-3b88773a0e71</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9715cfa07bc54f829aa383179c605554-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">77d6dddc-1027-47ee-aba8-69be5912d225</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8675c746-c73e-4f76-b61d-03ec8469eff3</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6833f9ee60ab7d82b44c62c2da533ff0-2.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:EvidenceSupplied> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6833f9ee60ab7d82b44c62c2da533ff0-2.1.1</cbc:ID> </cac:EvidenceSupplied> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">83816e7d-2692-41db-9b24-45ec786c6fdd</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">642c63e9ae63a12207197f19f3d6a53e-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">15eebb1a-2ab9-4376-bf2f-2e141ad3e24a</cbc:ID> <cbc:ResponseIndicator>true</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">218f99b6-edd0-4a8a-a24b-5721d4599e43</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">560e5e7ef0d3d163430768039c402848-2.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:EvidenceSupplied> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">560e5e7ef0d3d163430768039c402848-2.1.1</cbc:ID> </cac:EvidenceSupplied> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1c8f5ba0-f1e2-4a52-a441-3c5885513d39</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e2eb7a88e019a3caf911d6a20865d056-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">daa49784-f5f5-4dae-92d7-263b94716a35</cbc:ID> <cbc:ResponseIndicator>true</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ab2f9b74-1ee1-4612-93f6-de5b53ad83ae</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.6</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4c364ba7-c468-4234-a2f6-f99fbf0f8e3d</cbc:ID> <cbc:ResponseIndicator>true</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0e6ae83c-ff96-428c-bb6b-c56c5e8a096e</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8f6f05690d25c2afdf53a2738aa200c9-1.1.1.2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7bd2d538-77e7-4e6e-a7b2-00e5cc477602</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8661e79a-f762-498e-9de0-7e6b1bce41e4</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1b863dc6-8b5b-4d5f-a2f4-736cbb54beb1</cbc:ID> <cbc:Description languageID="ET">IMSP Spitalul Clinic Balti Spitalul Clinic de Traumatologie și Ortopedie</cbc:Description> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3834712f-cc36-4ce2-9449-9bb31c31c7ca</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.2</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4eda7944-3a4f-4ad9-92f5-dbe125bee543</cbc:ID> <cbc:Description languageID="ET">Gheorge Brinza -Director IMSP Spitalul Clinic Balti Serghei ȘTEPA - Director Spitalul Clinic de Traumatologie și Ortopedie</cbc:Description> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f757b6ff-d951-4785-8ac4-543483e2ea45</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">72c5b6f8a812c1cf6bd5ee278635f382-1.1.1.1.3</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0c94871b-23d2-470a-a556-4309bae5a168</cbc:ID> <cbc:Description languageID="ET">[email protected] IMSP Spitalul Clinic Balti [email protected] Spitalul Clinic de Traumatologie și Ortopedie</cbc:Description> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d17b420e-f69e-49d8-87ee-d7e58b735652</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">723446d3-9d09-41c6-9619-fb6ffd372730</cbc:ID> <cbc:Description languageID="ET">Contract nr. 203225849 from 29 September 2023 whith World Health Organization.</cbc:Description> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">29efafbf-11f3-4e6c-8f73-a7f117a4d3a6</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.2</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b28a7246-eceb-4cae-bd32-e096967bea4e</cbc:ID> <cbc:ResponseAmount currencyID="USD">127216</cbc:ResponseAmount> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">712f5a58-61b9-4923-9092-53518faa7e62</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.3</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ebf93cb9-9eb4-4745-842d-c84eac4bbf93</cbc:ID> <cbc:Description languageID="ET">Delivery, Instalation and further maintenance</cbc:Description> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5366e50b-d72d-4ca2-b02b-cf0d1b2e0e8a</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.4</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6349cf20-8208-4476-845a-121c08784975</cbc:ID> <cbc:ResponseAmount currencyID="EUR">2</cbc:ResponseAmount> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">08f22696-94d9-497c-92a4-c6fecb2317ab</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a2365a0f62f0b9dd822fa8cfbfca2fcb-1.1.1.5</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ApplicablePeriod> <cbc:StartDate>2023-09-29</cbc:StartDate> <cbc:EndDate>2023-10-30</cbc:EndDate> </cac:ApplicablePeriod> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">94aff3cd-3a03-4549-b6db-cfb97096a790</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d71f2afecb0aec233e2f178327ac18d1-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">500ad089-b960-4719-a5b6-177e13131c46</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">97523946-3284-4626-a0b2-49ff732aa37d</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">795818013abcd8fa0b614f8ab21ae90b-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6db42ac5-d983-47dc-9acb-9a54b7d2c677</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ca8f479e-979e-486e-a957-9037a18e98d4</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">94bafa958a57a2f5fa7af1f5c03b1e54-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4fce9cf6-3aa5-4b17-bf7a-fbf58ed08fa2</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9ad0b9df-0c91-4090-b161-61eca6daf601</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">07df47ce65627207b1b045f7a91524fe-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0759c227-a4b0-4a1b-9e53-5d3e7697b211</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">29a30ca5-1af3-4851-bd9d-0009214bf73d</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8a42266c5fb24e32ff421942459d66ac-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">07380ad9-decb-4013-b7cd-6bb2eded5c38</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">36d4fbb6-02ed-42a7-989c-6fe446fb96bd</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7498d35783aaf5b55a3d4b5b1f7995d2-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7a3736ef-1571-4e3a-b2a7-2fe23f4eb584</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9c2027aa-5f5d-4330-98dc-c1ed5b325035</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8486f521e63eee007f5f05abbddcaae9-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f764541d-a29b-4fa2-beae-a41d2be0d6a8</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">59c38fbb-8aad-4f53-a5c1-bd313e313cdc</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">03299642dcd03d0b74e6fcec1d941d60-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">10721478-6302-4870-910e-1fb3f4d38ff3</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0efd1821-4146-4cb0-b5ac-89746b9f013e</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">664e928718e7857cd0a1f6f4ce5d5e78-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">03e53e04-ff7c-4c2b-b37e-558ffd1936dc</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9b27f72b-62bc-4e85-ba92-488107f96bfb</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e63f6d15c35d9de0ca7ce2f47548ba6-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">65718e3c-40e0-428e-be23-8a15d4958494</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">cf1cc9ac-4066-4851-8baf-60c739f938bc</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d2b922c3afdd52c13d295e3333eafa67-1.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">62ff91e3-b5ce-4e32-ace1-5ccd9783bd26</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e8e5d885-6593-48c7-9a9b-11f3d34aaf68</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e5f319d2c9fe7a95fde7de1281fac693-1.2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">85569c80-57f1-4d4e-a8d8-8f5899cf6878</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b6c35f2b-fd7b-4cf6-92d7-be50bc2bde7e</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b1f1dc7c01597a65463e2c18253f83c0-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">02599796-e171-4760-a67e-86f9026d23a8</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c58f207b-2553-49c8-9a0f-8eb56c906126</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">962c3b6715f062c66fb25afbefe1360a-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5e01483d-7876-4a3b-9e6c-0825af4e7563</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4eeacdca-484c-4b68-adbe-a05f9864c6a6</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">699c2f5f4ae65e623002d40bb3ee7ee9-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dc9bdeb8-cdf8-48b4-a63b-c53f2712b988</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a01afab7-e624-4268-b421-91c0da065ea3</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">476a15b9d9f85459a63cadc3e3b73460-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">96b79038-47f8-4135-b570-2411652c5578</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">923dffb8-cdd2-4ea6-9a7e-a657a6429054</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">db41347baa09a8c0a5cae4ca70927e9d-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">58ac29d5-57c5-4946-9f5f-bb0952672ca2</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ff665be3-572e-445f-911c-b99f86b7c0c1</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ece600a9097944288e11a1b6699fb6bb-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8dd5594f-302c-4e67-add5-d3b854cb828b</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">245ef8fd-00ef-4415-8ff9-bee516b0c24d</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e84b04d9cced34ecb51466b1045b0324-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">41648f4b-5535-4e30-b7db-8ac731565963</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f56314b2-6950-48ef-9a64-6b271f8fd522</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1ee9e1dfca8300341b206644744d8fe0-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c9811c7b-33db-420d-a2cb-13bd431075a6</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">64f7a065-b718-437e-897d-88d3fdb28f49</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">130b632716c48f4b7f69f61016f3ef5c-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">cfd12f38-d3a6-4676-9974-5bd34e3893d7</cbc:ID> <cbc:ResponseIndicator>true</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ff04619b-0f54-42b5-b4a6-0040c0c8ed8a</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">557c987e3ce67681b7c884af3c38f3f4-2.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:EvidenceSupplied> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">557c987e3ce67681b7c884af3c38f3f4-2.1.1</cbc:ID> </cac:EvidenceSupplied> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2443291e-5da0-4140-9413-b633246dc11b</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">916ab5ce762c49fbffd04765384d9195-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">becdc6f0-1578-4823-a22e-857b9b572635</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">24bcd4b7-b11c-40a9-be46-03bb334e9c99</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8511a8ee6a5fe826b0c1c6759cc36403-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b5e4f3dd-bf14-4d1e-b8bc-55c6ee2c4409</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6860e129-014e-473d-8ed6-5d6769a6bc64</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c97dab162756613157478a51204f9c86-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dd77a40a-8de0-4980-8331-c4942c445e2d</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">69a34565-1ebe-4fe6-906c-c73e6e20c334</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">036d42bf0ba523328b09842e95e5a483-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">12982659-632a-41ef-a9f1-4e7037cdf5e1</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">61043f77-d331-4c0a-b9ed-899545766555</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">85d57d4b7fa89f637f91d9d8b027405c-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3b7e1be9-c651-478f-af6d-4a31aee1a81a</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">1fb10235-2722-4167-9963-7f449ef15037</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2d902c8235ebefb9296053f5363306ef-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">f58276ed-0133-4d68-8806-990f1d99c151</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">cfe97c96-0cc9-4f3f-9ef2-eced1cfed57c</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3c0b4f12a3e8a3f4f4023932e10ed8a9-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">16a7fb3a-722a-467e-a568-05c2a5720aaf</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">cf942d4a-8e2c-4b2f-9ada-c20032b61b47</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67b088a852a32478afb7cc8fd19d3fb5-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d7a6d8db-62ca-40ae-88b0-dda875be2466</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dc405982-6dd9-4c59-a24f-1dbf4add3257</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">88f454ed56cf088fa5cd0eb926751769-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">ffd17883-9fee-494e-ac1f-1bdf04890f6e</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">3801cc7f-83e1-4e13-826d-734cd814f5dd</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">24f26f42d53a913959ce42027dc14bb1-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">4bf40f5b-73c6-490c-9450-1f23e06c01a0</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c863d196-8150-4670-8e0c-eda5e5af285f</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">056f8a7d83e7385f1028c51aa00aa34b-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bd3df87e-c019-49d1-9ecf-18aaefa72970</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">817a33b0-02e6-4c42-9889-cd26b2fbe668</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">de8e758fa6893cfd64668285fa226847-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2b16a1e4-e841-44c6-a2a2-d8d63f17ee80</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b00cbaef-0c36-4117-9142-c3456a3af6bf</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a798f5c4df3b296808ec367318de88e5-1.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9ec496fd-f447-4a32-9e05-2fe4a02bd516</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">31e59e23-b3d6-4f4c-a296-d6502a1cbd51</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">06238c8b82047ad5f649f64687cfed04-1.2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">feeee688-2f4e-47d1-96ec-2eefcb6e42ac</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dcb6c4c9-60b0-4de5-8808-0ec3d20566f4</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dced61ca05d4b6509ba11c848f7efc58-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">901a6dfb-506a-45e4-a4ca-92fc26aa3a3f</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">2cf1ff42-6c93-43a8-b621-6b34646c6de7</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0cc2de07ff96b1169913b554d5735478-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">714705fb-6e35-4445-b1f9-9a1aab6a4cef</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">a6a7ed56-e5e4-49eb-ad7c-f0449bfe1883</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">67abefe9c6becc08ff7027f880cf8e58-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">e6f3ce4d-45f5-4b68-ad39-22467392e3e1</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0743fea0-5f07-483d-8ee4-1fb1e7ae9032</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">431420fc0327c7dfc0c8e338db661a4f-2.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:EvidenceSupplied> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">431420fc0327c7dfc0c8e338db661a4f-2.1.1</cbc:ID> </cac:EvidenceSupplied> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">d4d37725-1ee4-4ba3-8ac7-85f401bdd53a</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">5a10919abd31fa6f8738ed8e2bfc2c30-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">82d7fd6b-9f65-41ac-bda2-f5f220162360</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c897cf2d-817d-490f-b708-860199feef8d</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">0da3567bd1587969627a71cc637bf3ff-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">dba1a53d-9fa0-470e-9eae-fe89a2fd12f5</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">530f173d-af25-4828-a48e-fd3ac007a14e</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9ec5f8c89b9cfb663ec773102d3d63ea-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">fec1cbf4-a078-454f-b340-c89b3023299f</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">7cdaab3e-fe40-4ee5-8263-ec27b25acf75</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">8474ff05cd1affe49977b11837ffc832-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">46b90eb1-26f0-430f-a5ea-2bc54a94a3f6</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">b608fc79-ab50-4734-b640-7daf2bcc563c</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bf6b522598fc8784858a6712851f7fa2-1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">27242c14-34e1-4e60-879f-3f2bad38afc2</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">feb2c095-6df7-407b-8193-03963e4523e9</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">6c3dc3029e6128b5025c2727085b8a67-2.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:ResponseValue> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">c3baa462-3ac1-4541-873c-25e0c903c70d</cbc:ID> <cbc:ResponseIndicator>false</cbc:ResponseIndicator> </cac:ResponseValue> </cac:TenderingCriterionResponse> <cac:TenderingCriterionResponse> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">bd97cc37-dd95-4e9a-b936-39c4d20099a2</cbc:ID> <cbc:ValidatedCriterionPropertyID schemeID="CriteriaTaxonomy" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9895d63fec57f19d41d599f8db9cdf91-2.1.1</cbc:ValidatedCriterionPropertyID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:EvidenceSupplied> <cbc:ID schemeID="ISO/IEC 9834-8:2008" schemeAgencyID="EU-COM-GROW" schemeVersionID="2.0.2">9895d63fec57f19d41d599f8db9cdf91-2.1.1</cbc:ID> </cac:EvidenceSupplied> </cac:TenderingCriterionResponse> <cac:Evidence> <cbc:ID schemeAgencyID="EU-COM-GROW">6833f9ee60ab7d82b44c62c2da533ff0-2.1.1</cbc:ID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:DocumentReference> <cbc:ID schemeAgencyID="EU-COM-GROW"></cbc:ID> <cac:Attachment> <cac:ExternalReference> <cbc:URI>https://riigihanked.riik.ee</cbc:URI> </cac:ExternalReference> </cac:Attachment> </cac:DocumentReference> </cac:Evidence> <cac:Evidence> <cbc:ID schemeAgencyID="EU-COM-GROW">560e5e7ef0d3d163430768039c402848-2.1.1</cbc:ID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:DocumentReference> <cbc:ID schemeAgencyID="EU-COM-GROW">IDNO 1002600048135</cbc:ID> <cac:Attachment> <cac:ExternalReference> <cbc:URI>https://date.gov.md/open/company-details</cbc:URI> </cac:ExternalReference> </cac:Attachment> </cac:DocumentReference> </cac:Evidence> <cac:Evidence> <cbc:ID schemeAgencyID="EU-COM-GROW">557c987e3ce67681b7c884af3c38f3f4-2.1.1</cbc:ID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:DocumentReference> <cbc:ID schemeAgencyID="EU-COM-GROW"></cbc:ID> <cac:Attachment> <cac:ExternalReference> <cbc:URI>https://riigihanked.riik.ee</cbc:URI> </cac:ExternalReference> </cac:Attachment> </cac:DocumentReference> </cac:Evidence> <cac:Evidence> <cbc:ID schemeAgencyID="EU-COM-GROW">431420fc0327c7dfc0c8e338db661a4f-2.1.1</cbc:ID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:DocumentReference> <cbc:ID schemeAgencyID="EU-COM-GROW"></cbc:ID> <cac:Attachment> <cac:ExternalReference> <cbc:URI>https://riigihanked.riik.ee</cbc:URI> </cac:ExternalReference> </cac:Attachment> </cac:DocumentReference> </cac:Evidence> <cac:Evidence> <cbc:ID schemeAgencyID="EU-COM-GROW">9895d63fec57f19d41d599f8db9cdf91-2.1.1</cbc:ID> <cbc:ConfidentialityLevelCode listID="ConfidentialityLevel" listAgencyID="EU-COM-GROW" listVersionID="2.0.2">CONFIDENTIAL</cbc:ConfidentialityLevelCode> <cac:DocumentReference> <cbc:ID schemeAgencyID="EU-COM-GROW"></cbc:ID> <cac:Attachment> <cac:ExternalReference> <cbc:URI>https://riigihanked.riik.ee</cbc:URI> </cac:ExternalReference> </cac:Attachment> </cac:DocumentReference> </cac:Evidence> </QualificationApplicationResponse> PUBLIC CONTRACT 4a,..05.2025 No 2-2/25 The Estonian Centre for Defence Investments, registry code 70009764, address Jarve 34a, 11314 Tallinn, Estonia, represented on the basis of the statute by Head of Procurement Department Tiaana Kalda (hereinafter: Buyer), By the General Staff of the National Arm y of the Republic of Moldova, registry code 1006601001263, address Hînce$ti Highway 84, Chi$inâu, Republic of Moldova, MD-2021, represented by Deputy Chief of the General Staff of the National Army, Brigade General Sergiu VOINU (hereinafter: Beneficiary) responsible of delivering the goods to the final end users, and By the Supply and Infrastructure Management Agency of the Ministry of Defense of the Republic of Moldova, registry code 1006601001229, address Hînceçti Highway 84, Chiÿinàu, Republic of Moldova, MD-2021, represented by Director of Supply and Infrastructure Management Agency, Colonel Stanislav POJAR (hereinafter: Consignee) responsible for customs procedures when the companies are delivering the goods, and Neotec SRL, registry code 1002600048135, address 57. I. Zaikin street, Chisinau, MD-2005, Moldova, represented by Andrei Botnaru, pursuant to articles ofo f attor separately: Party and jointly: Parties, have concluded the following Public Contract (hereinafter: Contract). 1. Basis and subject of the Contract 1.1. The Contract is concluded on the basis of the founding documents and the Tender of the Seller for the public procurement „Mobile C-arm x-ray device" (reference number 279740). 1.2. The subject of the Contract is a mobile C-arm x-ray device (arcoscope) (hereinafter: the Goods) with delivery and installation as well as the initial user training (hereinafter: the Sendees). 1.3. The delivery time for the Goods is no later than 1 month from signing the contract. 1.4. The Goods and the Services are financed in the framework of the European Peace Facility Contribution Agreement EPF/2023/21, signed by the Buyer and the European Commission as administrator for Assistance Measure under the European Peace Facility to support the Armed Forces of the Republic of Moldova. 1.5. By this Contract the Seller undertakes to deliver to the Beneficiary the Goods, according to the Technical Description (Annex 1) and the Tender of the Seller and transfer it to the Beneficiary together with all property rights to it, and the Buyer undertakes to pay for proper and timely delivered Goods following provisions and procedures of this Contract. The Seller shall, together with the Goods, provide full relevant information, usage instructions and other information required for adequate use of the Goods. In the event that the Goods are purchased with life-cycle Services, contractual conditions for the provision of Services stipulated in the Law of Obligations Act of the Republic of Estonia shall be applied for such provision of Services, which are not regulated, are in contradiction or are not applicable towards the nature of the Service. 1.6. The scope and quantity of the Goods, requirements for the Goods, the related Services and terms and other information related to the delivery of the Goods are detailed in the Technical Description, Tender of the Seller, which are an integral part thereof. When performing the  Seller must follow the terms and conditions of the Contract and its Annexes, properly fulfill all the requirements specified therein. 1.7. The Contract is concluded with the Seller, relying on the Tender of the Seller, the Seller's applications and confirmations stipulated within this Contract, and the premise of good faith in the Seller's professionalism and capability to perform the Contract duly. In the event that the Seller employs subcontractors, responsibility of the proper performance of the Contract rests on the Seller. 1.8. The Seller states and confirms that: 1.8.1. they and their representative have all the necessary rights and mandates to conclude this Contract; 1.8.2. they have read the Contract and the founding documents of the public procurement and that they understand fully the content and repercussions of duties undertaken and that they agree with the conditions therein; 1.8.3. with the performance of this Contract, the rights of third parties are not affected and that there are no such circumstances which might exclude their rights to conclude this Contract and perform it duly; 1.8.4. they have all the necessary and valid licenses, registrations, rights of representation and certificates, and at their expiry during the duration of the Contract agrees to extend/ renew them. If the renewal of licenses, registrations, rights of representation and certificates is not possible due to circumstances independent of the Seller, it is the Seller's obligation to promptly notify the Buyer about it; 1.8.5. the Seller confirms the absence of any claims or other rights applicable on the transferred Goods o r rendered Services by third parties, which third parties have the right to apply to the Goods or Services; 1.8.6. they and their offered Goods or Services are not subject to international sanctions or originated in an area subject to sanctions in accordance with the International Sanctions Act of the Republic of Estonia. 1.9. The Goods must be in compliance with the founding documents of the public procurement, the invitation to tender and the Seller's submitted tender. The delivered Goods must be in compliance with the terms of this Contract, including in terms of quality, type, currency, description and quantity. All documents and packaging accompanying the Goods must also be in compliance with the terms of this Contract. 1.10. Services must be in compliance with the terms of the Contract, specifically in terms of quality and description. 2. Parts of the Contract The integral parts of the Contract are invitation to tender, Tender of the Seller and its annexes, explanations, confirmation letters, notices and all concluded amendments between the Parties. 3. The Buyer's Rights and Obligations 3.1. The Buyer has the right to check the performance of contractual obligations and documents relevant to the ordering of Goods or Services on an ongoing basis. 3.2. The Buyer has the right to check the validity and compliance of issued invoices, calculations and other expenses. If necessary, the Buyer has the right to claim invoices from subcontractors. 3.3. The Buyer has the right to consult with the Seller about questions relevant to the Goods or Services, e.g. questions relating to the delivery and use of the Goods or provision of Services. 3.4. The Buyer is obligated to pay to the Seller for the contractually delivered Goods and rendered Services in accordance with the conditions stipulated in this Contract. 3.5. The Buyer is obligated to reply within a reasonable time to all the Seller's requests in order to specify instructions. 3.6. The Buyer is obligated to immediately notify the Beneficiary and the Seller of a breach of Contract conditions, where such a breach has been detected. 2/12  3.7. The Buyer is obligated to confirm, while requested, the appropriateness of the provided Goods. 4. The Seller's Rights and Obligations 4.1. The Seller is obligated to transfer the Goods specified in this Contract to the Beneficiary. 4.2. The Seller is obligated, on the Buyer's demand, to submit a centralized statement for all Goods and Services ordered in MS Excel format or in another format agreed upon with the Buyer within 10 days after receiving said request, unless agreed otherwise. 4.3. The Seller is obligated to submit information (quantity and purpose) on the Buyer's demand about subcontractors. In the event that such information has been submitted by the Seller prior to the conclusion of this Contract, the Seller must coordinate any changes with contact persons with the Buyer. 4.4. The Seller is obligated to inform the Buyer and Beneficiary about any circumstances which obstruct the performance of this Contract. 4.5. The Seller is obligated to inform the Buyer and Beneficiary promptly about cyber-attacks and cyber incidents undertaken against the Seller and issue a cyber-incident report to the Buyer and Beneficiary on the Buyer's or Beneficiary's demand. 4.6. The Seller is obligated to follow fair trade conditions, environmentally friendly principles and not use slave or child labor during the performance of the Contract. 4.7. The Seller is obligated to provide to the Beneficiary in full the property rights to the Goods. 4.8. The Seller is obligated not to satisfy at least one of the prohibited conditions provided for in the Council Regulation (EU) No 833/2014 of 31 July 2014 concerning restrictive measures in view of Russia's actions destabilizing the situation in Ukraine, including amendments made by Council Regulation (EU) 2022/576 of 8 April 2022 amending Regulation (EU) No 833/2014, Council Regulation (EU) No 269/2014 of 17 March 2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine, including amendments made by Council Implementing Regulation (EU) 2022/581 of 8 April 2022. 4.9. The Seller has the right to receive the agreed-upon payment for delivered Goods or rendered Services in accordance with the terms of this Contract. 4.10. The Seller has the right to receive instructions, explanations or other information which affects the performance of the Contract. 5. The Beneficiary's Rights and Obligations 5.1. The Beneficiary is obligated to accept the Goods and Services specified in this Contract for its ownership. 5.2. The Beneficiary is obligated to provide the Seller with information and/or documents reasonably requested thereby and assistance in the performance of the Contract. Upon receipt of the request of the Seller for the provision of information required for the performance of the Contract, the Beneficiary undertakes to provide the requested information no later than within 5 working days from the receipt of such request. If the amount of information requested by the Seller is large or requires additional analysis, the Beneficiary shall be granted an additional reasonable term for the provision of such information. 5.3. The Beneficiary is obligated to immediately notify the Seller and the Buyer of a breach of Contract conditions, where such a breach has been detected. 5.4. The Beneficiary is obligated to confirm, while requested, the appropriateness of the provided Goods. 5.5. The Beneficiary is obligated to properly perform all other obligations set forth in the Contract, its Annexes, legal acts applicable to the delivery of these Goods and (or) arising from the essence of this Contract. 5.6. The Beneficiary has the right to control the delivery of Goods in a timely manner. 3/12 6. Packaging and Labelling of the Goods 6.1. The Seller is obligated to provide packaging of Goods in such a way that ensures its conservation during transport and storage in an unchanged manner. The terms for packing and labeling of the Goods, as well as the way of transporting them are set out in the Conditions for Packaging and Delivering (Annex 2). 6.2. For packaging and marking Goods, the Seller must adhere to the requirements stipulated by the Buyer. 7. Delivery and Acceptance of the Goods 7.1. The place of delivery of the Goods is Republic of Moldova, Chisinau, Incoterms 2020 DAP. The exact place of delivery of the Goods will be specified by the Beneficiary 7 days before the expected delivery of the Goods. 7.2. In the event that the Goods are subject to export inspection by the Seller's country of origin, the Seller shall submit to the Buyer an appropriate form of the end user's certificate and provide the necessary export license. 7.3. The Seller shall prepare and agree with the Buyer and the Beneficiary a free form schedule for delivery of the Goods no later than 10 days after the entry into force of the Contract. 7.4. The Beneficiary and the Buyer, having verified and satisfied that the Goods meet the requirements set out in the Contract and its Annexes and that all other obligations of the Seller under the Contract have been fulfilled, must accept the provided Goods and sign the Delivery-Acceptance Act of Goods. 7.5. The Seller shall issue a Delivery-Acceptance Act, which shall be signed consecutively by the Seller, Buyer and Beneficiary and sent to the Parties. The parties shall also accept scanned versions of the Delivery-Acceptance Act with the physical signatures. In this case Parties agree that they shall send a copy of the Delivery-Acceptance Act with the original signatures within one month from the moment the need was expressed. 7.6. The Seller shall submit to the Beneficiary a shipping notice for the delivery of Goods at least 5 working days prior to the scheduled delivery time to the e-mail addresses [email protected] and [email protected]. 7.7. The shipping notice must include: 7.7.1. name of Goods; 7.7.2. public procurement reference number 279740; 7.7.3. delivered quantity, incl. number of pallets, containers etc; 7.7.4. logistical unit measurements; 7.7.5. packaging method (plastic packaging, net wrapping, pallet etc.); 7.7.6. mode of transportation, which is used for delivery (truck, lorry etc.), and quantity; 7.7.7. specific requirements or needs to unload the delivery; 7.7.8. scheduled delivery date and time; 7.7.9. delivery address. 7.8. The Seller shall deliver the Goods to the Beneficiary and the Beneficiary shall accept the delivery under agreed-upon conditions. 7.9. The Seller shall issue a Delivery-Acceptance Act (Annex 4) alongside a shipping notice or during the delivery of the Goods at the latest or after a Service has been rendered. The Delivery-Acceptance Act must include: 7.9.1. the Seller's details; 7.9.2. the Beneficiary's details; 7.9.3. name, product code and quantity of Goods / type and time of provision of Service. 7.10. In addition to the Delivery-Acceptance Act, the Seller is obligated to hand over to the Beneficiary all documents that are necessary for the receiving, management, use and disposal of the Goods. 4/12  7.11. The Beneficiary has the right to inspect the quality of delivered Goods or rendered Services for compliance with the terms of the Contract within two weeks. 7.12. In the absence of the Delivery-Acceptance Act, the Beneficiary has the right to take possession of the given Goods or accept the rendered Service, however, delivery and acceptance shall be deemed to be finalized upon the reception of a proper Delivery- Acceptance Act. 8. Contract Price and Terms of Payment 8.1. The price of the Contract is 88 000 Euros, with 0% value added tax (VAT). 8.2. Prices are fixed for the duration of the Contract. 8.3. The price of the Contract includes the price of all Goods delivered and related Services provided under this Contract, all taxes and fees and other costs (excluding costs and/or taxes related to the importation of Goods), delivery costs, costs of exporting the Goods and the cost of providing documents for payment, if any, related to the proper performance of the Contract. No additional costs of the Seller shall be paid or reimbursed. 8.4. If the purchased Goods will be exported to Moldova, all export procedures and documents relating to the export of the purchased Goods are handled and signed by the Seller. In this respect, the Seller will issue an invoice at a 096 VA T rate. 8.5. If the Goods to be purchased will be imported into Moldova, all import procedures including V A T exemptions and import-related documents, are handled and signed by the Beneficiary in accordance with the provisions of the Moldova's Government Decision nr 246/2010 and in accordance with confirmation letter of VA T exemption for ECDI by the Delegation of the European Union. All taxes and costs related to the import is the responsibility of the Beneficiary. 8.6. If the Party concerned encounters unforeseen difficulties (e.g. lack of action by the authorities, lack of necessary documentation, etc.) in carrying out export or import procedures, they shall immediately inform the other Parties of these circumstances. 8.7. Payments shall be made in Euros in accordance with the following procedure: 8.7.1. When the Seller, by means of the Delivery-Acceptance Act, has satisfactorily and timely delivered the Goods in accordance with the terms of the Contract, as specified in Clause 1.2 of the Contract, and correspond to the price of the delivered Goods, payment shall be made on the basis of the quantity of Goods actually delivered at the Goods price specified in Clause 8.1. of the Contract. 8.7.2. In accordance with the delivery schedule referred to in Clause 7.3 of the Contract, once the Seller has delivered some o r all of the Goods and handed them over in accordance with the procedures set out in the Contract, the Buyer shall make the payment in accordance with the Seller's invoice. 8.8. The Seller bears all costs relevant to the delivery and transportation of Goods until the delivery has been finalized. The Seller also bears all Goods-related costs and incumbrances until the delivery has been finalized, except costs which derive from circumstances arising from the Buyer and/or Beneficiary. 8.9. Unit prices for the Services are stipulated in the Tender of Seller. Unit prices for the Services include all costs necessary for the performance of the Contract, including actions listed in the Technical Description. 8.10. For the Services, payments shall be made in accordance with ordered and actually rendered the Services, by taking into account the Delivery-Acceptance Act signed by the Buyer, Beneficiary and Seiler. 8.11. One e-invoice shall be issued for each delivery or rendered the Service, unless agreed otherwise. 8.12. The Seller shall issue an e-invoice to the Buyer. In the event that the Seller is registered outside of the Republic of Estonia and has no technical capabilities to issue e-invoices, then they shall issue invoices in PDF-format to the e-mail address stipulated [email protected]. The Seller shall issue an (e-)invoice with details stated below: 5/12  8 . 12. 1. The Buyer's details: Estonian Centre for Defence Investments, Jarve 34a, 11314 Tallinn, Estonia, registry code 70009764. 8.12.2. Other details to be included on the invoice: Contact person name; Contract number: 2-2/25/ Public procurement reference number 279740; Quantity and name of Goods / type and time of rendered Services; 15-digit reference number: 279740 001000 000; EPF/2023/21. 8.12.3. The seller's bank details: Bank name: OTP Bank S.A.; IBAN: MD84M02224ASV23445907100; SWIFT: MOBBMD22XXX. 8.13. The Seller shall issue an additional invoice to the Beneficiary on the Beneficiary's invoice template (Annex 4). 8.14. The Buyer shall pay for the Goods or Services that were accepted by the Buyer and Beneficiary and comply with the terms of the Contract to the billing account set on the invoice within 28 days of receiving an invoice that complies with the terms of the Contract. The basis for issuing an invoice is a Delivery-Acceptance Act that is signed by Buyer, Beneficiary and Seller. 8.15. The Buyer shall not accept an invoice which does not comply with the terms of the Contract. In such an event, the Seller shall issue a new invoice within seven working days. 8.16. For a Seller registered in the Republic of Estonia, prior to finalizing a payment, which is 10 000 Euros with VA T or more, the Buyer shall check for the absence of tax arrears via the Tax and Customs Board website. In the event of a tax arrear of 10 000 Euros or more, the Buyer shall inform the Tax and Customs Board of the invoice that is due for payment. 9. Force Majeure 9.1. Breach of contractual obligations is excusable, if the Party was in breach of obligations due to force majeure. Under force majeure, the Parties deem circumstances, which the Party that was in breach of obligation could not influence, and on the grounds of the prudent person principle the Party could not have been expected to take that circumstance into account during the performance of the Contract or avoid it or overcome the hindrance or its consequence, e.g. natural disasters, power failures, hostilities, blockades. The Parties do not deem the inability of the Seller's third party contractual partner to perform the Contract as force majeure. 9.2. If any circumstance that applies to the conditions of force majeure incurred the non­ performance of the Contract within a deadline stipulated in the Contract or its annexes and its effect is temporary, the behavior of the Party in breach of obligations is excusable only at a time when the force majeure inhibited the performance of the obligation. 9.3. Due to the event of a force majeure, the time limit for the performance of the contractual obligation shall be postponed, but for no more than 90 calendar days, unless the Parties have agreed otherwise. 9.4. The Party who cannot perform their obligations due to force majeure must promptly notify the other Party of the arisen circumstance and its conclusion. Failure to notify or failure to notify timely removes from the Party the right to refer to the excusability of the breach, ¡.e. the emergence of the force majeure, and the Party who was in breach of obligation to notify is responsible for the breach of contractual obligations, according to the stipulations of this Contract. 9.5. In the event that the effect of the force majeure is permanent and does not enable the Parties 6/12  to perform their contractual obligations in full or partially, the Parties have the right to terminate or withdraw from the Contract, by submitting a corresponding termination of / withdrawal from the Contract to the other Party. 9.6. Circumstances arising from the COVID-19 pandemic shall not be deemed as force majeure. In the event that new unforeseen restrictions are implemented after the conclusion of the Contract, which are related to the COVID-19 pandemic and prohibit or inhibit the performance of the Contract, they may be deemed as force majeure. 9.7. Effects on the obligation of delivering Goods or providing Services arising from the restrictions on import from the Russian Federation and Republic of Belarus shall not be deemed as force majeure by the Parties, provided that these circumstances were present at the moment of conclusion of the Contract. 10. Warranty Obligation 10.1. With this Contract, the Seller grants a 12-month warranty for all goods, accessories, auxiliary equipment and tools, a 12-month warranty for performed repair works and a 12-month warranty for installed spare parts. 10.2. Warranty applies from the moment that the Goods have been received by the Beneficiary without any deficiencies or from the moment that the Delivery-Acceptance Act has been signed by the Buyer, Beneficiary and Seller for Services which have been rendered without deficiencies. 10.3. In the event that the manufacturer's warranty for Goods or Services is in any way more favorable towards the Beneficiary (e.g. in terms of time) than the warranty obligation stipulated in the Contract, the Seller is obligated to provide the utilization of such warranty claim to the Beneficiary, if such a circumstance arises, under more favorable conditions towards the Beneficiary, which are derived from the manufacturer's warranty conditions. 10.4. Warranty covers all deficiencies that become evident during the warranty period, ail the while taking into account normal wear and tear for Goods, and for Services, the manufacturer's instructions. 10.5. The Beneficiary is obligated to inform the Seller about deficiencies regarding ordered Goods or Services to the Seller's e-mail address. 10.6. The Seller is obligated to replace the defective Goods or remedy the repercussions of insufficiently rendered Services free of charge within 90 calendar days, starting from the moment that the Beneficiary's corresponding and justified warranty claim was received. With the Beneficiary’s written consent, this period may be longer. 10.7. The Seller covers all costs relevant to the replacement of defective Goods or insufficiently rendered Services. 10.8. Goods replaced or Services rendered insufficiently during the warranty period shall be given a new warranty that has the same duration as the original Goods or Services. 11. Confidentiality and Security Requirements 11.1. Under confidential information, the Parties deem information, personal details, security details and documents that are clearly marked for internal use only, that become available during the performance of the Contract, and other information, whose disclosure might damage the interests of the Party. Confidential information does not include information whose obligation of disclosure derives from legislation, on the condition that such a disclosure is performed in the most restricted way possible from all possible options. 11.2. Parties agree not to disclose the other Party's confidential information neither during the duration of the Contract nor later without the other Party's written agreement. Parties shall protect the confidentiality of the information that was made known to them during the performance of the Contract. 11.3. The Seller agrees not to use any documents or information that pertains to the Contract without the Buyer's, Beneficiary's or Consignee's written agreement, except in cases which are necessary to perform the contract. All documents except the Contract are property of the Buyer and at the Buyer's Beneficiary's or Consignee's demand, the Seller is obligated to return them after the expiry of the Contract. 7/12  11.4. Disclosure of information to any third parties that is for internal use only is prohibited. 11.5. In the event that the Seller must enter premises under the area of administration of the Ministry of Defense of the Republic of Moldova in order to perform the Contract, the Seller must follow applicable security conditions that are mutually agreed between the parties. In the event that the Seller employs subcontractors at the aforementioned premises, they must previously be coordinated with the Beneficiary in writing and all security conditions stipulated in the Contract apply to them as well. Responsibility for the performance of security conditions by the subcontractors rests on the Seller. 11.6. Notices relating to the subject of the Contract or its performance that are directed towards the general public, including press releases, referring to the Buyer or Beneficiary in an advertisement or Internet publication, is allowed only with the Buyer's or Beneficiary's consent by any means capable of producing a written record. 12. Intellectual Property Rights In the event that the Goods or a part of them (incl. relevant information) are protected by intellectual property rights, the Seller shall grant to the Buyer a global irrevocable royalty-free license in accordance with the Copyright Law, which is valid until the term of protection of copyright. The license shall be deemed to be transferred from the moment that the Goods or a part of them (incl. relevant information) have been transferred. The terms for transfer and utilization of intellectual property rights can be agreed upon otherwise in the corresponding public contract. 13. Liability 13.1. In the event of improper performance or non-performance of contractual obligations. Parties shall accept responsibilities with regard to the other, in accordance with the terms of the Contract and valid legislation. 13.2. Ownership of Goods and the risk of loss of, or damage to, the Goods are transferred from the Seller to the Beneficiary generally at the appropriate delivery of Goods, unless agreed otherwise. 13.3. The Seller is responsible for the non-compliance of Goods (deficiencies) to the terms of the Contract, if the non-compliance exists during the transfer of risk of loss of, or damage to, the Goods to the Beneficiary and if the non-compliance of Goods to the terms of the Contract is discovered (i.e it was not possible to discover the deficiencies during normal inspection, so- called hidden deficiencies) after the said risk was transferred to the Beneficiary. 13.4. The Seller is responsible for the non-compliance of Services (deficiencies) to the terms of the contract, if the non-compliance of the Service to the terms of the Contract is discovered (i.e. it was not possible to discover the non-compliance during regular inspection, so-called hidden deficiencies) after the Service was rendered. 13.5. In the event that the Seller performs the Contract improperly, the Buyer and Beneficiary have the right to refuse the acceptance of Goods or rendered Services and the obligation of payment per purchase price, and issue to the Seller a claim to perform the obligation in accordance with the contract after the discovery of the breach of obligation, by giving the Seller a reasonable time limit to perform the contract. Until the proper delivery of Goods or provision of Services to the Beneficiary, the Seller is deemed late with delivery. 13.6. Goods do not comply with the terms of the contract inter alia if the Goods do not have the agreed-upon attributes, the Goods cannot be utilized for their intended purpose, a third party has claims to the Goods or other claims that they can issue or the Goods have not been packaged in accordance with the terms of the contract or the Delivery-Acceptance Act is absent. 13.7. Services do not comply with the terms of the contract inter alia if the Service has not been rendered according to the expected quality or if no Delivery-Acceptance Act has been issued for the Service. 13.8. The Beneficiary is obligated to inform the Seller in writing about the non-compliance of the Goods or Services (incl. deficit with the Goods) within 14 days, if the Beneficiary or the Beneficiary's authorized representative discovered the non-compliance of the Goods or Services to the terms of the Contract. In said notice, the Beneficiary is obligated to claim 8/12  performance of the obligation, by giving a reasonable time limit to the Seller for the duly performance of the obligation, which generally cannot be longer than 60 days. 13.9. In the event that the Beneficiary does not inform the Seller about deficiencies with the Goods or Services within the time limit stipulated in the Contract after the discovery of the deficiencies, the Seller is free from responsibility from the deficiencies with the Goods or Services, except in cases when not informing the other Party of deficiencies was reasonably excusable. 13.10. If the Goods delivered or Services rendered to the Beneficiary are not in compliance with the terms of the Contract, the Beneficiary has the right to demand from the Seller the replacement of non-compliant Goods with Goods that are in accordance with the terms of the Contract or the second provision of Services that is in compliance with the terms of the Contract. 13.11. If the Goods have not been delivered or Services have not been rendered by the set time limit, the Buyer has the right to claim a contractual penalty of up to 0.25% per day of the Goods not delivered or Services not rendered on time for every calendar day due, but no more than 50% of the cost of the contract. 13.12. The Seller shall pay to the Buyer for shortcomings/inconsistencies of the Goods, which are irreparable or have not been repaired within the reasonable period set by the Buyer or Beneficiary, a contractual penalty in the amount of 5% of the price of the Goods delivered improperly. 13.13. If the Contract is terminated due to the fault of the Seller (including the cases when the Contract is terminated on Seller's own initiative), Seller shall pay to the Buyer a contractual penalty in the amount of 10% of the initial Contract price. 13.14. The Seller shall pay to the Buyer for failure to provide warranty services according to Clause 10 of the Contract 5% of the value of particular Good. 13.15. If during the performance of the Contract, it is established that the Seller, their subcontractors, the economic entities whose capacities are relied upon, or persons controlling them, or the Goods supplied by the Seller (including their components and manufacturers of goods and parts thereof) pose a threat to the national security of the Beneficiary state and/or satisfies at least one of the prohibited conditions provided for in the Council Regulation (EU) No 833/2014 of 31 July 2014 concerning restrictive measures in view of Russia's actions destabilizing the situation in Ukraine, including amendments made by Council Regulation (EU) 2022/576 of 8 April 2022 amending Regulation (EU) No 833/2014, Council Regulation (EU) No 269/2014 of 17 March 2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine, including amendments made by Council Implementing Regulation (EU) 2022/581 of 8 April 2022, a fine shall be applied 10% of the initial Contract price, indicated in Clause 8.1 of the Public Contract. 13.16. In addition to terminating the Contract or withdrawing from it, Parties have the right to claim a contractual penalty for a significant breach of the Contract in accordance with the extent of the incurred damage. 13.17. If the Seller is in breach of any other contractual obligations beside on-time delivery or on- time provision of Services, the Buyer has the right to claim a contractual penalty of up to 10% of the total cost of the Goods or Services. 13.18. If a Party is in breach of a confidentiality obligation, the other Party has the right to claim a contractual penalty of up to 10 000 Euros per each corresponding breach. 13.19. In the event that the Buyer delays payment of the invoice, the Seller has the right to claim from the Buyer default interest stipulated in the Law of Obligations § 113 subsection 1 for the sum unpaid by the time limit of up to 0.25% per day for every calendar day overdue, on the condition that the Buyer has been informed of the default interest within 30 days since its occurrence. The total sum of the default interest shall not exceed 10% of the sum overdue. 13.20. Contractual penalties are to ensure the performance of the agreed-upon obligation, not to replace the performance of the obligation. Claiming a contractual penalty does not remove from the Buyer the right to claim compensation of damages relevant to the breach of Contract. 13.21. The right of claim of contractual penalties is 180 days from the discovery of the corresponding breach. 9/12  13.22. Contractual penalties and default interests are paid within 28 working days, starting from the reception of the corresponding claim. The Buyer has the right to deduct the sums of claims of the contractual penalties and sums of compensations from the amounts to be paid to the Buyer. 13.23. In the event that the Seller does not start to perform the Contract, the Buyer has the right to claim compensation of damages within the range of difference in cost between the Seller's tender and the second tenderer's tender. ’ 13.24. If there is a deficit in the quantity of the Goods, the Beneficiary is entitled to accept the given Goods and issue a claim to the Seller to deliver the missing quantity of the Goods to a delivery point designated by the Beneficiary at the Seller's expense. 14. Grounds for Term ination of Contract 14.1. Upon termination of or withdrawal from the Contract, the Buyer shall grant the Seller a reasonable time limit for performing the Contract, which generally cannot be longer than 30 days. The time limit provided for the performance of the Contract does not exempt the Party from the liability for breach of obligations. 14.2. The Buyer is not obligated to grant the Seller a time limit for performing the Contract upon the termination of / withdrawal from the Contract in the event of a significant breach of Contract. In such an event, the Buyer shall submit to the Seller an application for termination of / withdrawal from the Contract within a reasonable time limit, starting from the moment the significant breach of Contract became apparent. The termination of / withdrawal from the Contract is deemed to have been finalized when the application for termination of / withdrawal from the contract has been received by the Seller. 14.3. Upon expiry of the additional time limit given for the performance of the Contract, the Buyer can submit to the Seller a written application for the termination of / withdrawal from the Contract. The Contract is deemed to be terminated / withdrawn from at the moment of the application's reception by the Seller. An application for the termination of / withdrawal from the Contract is not necessary, if upon previously granting an additional time limit, the Buyer has informed the Seller in writing about the termination of / withdrawal from the Contract in the event of an unperformed contractual obligation during the given time limit. In such an event, the Contract shall be terminated upon the passing of the time limit provided by the Buyer for the performance of the Contract and on the condition that the Seller has not offered proper performance of the Contract to the Buyer. 14.4. Both Parties have the right to terminate or withdraw from the Contract, if the other Party is in significant breach of contractual obligations (significant breach of contract). Significant breaches of Contract include inter a li : 14.4.1. one Party is in breach of contractual obligations willfully or due to severe negligence; 14.4.2. the Seller has not performed their obligations during the additional time limit given by the Buyer; 14.4.3. the Seller has notified the Buyer about their refusal to perform the Contract; 14.4.4. the Seller has submitted false information or forged information; 14.4.5. one Party is in breach of the obligation of confidentiality; 14.4.6. the breach of obligation gives one Party reasonable cause to presume that the other Party will not be performing their obligations in the future; 14.4.7. the Seller has infringements of the law with the sale of the item of the Contract or provision of Services; 14.4.8. the Seller's licenses for the performance of the Contract expire and the Seller does not extend them or the extension of the licenses is not possible for circumstances independent of the Seller; 14.4.9. the Seller has been in breach of contractual conditions more than three times. 14.5. The Buyer has the right to terminate the Contract under extraordinary circumstances, if a bankruptcy order or process of liquidation has been initiated towards the Seller. 10/12  14.6. The Buyer has the right to terminate or withdraw from the contract at any time, by informing the Seller at least BO calendar days beforehand. 14.7. Parties have the right to terminate the Contract at any time with Parties' written consent. 14.8. In the event of terminating the Contract, the Parties are not obligated to perform the Contract. In the event of a termination of / withdrawal from the Contract, Parties are obligated to return to the other Parties everything that has been already delivered for the time following the termination of the Contract, in accordance with the Law of Obligations Act. 15. Contact Persons 15.1. The Buyer's contact person is the corresponding category manager, who at the time of the conclusion of this contract is Strategic Category Manager (Soldier equipment and life support) Ms. Maia Prunt (phone +372 5554 6781, e-mail [email protected]). 15.2. The Seller's contact person is Andrei Botnaru (e-mail [email protected]. phone +373 69111661). 15.3. The Beneficiary's contact person is Vadim Ciuhrii (phone +373 7940 2339, e-mail vadim.ciuhrii@armv,md). 15.4. The Consignee's contact person is Sergiu Zabolotnii (phone +373 7969 6532, sergiu.?ftfrQl9 tnjj@ y m y .m d ). 15.5. All notices which do not have legal consequences shall be issued via e-mail and must be addressed to the contractual persons of Contact, unless agreed otherwise in the Contract. 15.6. Notices sent by the Parties to each other shall be prepared in English and sent to the Contact persons by e-mail. 15.7. In the event of changes to Contact persons or other information, the corresponding Party shall inform the other Party of such changes promptly via e-mail. This notice shall not be deemed as amendment to the Contract. 16. Final Provisions 16.1. This Contract is concluded by e-mail, exchanging scanned versions of the Contract with the physical signatures. 16.2. Scanned versions of the Contract with the physical signatures will be exchanged via e-mails indicated in Clause 15 of the Contract. 16.3. The Contract enters into force on the date of its signing by all Parties. 16.4. Parties agree that they shall receive a copy of the Contract with the original signatures within one month from the moment the need was expressed. 16.5. Scanned copies of the Contract signed by all Parties shall have full legal force prior to the exchange of the originals of the Contract, give rise to rights and obligations for the Parties, and may not be disputed by the Party on whose behalf they were signed and sent. 16.6. If the person authorized to sign such agreements changes, before the Parties exchange the originals of the Contract, the original of the Contract shall be signed, containing the original physical signature of the changed person authorized to sign such agreements, and reproduces by scanning signatures of persons authorized to sign such agreements along with their scanned signatures. 16.7. The Contract signed in this way is considered by the Parties to be the original of the Contract, which is kept by the Beneficiary. 16.8. In cases when it is established that the Seller, their subcontractors, the economic entities whose capacities are relied upon, or persons controlling them, or Goods poses threat for national security of the Beneficiary state, the Seller is recognized as not meeting the requirements set out in the Terms of procurement regarding national security, therefore further Contract signing procedures with this Seller are terminated. 16.9. Language used to perform the Contract is English. 16.10. For the performance of this Contract and disputes arising from the Contract, legislation of the Republic of Estonia is prevalent. 11/12  16.11. Parties have agreed to use all means necessary to settle differences between one another through negotiations. In the event of not reaching an agreement, the dispute shall be settled in accordance with the legislation of the Republic of Estonia at the Harju District Court. 16.12. The invalidity of a single provision of the Contract does not bring about the invalidity of the entire Contract or other provisions. 16.13. Neither Party has the right to transfer their contractual rights and obligations to third parties without a written consent of the other Party. 16.14. Amending the concluded Contract can be agreed upon on the grounds and extent of the Estonian Public Procurement Act. 16.15. Amendments to the Contract are valid if they have been formalized in writing. Not following the written format requirement deems any amendments to the Contract void. All amendments to the Contract shall enter into force upon signature by all Parties or upon the time limit stipulated by the Parties. 16.16. Notifications of legal effect between the Parties must be submitted in writing or via e-mail with signatures from the respective Party. A written notice shall be deemed to have been received inter alia if it has been sent by registered mail to the address specified in the Contract and 5 working days have passed since the notice was mailed. When sending the notice via e-mail, the notice is be deemed to have been received on the working day after the notice was sent. 17. Annexes 17.1. Annex 1. Technical specification; 17.2. Annex 2. Conditions for Packaging and Delivering Spare Parts; 17.3. Annex 3. Delivery-acceptance act; 17.4. Annex 4. Invoice template; 17.5. Annex 5. The seller's tender. Buyer. Seller: Digitally signed bv Botnara Andrei Date: 2025.05.13 16:14:58 BEST Reason: MoldSign Signature l3.0S-.JLOJ.H Locati onrMcrklcTva - _------------- Signature/Date fMOLD^giwa^iri Tiaana Kalda Andrei Botnaru Head of Procurement Department Signature/Date Sergiu Voinu Deputy Chief of the General Staff Director of Supply and Infrastructure of the National Army Management Agency 12/12 I  Annex 2 Conditions for Packaging and Delivering Spare Parts 1. labelling Spare Parts (hereinafter „Goods") The label attached to the original packaging of the Goods must contain the following details at a minimum: • name of the Goods; • vehicle make; • NSN-code (if applicable); • product code; • the Seller's warehouse code. 2. Packaging When transporting Goods on pallets, the products are packaged into grouped packaging (packing crates). The Seller agrees to provide packaging that ensures the Goods' conservation during its transportation to the destination and its tong-term storage in unchanged form. Labels for grouped packaging are at least an A4-size in capital letters and in bold. The minimum letter height is 8 mm. There is a label on at least two sides of the packing box. The labelling details on the label are in the following order: • name of the Goods; • product and/or NSN-code (if applicable); • quantity and unit (pieces/EA); • delivery time (month and year); • contract number and batch number (if the Goods are delivered in several parts); • the Seller's name; • the Seller's address; • delivery address. Packing crates are placed on pallets. The pallet dimensions are 800x1200 mm. Pallets must be intact (not decayed, mouldy and with no broken boards), clean and there cannot be any protruding nails. Pallets must endure the long-term storage of the Goods. The maximum height of packing crates placed on pallets is 1200 mm (pallets are not returnable). Plastic film is used for transport, which covers the packing crates on the pallets. Plastic film keeps the product crates firmly on pallets and protects them from the elements. Labels for transporting packaging are at least an A4-size in capital letters and in bold. The minimum letter height is 8 mm. There is a label attached on all sides (four labels on one package). The conservation conditions are up to five years in ventilated permanent structures. Transport is in confined form and on land, air and sea. The package must endure handling with mechanical tools. The labelling details on the label are in the following order: • NSN-code (if applicable); • product name; • quantity and unit (pieces/EA); • delivery time (month and year); • contract number and batch number; 1/2 • the Seller's name; • the Seller's address; • delivery address. If the order is for a single product or a small quantity of Goods, then the Goods must be packaged in other appropriate and suitable packaging. The cost of the Goods's packaging is covered within the cost of the sold Goods. 3. Delivery Conditions The Goods must be delivered unbroken and unspoiled and in suitable packaging for transport. Delivery addresses in Moldova: - Headquarters Regiment "General de brigadă Nicolae Petrica", 3 Petrarilor Street, Chisinau, Republic of Moldova The Buyer shall specify delivery locations during the performance of the Contract. Transport of the Goods to the destination set by the Buyer takes place with the Seller's own mode of transportation. 2/2  Annex 3 To the Public Contract „Mobiilne röntgenseade" (reference number 279740) INTERIM/FINAL DELIVERY - ACCEPTANCE ACT Pursuant to the Contract No.______________o f _____ 20 I. Subject 1. The present act is to certify that: 1.1. the Seller has delivered the Goods according to the Technical Specification: Name of the Goods (quantity) &supporting materials, training (if applicable) Cost, EUR 1.2. The Buyer and the Beneficiary have accepted the Goods according to the Technical specification, as delivered on time and meeting the requirements specified in the Contract and its annexes. The Parties don’t have claims to each other;________________________________________________________________________________________________ _______ __ 1.3. Th e Beneficiary has accepted the Goods according to the list indicated in Clause 1.1. of this Act for its ow nership. In theevent of defects being discovered at the time of acceptance of the Goods, the following provisions shall apply instead of paragraphs 1.2to 1.3 above. To be deleted if not applicable 1.2 The Buyer / Beneficiary has remarks on the quantity/or quality of the Goods delivered and/or detected defects in the quality of the Goods supplied and/or deviations from the requirements set in the Contract and its annexes (a list of defects/deviations found is attached to this Act) and accepts the Goods partly (if applicable) according to the list indicated in Clause 1.1. of this Act;___________________________________________________________________________________ 1.3 The Buyer /Beneficiary has set the following time limit for rectification of the defects/deviations of Goods_ (please indicate)______________ __ _______________________ _____________________________________________________ II. Settlements 2.1. The value of the Goods delivered by the Seller according to the list indicated in Clause 1.1. of this Act amounts to EUR (including VAT and all related taxes)._______________________________________________ III. Legal effect of the act 3.1. The present act is drawn up in 3 (three) copies all having an identical legal effect, one copy for each of the Parties. IV. Place of unloading, address____________________________ _______________________________________________________ 4.1. full address in English full address in Beneficiary's language V. Signatures of the Parties BUYER BENEFICIARY SELLER Date andsignoture,stamp Date and signature, stony) Date andsignoture, starry  4 Annex 4 To the Public Contract „Mobiilne rontgenseade" (reference number 279740) INVOICE No. Date:__________________ Contract No.___________________________ Seller: Beneficiary: Legal entity's name: Legal entity's name: General Staff of the National Arm y Address: Address: Hlnchesti highway 84, Chisinau, Republic of Moldova, MD-2021 Registry code: Registry code: 1006601001263 VAT payer code: Bank: Bank code (SWIFT): Bank account (IBAN) No.: Contact Person ( name,phone nr. email): Buyer: Consignee: Legal entity’s name: Estonian Centre fo r Defence Investments Legal entity's name: Supply and Infrastructure Management Agency, M O D Address: Jtirve 34a, 11314 Tallinn, Estonia Address: Hlnchesti highway 84, Chisinau, Republic of Moldova, MD-2021 Registry code: 70009764 Registry code: 1006601001229 Contact Person (name, phone nr. email): Quantity Commodity Description Weight (kg) Unit price (Euro) Total price (Euro) (as In the Contract) gross net Total to be paid .... t * * 4 * •*«*•«••*»•»•♦*•« EUR VAT exempt........... .... (if applicable) Delivery Incoterms 2020: DAP European Peace Facility Agreement Number: EPF 2023/21  , IIH t lllllll) „ t ira m lm n w m F e e ta m o r ti m d o w e M M u * h • m t a m n w t a t h e p ro d u c t t h e * (M U S T o r O P T S O N A l] t. GM NOM t Opescope Acteno FD type (Shimadzu/Japan) u S ID a t Im H 100 cm MUST V et, 1 00,S e r a , p o g .4 P ro d u ct Data i.2 C -a r m tiree y m at I n a l 71 c m M UST Ye t, T S c r a , Pag 4 Produ ct Data 1.1 C -a r m d e p th at l e e « € 7 c m M UST Y e t, 67 .7 , p a g 7 P ro d u c t D o ts L4 C -m m ro ta tio n range at least 120 deg M UST To*. 1 2 0 d a g.. Pag 4 P ro d u c t O ita U C -a r m h W ro ta tio n ro n «o at least 4 2 0 tic «. MUST V e t, 30 0 /1 20 * , pa g .4 P ro d u c t Oaaa Y e t.7 7 4 m m (U n d e r x -r a y tu b e pe tition} L ft MUST j g f / d o w r t fo r qu icker a nd » f o r o perations. l ti M m r n (O v e r X -ra y t id m p ositio n } P a g 4 Product Data 17 C -a rm u p / d e w n » a v a l r a m o h a t to Iw a t t i n t 4 5 cm M UST Y e t, 4 5 c m , pa g.4 P rodu ct Data L* G e r m F W D / tif V travel has to bo at teast 20 cm M UST Y e t, 2 0 c m ., Pag 4 P ro d u c t data l* C -arra swhaeflng has to b o at le a p 2 5 d a g MUST Y e h 112-5*, p a g.4 P ro d u c t Data 110 C -a r m m a in u n it 9 0 cm m a x w u r r M UST Y e t, 4 0 c m . p a «. 2 a nd 7 P ro d u c t Data L U n w iM iM M H I * w e ig iN o * t iw C -a r m * 3 2 5 kg M UST Yak, 2 6 0 * 4 1 * 4 7 P ro d u c t B e ta 112 MUST Yak. ffe c ta o n u g n a tit lack m aefcaabm . p a t 4 P re d titt D a ta 143 F mH Ä N N E tlü if C - n m m o w w m r t i lo d ^ / in liw w t M M y fr o m l«l» oMfro MUST Yea, fro m FP O «M e , S i * P a n t! Pag 2 2 3 tattaoctfen M a n u a l U 4 S e co n d a ry ea p o so m control h a n d sw itch MUST Ye t, p a g .l Produ ct Data a. »w y ta a tw ia a l 2.1 M o m inai m i* , o u tp u t SOW M UST Ye t, 2 k W . pag 4 P ro d u ct Data 2.2 frwoiitMr i y j m i frooot M UST Y o h p t g - i P ro d u c t Ba ta 2.3 M a s . fre q u e n cy o f g en e ra to r at least 5 0 ttfc MUST f t* . SO lf t , pag 6 Produ ct Da ta 2.4 M in im u m v alu e o f tu b a vaN ag p n o t m a r a titan 40fcV M UST Ye t, 3 0 bV, p og. 4 P rodu ct Bata 24 M a x . v o h m u f tu b e voltag e n o t m e re th a n 120 k V MUST Y e t, 1 1 0 I V , p a g 4 P ro d u ct B a la 2 .6 M M m u m v a t u e s f n i A s n o t m o re tfcaa 6 .5 MUST Y e t, 4 5 ^ p * . 4 P ro d u c t P u n 2.7 M a ra ta * o f m A » n o t lo t« tho n 1 m A MUST T o y 3 TOrnAk, wag. 4 p ro d u c t da ta ..................... . . ................................ M P u tted R a w o t t t w typ o fa r tfo tt N t i K t a n MUST Y e t peg. 4 P ro d u ct Bata 2 .» M&$l Wit# o f fniH # floOOOiCOOV frp# M UST 15, * 4 4 p ro d u c t d a ta 210 M H rota o1 p u tt* flu oroscopy at t ra it 3,75 fpc MUST Yaa, 3.7 5 , p a g 4 P ro d u c t Oota f <e MUST ! i 2 .1 1 M a x . tu b e cu rre n t in p u iie ti f lu oroscopy 4 0 m A 1 J. gm gTu b e i I 14 M UST Yns, M O M to . p a g 4 P ro d u c t 0 » i i s S s 3.2 Focus t i l e 0 .3 0.7 m m MUST v e t, 0 .6 , p a g 4 P ro d u ct B a ta 3.3 T a r « « angle at least 1 tie « M UST Ye t, fl, pag 4 P rodu ct Oata 1.4 C c M m a to r s h ape boa te b e r o u n d , hexagonal, octag onal o r « ¡ u h * M UST M Beam h a r d e n » « fitter m a d e from Co 4 1 m m . 0 .2 m m o r 0 4 n w r MUST Yes, C u 0 .1 m m , 4 2 m m o r a j m m , p a g. 4 P ro d u ct O ota 4. H o t P a n e l D e te c to r, M e m o r y , M o n ito r Y tk . 2 1 0 m m ( V ) « 2 1 0 m m (M l. p a g. 4 P rodu ct Data I S MUST * g 4 .1 I i 1 Ü 12 F O V a tta c h e * r anti 6* M UST Y e t, r , pag. 4 5 1 O P fS C O P C A T T E N D F O ty p e b rd n ic tio n M a n u a l 4 .3 betel p itc h 20$ | M m a tim w m M UST Y a t, 205, p e g 4 P ro d u c t B a ta 44 P Q Io ta tim u m tT » MUST Yea, 6 2 tt, * 4 5 P ro d u c t B e ta 4 .S D y n a m ic rang e « f e a s t 16 M tt M UST Ya t» 1 6 bit, p a g S Pro d u ct Oa ta 4 .6 la s t im a «e f w h f (U f f) reco rti avertable M UST Y e t, p i t 3 P ro d u c t Oa ta Y t h U H o r lo o p Im ago* 4 .7 F ra m e {lo o p } m e m o ry O P T IO N A L lO O C * lO O O ra * tri* .l6 W H pag.5 P roduct Data 4A M e m o r y fo r a ngle am i co M m o tia n s etting anti X -ra y com Sttons at seuarai C -a r m petitions M UST Yea, S m a rt C M e m o ry , pag. 3 - t f tnm ructien M a n u a l 4 .f Vag, U n M o n ito r im a g e Display o n th e C -a rm M a in Panel, p a g 3 -1 0 1 b u tru c tio n M a n u a l 440 Sire of the m o n tie r o n th e m o ntier cart at ieevt I f * MUST Ye t. 19, pag 5 P ro d u c t Data A lfllta t o d fe M ay tim t a m e ttw S flu o ro ica p y jin ia g e o n t a w m o nito r* i n d U fo ra n ld ira c rla w k c o B io t m e a t 4 .1 1 M UST r a t , d o n e O ttp M y, p e g . 7 - f taatiuetton M a n u a l staff ca n te e it fro m different positions y r f e lt y lf t e ti’i j u n p h y tlwft 54 MUST Ye*, im a c ln g M o d e . p a g. 5 P ro d u ct 0 « » (o p tia a i t a u t b y m o d e 54 S P O T o ctyuM tkrn 1 0 0 0 4 0 0 0 m a trtt. 16 titi MUST Y e t, pag. 5 P ro d u ct O ata 54 F lu o ro scopy aegtatittan 1 000X1000 m atrix, 16 W t MUST Y e t, pag. 5 P ro d u ct Bata 54 H D O im a g e sto rage at least 3 0 0 0 0 im ages MUST Ye t, pag. 5 P ro d u c t O m 54 Serial arm m itier* iOOO xiOOO m a r ri., 14 t e to r d n e t o o g M UST Yes, pag 5 P ro d u ct Bata 5 j6 0 5 at feast W in d o w s 1 0 o r U m a MUST Yes, yy 1C p e g. S P ro d u c t D o u T h e im a g e p ro c e w b ig ie f N m r e warnt allour » a w i n g tg i to 4 t im e «. «B pping a n d i a a a to g tim im a g a t. 5 .7 M OST V e t, p* 4 $ P ro d u c t B a u y l a p e e u r o B o n e C ara 1 1 1 I I M UST s 41 Yes. p a g 3 P ro d u ct Onto f 42 Vtrtu ai cotlim atton MUST Ya t, p a g 3 P rodu ct c a * 43 Q riti h a t t e b e r e m o v o M a «vhan n a c e tM ry MUST Ye s ,p a g . 3 P io d u a t t a t a T. U p g m tio b W ty 74 M UST Yes, T o u c h F ocu s Fu nction, pag. 3 1 M m se nK tra n M a n u a l 74 llp g n if itn B T y to in teg rate d igital p reewtairg unit M UST Yo t, m a g ra d a d 74 U p g r a d eM tay te axport selected a n aget wa USB p o r t M UST T o t. O u tp u t M a c * , p a g 5 P ro d u c t D ata 74 U p gradobrBty t o h o u e P I C O M t « P t i f o / m o d i a s lo t a g o / p rin t MUST Yos, P a g 3 P ro d u c t Bate 74 U pgratiatitiR y te tim e O IC O M M W W M W M UST ....................................... ................................................ T P M « f S F r o d u c t O o te ........................................................... 74 U p ira O M riH ty t e baue O IC O M P O M M UST Y e t, p e g i p g d u c t O a ta 7.7 U p * a d a fc iN ty t o h ave 0 5 A tanetton MUST Y o t, OSA aegte titie n. p a g 3 p ro d u c t Bata 7 J U p g r a tM M H y t e h a v e m o tio n artifact sotation to r BSA. M UST VOM3&* P o tt P ro c e s O n g , p a g 2 2 S S O K -1 2 Q F g rte re n c e C M * 4 O th e r* 41 p f l f l ( ( CT| « . . u - 'f l-o r ra * m MUST Y f f G ll k f l -C f P M g l t A U M M u r t i o n k i ^ m ^ I 1 M UST I ! i 1 a ! I I 14 s i .... .. 43 Free S a h » C artffkate fo r I C U S A , C m * , tm m M UST .......... ... . ....... ............ .............. .............. 1 44 f M UST Yo t f i i Annex 4 To the Public Contract „Mobiilne röntgenseade“ (reference number 279740) INVOICE No.___________ Date:________________ Contract No._________________________ Seller: Beneficiary: Legal entity's name: Legal entity's name: General Staff of the National Army Address: Address: Hinchesti highway 84, Chisinau, Republic of Moldova, MD-2021 Registry code: Registry code: 1006601001263 VAT payer code: Bank: Bank code (SWIFT): Bank account (IBAN) No.: Contact Person (name, phone nr. email): Buyer: Consignee: Legal entity's name: Estonian Centre for Defence Investments Legal entity's name: Supply and Infrastructure Management Agency, MOD Address: Järve 34a, 11314 Tallinn, Estonia Address: Hinchesti highway 84, Chisinau, Republic of Moldova, MD-2021 Registry code: 70009764 Registry code: 1006601001229 Contact Person (name, phone nr. email): Quantity Commodity Description Weight (kg) Unit price (Euro) Total price (Euro) (as in the Contract) gross net Total to be paid ………………………………………….. EUR VAT exempt……………………………………………………………………..(if applicable) Delivery Incoterms 2020: DAP European Peace Facility Agreement Number: EPF 2023/21 Annex 3 To the Public Contract „Mobiilne röntgenseade“ (reference number 279740) INTERIM/FINAL DELIVERY – ACCEPTANCE ACT Pursuant to the Contract No.____________ of ____ 20__ I. Subject 1. The present act is to certify that: 1.1. the Seller has delivered the Goods according to the Technical Specification: # Name of the Goods (quantity) &supporting materials, training (if applicable) Cost, EUR 1 2 1.2. The Buyer and the Beneficiary have accepted the Goods according to the Technical specification, as delivered on time and meeting the requirements specified in the Contract and its annexes. The Parties don't have claims to each other; 1.3. The Beneficiary has accepted the Goods according to the list indicated in Clause 1.1. of this Act for its ownership. In the event of defects being discovered at the time of acceptance of the Goods, the following provisions shall apply instead of paragraphs 1.2 to 1.3 above. To be deleted if not applicable 1.2 The Buyer / Beneficiary has remarks on the quantity/or quality of the Goods delivered and/or detected defects in the quality of the Goods supplied and/or deviations from the requirements set in the Contract and its annexes (a list of defects/deviations found is attached to this Act) and accepts the Goods partly (if applicable) according to the list indicated in Clause 1.1. of this Act; 1.3 The Buyer /Beneficiary has set the following time limit for rectification of the defects/deviations of Goods_____ (please indicate) II. Settlements 2.1. The value of the Goods delivered by the Seller according to the list indicated in Clause 1.1. of this Act amounts to _________________________ EUR (including VAT and all related taxes). III. Legal effect of the act 3.1. The present act is drawn up in 3 (three) copies all having an identical legal effect, one copy for each of the Parties. IV. Place of unloading, address 4.1. full address in English full address in Beneficiary's language V. Signatures of the Parties BUYER BENEFICIARY SELLER Date and signature, stamp Date and signature, stamp Date and signature, stamp